,level_0,pmid,rpsid,pmidlink,components_type,rna_id,rna_id_interface,rnas,rna_length,rna_sequence,rna_classification,source,protein_sequence,protein_name,protein_region,protein_modification,protein_sequence_length,Uniprot ID,mark,link,IDR,low complexity domain,In_vitrovivo,solute_concentration,salt_concentration,buffer,temperature,incubation_time,other_requirement,detection_method,morphology,description,rna_length_num
0,44,PMID: 26015579,RNAPS0000090,https://pubmed.ncbi.nlm.nih.gov/26015579,RNA + protein,-,-,polyU(50),50nt,UUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUU,poly RNA,-,"sp|D0PV95|DDX3_CAEEL ATP-dependent RNA helicase laf-1 OS=Caenorhabditis elegans OX=6239 GN=laf-1 PE=1 SV=1|length=708aa|residues=1-708
MESNQSNNGGSGNAALNRGGRYVPPHLRGGDGGAAAAASAGGDDRRGGAGGGGYRRGGGN
SGGGGGGGYDRGYNDNRDDRDNRGGSGGYGRDRNYEDRGYNGGGGGGGNRGYNNNRGGGG
GGYNRQDRGDGGSSNFSRGGYNNRDEGSDNRGSGRSYNNDRRDNGGDGQNTRWNNLDAPP
SRGTSKWENRGARDERIEQELFSGQLSGINFDKYEEIPVEATGDDVPQPISLFSDLSLHE
WIEENIKTAGYDRPTPVQKYSIPALQGGRDLMSCAQTGSGKTAAFLVPLVNAILQDGPDA
VHRSVTSSGGRKKQYPSALVLSPTRELSLQIFNESRKFAYRTPITSALLYGGRENYKDQI
HKLRLGCHILIATPGRLIDVMDQGLIGMEGCRYLVLDEADRMLDMGFEPQIRQIVECNRM
PSKEERITAMFSATFPKEIQLLAQDFLKENYVFLAVGRVGSTSENIMQKIVWVEEDEKRS
YLMDLLDATGDSSLTLVFVETKRGASDLAYYLNRQNYEVVTIHGDLKQFEREKHLDLFRT
GTAPILVATAVAARGLDIPNVKHVINYDLPSDVDEYVHRIGRTGRVGNVGLATSFFNDKN
RNIARELMDLIVEANQELPDWLEGMSGDMRSGGGYRGRGGRGNGQRFGGRDHRYQGGSGN
GGGGNGGGGGFGGGGQRSGGGGGFQSGGGGGRQQQQQQRAQPQQDWWS",laf-1,-,-,708aa(1-708),D0PV95,"PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/D0PV95,http://llps.biocuckoo.cn/view.php?id=LLPS-Cae-0337,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0001,http://db.phasep.pro/browse/",-,-,In vitro,0-8 µM [laf-1];|5 µM polyU,100-400 mM NaCl,"20 mM Tris, pH 7.4, 1 mM DTT",20˚C,> 1 h,-,FRAP,"solute, liquid","RNA is recruited to droplets but does not shift the phase boundary. Addition of 5 µM RNA has no effect on the phase diagram of LAF-1. RNA concentration in the dilute phase vs. total LAF-1 concentration at 250 mM NaCl. Unlike LAF-1, which is in equilibrium with a constant saturation concentration in the dilute phase (Fig. 2D), the RNA concentration in the dilute phase decreases as total protein concentration increases. RNA concentration was directly measured using absorbance at A260 in the bulk phase after centrifugation of droplets.",50
1,94,PMID: 26791895,RNAPS0000054,https://pubmed.ncbi.nlm.nih.gov/26791895,RNA + protein,-,-,polyU,"-(600–1,000 kDa)",-,poly RNA,-,RRASLRRASLRRASL,RRASL,-,-,15aa,-,-,-,-,-,In vitro,1 mM [RRASL]3;|0.05 % (w/w) polyU,"150 mM NaCl, 4 mM MgCl2","50 mM HEPES buffer, pH 7.4, 1.6 mM DTT",37˚C,> 10 min,"other_molecular:0.01 mg/ml PKA,3.2 mM ATP",Turbidity measurement,solute,"The sequence was inspired by the peptide LRRASLG or ‘Kemptide’, which is a model synthetic substrate for PKA37,38. Addition of RRASLRRASL to a buffered solution of 0.05% (wt/wt) (∼0.06 mg ml–1) polyU resulted in complex coacervation.",
2,95,PMID: 26791895,RNAPS0000054,https://pubmed.ncbi.nlm.nih.gov/26791895,RNA + protein,-,-,polyU,"-(600–1,000 kDa)",-,poly RNA,-,RRASLRRASLRRASL,RRASL,-,-,15aa,-,-,-,-,-,In vitro,1 mM [RRASL]3;|0.05 % (w/w) polyU,"150 mM NaCl, 4 mM MgCl2, 1 mM MnCl2","50 mM HEPES buffer, pH 7.4, 1.6 mM DTT",37˚C,> 5 min,"other_molecular:0.01 mg/ml PKA,3.2 mM ATP0.004 mg/ml LPP","Turbidity measurement,Confocal microscopy,Fluorescence microscopy",liquid,We monitored coacervate formation in the polyU/RRASLRRASL system by confocal microscopy. Figure 2e and Supplementary Movies 1-5 show differential interference contrast (DIC) and fluorescence images throughout the course of the reaction.,
3,96,PMID: 26791895,RNAPS0000054,https://pubmed.ncbi.nlm.nih.gov/26791895,RNA + protein,-,-,polyU,"-(600–1,000 kDa)",-,poly RNA,-,RRASLRRASLRRASL,RRASL,-,-,15aa,-,-,-,-,-,In vitro,1 mM [RRASL]3;|0.05 % (w/w) polyU,"150 mM NaCl, 4 mM MgCl2","50 mM HEPES, pH 7.4, 1.6 mM DTT",37˚C,≤ 60 min,"other_molecular:0.01 mg/ml PKA,3.2 mM ATP",Turbidity measurement,solute,PKA activity was able to cause dissolution of polyU/triple RRASL coacervates in 150 mM NaCl buffered solution. Addition of 0.01 mg/mL PKA resulted in coacervate dissolution as we observed with the poly U/RRASLRRASL system.,
4,97,PMID: 26791895,RNAPS0000054,https://pubmed.ncbi.nlm.nih.gov/26791895,RNA + protein,-,-,polyU,"-(600–1,000 kDa)",-,poly RNA,-,RRASLRRASLRRASL,RRASL,-,-,15aa,-,-,-,-,-,In vitro,1 mM [RRASL]3;|0.05 % (w/w) polyU,"150 mM NaCl, 4 mM MgCl2","50 mM HEPES, pH 7.4, 1.6 mM DTT",37˚C,≤ 60 min,"other_molecular:0.01 mg/ml PKA,3.2 mM ADP",Turbidity measurement,liquid,PKA activity was able to cause dissolution of polyU/triple RRASL coacervates in 150 mM NaCl buffered solution. Addition of 0.01 mg/mL PKA resulted in coacervate dissolution as we observed with the poly U/RRASLRRASL system.,
5,98,PMID: 26791895,RNAPS0000054,https://pubmed.ncbi.nlm.nih.gov/26791895,RNA + protein,-,-,polyU,"-(600–1,000 kDa)",-,poly RNA,-,RRASLRRASLRRASL,RRASL,-,-,15aa,-,-,-,-,-,In vitro,1 mM [RRASL]3;|0.05 % (w/w) polyU,"150 mM NaCl, 4 mM MgCl2","50 mM HEPES, pH 7.4, 1.6 mM DTT",37˚C,> 10 min,other_molecular:3.2 mM ATP,Turbidity measurement,liquid,PKA activity was able to cause dissolution of polyU/triple RRASL coacervates in 150 mM NaCl buffered solution. Addition of 0.01 mg/mL PKA resulted in coacervate dissolution as we observed with the poly U/RRASLRRASL system.,
6,99,PMID: 26791895,RNAPS0000054,https://pubmed.ncbi.nlm.nih.gov/26791895,RNA + protein,-,-,polyU,"-(600–1,000 kDa)",-,poly RNA,-,RRASLRRASLRRASL,RRASL,-,-,15aa,-,-,-,-,-,In vitro,<100 µM [RRASL]3;|0.05% (w/w) polyU,4 mM MgCl2,"50 mM HEPES, pH 7.4, 1.6 mM dithiothreitol",37˚C,> 5 min,other_molecular:2.25 mM ATP,"Turbidity measurement,Confocal microscopy,Fluorescence microscopy",solute,"For polyU/RRASLRRASLRRASL (triple RRASL) coacervates, the CCC shifts to 100 µM peptide (Fig. 1b, dashed line). These coacervates were stable at 150 mM NaCl (physiological salt concentration) and did not show an appreciable decrease in turbidity until 300 mM NaCl was reached; they dissolved at 350 mM NaCl.",
7,100,PMID: 26791895,RNAPS0000054,https://pubmed.ncbi.nlm.nih.gov/26791895,RNA + protein,-,-,polyU,"-(600–1,000 kDa)",-,poly RNA,-,RRASLRRASLRRASL,RRASL,-,-,15aa,-,-,-,-,-,In vitro,>100 µM [RRASL]3;|0.05% (w/w) polyU,4 mM MgCl2,"50 mM HEPES, pH 7.4, 1.6 mM dithiothreitol",37˚C,> 5 min,other_molecular:2.25 mM ATP,"Turbidity measurement,Confocal microscopy,Fluorescence microscopy",liquid,"For polyU/RRASLRRASLRRASL (triple RRASL) coacervates, the CCC shifts to 100 µM peptide (Fig. 1b, dashed line). These coacervates were stable at 150 mM NaCl (physiological salt concentration) and did not show an appreciable decrease in turbidity until 300 mM NaCl was reached; they dissolved at 350 mM NaCl.",
8,101,PMID: 26791895,RNAPS0000054,https://pubmed.ncbi.nlm.nih.gov/26791895,RNA + protein,-,-,polyU,"-(600–1,000 kDa)",-,poly RNA,-,RRASLRRASL,RRASL,-,-,10aa,-,-,-,-,-,In vitro,1 mM [RRASL]2;|0.05% (w/w) polyU,"4 mM MgCl2, NaCl<50 mM","50 mM HEPES, pH 7.4, 1.6 mM dithiothreitol",37˚C,> 5 min,other_molecular:2.25 mM ATP,Turbidity measurement,liquid,"Charge screening with additional NaCl decreased the turbidity to ∼35% at 50 mM NaCl, and the coacervates dissolved at 100 mM NaCl. For polyU/RRASLRRASLRRASL (triple RRASL) coacervates, the CCC shifts to 100 µM peptide. These coacervates were stable at 150 mM NaCl (physiological salt concentration) and did not show an appreciable decrease in turbidity until 300 mM NaCl was reached; they dissolved at 350 mM NaCl.",
9,102,PMID: 26791895,RNAPS0000054,https://pubmed.ncbi.nlm.nih.gov/26791895,RNA + protein,-,-,polyU,"-(600–1,000 kDa)",-,poly RNA,-,RRASLRRASL,RRASL,-,-,10aa,-,-,-,-,-,In vitro,1 mM [RRASL]2;|0.05% (w/w) polyU,"4 mM MgCl2, NaCl>100 mM","50 mM HEPES, pH 7.4, 1.6 mM dithiothreitol",37˚C,> 5 min,other_molecular:2.25 mM ATP,Turbidity measurement,solute,"Charge screening with additional NaCl decreased the turbidity to ∼35% at 50 mM NaCl, and the coacervates dissolved at 100 mM NaCl. For polyU/RRASLRRASLRRASL (triple RRASL) coacervates, the CCC shifts to 100 µM peptide. These coacervates were stable at 150 mM NaCl (physiological salt concentration) and did not show an appreciable decrease in turbidity until 300 mM NaCl was reached; they dissolved at 350 mM NaCl.",
10,103,PMID: 26791895,RNAPS0000054,https://pubmed.ncbi.nlm.nih.gov/26791895,RNA + protein,-,-,polyU,"-(600–1,000 kDa)",-,poly RNA,-,RRASLRRASL,RRASL,-,-,10aa,-,-,-,-,-,In vitro,<250 µM [RRASL]2;|0.05% (w/w) polyU,4 mM MgCl2,"50 mM HEPES, pH 7.4, 1.6 mM dithiothreitol",37˚C,> 5 min,other_molecular:2.25 mM ATP,"Turbidity measurement,Confocal microscopy,Fluorescence microscopy",solute,"Addition of RRASLRRASL to a buffered solution of 0.05% (wt/wt) (∼0.06 mg ml–1) polyU resulted in complex coacervation. The minimum concentration necessary for coacervate formation, or the critical coacervate concentration (CCC), was 250 µM RRASLRRASL.",
11,104,PMID: 26791895,RNAPS0000054,https://pubmed.ncbi.nlm.nih.gov/26791895,RNA + protein,-,-,polyU,"-(600–1,000 kDa)",-,poly RNA,-,RRASLRRASL,RRASL,-,-,10aa,-,-,-,-,-,In vitro,>250 µM [RRASL]2;|0.05% (w/w) polyU,4 mM MgCl2,"50 mM HEPES, pH 7.4, 1.6 mM dithiothreitol",37˚C,> 5 min,other_molecular:2.25 mM ATP,"Turbidity measurement,Confocal microscopy,Fluorescence microscopy",liquid,"Addition of RRASLRRASL to a buffered solution of 0.05% (wt/wt) (∼0.06 mg ml–1) polyU resulted in complex coacervation. The minimum concentration necessary for coacervate formation, or the critical coacervate concentration (CCC), was 250 µM RRASLRRASL.",
12,105,PMID: 26791895,RNAPS0000054,https://pubmed.ncbi.nlm.nih.gov/26791895,RNA + protein,-,-,polyU,"-(600–1,000 kDa)",-,poly RNA,-,RRASLRRASLRRASL,RRASL,-,-,15aa,-,-,-,-,-,In vitro,1 mM [RRASL]3;|0.05% (w/w) polyU,"4 mM MgCl2, <300 mM NaCl","50 mM HEPES, pH 7.4, 1.6 mM dithiothreitol",37˚C,> 5 min,other_molecular:2.25 mM ATP,Turbidity measurement,liquid,"For polyU/RRASLRRASLRRASL (triple RRASL) coacervates, the critical coacervate concentration (CCC) shifts to 100 µM peptide. These coacervates were stable at 150 mM NaCl (physiological salt concentration) and did not show an appreciable decrease in turbidity until 300 mM NaCl was reached; they dissolved at 350 mM NaCl.",
13,106,PMID: 26791895,RNAPS0000054,https://pubmed.ncbi.nlm.nih.gov/26791895,RNA + protein,-,-,polyU,"-(600–1,000 kDa)",-,poly RNA,-,RRASLRRASLRRASL,RRASL,-,-,15aa,-,-,-,-,-,In vitro,1 mM [RRASL]3;|0.05% (w/w) polyU,"4 mM MgCl2, >350 mM NaCl","50 mM HEPES, pH 7.4, 1.6 mM dithiothreitol",37˚C,> 5 min,other_molecular:2.25 mM ATP,Turbidity measurement,solute,"For polyU/RRASLRRASLRRASL (triple RRASL) coacervates, the critical coacervate concentration (CCC) shifts to 100 µM peptide. These coacervates were stable at 150 mM NaCl (physiological salt concentration) and did not show an appreciable decrease in turbidity until 300 mM NaCl was reached; they dissolved at 350 mM NaCl.",
14,107,PMID: 26791895,RNAPS0000054,https://pubmed.ncbi.nlm.nih.gov/26791895,RNA + protein,-,-,polyU,"-(600–1,000 kDa)",-,poly RNA,-,RRASLRRASL,RRASL,-,protein_ptm:Phosphorylation,10aa,-,-,-,-,-,In vitro,1 mM [RRASL]2;|0.05% (w/w) polyU,"4 mM MgCl2, 1 mM MnCl2","50 mM HEPES, pH 7.4, 1.6 mM dithiothreitol",37˚C,> 15 min,other_molecular:0.040 µM LPP,Turbidity measurement,liquid,"Addition of 0.001 mg/ml–1 LPP (800 U ml–1, 0.040 µM) to a solution containing polyU and RRApSLRRApSL resulted in a turbid solution after 10 min. Without LPP or Mn2+ for LPP activity, the solution did not become turbid. Dephosphorylation of RRApSLRRApSL by LPP was able to produce RRASLRRASL, and coacervation was subsequently observed.",
15,108,PMID: 26791895,RNAPS0000054,https://pubmed.ncbi.nlm.nih.gov/26791895,RNA + protein,-,-,polyU,"-(600–1,000 kDa)",-,poly RNA,-,RRASLRRASL,RRASL,-,protein_ptm:Phosphorylation,10aa,-,-,-,-,-,In vitro,1 mM [RRASL]2;|0.05% (w/w) polyU,"4 mM MgCl2, 1 mM MnCl2","50 mM HEPES, pH 7.4, 1.6 mM dithiothreitol",37˚C,≤ 60 min,-,Turbidity measurement,solute,"Addition of 0.001 mg/ml–1 LPP (800 U ml–1, 0.040 µM) to a solution containing polyU and RRApSLRRApSL resulted in a turbid solution after 10 min. Without LPP or Mn2+ for LPP activity, the solution did not become turbid. Dephosphorylation of RRApSLRRApSL by LPP was able to produce RRASLRRASL, and coacervation was subsequently observed.",
16,109,PMID: 26791895,RNAPS0000054,https://pubmed.ncbi.nlm.nih.gov/26791895,RNA + protein,-,-,polyU,"-(600–1,000 kDa)",-,poly RNA,-,RRASLRRASL,RRASL,-,protein_ptm:Phosphorylation,10aa,-,-,-,-,-,In vitro,1 mM [RRASL]2;|0.05% (w/w) polyU,4 mM MgCl2 ,"50 mM HEPES, pH 7.4, 1.6 mM dithiothreitol",37˚C,≤ 60 min,other_molecular:0.040 µM LPP,Turbidity measurement,solute,"Addition of 0.001 mg/ml–1 LPP (800 U ml–1, 0.040 µM) to a solution containing polyU and RRApSLRRApSL resulted in a turbid solution after 10 min. Without LPP or Mn2+ for LPP activity, the solution did not become turbid. Dephosphorylation of RRApSLRRApSL by LPP was able to produce RRASLRRASL, and coacervation was subsequently observed.",
17,110,PMID: 26791895,RNAPS0000054,https://pubmed.ncbi.nlm.nih.gov/26791895,RNA + protein,-,-,polyU,"-(600–1,000 kDa)",-,poly RNA,-,RRASLRRASLRRASL,RRASL,-,-,15aa,-,-,-,-,-,In vitro,1 mM [RRASL]3;|0.05 % (w/w) polyU,"150 mM NaCl, 4 mM MgCl2, 1 mM MnCl2","50 mM HEPES buffer, pH 7.4, 1.6 mM DTT",37˚C,≤ 40 min,"other_molecular:0.01 mg/ml PKA,3.2 mM ATP",Turbidity measurement,solute,"Dephosphorylation of RRApSLRRApSL by LPP was able to produce RRASLRRASL, and coacervation was subsequently observed. Coacervate formation by phosphatase activity was not limited to just polyU and RRASLRRASL. LPP activity also triggered coacervation with polyU and triple RRApSL in 150 mM NaCl buffered solution and with tRNA and RRApSLRRApSL in buffered solution.",
18,111,PMID: 26791895,RNAPS0000054,https://pubmed.ncbi.nlm.nih.gov/26791895,RNA + protein,-,-,polyU,"-(600–1,000 kDa)",-,poly RNA,-,RRASLRRASLRRASL,RRASL,-,-,15aa,-,-,-,-,-,In vitro,1 mM [RRASL]3;|0.05 % (w/w) polyU,"150 mM NaCl, 4 mM MgCl2","50 mM HEPES buffer, pH 7.4, 1.6 mM DTT",37˚C,≤ 40 min,"other_molecular:0.01 mg/ml PKA,3.2 mM ATP0.004 mg/ml LPP",Turbidity measurement,solute,"Dephosphorylation of RRApSLRRApSL by LPP was able to produce RRASLRRASL, and coacervation was subsequently observed. Coacervate formation by phosphatase activity was not limited to just polyU and RRASLRRASL. LPP activity also triggered coacervation with polyU and triple RRApSL in 150 mM NaCl buffered solution and with tRNA and RRApSLRRApSL in buffered solution.",
19,112,PMID: 26791895,RNAPS0000054,https://pubmed.ncbi.nlm.nih.gov/26791895,RNA + protein,-,-,polyU,"-(600–1,000 kDa)",-,poly RNA,-,RRASLRRASL,RRASL,-,-,10aa,-,-,-,-,-,In vitro,1 mM [RRASL]2;|0.05% (w/w) polyU,4 mM MgCl2,"50 mM HEPES, pH 7.4,  1.6 mM dithiothreitol",37˚C,> 6 min,other_molecular:0.24 µM PKA2.25 mM ATP,Turbidity measurement,solute,"Addition of protein kinase A resulted in a transparent solution after ~6 min. Dissolution was rapid, and the sample went from turbid to transparent in ~2 min. Turbidity persisted in controls lacking kinase and in those with adenosine diphosphate (ADP) substituted for ATP. PolyU/RRASLRRASL coacervates could be reversibly formed and dissolved in the same solution by controlling phosphatase and kinase activity through the addition of reagents. The coacervate formation/dissolution was the result of RRASLRRASL concentration rather than changes in the solution ionic strength/composition from adding the reagents.",
20,113,PMID: 26791895,RNAPS0000054,https://pubmed.ncbi.nlm.nih.gov/26791895,RNA + protein,-,-,polyU,"-(600–1,000 kDa)",-,poly RNA,-,RRASLRRASL,RRASL,-,-,10aa,-,-,-,-,-,In vitro,1 mM [RRASL]2;|0.05% (w/w) polyU,4 mM MgCl2,"50 mM HEPES, pH 7.4,  1.6 mM dithiothreitol",37˚C,≤ 60 min,other_molecular:2.25 mM ATP,Turbidity measurement,liquid,"Addition of protein kinase A resulted in a transparent solution after ~6 min. Dissolution was rapid, and the sample went from turbid to transparent in ~2 min. Turbidity persisted in controls lacking kinase and in those with adenosine diphosphate (ADP) substituted for ATP. PolyU/RRASLRRASL coacervates could be reversibly formed and dissolved in the same solution by controlling phosphatase and kinase activity through the addition of reagents. The coacervate formation/dissolution was the result of RRASLRRASL concentration rather than changes in the solution ionic strength/composition from adding the reagents.",
21,114,PMID: 26791895,RNAPS0000054,https://pubmed.ncbi.nlm.nih.gov/26791895,RNA + protein,-,-,polyU,"-(600–1,000 kDa)",-,poly RNA,-,RRASLRRASL,RRASL,-,-,10aa,-,-,-,-,-,In vitro,1 mM [RRASL]2;|0.05% (w/w) polyU,4 mM MgCl2,"50 mM HEPES, pH 7.4,  1.6 mM dithiothreitol",37˚C,≤ 60 min,other_molecular:0.24 µM PKA2.25 mM ADP,Turbidity measurement,liquid,"Addition of protein kinase A resulted in a transparent solution after ~6 min. Dissolution was rapid, and the sample went from turbid to transparent in ~2 min. Turbidity persisted in controls lacking kinase and in those with adenosine diphosphate (ADP) substituted for ATP. PolyU/RRASLRRASL coacervates could be reversibly formed and dissolved in the same solution by controlling phosphatase and kinase activity through the addition of reagents. The coacervate formation/dissolution was the result of RRASLRRASL concentration rather than changes in the solution ionic strength/composition from adding the reagents.",
22,132,PMID: 27212236,RNAPS0000058,https://pubmed.ncbi.nlm.nih.gov/27212236,RNA + protein,-,-,polyU(50),50nt,UUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUU,poly RNA,-,"sp|Q22053|FBRL_CAEEL rRNA 2'-O-methyltransferase fibrillarin OS=Caenorhabditis elegans OX=6239 GN=fib-1 PE=2 SV=1|length=352aa|residues=1-352
MGRPEFNRGGGGGGFRGGRGGDRGGSRGGFGGGGRGGYGGGDRGSFGGGDRGGFRGGRGG
GDRGGFRGGRGGGDRGGFGGRGSPRGGFGGRGSPRGGRGSPRGGRGGAGGMRGGKTVVVE
PHRLGGVFIVKGKEDALATKNMVVGESVYGEKRVSVDDGAGSIEYRVWNPFRSKLAASIM
GGLENTHIKPGTKLLYLGAASGTTVSHCSDVVGPEGIVYAVEFSHRSGRDLLGVAKKRPN
VVPIVEDARHPHKYRMLVGMVDVIFSDVAQPDQARIVALNAQNFLRNGGHAVISIKANCI
DSTAEPEAVFAGEVNKLKEEKFKPLEQVTLEPYERDHAVVVAVYRPVKGKKV",fib1,-,-,352aa(1-352),Q22053,"PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q22053,http://llps.biocuckoo.cn/view.php?id=LLPS-Cae-0032,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0019,http://db.phasep.pro/browse/",[1-115],[8-114],In vitro,600 nM [fib1];|5 µM polyU,150 mM NaCl,"20 mM Tris, pH 7.5, 1 mM DTT",RT,> 30 min,-,Microscopy,liquid,"Indeed, in the presence of 5 mg/ml rRNA and 150 mM NaCl, FIB1 condenses into droplets at a protein concentration of 600 nM. FIB1 can phase separate even in the presence of non-specific poly-U50 and heparin, suggesting that electrostatic interactions contribute to droplet assembly.",50
23,155,PMID: 27599198,RNAPS0000071,https://pubmed.ncbi.nlm.nih.gov/27599198,RNA,-,-,polyU,2000-3200nt,-,poly RNA,-,-,-,-,-,-,-,-,-,-,-,In vitro,0.5-0.6[polyU],-,"5 mM HEPES,pH 7.6",37˚C,-,other molecular:0.5%wt spermine (a charge ratio of 56:1),Differential interference contrast microscopy,liquid,"Inspection of the turbid solutions by optical microscopy revealed the presence of spherical liquid coacervate droplets. Centrifugation of the bulk samples resulted in a very small, coalesced coacervate phase at the bottom of the centrifuge tube.",3200
24,156,PMID: 27599198,RNAPS0000071,https://pubmed.ncbi.nlm.nih.gov/27599198,RNA,-,-,polyU,2000-3200nt,-,poly RNA,-,-,-,-,-,-,-,-,-,-,-,In vitro,0.5-0.6[polyU],-,"5 mM HEPES,pH 7.6",37˚C,-,other molecular:0.5%wt spermidine(a charge ratio of 61:1),Differential interference contrast microscopy,liquid,"Inspection of the turbid solutions by optical microscopy revealed the presence of spherical liquid coacervate droplets. Centrifugation of the bulk samples resulted in a very small, coalesced coacervate phase at the bottom of the centrifuge tube.",3200
25,157,PMID: 27599198,RNAPS0000071,https://pubmed.ncbi.nlm.nih.gov/27599198,RNA,-,-,polyU,2000-3200nt,-,poly RNA,-,-,-,-,-,-,-,-,-,-,-,In vitro,0.5-0.6[polyU],"0-200mM NaCl, 1 mM MgCl2","5 mM HEPES,pH 7.6",37˚C,-,other molecular:0.5%wt spermine (a charge ratio of 56:1),Turbidity measurement,liquid,"Inspection of the turbid solutions by optical microscopy revealed the presence of spherical liquid coacervate droplets. Centrifugation of the bulk samples resulted in a very small, coalesced coacervate phase at the bottom of the centrifuge tube.",3200
26,158,PMID: 27599198,RNAPS0000071,https://pubmed.ncbi.nlm.nih.gov/27599198,RNA,-,-,polyU,2000-3200nt,-,poly RNA,-,-,-,-,-,-,-,-,-,-,-,In vitro,0.5-0.6[polyU],"0-25mM NaCl, 1 mM MgCl2","5 mM HEPES,pH 7.6",37˚C,-,other molecular:0.5%wt spermidine(a charge ratio of 61:1),Turbidity measurement,liquid,"Inspection of the turbid solutions by optical microscopy revealed the presence of spherical liquid coacervate droplets. Centrifugation of the bulk samples resulted in a very small, coalesced coacervate phase at the bottom of the centrifuge tube.",3200
27,159,PMID: 27602576,RNAPS0000073,https://pubmed.ncbi.nlm.nih.gov/27602576,Undefined,-,-,polyA,-,-,poly RNA,-,"sp|Q13283|G3BP1_HUMAN Ras GTPase-activating protein-binding protein 1 OS=Homo sapiens OX=9606 GN=G3BP1 PE=1 SV=1
MVMEKPSPLLVGREFVRQYYTLLNQAPDMLHRFYGKNSSYVHGGLDSNGKPADAVYGQKE
IHRKVMSQNFTNCHTKIRHVDAHATLNDGVVVQVMGLLSNNNQALRRFMQTFVLAPEGSV
ANKFYVHNDIFRYQDEVFGGFVTEPQEESEEEVEEPEERQQTPEVVPDDSGTFYDQAVVS
NDMEEHLEEPVAEPEPDPEPEPEQEPVSEIQEEKPEPVLEETAPEDAQKSSSPAPADIAQ
TVQEDLRTFSWASVTSKNLPPSGAVPVTGIPPHVVKVPASQPRPESKPESQIPPQRPQRD
QRVREQRINIPPQRGPRPIREAGEQGDIEPRRMVRHPDSHQLFIGNLPHEVDKSELKDFF
QSYGNVVELRINSGGKLPNFGFVVFDDSEPVQKVLSNRPIMFRGEVRLNVEEKKTRAARE
GDRRDNRLRGPGGPRGGLGGGMRGPPRGGMVQKPGFGVGRGLAPRQ",G3BP1,-,-,466aa(1-466),Q13283,"DrLLPS,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-0862,http://db.phasep.pro/browse/","[144-172],[184-243],[255-329],[413-466]","[142-167],[184-213],[291-307],[421-450]",In vivo,-,-,-,37˚C,-,other molecular:NaAsO2;organelle:stress granule;cell:U2OS cell,Microscopy,-,"We identify these GFP-G3BP1 foci in lysates as stress granule cores since they contain PABP1, polyA+ RNA, and eIF4G. GFP-G3BP1 foci in lysates probed for poly (A+) RNA by oligo-dT or secondary-only antibody from cells NaAsO2 stressed for 15 min.",0
28,183,PMID: 27692063,RNAPS0000087,https://pubmed.ncbi.nlm.nih.gov/27692063,RNA + protein,-,-,polyU,-,-,poly RNA,-,"sp|P39517|DHH1_YEAST ATP-dependent RNA helicase DHH1 OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) OX=559292 GN=DHH1 PE=1 SV=1|length=506aa|residues=1-506
MGSINNNFNTNNNSNTDLDRDWKTALNIPKKDTRPQTDDVLNTKGNTFEDFYLKRELLMG
IFEAGFEKPSPIQEEAIPVAITGRDILARAKNGTGKTAAFVIPTLEKVKPKLNKIQALIM
VPTRELALQTSQVVRTLGKHCGISCMVTTGGTNLRDDILRLNETVHILVGTPGRVLDLAS
RKVADLSDCSLFIMDEADKMLSRDFKTIIEQILSFLPPTHQSLLFSATFPLTVKEFMVKH
LHKPYEINLMEELTLKGITQYYAFVEERQKLHCLNTLFSKLQINQAIIFCNSTNRVELLA
KKITDLGYSCYYSHARMKQQERNKVFHEFRQGKVRTLVCSDLLTRGIDIQAVNVVINFDF
PKTAETYLHRIGRSGRFGHLGLAINLINWNDRFNLYKIEQELGTEIAAIPATIDKSLYVA
ENDETVPVPFPIEQQSYHQQAIPQQQLPSQQQFAIPPQQHHPQFMVPPSHQQQQAYPPPQ
MPSQQGYPPQQEHFMAMPPGQSQPQY",DHH1,-,-,506aa(1-506),P39517,"DrLLPS,LLPSDB,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Sac-0503,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0168,http://db.phasep.pro/browse/",-,-,In vitro,6.2 µM [DHH1];|0.075 mg/ml polyU,"150 mM KCl, 2 mM MgCl2",30 mM HEPES-KOH pH 7.4,4˚C,> 20 min,-,Wide-field fluorescence microscopy,solute,"Dhh1 liquid droplet formation requires ATP binding. Dhh1 droplets did not form in the absence of ATP, demonstrating that Dhh1 in its ATP-bound form promotes liquid droplet formation.",0
29,184,PMID: 27692063,RNAPS0000087,https://pubmed.ncbi.nlm.nih.gov/27692063,RNA + protein,-,-,polyU,-,-,poly RNA,-,"sp|P39517|DHH1_YEAST ATP-dependent RNA helicase DHH1 OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) OX=559292 GN=DHH1 PE=1 SV=1|length=506aa|residues=1-506|mutation=F66R
MGSINNNFNTNNNSNTDLDRDWKTALNIPKKDTRPQTDDVLNTKGNTFEDFYLKRELLMG
IFEAGREKPSPIQEEAIPVAITGRDILARAKNGTGKTAAFVIPTLEKVKPKLNKIQALIM
VPTRELALQTSQVVRTLGKHCGISCMVTTGGTNLRDDILRLNETVHILVGTPGRVLDLAS
RKVADLSDCSLFIMDEADKMLSRDFKTIIEQILSFLPPTHQSLLFSATFPLTVKEFMVKH
LHKPYEINLMEELTLKGITQYYAFVEERQKLHCLNTLFSKLQINQAIIFCNSTNRVELLA
KKITDLGYSCYYSHARMKQQERNKVFHEFRQGKVRTLVCSDLLTRGIDIQAVNVVINFDF
PKTAETYLHRIGRSGRFGHLGLAINLINWNDRFNLYKIEQELGTEIAAIPATIDKSLYVA
ENDETVPVPFPIEQQSYHQQAIPQQQLPSQQQFAIPPQQHHPQFMVPPSHQQQQAYPPPQ
MPSQQGYPPQQEHFMAMPPGQSQPQY",DHH1,-,protein_mutation:F66R,506aa(1-506),P39517,"DrLLPS,LLPSDB,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Sac-0503,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0168,http://db.phasep.pro/browse/","[22-39],[61-85],[323-328],[411-453],[464-504]",-,In vitro,6.2 µM [DHH1];|0.075 mg/ml polyU,"150 mM KCl, 2 mM MgCl2",30 mM HEPES-KOH pH 7.4,4˚C,> 1 h,other_molecular:5 mM ATP,Wide-field fluorescence microscopy,solute,"Dhh1_M(F66R) showed only a minor defect in PB localization following glucose starvation, this mutant showed a dramatic loss of droplet formation in vitro.",0
30,185,PMID: 27692063,RNAPS0000087,https://pubmed.ncbi.nlm.nih.gov/27692063,RNA + protein,-,-,polyU,-,-,poly RNA,-,"sp|P39517|DHH1_YEAST ATP-dependent RNA helicase DHH1 OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) OX=559292 GN=DHH1 PE=1 SV=1|length=506aa|residues=1-506
MGSINNNFNTNNNSNTDLDRDWKTALNIPKKDTRPQTDDVLNTKGNTFEDFYLKRELLMG
IFEAGFEKPSPIQEEAIPVAITGRDILARAKNGTGKTAAFVIPTLEKVKPKLNKIQALIM
VPTRELALQTSQVVRTLGKHCGISCMVTTGGTNLRDDILRLNETVHILVGTPGRVLDLAS
RKVADLSDCSLFIMDEADKMLSRDFKTIIEQILSFLPPTHQSLLFSATFPLTVKEFMVKH
LHKPYEINLMEELTLKGITQYYAFVEERQKLHCLNTLFSKLQINQAIIFCNSTNRVELLA
KKITDLGYSCYYSHARMKQQERNKVFHEFRQGKVRTLVCSDLLTRGIDIQAVNVVINFDF
PKTAETYLHRIGRSGRFGHLGLAINLINWNDRFNLYKIEQELGTEIAAIPATIDKSLYVA
ENDETVPVPFPIEQQSYHQQAIPQQQLPSQQQFAIPPQQHHPQFMVPPSHQQQQAYPPPQ
MPSQQGYPPQQEHFMAMPPGQSQPQY",DHH1,-,-,506aa(1-506),P39517,"DrLLPS,LLPSDB,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Sac-0503,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0168,http://db.phasep.pro/browse/",-,-,In vitro,6.2 µM [DHH1];|0.075 mg/ml polyU,"150 mM KCl, 2 mM MgCl2",30 mM HEPES-KOH pH 7.4,4˚C,≤ 20 min,"other_molecular:5 mM ATP,5 μM RNase A",Wide-field fluorescence microscopy,liquid,"Remarkably, recombinant Dhh1, in the presence of RNA and ATP, readily formed droplets in solution. These droplets showed hallmarks of liquid-liquid phase separation, undergoing growth and fusion events and reversible deformation, consistent with the reported biophysical behavior of PBs. Dhh1 droplet formation was RNA-dependent, as no droplets formed when RNA was omitted, and the number and size of droplets rapidly decreased upon addition of RNase A, but not with buffer alone.",0
31,186,PMID: 27692063,RNAPS0000087,https://pubmed.ncbi.nlm.nih.gov/27692063,RNA + protein,-,-,polyU,-,-,poly RNA,-,"sp|P39517|DHH1_YEAST ATP-dependent RNA helicase DHH1 OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) OX=559292 GN=DHH1 PE=1 SV=1|length=506aa|residues=1-506
MGSINNNFNTNNNSNTDLDRDWKTALNIPKKDTRPQTDDVLNTKGNTFEDFYLKRELLMG
IFEAGFEKPSPIQEEAIPVAITGRDILARAKNGTGKTAAFVIPTLEKVKPKLNKIQALIM
VPTRELALQTSQVVRTLGKHCGISCMVTTGGTNLRDDILRLNETVHILVGTPGRVLDLAS
RKVADLSDCSLFIMDEADKMLSRDFKTIIEQILSFLPPTHQSLLFSATFPLTVKEFMVKH
LHKPYEINLMEELTLKGITQYYAFVEERQKLHCLNTLFSKLQINQAIIFCNSTNRVELLA
KKITDLGYSCYYSHARMKQQERNKVFHEFRQGKVRTLVCSDLLTRGIDIQAVNVVINFDF
PKTAETYLHRIGRSGRFGHLGLAINLINWNDRFNLYKIEQELGTEIAAIPATIDKSLYVA
ENDETVPVPFPIEQQSYHQQAIPQQQLPSQQQFAIPPQQHHPQFMVPPSHQQQQAYPPPQ
MPSQQGYPPQQEHFMAMPPGQSQPQY",DHH1,-,-,506aa(1-506),P39517,"DrLLPS,LLPSDB,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Sac-0503,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0168,http://db.phasep.pro/browse/",-,-,In vitro,1.5-12.5 µM [DHH1];|0.075 mg/ml polyU,"150 mM KCl, 2 mM MgCl2",30 mM HEPES-KOH pH 7.4,4˚C,> 1 h,other_molecular:5 mM ATP,Wide-field fluorescence microscopy,liquid,"Remarkably, recombinant Dhh1, in the presence of RNA and ATP, readily formed droplets in solution. These droplets showed hallmarks of liquid-liquid phase separation, undergoing growth and fusion events and reversible deformation, consistent with the reported biophysical behavior of PBs. Dhh1 droplet formation was RNA-dependent, as no droplets formed when RNA was omitted, and the number and size of droplets rapidly decreased upon addition of RNase A, but not with buffer alone. Dhh1 droplets did not form in the absence of ATP, demonstrating that Dhh1 in its ATP-bound form promotes liquid droplet formation.",0
32,187,PMID: 27692063,RNAPS0000088,https://pubmed.ncbi.nlm.nih.gov/27692063,RNA + proteins,-,-,polyU,-,-,poly RNA,-,"sp|P39517|DHH1_YEAST ATP-dependent RNA helicase DHH1 OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) OX=559292 GN=DHH1 PE=1 SV=1|length=506aa|residues=1-506
MGSINNNFNTNNNSNTDLDRDWKTALNIPKKDTRPQTDDVLNTKGNTFEDFYLKRELLMG
IFEAGFEKPSPIQEEAIPVAITGRDILARAKNGTGKTAAFVIPTLEKVKPKLNKIQALIM
VPTRELALQTSQVVRTLGKHCGISCMVTTGGTNLRDDILRLNETVHILVGTPGRVLDLAS
RKVADLSDCSLFIMDEADKMLSRDFKTIIEQILSFLPPTHQSLLFSATFPLTVKEFMVKH
LHKPYEINLMEELTLKGITQYYAFVEERQKLHCLNTLFSKLQINQAIIFCNSTNRVELLA
KKITDLGYSCYYSHARMKQQERNKVFHEFRQGKVRTLVCSDLLTRGIDIQAVNVVINFDF
PKTAETYLHRIGRSGRFGHLGLAINLINWNDRFNLYKIEQELGTEIAAIPATIDKSLYVA
ENDETVPVPFPIEQQSYHQQAIPQQQLPSQQQFAIPPQQHHPQFMVPPSHQQQQAYPPPQ
MPSQQGYPPQQEHFMAMPPGQSQPQY;
sp|P25655|NOT1_YEAST General negative regulator of transcription subunit 1 OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) OX=559292 GN=CDC39 PE=1 SV=3|length=247aa|residues=754-1000
RSRPVQEMIPLKFFAVDEVSCQINQEGAPKDVVEKVLFVLNNVTLANLNNKVDELKKSLT
PNYFSWFSTYLVTQRAKTEPNYHDLYSKVIVAMGSGLLHQFMVNVTLRQLFVLLSTKDEQ
AIDKKHLKNLASWLGCITLALNKPIKHKNIAFREMLIEAYKENRLEIVVPFVTKILQRAS
ESKIFKPPNPWTVGILKLLIELNEKANWKLSLTFEVEVLLKSFNLTTKSLKPSNFINTPE
VIETLSG",DHH1;|NOT1,[DHH1]:-;|[NOT1]:MIF4G,-;|-,506aa(1-506);|247aa(754-1000),P39517;P25655,"DrLLPS,LLPSDB,PhaSepDB;DrLLPS,LLPSDB,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Sac-0503,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0168,http://db.phasep.pro/browse/;http://llps.biocuckoo.cn/view.php?id=LLPS-Sac-0403,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0169,http://db.phasep.pro/browse/",-;|-,-;|-,In vitro,6.2 µM [DHH1];|5 µM [NOT1 MIF4G];|0.075 mg/ml polyU,"150 mM KCl, 2 mM MgCl2",30 mM HEPES-KOH pH 7.4,4˚C,> 1 h,other_molecular:5 mM ATP,Wide-field fluorescence microscopy,liquid,"Addition of Not1 MIF4G triggered the dissolution of pre-formed Dhh1 liquid droplets. Furthermore, no assembly occurred when Not1 MIF4G was added before polyU during the assembly reaction.",0
33,188,PMID: 27692063,RNAPS0000088,https://pubmed.ncbi.nlm.nih.gov/27692063,RNA + proteins,-,-,polyU,-,-,poly RNA,-,"sp|P39517|DHH1_YEAST ATP-dependent RNA helicase DHH1 OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) OX=559292 GN=DHH1 PE=1 SV=1|length=506aa|residues=1-506|mutation=E195Q
MGSINNNFNTNNNSNTDLDRDWKTALNIPKKDTRPQTDDVLNTKGNTFEDFYLKRELLMG
IFEAGFEKPSPIQEEAIPVAITGRDILARAKNGTGKTAAFVIPTLEKVKPKLNKIQALIM
VPTRELALQTSQVVRTLGKHCGISCMVTTGGTNLRDDILRLNETVHILVGTPGRVLDLAS
RKVADLSDCSLFIMDQADKMLSRDFKTIIEQILSFLPPTHQSLLFSATFPLTVKEFMVKH
LHKPYEINLMEELTLKGITQYYAFVEERQKLHCLNTLFSKLQINQAIIFCNSTNRVELLA
KKITDLGYSCYYSHARMKQQERNKVFHEFRQGKVRTLVCSDLLTRGIDIQAVNVVINFDF
PKTAETYLHRIGRSGRFGHLGLAINLINWNDRFNLYKIEQELGTEIAAIPATIDKSLYVA
ENDETVPVPFPIEQQSYHQQAIPQQQLPSQQQFAIPPQQHHPQFMVPPSHQQQQAYPPPQ
MPSQQGYPPQQEHFMAMPPGQSQPQY;
sp|P25655|NOT1_YEAST General negative regulator of transcription subunit 1 OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) OX=559292 GN=CDC39 PE=1 SV=3|length=247aa|residues=754-1000
RSRPVQEMIPLKFFAVDEVSCQINQEGAPKDVVEKVLFVLNNVTLANLNNKVDELKKSLT
PNYFSWFSTYLVTQRAKTEPNYHDLYSKVIVAMGSGLLHQFMVNVTLRQLFVLLSTKDEQ
AIDKKHLKNLASWLGCITLALNKPIKHKNIAFREMLIEAYKENRLEIVVPFVTKILQRAS
ESKIFKPPNPWTVGILKLLIELNEKANWKLSLTFEVEVLLKSFNLTTKSLKPSNFINTPE
VIETLSG",DHH1;|NOT1,[DHH1]:-;|[NOT1]:MIF4G,protein_mutation:E195Q|protein_mutation:-,506aa(1-506);|247aa(754-1000),P39517;P25655,"DrLLPS,LLPSDB,PhaSepDB;DrLLPS,LLPSDB,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Sac-0503,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0168,http://db.phasep.pro/browse/;http://llps.biocuckoo.cn/view.php?id=LLPS-Sac-0403,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0169,http://db.phasep.pro/browse/","[22-39],[64-85],[323-328],[411-453],[464-504];|-",-;|-,In vitro,6.2 µM [DHH1];|5 µM [NOT1 MIF4G];|0.075 mg/ml polyU,"150 mM KCl, 2 mM MgCl2",30 mM HEPES-KOH pH 7.4,4˚C,> 1 h,other_molecular:5 mM ATP,Wide-field fluorescence microscopy,liquid,"Dhh1_M(DQAD) formed droplets to a similar extent as wild-type Dhh1, these structures did not dissolve in the presence of Not1 MIF4G, supporting the specificity of the observed effect. Interestingly, the Dhh1_M(DQAD) droplets slightly increased in size and number upon Not1 MIF4G addition. It is likely that the MIF4G domain of Not1, like other MIF4G domains, stabilizes a conformation of the two RecA domains which facilitates nucleotide and RNA loading.",0
34,193,PMID: 27914198,RNAPS0000091,https://pubmed.ncbi.nlm.nih.gov/27914198,RNA + protein,-,-,polyU(30),30nt,UUUUUUUUUUUUUUUUUUUUUUUUUUUUUU,poly RNA,-,"tr|Q9TXM1|Q9TXM1_CAEEL Uncharacterized protein OS=Caenorhabditis elegans OX=6239 GN=meg-3 PE=4 SV=1|length=544aa|residues=1-544
MSSSKPYPSGLPNSRRKRGGRRSSSRSNQESASNNMEHQITLDELFNPIAKQDSAQSTSR
EYGAKSGISHHGSVSFNGNTFMNGQQLNHSMTRHGRVFNQSMHAAQGNGSNAFNSIPPTA
PVFSADFRRNLQTRNSSSWYERRFPVSTDQDDVQQSNTRRSRSRQNGQHGLSFSDGSNNY
GHAGNKSFSVSSVPVGFQKQENNSKKLRQTNVHQQCLGNKSFNAQAGVHGHAFKKGHKDN
KNASGKEVINSSLVQKHDAIKSRNLNQSFSGFPTHETSSMKNQQQKSRNDRKKSRGSSNF
QDRTYFNTNDDELTDDVFIDDSMDAARGRRSRSVTKKLQQSTYSKQNAGSKQLTEKCKSS
EEAAKRNLVSNVFSKDGTELSIEQLLEIVSMKIGQQIHLPSSSHGECSNLNRTLPASDLN
CSIGEDFDSSFVDANNQTLPVSLPKKTSLSIKRRGSSRSASRLASLDVTLETVEEDEEPT
PSPQPSSPPKISRRKWTGTFDANVEEMRRLLHGDPEMPKSANRASSSKDQINRNNVDVKR
TPSS",meg-3,IDR,-,544aa(1-544),Q9TXM1,"PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q9TXM1,http://llps.biocuckoo.cn/view.php?id=LLPS-Cae-2080,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0145,http://db.phasep.pro/browse/","[1-37],[52-71],[141-187],[259-307],[326-352],[446-495],[510-534]","[14-27],[154-168],[456-492]",In vitro,0.1-5 µM [MEG3 IDR];|0.1-10 µM polyU,150 mM NaCl,"25 mM HEPES, pH7.4",RT,≤ 10 min,-,Confocal microscopy,liquid,"MEG-3 and MEG-3IDR behaved similarly to each other, except that in the low concentration range (<5 mM), MEG-3 formed more condensates than MEG-3IDR, and in the high concentration range (>5 mM) MEG-3IDR tended to form larger condensates.",30
35,194,PMID: 27914198,RNAPS0000091,https://pubmed.ncbi.nlm.nih.gov/27914198,RNA + protein,-,-,polyU(30),30nt,UUUUUUUUUUUUUUUUUUUUUUUUUUUUUU,poly RNA,-,"tr|Q9TXM1|Q9TXM1_CAEEL Uncharacterized protein OS=Caenorhabditis elegans OX=6239 GN=meg-3 PE=4 SV=1|length=862aa|residues=1-862
MSSSKPYPSGLPNSRRKRGGRRSSSRSNQESASNNMEHQITLDELFNPIAKQDSAQSTSR
EYGAKSGISHHGSVSFNGNTFMNGQQLNHSMTRHGRVFNQSMHAAQGNGSNAFNSIPPTA
PVFSADFRRNLQTRNSSSWYERRFPVSTDQDDVQQSNTRRSRSRQNGQHGLSFSDGSNNY
GHAGNKSFSVSSVPVGFQKQENNSKKLRQTNVHQQCLGNKSFNAQAGVHGHAFKKGHKDN
KNASGKEVINSSLVQKHDAIKSRNLNQSFSGFPTHETSSMKNQQQKSRNDRKKSRGSSNF
QDRTYFNTNDDELTDDVFIDDSMDAARGRRSRSVTKKLQQSTYSKQNAGSKQLTEKCKSS
EEAAKRNLVSNVFSKDGTELSIEQLLEIVSMKIGQQIHLPSSSHGECSNLNRTLPASDLN
CSIGEDFDSSFVDANNQTLPVSLPKKTSLSIKRRGSSRSASRLASLDVTLETVEEDEEPT
PSPQPSSPPKISRRKWTGTFDANVEEMRRLLHGDPEMPKSANRASSSKDQINRNNVDVKR
TPSSSIIPTPKALIGERCLTSSSKSSKLNKSLGVVDSKATKSPMYSVTVSGKETASGKRI
AQKLTPKVVALESSYITGIPVSTDCNGCPTPKRSGINCEIRAAEVYNQAGKWPFEITSDP
APLPCESADRIEYPSQDCTQDPASTSPPPRISESLTAFLEAQQDFNDYIDTNYKEKTQLL
KVNLNIHGMSPERWLYLNYFCTETIPRLDGPYADDPRVPPVRNMFRKWFLRFAEACLGNP
HQLAVMQEIAATFVQARLDDTSSSTDSTNMLYMLWKECIGQKNIIAIADACLLAHLRKSD
PIKYLNVKRDWLESIFDPPRDQ",meg-3,-,-,862aa(1-862),Q9TXM1,"PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q9TXM1,http://llps.biocuckoo.cn/view.php?id=LLPS-Cae-2080,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0145,http://db.phasep.pro/browse/","[1-37],[52-71],[141-187],[259-307],[326-352],[446-495],[510-534]","[14-27],[154-168],[456-492],[559-572],[799-808]",In vitro,0.1-5 µM [MEG3];|0.1-10 µM polyU,150 mM NaCl,"25 mM HEPES, pH7.4",RT,≤ 10 min,-,Confocal microscopy,liquid,"We pre-incubated recombinant MEX-5 with poly-U in buffer for 30 min before adding MEG-3. We found that MEX-5 strongly inhibited MEG-3 phase separation induced by RNA. Addition of excess RNA (3-fold increase) restored robust phase separation in the presence of MEX-5. Additionally, MEX-5 had no effect on the phase separation of MEG-3 in the absence of RNA. MEG-3 and MEG-3IDR behaved similarly to each other, except that in the low concentration range (<5 mM), MEG-3 formed more condensates than MEG-3IDR, and in the high concentration range (>5 mM) MEG-3IDR tended to form larger condensates.",30
36,195,PMID: 27914198,RNAPS0000092,https://pubmed.ncbi.nlm.nih.gov/27914198,RNA + proteins,-,-,polyU(30),30nt,UUUUUUUUUUUUUUUUUUUUUUUUUUUUUU,poly RNA,-,"tr|Q9TXM1|Q9TXM1_CAEEL Uncharacterized protein OS=Caenorhabditis elegans OX=6239 GN=meg-3 PE=4 SV=1|length=862aa|residues=1-862
MSSSKPYPSGLPNSRRKRGGRRSSSRSNQESASNNMEHQITLDELFNPIAKQDSAQSTSR
EYGAKSGISHHGSVSFNGNTFMNGQQLNHSMTRHGRVFNQSMHAAQGNGSNAFNSIPPTA
PVFSADFRRNLQTRNSSSWYERRFPVSTDQDDVQQSNTRRSRSRQNGQHGLSFSDGSNNY
GHAGNKSFSVSSVPVGFQKQENNSKKLRQTNVHQQCLGNKSFNAQAGVHGHAFKKGHKDN
KNASGKEVINSSLVQKHDAIKSRNLNQSFSGFPTHETSSMKNQQQKSRNDRKKSRGSSNF
QDRTYFNTNDDELTDDVFIDDSMDAARGRRSRSVTKKLQQSTYSKQNAGSKQLTEKCKSS
EEAAKRNLVSNVFSKDGTELSIEQLLEIVSMKIGQQIHLPSSSHGECSNLNRTLPASDLN
CSIGEDFDSSFVDANNQTLPVSLPKKTSLSIKRRGSSRSASRLASLDVTLETVEEDEEPT
PSPQPSSPPKISRRKWTGTFDANVEEMRRLLHGDPEMPKSANRASSSKDQINRNNVDVKR
TPSSSIIPTPKALIGERCLTSSSKSSKLNKSLGVVDSKATKSPMYSVTVSGKETASGKRI
AQKLTPKVVALESSYITGIPVSTDCNGCPTPKRSGINCEIRAAEVYNQAGKWPFEITSDP
APLPCESADRIEYPSQDCTQDPASTSPPPRISESLTAFLEAQQDFNDYIDTNYKEKTQLL
KVNLNIHGMSPERWLYLNYFCTETIPRLDGPYADDPRVPPVRNMFRKWFLRFAEACLGNP
HQLAVMQEIAATFVQARLDDTSSSTDSTNMLYMLWKECIGQKNIIAIADACLLAHLRKSD
PIKYLNVKRDWLESIFDPPRDQ;
sp|Q9XUB2|MEX5_CAEEL Zinc finger protein mex-5 OS=Caenorhabditis elegans OX=6239 GN=mex-5 PE=1 SV=1|length=233aa|residues=236-468
TMSAEKENHFHEHRGEKFGRRGFPIPETDSQQPPNYKTRLCMMHASGIKPCDMGARCKFA
HGLKELRATDAPARYPNNKYKTKLCKNFARGGTGFCPYGLRCEFVHPTDKEFQNIPPYQR
MSHDDQDYDQDVIPEDYVVARHQPRFMRTGGRATTPTKVMLKHRNVAGSMMCLSNAGRDL
QAGGDYNQPESNEDDLPPHLRRNRRENPPMNKRRTSLSTKWTSEENLGLRGHY",meg-3;|mex-5,-;|-,-;|-,862aa(1-862);|233aa(236-468),Q9TXM1;Q9XUB2,"PhaSePro,DrLLPS,LLPSDB,PhaSepDB;DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q9TXM1,http://llps.biocuckoo.cn/view.php?id=LLPS-Cae-2080,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0145,http://db.phasep.pro/browse/;http://llps.biocuckoo.cn/view.php?id=LLPS-Cae-2100,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0146,http://db.phasep.pro/browse/","[1-37],[52-71],[141-187],[259-307],[326-352],[446-495],[510-534];|[243-269],[414-468]","[14-27],[154-168],[456-492],[559-572],[799-808];|-",In vitro,5 µM [MEG3];|3.5 µM [MEX-5 236-468];|20 µM polyU,150 mM NaCl,"25 mM HEPES, pH7.4",RT,≤ 10 min,-,Confocal microscopy,liquid,"We pre-incubated recombinant MEX-5 with poly-U in buffer for 30 min before adding MEG-3. We found that MEX-5 strongly inhibited MEG-3 phase separation induced by RNA. Addition of excess RNA (3-fold increase) restored robust phase separation in the presence of MEX-5. Additionally, MEX-5 had no effect on the phase separation of MEG-3 in the absence of RNA.",30
37,196,PMID: 27914198,RNAPS0000092,https://pubmed.ncbi.nlm.nih.gov/27914198,RNA + proteins,-,-,polyU(30),30nt,UUUUUUUUUUUUUUUUUUUUUUUUUUUUUU,poly RNA,-,"tr|Q9TXM1|Q9TXM1_CAEEL Uncharacterized protein OS=Caenorhabditis elegans OX=6239 GN=meg-3 PE=4 SV=1|length=862aa|residues=1-862
MSSSKPYPSGLPNSRRKRGGRRSSSRSNQESASNNMEHQITLDELFNPIAKQDSAQSTSR
EYGAKSGISHHGSVSFNGNTFMNGQQLNHSMTRHGRVFNQSMHAAQGNGSNAFNSIPPTA
PVFSADFRRNLQTRNSSSWYERRFPVSTDQDDVQQSNTRRSRSRQNGQHGLSFSDGSNNY
GHAGNKSFSVSSVPVGFQKQENNSKKLRQTNVHQQCLGNKSFNAQAGVHGHAFKKGHKDN
KNASGKEVINSSLVQKHDAIKSRNLNQSFSGFPTHETSSMKNQQQKSRNDRKKSRGSSNF
QDRTYFNTNDDELTDDVFIDDSMDAARGRRSRSVTKKLQQSTYSKQNAGSKQLTEKCKSS
EEAAKRNLVSNVFSKDGTELSIEQLLEIVSMKIGQQIHLPSSSHGECSNLNRTLPASDLN
CSIGEDFDSSFVDANNQTLPVSLPKKTSLSIKRRGSSRSASRLASLDVTLETVEEDEEPT
PSPQPSSPPKISRRKWTGTFDANVEEMRRLLHGDPEMPKSANRASSSKDQINRNNVDVKR
TPSSSIIPTPKALIGERCLTSSSKSSKLNKSLGVVDSKATKSPMYSVTVSGKETASGKRI
AQKLTPKVVALESSYITGIPVSTDCNGCPTPKRSGINCEIRAAEVYNQAGKWPFEITSDP
APLPCESADRIEYPSQDCTQDPASTSPPPRISESLTAFLEAQQDFNDYIDTNYKEKTQLL
KVNLNIHGMSPERWLYLNYFCTETIPRLDGPYADDPRVPPVRNMFRKWFLRFAEACLGNP
HQLAVMQEIAATFVQARLDDTSSSTDSTNMLYMLWKECIGQKNIIAIADACLLAHLRKSD
PIKYLNVKRDWLESIFDPPRDQ;
sp|Q9XUB2|MEX5_CAEEL Zinc finger protein mex-5 OS=Caenorhabditis elegans OX=6239 GN=mex-5 PE=1 SV=1|length=233aa|residues=236-468
TMSAEKENHFHEHRGEKFGRRGFPIPETDSQQPPNYKTRLCMMHASGIKPCDMGARCKFA
HGLKELRATDAPARYPNNKYKTKLCKNFARGGTGFCPYGLRCEFVHPTDKEFQNIPPYQR
MSHDDQDYDQDVIPEDYVVARHQPRFMRTGGRATTPTKVMLKHRNVAGSMMCLSNAGRDL
QAGGDYNQPESNEDDLPPHLRRNRRENPPMNKRRTSLSTKWTSEENLGLRGHY",meg-3;|mex-5,-;|-,-;|-,862aa(1-862);|233aa(236-468),Q9TXM1;Q9XUB2,"PhaSePro,DrLLPS,LLPSDB,PhaSepDB;DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q9TXM1,http://llps.biocuckoo.cn/view.php?id=LLPS-Cae-2080,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0145,http://db.phasep.pro/browse/;http://llps.biocuckoo.cn/view.php?id=LLPS-Cae-2100,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0146,http://db.phasep.pro/browse/","[1-37],[52-71],[141-187],[259-307],[326-352],[446-495],[510-534];|[243-269],[414-468]","[14-27],[154-168],[456-492],[559-572],[799-808];|-",In vitro,5 µM [MEG3];|3.5 µM [MEX-5 236-468];|60 µM polyU,150 mM NaCl,"25 mM HEPES, pH7.4",RT,≤ 10 min,-,Confocal microscopy,liquid,"We pre-incubated recombinant MEX-5 with poly-U in buffer for 30 min before adding MEG-3. We found that MEX-5 strongly inhibited MEG-3 phase separation induced by RNA. Addition of excess RNA (3-fold increase) restored robust phase separation in the presence of MEX-5. Additionally, MEX-5 had no effect on the phase separation of MEG-3 in the absence of RNA.",30
38,197,PMID: 28283059,RNAPS0000093,https://pubmed.ncbi.nlm.nih.gov/28283059,RNA + protein,-,-,polyA(19),19nt,AAAAAAAAAAAAAAAAAAA,poly RNA,-,"sp|P04147|PABP_YEAST Polyadenylate-binding protein, cytoplasmic and nuclear OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) OX=559292 GN=PAB1 PE=1 SV=4|length=597aa|residues=2-577
MGSSHHHHHHHHASENLYFQSADITDKTAEQLENLNIQDDQKQAATGSESQSVENSSASL
YVGDLEPSVSEAHLYDIFSPIGSVSSIRVCRDAITKTSLGYAYVNFNDHEAGRKAIEQLN
YTPIKGRLCRIMWSQRDPSLRKKGSGNIFIKNLHPDIDNKALYDTFSVFGDILSSKIATD
ENGKSKGFGFVHFEEEGAAKEAIDALNGMLLNGQEIYVAPHLSRKERDSQLEETKAHYTN
LYVKNINSETTDEQFQELFAKFGPIVSASLEKDADGKLKGFGFVNYEKHEDAVKAVEALN
DSELNGEKLYVGRAQKKNERMHVLKKQYEAYRLEKMAKYQGVNLFVKNLDDSVDDEKLEE
EFAPYGTITSAKVMRTENGKSKGFGFVCFSTPEEATKAITEKNQQIVAGKPLYVAIAQRK
DVRRSQLAQQIQARNQMRYQQATAAAAAAAAGMPGQFMPPMFYGVMPPRGVPFNGPNPQQ
MNPMGGMPKNGMPPQFRNGPVYGVPPQGGFPRNANDNNQFYQQKQRQALGEQLYKKVSAK
TSNEEAAGKITGMILDLPPQEVFPLLESDELFEQHYKEASAAYESFKKEQEQQTEQA",Pab1,-,-,597aa(1-597),P04147,"PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/P04147,http://llps.biocuckoo.cn/view.php?id=LLPS-Sac-0254,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0048,http://db.phasep.pro/browse/","[1-12],[29-65],[118-118],[130-143],[199-207],[217-231],[307-327],[357-357],[414-450],[471-501],[549-566],[588-596]",-,In vitro,15 µM [Pab1 2-577];|100 µg/ml polyA,"150 mM KCl, 2.5 mM MgCl2",20 mM HEPES pH 6.4,46˚C,> 30 min,-,Gel filtration,solute,"Adding RNA increasingly inhibited Pab1 demixing. Pab1 releases RNA and demixes, forming particles stabilized by protein-protein interactions, consistent with its behavior in vivo.",19
39,198,PMID: 28306503,RNAPS0000094,https://pubmed.ncbi.nlm.nih.gov/28306503,RNA + protein,-,-,polyU(30),30nt,UUUUUUUUUUUUUUUUUUUUUUUUUUUUUU,poly RNA,-,PRPRPRPRPRPRPRPRPRPRPRPRPRPRPRPRPRPRPRPR,poly(proline−arginine)20,-,-,[PR]20:40aa,-,-,-,-,-,In vitro,0-250 µM [PR]20;|0-1 µg/µl polyU,-,100mM K2HPO4/KH2PO4 buffer,RT,-,-,"Turbidity measurement,FRAP,Cryo-EM",liquid,"This raised the idea that biological anions could support PR LLPS as well. Indeed, addition of polyU RNA promoted LLPS in a dose-dependent manner even without molecular crowders being present.",30
40,199,PMID: 28306503,RNAPS0000095,https://pubmed.ncbi.nlm.nih.gov/28306503,RNA + protein,-,-,polyU(30),30nt,UUUUUUUUUUUUUUUUUUUUUUUUUUUUUU,poly RNA,-,"sp|Q96LT7|CI072_HUMAN Guanine nucleotide exchange C9orf72 OS=Homo sapiens OX=9606 GN=C9orf72 PE=1 SV=2
MSTLCPPPSPAVAKTEIALSGKSPLLAATFAYWDNILGPRVRHIWAPKTEQVLLSDGEIT
FLANHTLNGEILRNAESGAIDVKFFVLSEKGVIIVSLIFDGNWNGDRSTYGLSIILPQTE
LSFYLPLHRVCVDRLTHIIRKGRIWMHKERQENVQKIILEGTERMEDQGQSIIPMLTGEV
IPVMELLSSMKSHSVPEEIDIADTVLNDDDIGDSCHEGFLLNAISSHLQTCGCSVVVGSS
AEKVNKIVRTLCLFLTPAERKCSRLCEAESSFKYESGLFVQGLLKDSTGSFVLPFRQVMY
APYPTTHIDVDVNTVKQMPPCHEHIYNQRRYMRSELTAFWRATSEEDMAQDTIIYTDESF
TPDLNIFQDVLHRDTLVKAFLDQVFQLKPGLSLRSTFLAQFLLVLHRKALTLIKYIEDDT
QKGKKPFKSLRNLKIDLDLTAEGDLNIIMALAEKIKPGLHSFIFGRPFYTSVQERDVLMT
F",C9orf72,-,-,481aa(1-481),Q96LT7,"DrLLPS,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-0616,http://db.phasep.pro/browse/",-,-,In vitro,0.05-0.25 µg/µL [polyU];|20 µM [C9orf72],200 µM NaCl,"50mM MES,pH 5",RT,≤ 200 min,-,FRAP,liquid,"Similar to the PEG-induced LLPS, PR20-RNA droplets were highly circular (Figure 4A). They also continuously increased in size over time, as measured by dynamic light scattering (DLS).",30
41,200,PMID: 28306503,RNAPS0000095,https://pubmed.ncbi.nlm.nih.gov/28306503,RNA + protein,-,-,polyU(30),30nt,UUUUUUUUUUUUUUUUUUUUUUUUUUUUUU,poly RNA,-,"sp|Q96LT7|CI072_HUMAN Guanine nucleotide exchange C9orf72 OS=Homo sapiens OX=9606 GN=C9orf72 PE=1 SV=2
MSTLCPPPSPAVAKTEIALSGKSPLLAATFAYWDNILGPRVRHIWAPKTEQVLLSDGEIT
FLANHTLNGEILRNAESGAIDVKFFVLSEKGVIIVSLIFDGNWNGDRSTYGLSIILPQTE
LSFYLPLHRVCVDRLTHIIRKGRIWMHKERQENVQKIILEGTERMEDQGQSIIPMLTGEV
IPVMELLSSMKSHSVPEEIDIADTVLNDDDIGDSCHEGFLLNAISSHLQTCGCSVVVGSS
AEKVNKIVRTLCLFLTPAERKCSRLCEAESSFKYESGLFVQGLLKDSTGSFVLPFRQVMY
APYPTTHIDVDVNTVKQMPPCHEHIYNQRRYMRSELTAFWRATSEEDMAQDTIIYTDESF
TPDLNIFQDVLHRDTLVKAFLDQVFQLKPGLSLRSTFLAQFLLVLHRKALTLIKYIEDDT
QKGKKPFKSLRNLKIDLDLTAEGDLNIIMALAEKIKPGLHSFIFGRPFYTSVQERDVLMT
F",C9orf72,-,-,481aa(1-481),Q96LT7,"DrLLPS,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-0616,http://db.phasep.pro/browse/",-,-,In vitro,0-1 µg/µL [polyU];|0-250 µm [C9orf72],-,"100mM K2HPO4/KH2PO4,pH 7",RT,-,-,"Turbidity measurement,FRAP,Cryo-EM",liquid,"This raised the idea that biological anions could support PR LLPS as well. Indeed, addition of polyU RNA promoted LLPS in a dose-dependent manner even without molecular crowders being present (Figures 3F, 4A, and S1E); and this was also the case for other arginine-rich peptides.",30
42,215,PMID: 28556382,RNAPS0000103,https://pubmed.ncbi.nlm.nih.gov/28556382,RNA + protein,-,-,polyU,2400-3100nt,-,poly RNA,-,RRxxxRRxxxRRxxx,RP3,-,-,15aa,-,-,-,-,-,In vitro,200 µM[RP3];|400µM[polyU],50 mM NaCl,"10mM Tris-HCl,pH 7.9",RT,≤ 60 min,other_molecular:1 µM T7 RNA polymerase,Confocal fluorescence microscopy,liquid,"RNA transcription by T7 RNA polymerase in presence of RLMs leads to the formation of phase-separated RLM/RNA droplets, while further increase in [RNA] by transcription leads to a subsequent mixing phase transition and dissolves the RLM/RNA droplets",3100
43,216,PMID: 28556382,RNAPS0000103,https://pubmed.ncbi.nlm.nih.gov/28556382,RNA + protein,-,-,polyU,2400-3100nt,-,poly RNA,-,RRxxxRRxxxRRxxx,RP3,-,-,15aa,-,-,-,-,-,In vitro,2~2000µM [RNA];|200 µM [RP3],25-225 nm NACl,"10mM Tris-HCl,pH 7.9",RT,-,-,Confocal fluorescence microscopy,"solute, liquid","We observe that RP3 and SR8 undergo sequential demixing and mixing phase transitions in response to increasing RNA concentration. These data suggest a window-like behavior for immiscibility, which is a hallmark for a reentrant phase transition. Within this window, the peptide/RNA microdroplets display liquid-like properties such as circular appearance (aspect ratio = 0.97±0.04; n =15), facile fusion, and rapid recovery of fluorescence after photobleaching.",3100
44,217,PMID: 28556382,RNAPS0000104,https://pubmed.ncbi.nlm.nih.gov/28556382,RNA + protein,-,-,polyU,2400-3100nt,-,poly RNA,-,sRsRsRsRxxxxxsRsRsRsR,SR8,-,-,21aa,-,-,-,-,-,In vitro,200µM[polyU];|200 µM[SR8],50 mM NaCl,"10mM Tris-HCl,pH 7.9",RT,-,-,Confocal fluorescence microscopy,liquid,"We observe that RP3 and SR8 undergo sequential demixing and mixing phase transitions in response to increasing RNA concentration. These data suggest a window-like behavior for immiscibility, which is a hallmark for a reentrant phase transition. Within this window, the peptide/RNA microdroplets display liquid-like properties such as circular appearance (aspect ratio = 0.97±0.04; n =15), facile fusion, and rapid recovery of fluorescence after photobleaching.",3100
45,218,PMID: 28556382,RNAPS0000105,https://pubmed.ncbi.nlm.nih.gov/28556382,RNA + protein,-,-,polyU,2400-3100nt,-,poly RNA,-,"sp|P35637|FUS_HUMAN RNA-binding protein FUS OS=Homo sapiens OX=9606 GN=FUS PE=1 SV=1
MASNDYTQQATQSYGAYPTQPGQGYSQQSSQPYGQQSYSGYSQSTDTSGYGQSSYSSYGQ
SQNTGYGTQSTPQGYGSTGGYGSSQSSQSSYGQQSSYPGYGQQPAPSSTSGSYGSSSQSS
SYGQPQSGSYSQQPSYGGQQQSYGQQQSYNPPQGYGQQNQYNSSSGGGGGGGGGGNYGQD
QSSMSSGGGSGGGYGNQDQSGGGGSGGYGQQDRGGRGRGGSGGGGGGGGGGYNRSSGGYE
PRGRGGGRGGRGGMGGSDRGGFNKFGGPRDQGSRHDSEQDNSDNNTIFVQGLGENVTIES
VADYFKQIGIIKTNKKTGQPMINLYTDRETGKLKGEATVSFDDPPSAKAAIDWFDGKEFS
GNPIKVSFATRRADFNRGGGNGRGGRGRGGPMGRGGYGGGGSGGGGRGGFPSGGGGGGGQ
QRAGDWKCPNPTCENMNFSWRNECNQCKAPKPDGPGGGPGGSHMGGNYGDDRRGGRGGYD
RGGYRGRGGDRGGFRGGRGGGDRGGFGPGKMDSRGEHRQDRRERPY",FUS,-,-,526aa(1-526),P35637,"PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/P35637,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-1390,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0002,http://db.phasep.pro/browse/","[1-507],[508-512]","[17-104],[106-261],[371-425],[450-507]",In vitro,0.3 µM[polyU];|10 µM[FUS],50 mM NaCl,"10mM Tris-HCl,pH 7.9",RT,-,-,Confocal fluorescence microscopy,liquid,"Below the threshold concentration for homologous LLPS, FUS titrated with RNA not only triggers a demixing transition into liquid droplets but also leads to droplet dissolution, which is analogous to the phase behavior of RP3 and SR8 peptides.",3100
46,230,PMID: 28683104,RNAPS0000117,https://pubmed.ncbi.nlm.nih.gov/28683104,RNA + protein,-,-,polyA,-(66-660 kDa),-,poly RNA,-,"sp|P10636-8|TAU_HUMAN Isoform Tau-F of Microtubule-associated protein tau OS=Homo sapiens OX=9606 GN=MAPT|length=187aa|residues=255-441|mutation=C291S
NVKSKIGSTENLKHQPGGGKVQIINKKLDLSNVQSKSGSKDNIKHVPGGGSVQIVYKPVD
LSKVTSKCGSLGNIHHKPGGGQVEVKSEKLDFKDRVQSKIGSLDNITHVPGGGNKKIETH
KLTFRENAKAKTDHGAEIVYKSPVVSGDTSPRHLSNVSSTGSIDMVDSPQLATLADEVSA
SLAKQGL",MAPT,C,protein_mutation:C291S,187aa(255-441),P10636,"DrLLPS,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-2853,http://db.phasep.pro/browse/","[257-264],[280-282],[284-286],[291-299],[340-350],[396-436]",-,In vitro,400 µM [Tau C];|800 µg/ml polyA,20 mM NaCl,"20 mM ammonium acetate at pH 7, 30% glycerol",RT,> 10 min,-,Confocal microscopy,liquid,"Confocal microscopy images of fluorescence-labeled tau verified that tau was predominantly contained within the droplet (Fig 4B). Depending on the specific condition, we were able to observe droplet formation with total Δtau187 protein concentration ranging between 2-400 µM, as will be discussed in greater detail next.",
47,231,PMID: 28683104,RNAPS0000117,https://pubmed.ncbi.nlm.nih.gov/28683104,RNA + protein,-,-,polyA,-(66-660 kDa),-,poly RNA,-,"sp|P10636-8|TAU_HUMAN Isoform Tau-F of Microtubule-associated protein tau OS=Homo sapiens OX=9606 GN=MAPT|length=187aa|residues=255-441|mutation=C291S
NVKSKIGSTENLKHQPGGGKVQIINKKLDLSNVQSKSGSKDNIKHVPGGGSVQIVYKPVD
LSKVTSKCGSLGNIHHKPGGGQVEVKSEKLDFKDRVQSKIGSLDNITHVPGGGNKKIETH
KLTFRENAKAKTDHGAEIVYKSPVVSGDTSPRHLSNVSSTGSIDMVDSPQLATLADEVSA
SLAKQGL",MAPT,C,protein_mutation:C291S,187aa(255-441),P10636,"DrLLPS,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-2853,http://db.phasep.pro/browse/","[257-264],[280-282],[284-286],[291-299],[340-350],[396-436]",-,In vitro,400 µM [Tau C];|[Tau C]:polyA were maintained at a mass ratio of 7:1 (corresponding to a charge ratio of 1.2:1) and a total mass concentration of 2 mg/ml,0-100 mM NaCl,20 mM ammonium acetate at pH 7,RT,> 10 min,-,Bright-field microscopy,liquid,"The systematic increase in salt concentration decreased the amount of tau-RNA droplet. This high salt concentration inhibition trend was observed repeatedly under a range of experimental conditions, including the use of different RNA types. Droplets formed in the presence of polyA and poly(U) tolerated higher than 100 mM salt concentration compared to tRNA.",
48,232,PMID: 28683104,RNAPS0000117,https://pubmed.ncbi.nlm.nih.gov/28683104,RNA + protein,-,-,polyA,-(66-660 kDa),-,poly RNA,-,"sp|P10636-8|TAU_HUMAN Isoform Tau-F of Microtubule-associated protein tau OS=Homo sapiens OX=9606 GN=MAPT|length=187aa|residues=255-441|mutation=C291S
NVKSKIGSTENLKHQPGGGKVQIINKKLDLSNVQSKSGSKDNIKHVPGGGSVQIVYKPVD
LSKVTSKCGSLGNIHHKPGGGQVEVKSEKLDFKDRVQSKIGSLDNITHVPGGGNKKIETH
KLTFRENAKAKTDHGAEIVYKSPVVSGDTSPRHLSNVSSTGSIDMVDSPQLATLADEVSA
SLAKQGL",MAPT,C,protein_mutation:C291S,187aa(255-441),P10636,"DrLLPS,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-2853,http://db.phasep.pro/browse/","[257-264],[280-282],[284-286],[291-299],[340-350],[396-436]",-,In vitro,400 µM [Tau C];|[Tau C]:polyA were maintained at a mass ratio of 7:1 (corresponding to a charge ratio of 1.2:1) and a total mass concentration of 2 mg/ml,≥150 mM NaCl,20 mM ammonium acetate at pH 7,RT,> 10 min,-,Bright-field microscopy,solute,"The systematic increase in salt concentration decreased the amount of tau-RNA droplet. This high salt concentration inhibition trend was observed repeatedly under a range of experimental conditions, including the use of different RNA types. Droplets formed in the presence of polyA and poly(U) tolerated higher than 100 mM salt concentration compared to tRNA.",
49,233,PMID: 28683104,RNAPS0000117,https://pubmed.ncbi.nlm.nih.gov/28683104,RNA + protein,-,-,polyA,-(66-660 kDa),-,poly RNA,-,"sp|P10636-8|TAU_HUMAN Isoform Tau-F of Microtubule-associated protein tau OS=Homo sapiens OX=9606 GN=MAPT|length=187aa|residues=255-441
NVKSKIGSTENLKHQPGGGKVQIINKKLDLSNVQSKCGSKDNIKHVPGGGSVQIVYKPVD
LSKVTSKCGSLGNIHHKPGGGQVEVKSEKLDFKDRVQSKIGSLDNITHVPGGGNKKIETH
KLTFRENAKAKTDHGAEIVYKSPVVSGDTSPRHLSNVSSTGSIDMVDSPQLATLADEVSA
SLAKQGL",MAPT,C,-,187aa(255-441),P10636,"DrLLPS,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-2853,http://db.phasep.pro/browse/","[255-375],[395-441]","[323-340],[380-403]",In vitro,400 µM [Tau C];|800 µg/ml polyA,-,"20 mM ammonium acetate at pH 7, 30% glycerol",RT,> 10 min,-,Bright-field microscopy,liquid,"Mixing of 4R2N or Δtau187 (similar to K18) with tRNA (25 kDa), polyA RNA (66~660 kDa), or poly(U) RNA (800~1000 kDa) reliably produced a turbid solution under a wide range of tau:RNA mass ratios and salt concentrations. According to bright-field microscopy, droplets formed and phase separated from the bulk aqueous phase with a clearly visible and highly spherical boundary. Tau droplets were capable of merging into a single droplet with the complete and nearly instantaneous loss of any boundary at the fusion interface, indicating that the droplets are fluidic with a relatively low interfacial tension.",
50,234,PMID: 28683104,RNAPS0000118,https://pubmed.ncbi.nlm.nih.gov/28683104,RNA + protein,-,-,polyU,-(800-1000 kDa),-,poly RNA,-,"sp|P10636-8|TAU_HUMAN Isoform Tau-F of Microtubule-associated protein tau OS=Homo sapiens OX=9606 GN=MAPT|length=187aa|residues=255-441|mutation=C291S
NVKSKIGSTENLKHQPGGGKVQIINKKLDLSNVQSKSGSKDNIKHVPGGGSVQIVYKPVD
LSKVTSKCGSLGNIHHKPGGGQVEVKSEKLDFKDRVQSKIGSLDNITHVPGGGNKKIETH
KLTFRENAKAKTDHGAEIVYKSPVVSGDTSPRHLSNVSSTGSIDMVDSPQLATLADEVSA
SLAKQGL",MAPT,C,protein_mutation:C291S,187aa(255-441),P10636,"DrLLPS,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-2853,http://db.phasep.pro/browse/","[257-264],[280-282],[284-286],[291-299],[340-350],[396-436]",-,In vitro,80 mM [Tau C];|120 mg/ml polyU,-,"20 mM ammonium acetate at pH 7, 0-50% glycerol",RT,> 10 min,-,Bright-field microscopy,liquid,"Specifically, at room temperature, a total protein concentration of 80 µM and in the presence of tRNA, the droplets reproducibly disappeared when the salt concentration was increased to 100 mM or higher.",
51,235,PMID: 28683104,RNAPS0000118,https://pubmed.ncbi.nlm.nih.gov/28683104,RNA + protein,-,-,polyU,-(800-1000 kDa),-,poly RNA,-,"sp|P10636-8|TAU_HUMAN Isoform Tau-F of Microtubule-associated protein tau OS=Homo sapiens OX=9606 GN=MAPT|length=187aa|residues=255-441|mutation=C291S
NVKSKIGSTENLKHQPGGGKVQIINKKLDLSNVQSKSGSKDNIKHVPGGGSVQIVYKPVD
LSKVTSKCGSLGNIHHKPGGGQVEVKSEKLDFKDRVQSKIGSLDNITHVPGGGNKKIETH
KLTFRENAKAKTDHGAEIVYKSPVVSGDTSPRHLSNVSSTGSIDMVDSPQLATLADEVSA
SLAKQGL",MAPT,C,protein_mutation:C291S,187aa(255-441),P10636,"DrLLPS,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-2853,http://db.phasep.pro/browse/","[257-264],[280-282],[284-286],[291-299],[340-350],[396-436]",-,In vitro,2.5 µM [Tau C];|7.5 µg/ml polyU,100 mM NaCl,20 mM ammonium acetate at pH 7,37˚C,> 10 min,-,Bright-field microscopy,liquid,"This observation is illustrated in a series of images presented in Fig 5E—droplets are observed at NaCl concentration as high as 100 mM and tau concentrations as low as 2.5 µM when the temperature is elevated to 37˚C, while maintaining the tau:RNA molar ratios. The quantity of droplets decreased with decreasing total tau concentration, and disappeared when tau concentration dropped from 2.5 to 1 µM.",
52,236,PMID: 28683104,RNAPS0000118,https://pubmed.ncbi.nlm.nih.gov/28683104,RNA + protein,-,-,polyU,-(800-1000 kDa),-,poly RNA,-,"sp|P10636-8|TAU_HUMAN Isoform Tau-F of Microtubule-associated protein tau OS=Homo sapiens OX=9606 GN=MAPT|length=187aa|residues=255-441|mutation=C291S
NVKSKIGSTENLKHQPGGGKVQIINKKLDLSNVQSKSGSKDNIKHVPGGGSVQIVYKPVD
LSKVTSKCGSLGNIHHKPGGGQVEVKSEKLDFKDRVQSKIGSLDNITHVPGGGNKKIETH
KLTFRENAKAKTDHGAEIVYKSPVVSGDTSPRHLSNVSSTGSIDMVDSPQLATLADEVSA
SLAKQGL",MAPT,C,protein_mutation:C291S,187aa(255-441),P10636,"DrLLPS,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-2853,http://db.phasep.pro/browse/","[257-264],[280-282],[284-286],[291-299],[340-350],[396-436]",-,In vitro,1 µM [Tau C];|3 µg/ml polyU,100 mM NaCl,20 mM ammonium acetate at pH 7,37˚C,> 10 min,-,Bright-field microscopy,solute,"This observation is illustrated in a series of images presented in Fig 5E—droplets are observed at NaCl concentration as high as 100 mM and tau concentrations as low as 2.5 µM when the temperature is elevated to 37˚C, while maintaining the tau:RNA molar ratios. The quantity of droplets decreased with decreasing total tau concentration, and disappeared when tau concentration dropped from 2.5 to 1 µM.",
53,237,PMID: 28683104,RNAPS0000118,https://pubmed.ncbi.nlm.nih.gov/28683104,RNA + protein,-,-,polyU,-(800-1000 kDa),-,poly RNA,-,"sp|P10636-8|TAU_HUMAN Isoform Tau-F of Microtubule-associated protein tau OS=Homo sapiens OX=9606 GN=MAPT|length=187aa|residues=255-441|mutation=C291S
NVKSKIGSTENLKHQPGGGKVQIINKKLDLSNVQSKSGSKDNIKHVPGGGSVQIVYKPVD
LSKVTSKCGSLGNIHHKPGGGQVEVKSEKLDFKDRVQSKIGSLDNITHVPGGGNKKIETH
KLTFRENAKAKTDHGAEIVYKSPVVSGDTSPRHLSNVSSTGSIDMVDSPQLATLADEVSA
SLAKQGL",MAPT,C,protein_mutation:C291S,187aa(255-441),P10636,"DrLLPS,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-2853,http://db.phasep.pro/browse/","[257-264],[280-282],[284-286],[291-299],[340-350],[396-436]",-,In vitro,100 µM [Tau C];|[Tau C]:polyU were maintained at approximately 1:1 charge ratio,30 mM NaCl,20 mM ammonium acetate at pH 7,≤22˚C,> 10 min,-,Bright-field microscopy,solute,The amount of tau-RNA droplet was also found to be sensitively and reversibly tunable by temperature. Droplets dissolve below 22˚C and appear at and above 23˚C.,
54,238,PMID: 28683104,RNAPS0000118,https://pubmed.ncbi.nlm.nih.gov/28683104,RNA + protein,-,-,polyU,-(800-1000 kDa),-,poly RNA,-,"sp|P10636-8|TAU_HUMAN Isoform Tau-F of Microtubule-associated protein tau OS=Homo sapiens OX=9606 GN=MAPT|length=187aa|residues=255-441|mutation=C291S
NVKSKIGSTENLKHQPGGGKVQIINKKLDLSNVQSKSGSKDNIKHVPGGGSVQIVYKPVD
LSKVTSKCGSLGNIHHKPGGGQVEVKSEKLDFKDRVQSKIGSLDNITHVPGGGNKKIETH
KLTFRENAKAKTDHGAEIVYKSPVVSGDTSPRHLSNVSSTGSIDMVDSPQLATLADEVSA
SLAKQGL",MAPT,C,protein_mutation:C291S,187aa(255-441),P10636,"DrLLPS,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-2853,http://db.phasep.pro/browse/","[257-264],[280-282],[284-286],[291-299],[340-350],[396-436]",-,In vitro,100 µM [Tau C];|[Tau C]:polyU were maintained at approximately 1:1 charge ratio,30 mM NaCl,20 mM ammonium acetate at pH 7,≥23˚C,> 10 min,-,Bright-field microscopy,liquid,The amount of tau-RNA droplet was also found to be sensitively and reversibly tunable by temperature. Droplets dissolve below 22˚C and appear at and above 23˚C.,
55,239,PMID: 28683104,RNAPS0000118,https://pubmed.ncbi.nlm.nih.gov/28683104,RNA + protein,-,-,polyU,-(800-1000 kDa),-,poly RNA,-,"sp|P10636-8|TAU_HUMAN Isoform Tau-F of Microtubule-associated protein tau OS=Homo sapiens OX=9606 GN=MAPT|length=187aa|residues=255-441|mutation=C291S
NVKSKIGSTENLKHQPGGGKVQIINKKLDLSNVQSKSGSKDNIKHVPGGGSVQIVYKPVD
LSKVTSKCGSLGNIHHKPGGGQVEVKSEKLDFKDRVQSKIGSLDNITHVPGGGNKKIETH
KLTFRENAKAKTDHGAEIVYKSPVVSGDTSPRHLSNVSSTGSIDMVDSPQLATLADEVSA
SLAKQGL",MAPT,C,protein_mutation:C291S,187aa(255-441),P10636,"DrLLPS,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-2853,http://db.phasep.pro/browse/","[257-264],[280-282],[284-286],[291-299],[340-350],[396-436]",-,In vitro,400 µM [Tau C];|[Tau C]:polyU were maintained at a mass ratio of 7:1 (corresponding to a charge ratio of 1.2:1) and a total mass concentration of 2 mg/ml,0-100 mM NaCl,20 mM ammonium acetate at pH 7,RT,> 10 min,-,Bright-field microscopy,liquid,"This high salt concentration inhibition trend was observed repeatedly under a range of experimental conditions, including the use of different RNA types. Droplets formed in the presence of polyA and poly(U) tolerated higher than 100 mM salt concentration compared to tRNA.",
56,240,PMID: 28683104,RNAPS0000118,https://pubmed.ncbi.nlm.nih.gov/28683104,RNA + protein,-,-,polyU,-(800-1000 kDa),-,poly RNA,-,"sp|P10636-8|TAU_HUMAN Isoform Tau-F of Microtubule-associated protein tau OS=Homo sapiens OX=9606 GN=MAPT|length=187aa|residues=255-441|mutation=C291S
NVKSKIGSTENLKHQPGGGKVQIINKKLDLSNVQSKSGSKDNIKHVPGGGSVQIVYKPVD
LSKVTSKCGSLGNIHHKPGGGQVEVKSEKLDFKDRVQSKIGSLDNITHVPGGGNKKIETH
KLTFRENAKAKTDHGAEIVYKSPVVSGDTSPRHLSNVSSTGSIDMVDSPQLATLADEVSA
SLAKQGL",MAPT,C,protein_mutation:C291S,187aa(255-441),P10636,"DrLLPS,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-2853,http://db.phasep.pro/browse/","[257-264],[280-282],[284-286],[291-299],[340-350],[396-436]",-,In vitro,5 µM [Tau C];|15 µg/ml polyU,-,20 mM ammonium acetate at pH 7,37˚C,> 10 min,-,Bright-field microscopy,liquid,"This general trend was observed repeatedly under a range of experimental conditions, including the use of different RNA types (Fig 5B and S6A Fig, left panel). Interestingly, droplets formed in the presence of poly(A) and poly(U) tolerated higher than 100 mM salt concentration compared to tRNA.",
57,241,PMID: 28683104,RNAPS0000118,https://pubmed.ncbi.nlm.nih.gov/28683104,RNA + protein,-,-,polyU,-(800-1000 kDa),-,poly RNA,-,"sp|P10636-8|TAU_HUMAN Isoform Tau-F of Microtubule-associated protein tau OS=Homo sapiens OX=9606 GN=MAPT|length=187aa|residues=255-441|mutation=C291S
NVKSKIGSTENLKHQPGGGKVQIINKKLDLSNVQSKSGSKDNIKHVPGGGSVQIVYKPVD
LSKVTSKCGSLGNIHHKPGGGQVEVKSEKLDFKDRVQSKIGSLDNITHVPGGGNKKIETH
KLTFRENAKAKTDHGAEIVYKSPVVSGDTSPRHLSNVSSTGSIDMVDSPQLATLADEVSA
SLAKQGL",MAPT,C,protein_mutation:C291S,187aa(255-441),P10636,"DrLLPS,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-2853,http://db.phasep.pro/browse/","[257-264],[280-282],[284-286],[291-299],[340-350],[396-436]",-,In vitro,5 µM [Tau C];|15 µg/ml polyU,100 mM NaCl,20 mM ammonium acetate at pH 7,37˚C,> 10 min,-,Bright-field microscopy,liquid,"This general trend was observed repeatedly under a range of experimental conditions, including the use of different RNA types (Fig 5B and S6A Fig, left panel). Interestingly, droplets formed in the presence of poly(A) and poly(U) tolerated higher than 100 mM salt concentration compared to tRNA.",
58,258,PMID: 29064502,RNAPS0000123,https://pubmed.ncbi.nlm.nih.gov/29064502,RNA + protein,-,-,polyA(3000),3000nt,AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA,poly RNA,-,"sp|D0PV95|DDX3_CAEEL ATP-dependent RNA helicase laf-1 OS=Caenorhabditis elegans OX=6239 GN=laf-1 PE=1 SV=1|length=708aa|residues=1-708
MESNQSNNGGSGNAALNRGGRYVPPHLRGGDGGAAAAASAGGDDRRGGAGGGGYRRGGGN
SGGGGGGGYDRGYNDNRDDRDNRGGSGGYGRDRNYEDRGYNGGGGGGGNRGYNNNRGGGG
GGYNRQDRGDGGSSNFSRGGYNNRDEGSDNRGSGRSYNNDRRDNGGDGQNTRWNNLDAPP
SRGTSKWENRGARDERIEQELFSGQLSGINFDKYEEIPVEATGDDVPQPISLFSDLSLHE
WIEENIKTAGYDRPTPVQKYSIPALQGGRDLMSCAQTGSGKTAAFLVPLVNAILQDGPDA
VHRSVTSSGGRKKQYPSALVLSPTRELSLQIFNESRKFAYRTPITSALLYGGRENYKDQI
HKLRLGCHILIATPGRLIDVMDQGLIGMEGCRYLVLDEADRMLDMGFEPQIRQIVECNRM
PSKEERITAMFSATFPKEIQLLAQDFLKENYVFLAVGRVGSTSENIMQKIVWVEEDEKRS
YLMDLLDATGDSSLTLVFVETKRGASDLAYYLNRQNYEVVTIHGDLKQFEREKHLDLFRT
GTAPILVATAVAARGLDIPNVKHVINYDLPSDVDEYVHRIGRTGRVGNVGLATSFFNDKN
RNIARELMDLIVEANQELPDWLEGMSGDMRSGGGYRGRGGRGNGQRFGGRDHRYQGGSGN
GGGGNGGGGGFGGGGQRSGGGGGFQSGGGGGRQQQQQQRAQPQQDWWS",laf-1,-,-,708aa(1-708),D0PV95,"PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/D0PV95,http://llps.biocuckoo.cn/view.php?id=LLPS-Cae-0337,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0001,http://db.phasep.pro/browse/",-,-,In vitro,0-9 mg/ml [laf-1];|75 nM polyA,0-500 mM NaCl,"20 mM Tris, pH 7.4, 1 mM DTT",RT,-,-,Confocal microscopy,"solute, liquid","In the presence of polyadenylate RNA (poly-rA) of various lengths, the low-concentration arm of the LAF-1 binodal and the concentrations corresponding to the critical region remain essentially invariant. However, upon addition of RNA we observe a marked shift of the high-concentration arm of the LAF-1 binodal, toward lower values of dense phase concentration.",3000
59,259,PMID: 29064502,RNAPS0000124,https://pubmed.ncbi.nlm.nih.gov/29064502,RNA + protein,-,-,polyA(30),30nt,AAAAAAAAAAAAAAAAAAAAAAAAAAAAAA,poly RNA,-,"sp|D0PV95|DDX3_CAEEL ATP-dependent RNA helicase laf-1 OS=Caenorhabditis elegans OX=6239 GN=laf-1 PE=1 SV=1|length=708aa|residues=1-708
MESNQSNNGGSGNAALNRGGRYVPPHLRGGDGGAAAAASAGGDDRRGGAGGGGYRRGGGN
SGGGGGGGYDRGYNDNRDDRDNRGGSGGYGRDRNYEDRGYNGGGGGGGNRGYNNNRGGGG
GGYNRQDRGDGGSSNFSRGGYNNRDEGSDNRGSGRSYNNDRRDNGGDGQNTRWNNLDAPP
SRGTSKWENRGARDERIEQELFSGQLSGINFDKYEEIPVEATGDDVPQPISLFSDLSLHE
WIEENIKTAGYDRPTPVQKYSIPALQGGRDLMSCAQTGSGKTAAFLVPLVNAILQDGPDA
VHRSVTSSGGRKKQYPSALVLSPTRELSLQIFNESRKFAYRTPITSALLYGGRENYKDQI
HKLRLGCHILIATPGRLIDVMDQGLIGMEGCRYLVLDEADRMLDMGFEPQIRQIVECNRM
PSKEERITAMFSATFPKEIQLLAQDFLKENYVFLAVGRVGSTSENIMQKIVWVEEDEKRS
YLMDLLDATGDSSLTLVFVETKRGASDLAYYLNRQNYEVVTIHGDLKQFEREKHLDLFRT
GTAPILVATAVAARGLDIPNVKHVINYDLPSDVDEYVHRIGRTGRVGNVGLATSFFNDKN
RNIARELMDLIVEANQELPDWLEGMSGDMRSGGGYRGRGGRGNGQRFGGRDHRYQGGSGN
GGGGNGGGGGFGGGGQRSGGGGGFQSGGGGGRQQQQQQRAQPQQDWWS",laf-1,-,-,708aa(1-708),D0PV95,"PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/D0PV95,http://llps.biocuckoo.cn/view.php?id=LLPS-Cae-0337,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0001,http://db.phasep.pro/browse/",-,-,In vitro,0-9 mg/ml [laf-1];|7.5 µM polyA,0-500 mM NaCl,"20 mM Tris, pH 7.4, 1 mM DTT",RT,-,-,Confocal microscopy,"solute, liquid","In the presence of polyadenylate RNA (poly-rA) of various lengths, the low-concentration arm of the LAF-1 binodal and the concentrations corresponding to the critical region remain essentially invariant. However, upon addition of RNA we observe a marked shift of the high-concentration arm of the LAF-1 binodal, toward lower values of dense phase concentration.",30
60,260,PMID: 29064502,RNAPS0000125,https://pubmed.ncbi.nlm.nih.gov/29064502,RNA + protein,-,-,polyA(15),15nt,AAAAAAAAAAAAAAA,poly RNA,-,"sp|D0PV95|DDX3_CAEEL ATP-dependent RNA helicase laf-1 OS=Caenorhabditis elegans OX=6239 GN=laf-1 PE=1 SV=1|length=708aa|residues=1-708
MESNQSNNGGSGNAALNRGGRYVPPHLRGGDGGAAAAASAGGDDRRGGAGGGGYRRGGGN
SGGGGGGGYDRGYNDNRDDRDNRGGSGGYGRDRNYEDRGYNGGGGGGGNRGYNNNRGGGG
GGYNRQDRGDGGSSNFSRGGYNNRDEGSDNRGSGRSYNNDRRDNGGDGQNTRWNNLDAPP
SRGTSKWENRGARDERIEQELFSGQLSGINFDKYEEIPVEATGDDVPQPISLFSDLSLHE
WIEENIKTAGYDRPTPVQKYSIPALQGGRDLMSCAQTGSGKTAAFLVPLVNAILQDGPDA
VHRSVTSSGGRKKQYPSALVLSPTRELSLQIFNESRKFAYRTPITSALLYGGRENYKDQI
HKLRLGCHILIATPGRLIDVMDQGLIGMEGCRYLVLDEADRMLDMGFEPQIRQIVECNRM
PSKEERITAMFSATFPKEIQLLAQDFLKENYVFLAVGRVGSTSENIMQKIVWVEEDEKRS
YLMDLLDATGDSSLTLVFVETKRGASDLAYYLNRQNYEVVTIHGDLKQFEREKHLDLFRT
GTAPILVATAVAARGLDIPNVKHVINYDLPSDVDEYVHRIGRTGRVGNVGLATSFFNDKN
RNIARELMDLIVEANQELPDWLEGMSGDMRSGGGYRGRGGRGNGQRFGGRDHRYQGGSGN
GGGGNGGGGGFGGGGQRSGGGGGFQSGGGGGRQQQQQQRAQPQQDWWS",laf-1,-,-,708aa(1-708),D0PV95,"PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/D0PV95,http://llps.biocuckoo.cn/view.php?id=LLPS-Cae-0337,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0001,http://db.phasep.pro/browse/",-,-,In vitro,0-9 mg/ml [laf-1];|15 µM polyA,0-500 mM NaCl,"20 mM Tris, pH 7.4, 1 mM DTT",RT,-,-,Confocal microscopy,"solute, liquid","In the presence of polyadenylate RNA (poly-rA) of various lengths, the low-concentration arm of the LAF-1 binodal and the concentrations corresponding to the critical region remain essentially invariant. However, upon addition of RNA we observe a marked shift of the high-concentration arm of the LAF-1 binodal, toward lower values of dense phase concentration.",15
61,290,PMID: 29483269,RNAPS0000145,https://pubmed.ncbi.nlm.nih.gov/29483269,RNA,-,-,polyA,-,-,poly RNA,-,-,-,-,-,-,-,-,-,-,-,In vitro,500 µg/mL homopolymers,750 mM NaCl,-,RT,-,crowding agent:10% PEG(MW3350),Laser scanning confocal microscopy,"solute, liquid","Evidence that non-Watson-Crick interactions can promote RNA self-assembly is that all four homopolymers self-assemble, with polyU forming rapidly relaxing droplets [as previously observed (32)], polyC forming slower relaxing droplets, polyA forming asymmetrical assemblies with very slow relaxation rates, and polyG forming an aggregate that is presumably based on G-quadruplexes (Fig. 2C and Fig. S4).",0
62,291,PMID: 29483269,RNAPS0000146,https://pubmed.ncbi.nlm.nih.gov/29483269,RNA,-,-,polyU,-,-,poly RNA,-,-,-,-,-,-,-,-,-,-,-,In vitro,500 µg/mL homopolymers,750 mM NaCl,-,RT,-,crowding agent:10% PEG(MW3350),Laser scanning confocal microscopy,"solute, liquid","Evidence that non-Watson-Crick interactions can promote RNA self-assembly is that all four homopolymers self-assemble, with polyU forming rapidly relaxing droplets [as previously observed (32)], polyC forming slower relaxing droplets, polyA forming asymmetrical assemblies with very slow relaxation rates, and polyG forming an aggregate that is presumably based on G-quadruplexes (Fig. 2C and Fig. S4).",0
63,292,PMID: 29483269,RNAPS0000147,https://pubmed.ncbi.nlm.nih.gov/29483269,RNA,-,-,polyG,-,-,poly RNA,-,-,-,-,-,-,-,-,-,-,-,In vitro,500 µg/mL homopolymers,750 mM NaCl,-,RT,-,crowding agent:10% PEG(MW3350),Laser scanning confocal microscopy,solid,"Evidence that non-Watson-Crick interactions can promote RNA self-assembly is that all four homopolymers self-assemble, with polyU forming rapidly relaxing droplets [as previously observed (32)], polyC forming slower relaxing droplets, polyA forming asymmetrical assemblies with very slow relaxation rates, and polyG forming an aggregate that is presumably based on G-quadruplexes (Fig. 2C and Fig. S4).",0
64,293,PMID: 29483269,RNAPS0000148,https://pubmed.ncbi.nlm.nih.gov/29483269,RNA,-,-,polyC,-,-,poly RNA,-,-,-,-,-,-,-,-,-,-,-,In vitro,500 µg/mL homopolymers,750 mM NaCl,-,RT,-,crowding agent:10% PEG(MW3350),Laser scanning confocal microscopy,"solute, liquid","Evidence that non-Watson-Crick interactions can promote RNA self-assembly is that all four homopolymers self-assemble, with polyU forming rapidly relaxing droplets [as previously observed (32)], polyC forming slower relaxing droplets, polyA forming asymmetrical assemblies with very slow relaxation rates, and polyG forming an aggregate that is presumably based on G-quadruplexes (Fig. 2C and Fig. S4).",0
65,439,PMID: 30197298,RNAPS0000246,https://pubmed.ncbi.nlm.nih.gov/30197298,RNA + protein,-,-,polyA,-,-,poly RNA,-,"tr|Q9A749|Q9A749_CAUVC Ribonuclease E OS=Caulobacter vibrioides (strain ATCC 19089 / CB15) OX=190650 GN=rne PE=1 SV=1|length=448aa|residues=451-898
TGVLEGTTHVCEHCEGTGRVRSVESSALAALRAVEAEALKGSGSVILKVSRSVGLYILNE
KRDYLQRLLTTHGLFVSVVVDDSLHAGDQEIERTELGERIAVAPPPFVEEDDDFDPNAYD
DEEEEDDVILDDEDDTDREDTDDDDATTRKSARDDERGDRKGRRGRRDRNRGRGRRDERD
GETESEDEDVVAEGADEDRGEFGDDDEGGRRRRRRGRRGGRRGGREDGDRPTDAFVWIRP
RVPFGENVFTWHDPAALVGGGESRRQAPEPRVDAATEAAPRPERAEREERPGRERGRRGR
DRGRRQRDEAPVAEMTSVESATVEAAEPFEAPILAPPVIAGPPADVWVELPEVEEAPKKP
KRSRARGKKATETSVEAIDTVTEVAAEAPAPETAEPEAVEVAPPAPTVEAAPEPGPVVEA
VEEAQPAEPDPNEITAPPEKPRRGWWRR",rne,CTD,-,448aa(451-898),Q9A749,"PhaSePro,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q9A749,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0174,http://db.phasep.pro/browse/","[545-686],[706-774],[802-828],[856-884],[890-892],[898-898]","[469-489],[554-680],[727-761],[830-879]",In vitro,12.4 µM [rne CTD];|10 µg/mL polyA,≤25 mM NaCl,20 mM Tris-Cl pH 7.4,4˚C,≤ 1 h,-,Microscopy,solute,"Because in vivo RNase E foci required the presence of RNA, whether addition of RNA could induce LLPS of the CTD-YFP protein in vitro was tested. Addition of 5–175 mg/mL poly-A RNA at a low concentration (12.4 mM) of CTD-YFP induced LLPS condensates and broadened the range in salt concentration over which they assemble",0
66,440,PMID: 30197298,RNAPS0000246,https://pubmed.ncbi.nlm.nih.gov/30197298,RNA + protein,-,-,polyA,-,-,poly RNA,-,"tr|Q9A749|Q9A749_CAUVC Ribonuclease E OS=Caulobacter vibrioides (strain ATCC 19089 / CB15) OX=190650 GN=rne PE=1 SV=1|length=448aa|residues=451-898
TGVLEGTTHVCEHCEGTGRVRSVESSALAALRAVEAEALKGSGSVILKVSRSVGLYILNE
KRDYLQRLLTTHGLFVSVVVDDSLHAGDQEIERTELGERIAVAPPPFVEEDDDFDPNAYD
DEEEEDDVILDDEDDTDREDTDDDDATTRKSARDDERGDRKGRRGRRDRNRGRGRRDERD
GETESEDEDVVAEGADEDRGEFGDDDEGGRRRRRRGRRGGRRGGREDGDRPTDAFVWIRP
RVPFGENVFTWHDPAALVGGGESRRQAPEPRVDAATEAAPRPERAEREERPGRERGRRGR
DRGRRQRDEAPVAEMTSVESATVEAAEPFEAPILAPPVIAGPPADVWVELPEVEEAPKKP
KRSRARGKKATETSVEAIDTVTEVAAEAPAPETAEPEAVEVAPPAPTVEAAPEPGPVVEA
VEEAQPAEPDPNEITAPPEKPRRGWWRR",rne,CTD,-,448aa(451-898),Q9A749,"PhaSePro,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q9A749,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0174,http://db.phasep.pro/browse/","[545-686],[706-774],[802-828],[856-884],[890-892],[898-898]","[469-489],[554-680],[727-761],[830-879]",In vitro,12.4 µM [rne CTD];|10 µg/mL polyA,≥200 mM NaCl,20 mM Tris-Cl pH 7.4,4˚C,≤ 1 h,-,Microscopy,solute,"Because in vivo RNase E foci required the presence of RNA, whether addition of RNA could induce LLPS of the CTD-YFP protein in vitro was tested. Addition of 5–175 mg/mL poly-A RNA at a low concentration (12.4 mM) of CTD-YFP induced LLPS condensates and broadened the range in salt concentration over which they assemble",0
67,441,PMID: 30197298,RNAPS0000246,https://pubmed.ncbi.nlm.nih.gov/30197298,RNA + protein,-,-,polyA,-,-,poly RNA,-,"tr|Q9A749|Q9A749_CAUVC Ribonuclease E OS=Caulobacter vibrioides (strain ATCC 19089 / CB15) OX=190650 GN=rne PE=1 SV=1|length=448aa|residues=451-898
TGVLEGTTHVCEHCEGTGRVRSVESSALAALRAVEAEALKGSGSVILKVSRSVGLYILNE
KRDYLQRLLTTHGLFVSVVVDDSLHAGDQEIERTELGERIAVAPPPFVEEDDDFDPNAYD
DEEEEDDVILDDEDDTDREDTDDDDATTRKSARDDERGDRKGRRGRRDRNRGRGRRDERD
GETESEDEDVVAEGADEDRGEFGDDDEGGRRRRRRGRRGGRRGGREDGDRPTDAFVWIRP
RVPFGENVFTWHDPAALVGGGESRRQAPEPRVDAATEAAPRPERAEREERPGRERGRRGR
DRGRRQRDEAPVAEMTSVESATVEAAEPFEAPILAPPVIAGPPADVWVELPEVEEAPKKP
KRSRARGKKATETSVEAIDTVTEVAAEAPAPETAEPEAVEVAPPAPTVEAAPEPGPVVEA
VEEAQPAEPDPNEITAPPEKPRRGWWRR",rne,CTD,-,448aa(451-898),Q9A749,"PhaSePro,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q9A749,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0174,http://db.phasep.pro/browse/","[545-686],[706-774],[802-828],[856-884],[890-892],[898-898]","[469-489],[554-680],[727-761],[830-879]",In vitro,12.4 µM [rne CTD];|5-175 µg/mL polyA,100 mM NaCl,20 mM Tris-Cl pH 7.4,4˚C,≤ 1 h,-,Microscopy,liquid,"Addition of 5-175 µg/mL poly-A RNA at a low concentration (12.4 µM) of CTD-YFP induced LLPS condensates and broadened the range in salt concentration over which they assemble. Interestingly, addition of excess poly-A RNA above 175 µg/mL prevented the assembly of condensates.",0
68,442,PMID: 30197298,RNAPS0000246,https://pubmed.ncbi.nlm.nih.gov/30197298,RNA + protein,-,-,polyA,-,-,poly RNA,-,"tr|Q9A749|Q9A749_CAUVC Ribonuclease E OS=Caulobacter vibrioides (strain ATCC 19089 / CB15) OX=190650 GN=rne PE=1 SV=1|length=448aa|residues=451-898
TGVLEGTTHVCEHCEGTGRVRSVESSALAALRAVEAEALKGSGSVILKVSRSVGLYILNE
KRDYLQRLLTTHGLFVSVVVDDSLHAGDQEIERTELGERIAVAPPPFVEEDDDFDPNAYD
DEEEEDDVILDDEDDTDREDTDDDDATTRKSARDDERGDRKGRRGRRDRNRGRGRRDERD
GETESEDEDVVAEGADEDRGEFGDDDEGGRRRRRRGRRGGRRGGREDGDRPTDAFVWIRP
RVPFGENVFTWHDPAALVGGGESRRQAPEPRVDAATEAAPRPERAEREERPGRERGRRGR
DRGRRQRDEAPVAEMTSVESATVEAAEPFEAPILAPPVIAGPPADVWVELPEVEEAPKKP
KRSRARGKKATETSVEAIDTVTEVAAEAPAPETAEPEAVEVAPPAPTVEAAPEPGPVVEA
VEEAQPAEPDPNEITAPPEKPRRGWWRR",rne,CTD,-,448aa(451-898),Q9A749,"PhaSePro,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q9A749,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0174,http://db.phasep.pro/browse/","[545-686],[706-774],[802-828],[856-884],[890-892],[898-898]","[469-489],[554-680],[727-761],[830-879]",In vitro,12.4 µM [rne CTD];|0-5 µg/mL polyA,100 mM NaCl,20 mM Tris-Cl pH 7.4,4˚C,≤ 1 h,-,Microscopy,solute,"Addition of 5-175 µg/mL poly-A RNA at a low concentration (12.4 µM) of CTD-YFP induced LLPS condensates and broadened the range in salt concentration over which they assemble. Interestingly, addition of excess poly-A RNA above 175 µg/mL prevented the assembly of condensates.",0
69,443,PMID: 30197298,RNAPS0000246,https://pubmed.ncbi.nlm.nih.gov/30197298,RNA + protein,-,-,polyA,-,-,poly RNA,-,"tr|Q9A749|Q9A749_CAUVC Ribonuclease E OS=Caulobacter vibrioides (strain ATCC 19089 / CB15) OX=190650 GN=rne PE=1 SV=1|length=448aa|residues=451-898
TGVLEGTTHVCEHCEGTGRVRSVESSALAALRAVEAEALKGSGSVILKVSRSVGLYILNE
KRDYLQRLLTTHGLFVSVVVDDSLHAGDQEIERTELGERIAVAPPPFVEEDDDFDPNAYD
DEEEEDDVILDDEDDTDREDTDDDDATTRKSARDDERGDRKGRRGRRDRNRGRGRRDERD
GETESEDEDVVAEGADEDRGEFGDDDEGGRRRRRRGRRGGRRGGREDGDRPTDAFVWIRP
RVPFGENVFTWHDPAALVGGGESRRQAPEPRVDAATEAAPRPERAEREERPGRERGRRGR
DRGRRQRDEAPVAEMTSVESATVEAAEPFEAPILAPPVIAGPPADVWVELPEVEEAPKKP
KRSRARGKKATETSVEAIDTVTEVAAEAPAPETAEPEAVEVAPPAPTVEAAPEPGPVVEA
VEEAQPAEPDPNEITAPPEKPRRGWWRR",rne,CTD,-,448aa(451-898),Q9A749,"PhaSePro,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q9A749,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0174,http://db.phasep.pro/browse/","[545-686],[706-774],[802-828],[856-884],[890-892],[898-898]","[469-489],[554-680],[727-761],[830-879]",In vitro,12.4 µM [rne CTD];|175-250 µg/mL polyA,100 mM NaCl,20 mM Tris-Cl pH 7.4,4˚C,≤ 1 h,-,Microscopy,solute,"Addition of 5-175 µg/mL poly-A RNA at a low concentration (12.4 µM) of CTD-YFP induced LLPS condensates and broadened the range in salt concentration over which they assemble. Interestingly, addition of excess poly-A RNA above 175 µg/mL prevented the assembly of condensates.",0
70,444,PMID: 30197298,RNAPS0000246,https://pubmed.ncbi.nlm.nih.gov/30197298,RNA + protein,-,-,polyA,-,-,poly RNA,-,"tr|Q9A749|Q9A749_CAUVC Ribonuclease E OS=Caulobacter vibrioides (strain ATCC 19089 / CB15) OX=190650 GN=rne PE=1 SV=1|length=448aa|residues=451-898
TGVLEGTTHVCEHCEGTGRVRSVESSALAALRAVEAEALKGSGSVILKVSRSVGLYILNE
KRDYLQRLLTTHGLFVSVVVDDSLHAGDQEIERTELGERIAVAPPPFVEEDDDFDPNAYD
DEEEEDDVILDDEDDTDREDTDDDDATTRKSARDDERGDRKGRRGRRDRNRGRGRRDERD
GETESEDEDVVAEGADEDRGEFGDDDEGGRRRRRRGRRGGRRGGREDGDRPTDAFVWIRP
RVPFGENVFTWHDPAALVGGGESRRQAPEPRVDAATEAAPRPERAEREERPGRERGRRGR
DRGRRQRDEAPVAEMTSVESATVEAAEPFEAPILAPPVIAGPPADVWVELPEVEEAPKKP
KRSRARGKKATETSVEAIDTVTEVAAEAPAPETAEPEAVEVAPPAPTVEAAPEPGPVVEA
VEEAQPAEPDPNEITAPPEKPRRGWWRR",rne,CTD,-,448aa(451-898),Q9A749,"PhaSePro,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q9A749,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0174,http://db.phasep.pro/browse/","[545-686],[706-774],[802-828],[856-884],[890-892],[898-898]","[469-489],[554-680],[727-761],[830-879]",In vitro,12.4 µM [rne CTD];|10 µg/mL polyA,50-175 mM NaCl,20 mM Tris-Cl pH 7.4,4˚C,≤ 1 h,-,Microscopy,liquid,"Because in vivo RNase E foci required the presence of RNA, whether addition of RNA could induce LLPS of the CTD-YFP protein in vitro was tested. Addition of 5–175 mg/mL poly-A RNA at a low concentration (12.4 mM) of CTD-YFP induced LLPS condensates and broadened the range in salt concentration over which they assemble",0
71,458,PMID: 30442662,RNAPS0000254,https://pubmed.ncbi.nlm.nih.gov/30442662,RNA + protein,-,-,polyU(40),40nt,UUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUU,poly RNA,-,"sp|P35637|FUS_HUMAN RNA-binding protein FUS OS=Homo sapiens OX=9606 GN=FUS PE=1 SV=1|length=526aa|residues=1-526|mutation=R244C
MASNDYTQQATQSYGAYPTQPGQGYSQQSSQPYGQQSYSGYSQSTDTSGYGQSSYSSYGQ
SQNTGYGTQSTPQGYGSTGGYGSSQSSQSSYGQQSSYPGYGQQPAPSSTSGSYGSSSQSS
SYGQPQSGSYSQQPSYGGQQQSYGQQQSYNPPQGYGQQNQYNSSSGGGGGGGGGGNYGQD
QSSMSSGGGSGGGYGNQDQSGGGGSGGYGQQDRGGRGRGGSGGGGGGGGGGYNRSSGGYE
PRGCGGGRGGRGGMGGSDRGGFNKFGGPRDQGSRHDSEQDNSDNNTIFVQGLGENVTIES
VADYFKQIGIIKTNKKTGQPMINLYTDRETGKLKGEATVSFDDPPSAKAAIDWFDGKEFS
GNPIKVSFATRRADFNRGGGNGRGGRGRGGPMGRGGYGGGGSGGGGRGGFPSGGGGGGGQ
QRAGDWKCPNPTCENMNFSWRNECNQCKAPKPDGPGGGPGGSHMGGNYGDDRRGGRGGYD
RGGYRGRGGDRGGFRGGRGGGDRGGFGPGKMDSRGEHRQDRRERPY",FUS,-,protein_mutation:R244C,526aa(1-526),P35637,"PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/P35637,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-1390,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0002,http://db.phasep.pro/browse/","[3-251],[284-292],[332-338],[375-415],[451-499],[501-501],[503-505],[507-526]",-,In vitro,1 µM [FUS];|1 µM polyU,100 mM NaCl,"50 mM Tris·HCl (pH 7.4), 1 mM EDTA, 1 mM DTT",RT,≤ 20 h,-,Microscopy,"liquid, solid","Within a period of 20 h, FUS_M(R244C)-RNA droplets formed and increased in both size and number. When UBQLN2 was present, the FUS_M(R244C)-RNA droplets formed were smaller in size but more numerous compared with those formed in the absence of UBQLN2. Notably, the FUS_M(R244C)-RNA droplets in the absence of UBQLN2 displayed nonspherical, irregular patterns, whereas those in the presence of UBQLN2 remained highly spherical over the entire time course. These nonspherical irregular droplets may represent the transition from the reversible liquid-like, phase-separated state of FUS to a more stable, solid state of FUS.",40
72,459,PMID: 30442662,RNAPS0000255,https://pubmed.ncbi.nlm.nih.gov/30442662,RNA + proteins,-,-,polyU(40),40nt,UUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUU,poly RNA,-,"sp|P35637|FUS_HUMAN RNA-binding protein FUS OS=Homo sapiens OX=9606 GN=FUS PE=1 SV=1|length=526aa|residues=1-526|mutation=R244C
MASNDYTQQATQSYGAYPTQPGQGYSQQSSQPYGQQSYSGYSQSTDTSGYGQSSYSSYGQ
SQNTGYGTQSTPQGYGSTGGYGSSQSSQSSYGQQSSYPGYGQQPAPSSTSGSYGSSSQSS
SYGQPQSGSYSQQPSYGGQQQSYGQQQSYNPPQGYGQQNQYNSSSGGGGGGGGGGNYGQD
QSSMSSGGGSGGGYGNQDQSGGGGSGGYGQQDRGGRGRGGSGGGGGGGGGGYNRSSGGYE
PRGCGGGRGGRGGMGGSDRGGFNKFGGPRDQGSRHDSEQDNSDNNTIFVQGLGENVTIES
VADYFKQIGIIKTNKKTGQPMINLYTDRETGKLKGEATVSFDDPPSAKAAIDWFDGKEFS
GNPIKVSFATRRADFNRGGGNGRGGRGRGGPMGRGGYGGGGSGGGGRGGFPSGGGGGGGQ
QRAGDWKCPNPTCENMNFSWRNECNQCKAPKPDGPGGGPGGSHMGGNYGDDRRGGRGGYD
RGGYRGRGGDRGGFRGGRGGGDRGGFGPGKMDSRGEHRQDRRERPY;
sp|Q9UHD9|UBQL2_HUMAN Ubiquilin-2 OS=Homo sapiens OX=9606 GN=UBQLN2 PE=1 SV=2|length=624aa|residues=1-624
MAENGESSGPPRPSRGPAAAQGSAAAPAEPKIIKVTVKTPKEKEEFAVPENSSVQQFKEA
ISKRFKSQTDQLVLIFAGKILKDQDTLIQHGIHDGLTVHLVIKSQNRPQGQSTQPSNAAG
TNTTSASTPRSNSTPISTNSNPFGLGSLGGLAGLSSLGLSSTNFSELQSQMQQQLMASPE
MMIQIMENPFVQSMLSNPDLMRQLIMANPQMQQLIQRNPEISHLLNNPDIMRQTLEIARN
PAMMQEMMRNQDLALSNLESIPGGYNALRRMYTDIQEPMLNAAQEQFGGNPFASVGSSSS
SGEGTQPSRTENRDPLPNPWAPPPATQSSATTSTTTSTGSGSGNSSSNATGNTVAAANYV
ASIFSTPGMQSLLQQITENPQLIQNMLSAPYMRSMMQSLSQNPDLAAQMMLNSPLFTANP
QLQEQMRPQLPAFLQQMQNPDTLSAMSNPRAMQALMQIQQGLQTLATEAPGLIPSFTPGV
GVGVLGTAIGPVGPVTPIGPIGPIVPFTPIGPIGPIGPTGPAAPPGSTGSGGPTGPTVSS
AAPSETTSPTSESGPNQQFIQQMVQALAGANAPQLPNPEVRFQQQLEQLNAMGFLNREAN
LQALIATGGDINAAIERLLGSQPS",FUS;|UBQLN2,-;|-,protein_mutation:R244C;|protein_mutation:-,526aa(1-526);|624aa(1-624),P35637;Q9UHD9,"PhaSePro,DrLLPS,LLPSDB,PhaSepDB;PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/P35637,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-1390,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0002,http://db.phasep.pro/browse/;https://phasepro.elte.hu/entry/Q9UHD9,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-0803,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0038,http://db.phasep.pro/browse/","[3-251],[284-292],[332-338],[375-415],[451-499],[501-501],[503-505],[507-526];|[450-624]",-;|-,In vitro,1 µM [FUS];|4 µM [UBQLN2];|1 µM polyU,100 mM NaCl,"50 mM Tris·HCl (pH 7.4), 1 mM EDTA, 1 mM DTT",RT,≤ 20 h,-,Microscopy,liquid,"Within a period of 20 h, FUS_M(R244C)-RNA droplets formed and increased in both size and number. When UBQLN2 was present, the FUS_M(R244C)-RNA droplets formed were smaller in size but more numerous compared with those formed in the absence of UBQLN2. Notably, the FUS_M(R244C)-RNA droplets in the absence of UBQLN2 displayed nonspherical, irregular patterns, whereas those in the presence of UBQLN2 remained highly spherical over the entire time course. These nonspherical irregular droplets may represent the transition from the reversible liquid-like, phase-separated state of FUS to a more stable, solid state of FUS.",40
73,460,PMID: 30648970,RNAPS0000087,https://pubmed.ncbi.nlm.nih.gov/30648970,RNA + protein,-,-,polyU,-,-,poly RNA,-,"sp|P39517|DHH1_YEAST ATP-dependent RNA helicase DHH1 OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) OX=559292 GN=DHH1 PE=1 SV=1|length=506aa|residues=1-506
MGSINNNFNTNNNSNTDLDRDWKTALNIPKKDTRPQTDDVLNTKGNTFEDFYLKRELLMG
IFEAGFEKPSPIQEEAIPVAITGRDILARAKNGTGKTAAFVIPTLEKVKPKLNKIQALIM
VPTRELALQTSQVVRTLGKHCGISCMVTTGGTNLRDDILRLNETVHILVGTPGRVLDLAS
RKVADLSDCSLFIMDEADKMLSRDFKTIIEQILSFLPPTHQSLLFSATFPLTVKEFMVKH
LHKPYEINLMEELTLKGITQYYAFVEERQKLHCLNTLFSKLQINQAIIFCNSTNRVELLA
KKITDLGYSCYYSHARMKQQERNKVFHEFRQGKVRTLVCSDLLTRGIDIQAVNVVINFDF
PKTAETYLHRIGRSGRFGHLGLAINLINWNDRFNLYKIEQELGTEIAAIPATIDKSLYVA
ENDETVPVPFPIEQQSYHQQAIPQQQLPSQQQFAIPPQQHHPQFMVPPSHQQQQAYPPPQ
MPSQQGYPPQQEHFMAMPPGQSQPQY",DHH1,-,-,506aa(1-506),P39517,"DrLLPS,LLPSDB,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Sac-0503,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0168,http://db.phasep.pro/browse/",-,-,In vitro,2 µM [DHH1];|0.1 mg/ml polyU,"150 mM KCl, 2 mM MgCl2",30 mM HEPES-KOH pH 7.4,RT,> 20 min,other_molecular:5 mM ATP,Fluorescence microscopy,liquid,"We found a stoichiometric ratio of 2.7:1 ± 0.13 of Dhh1 to Pat1 in the in vitro phase-separated droplets, closely resembling the Dhh1:Pat1 ratio of mature PBs in vivo.",0
74,461,PMID: 30648970,RNAPS0000087,https://pubmed.ncbi.nlm.nih.gov/30648970,RNA + protein,-,-,polyU,-,-,poly RNA,-,"sp|P39517|DHH1_YEAST ATP-dependent RNA helicase DHH1 OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) OX=559292 GN=DHH1 PE=1 SV=1|length=506aa|residues=1-506
MGSINNNFNTNNNSNTDLDRDWKTALNIPKKDTRPQTDDVLNTKGNTFEDFYLKRELLMG
IFEAGFEKPSPIQEEAIPVAITGRDILARAKNGTGKTAAFVIPTLEKVKPKLNKIQALIM
VPTRELALQTSQVVRTLGKHCGISCMVTTGGTNLRDDILRLNETVHILVGTPGRVLDLAS
RKVADLSDCSLFIMDEADKMLSRDFKTIIEQILSFLPPTHQSLLFSATFPLTVKEFMVKH
LHKPYEINLMEELTLKGITQYYAFVEERQKLHCLNTLFSKLQINQAIIFCNSTNRVELLA
KKITDLGYSCYYSHARMKQQERNKVFHEFRQGKVRTLVCSDLLTRGIDIQAVNVVINFDF
PKTAETYLHRIGRSGRFGHLGLAINLINWNDRFNLYKIEQELGTEIAAIPATIDKSLYVA
ENDETVPVPFPIEQQSYHQQAIPQQQLPSQQQFAIPPQQHHPQFMVPPSHQQQQAYPPPQ
MPSQQGYPPQQEHFMAMPPGQSQPQY",DHH1,-,-,506aa(1-506),P39517,"DrLLPS,LLPSDB,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Sac-0503,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0168,http://db.phasep.pro/browse/",-,-,In vitro,4 µM [DHH1];|0.2 mg/ml polyU,"150 mM KCl, 2 mM MgCl2",30 mM HEPES-KOH pH 7.4,RT,> 20 min,other_molecular:3.2 mM ATP,Fluorescence microscopy,liquid,"We therefore next analyzed whether the Pat1-Dhh1 droplets are still responsive to Not1. Similar to what we observed in vivo (Figure 5), Not1MIF4G also diminishes formation Dhh1 droplets in the presence of Pat1 in vitro (Figure 6B).",0
75,462,PMID: 30648970,RNAPS0000088,https://pubmed.ncbi.nlm.nih.gov/30648970,RNA + proteins,-,-,polyU,-,-,poly RNA,-,"sp|P39517|DHH1_YEAST ATP-dependent RNA helicase DHH1 OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) OX=559292 GN=DHH1 PE=1 SV=1|length=506aa|residues=1-506
MGSINNNFNTNNNSNTDLDRDWKTALNIPKKDTRPQTDDVLNTKGNTFEDFYLKRELLMG
IFEAGFEKPSPIQEEAIPVAITGRDILARAKNGTGKTAAFVIPTLEKVKPKLNKIQALIM
VPTRELALQTSQVVRTLGKHCGISCMVTTGGTNLRDDILRLNETVHILVGTPGRVLDLAS
RKVADLSDCSLFIMDEADKMLSRDFKTIIEQILSFLPPTHQSLLFSATFPLTVKEFMVKH
LHKPYEINLMEELTLKGITQYYAFVEERQKLHCLNTLFSKLQINQAIIFCNSTNRVELLA
KKITDLGYSCYYSHARMKQQERNKVFHEFRQGKVRTLVCSDLLTRGIDIQAVNVVINFDF
PKTAETYLHRIGRSGRFGHLGLAINLINWNDRFNLYKIEQELGTEIAAIPATIDKSLYVA
ENDETVPVPFPIEQQSYHQQAIPQQQLPSQQQFAIPPQQHHPQFMVPPSHQQQQAYPPPQ
MPSQQGYPPQQEHFMAMPPGQSQPQY;
sp|P25655|NOT1_YEAST General negative regulator of transcription subunit 1 OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) OX=559292 GN=CDC39 PE=1 SV=3|length=247aa|residues=754-1000
RSRPVQEMIPLKFFAVDEVSCQINQEGAPKDVVEKVLFVLNNVTLANLNNKVDELKKSLT
PNYFSWFSTYLVTQRAKTEPNYHDLYSKVIVAMGSGLLHQFMVNVTLRQLFVLLSTKDEQ
AIDKKHLKNLASWLGCITLALNKPIKHKNIAFREMLIEAYKENRLEIVVPFVTKILQRAS
ESKIFKPPNPWTVGILKLLIELNEKANWKLSLTFEVEVLLKSFNLTTKSLKPSNFINTPE
VIETLSG",DHH1;|NOT1,[DHH1]:-;|[NOT1]:MIF4G,-;|-,506aa(1-506);|247aa(754-1000),P39517;P25655,"DrLLPS,LLPSDB,PhaSepDB;DrLLPS,LLPSDB,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Sac-0503,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0168,http://db.phasep.pro/browse/;http://llps.biocuckoo.cn/view.php?id=LLPS-Sac-0403,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0169,http://db.phasep.pro/browse/",-;|-,-;|-,In vitro,4 µM [DHH1];|4 µM [NOT1 MIF4G];|0.2 mg/ml polyU,"150 mM KCl, 2 mM MgCl2",30 mM HEPES-KOH pH 7.4,RT,> 20 min,other_molecular:3.2 mM ATP,Fluorescence microscopy,solute,"We therefore next analyzed whether the Pat1-Dhh1 droplets are still responsive to Not1. Similar to what we observed in vivo (Figure 5), Not1MIF4G also diminishes formation Dhh1 droplets in the presence of Pat1 in vitro (Figure 6B).",0
76,463,PMID: 30648970,RNAPS0000256,https://pubmed.ncbi.nlm.nih.gov/30648970,RNA + proteins,-,-,polyU,-,-,poly RNA,-,"sp|P39517|DHH1_YEAST ATP-dependent RNA helicase DHH1 OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) OX=559292 GN=DHH1 PE=1 SV=1|length=506aa|residues=1-506
MGSINNNFNTNNNSNTDLDRDWKTALNIPKKDTRPQTDDVLNTKGNTFEDFYLKRELLMG
IFEAGFEKPSPIQEEAIPVAITGRDILARAKNGTGKTAAFVIPTLEKVKPKLNKIQALIM
VPTRELALQTSQVVRTLGKHCGISCMVTTGGTNLRDDILRLNETVHILVGTPGRVLDLAS
RKVADLSDCSLFIMDEADKMLSRDFKTIIEQILSFLPPTHQSLLFSATFPLTVKEFMVKH
LHKPYEINLMEELTLKGITQYYAFVEERQKLHCLNTLFSKLQINQAIIFCNSTNRVELLA
KKITDLGYSCYYSHARMKQQERNKVFHEFRQGKVRTLVCSDLLTRGIDIQAVNVVINFDF
PKTAETYLHRIGRSGRFGHLGLAINLINWNDRFNLYKIEQELGTEIAAIPATIDKSLYVA
ENDETVPVPFPIEQQSYHQQAIPQQQLPSQQQFAIPPQQHHPQFMVPPSHQQQQAYPPPQ
MPSQQGYPPQQEHFMAMPPGQSQPQY;
sp|P25644|PAT1_YEAST DNA topoisomerase 2-associated protein PAT1 OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) OX=559292 GN=PAT1 PE=1 SV=4|length=419aa|residues=5-79,456-787
GLENSGNARDGPLDFEESYKGYGEHELEENDYLNDETFGDNVQVGTDFDFGNPHSSGSSG
NAIGGNGVGATARSYGGSGGSGGSGGSSSYAFNNGNGATNLNKSGGKKFILELIETVYEE
ILDLEANLRNGQQTDSTAMWEALHIDDSSYDVNPFISMLSFDKGIKIMPRIFNFLDKQQK
LKILQKIFNELSHLQIIILSSYKTTPKPTLTQLKKVDLFQMIILKIIVSFLSNNSNFIEI
MGLLLQLIRNNNVSFLTTSKIGLNLITILISRAALIKQDSSRSNILSSPEISTWNEIYDK
LFTSLESKIQLIFPPREYNDHIMRLQNDKFMDEAYIWQFLASLALSGKLNHQRIIIDEVR
DEIFATINEAETLQKKEKELSVLPQRSQELDTELKSIIYNKEKLYQDLNLFLNVMGLVY",DHH1;|PAT1,[DHH1]:-;|[PAT1]:NC,-;|-,"506aa(1-506);|419aa(5-79,456-787)",P39517;P25644,"DrLLPS,LLPSDB,PhaSepDB;DrLLPS,LLPSDB,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Sac-0503,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0168,http://db.phasep.pro/browse/;http://llps.biocuckoo.cn/view.php?id=LLPS-Sac-0330,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0246,http://db.phasep.pro/browse/","-;|[5-24],[55-79],[456-469]","-;|[59-74],[545-555],[571-583]",In vitro,2 µM [DHH1];|4 µM [PAT1 NC];|0.1 mg/ml polyU,"150 mM KCl, 2 mM MgCl2",30 mM HEPES-KOH pH 7.4,RT,> 20 min,other_molecular:5 mM ATP,Fluorescence microscopy,liquid,"We found a stoichiometric ratio of 2.7:1 ± 0.13 of Dhh1 to Pat1 in the in vitro phase-separated droplets, closely resembling the Dhh1:Pat1 ratio of mature PBs in vivo.",0
77,464,PMID: 30648970,RNAPS0000256,https://pubmed.ncbi.nlm.nih.gov/30648970,RNA + proteins,-,-,polyU,-,-,poly RNA,-,"sp|P39517|DHH1_YEAST ATP-dependent RNA helicase DHH1 OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) OX=559292 GN=DHH1 PE=1 SV=1|length=506aa|residues=1-506
MGSINNNFNTNNNSNTDLDRDWKTALNIPKKDTRPQTDDVLNTKGNTFEDFYLKRELLMG
IFEAGFEKPSPIQEEAIPVAITGRDILARAKNGTGKTAAFVIPTLEKVKPKLNKIQALIM
VPTRELALQTSQVVRTLGKHCGISCMVTTGGTNLRDDILRLNETVHILVGTPGRVLDLAS
RKVADLSDCSLFIMDEADKMLSRDFKTIIEQILSFLPPTHQSLLFSATFPLTVKEFMVKH
LHKPYEINLMEELTLKGITQYYAFVEERQKLHCLNTLFSKLQINQAIIFCNSTNRVELLA
KKITDLGYSCYYSHARMKQQERNKVFHEFRQGKVRTLVCSDLLTRGIDIQAVNVVINFDF
PKTAETYLHRIGRSGRFGHLGLAINLINWNDRFNLYKIEQELGTEIAAIPATIDKSLYVA
ENDETVPVPFPIEQQSYHQQAIPQQQLPSQQQFAIPPQQHHPQFMVPPSHQQQQAYPPPQ
MPSQQGYPPQQEHFMAMPPGQSQPQY;
sp|P25644|PAT1_YEAST DNA topoisomerase 2-associated protein PAT1 OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) OX=559292 GN=PAT1 PE=1 SV=4|length=75aa|residues=5-79
GLENSGNARDGPLDFEESYKGYGEHELEENDYLNDETFGDNVQVGTDFDFGNPHSSGSSG
NAIGGNGVGATARSY",DHH1;|PAT1,[DHH1]:-;|[PAT1]:N,-;|-,506aa(1-506);|75aa(5-79),P39517;P25644,"DrLLPS,LLPSDB,PhaSepDB;DrLLPS,LLPSDB,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Sac-0503,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0168,http://db.phasep.pro/browse/;http://llps.biocuckoo.cn/view.php?id=LLPS-Sac-0330,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0246,http://db.phasep.pro/browse/","-;|[5-24],[55-79]",-;|[59-74],In vitro,8 µM [DHH1];|4-8 µM [PAT1 N];|0.2 mg/ml polyU,"150 mM KCl, 2 mM MgCl2",30 mM HEPES-KOH pH 7.4,RT,> 20 min,other_molecular:3.2 mM ATP,Fluorescence microscopy,liquid,"We did not observe any Dhh1 droplets upon addition of increasing concentrations of Pat1 NC when RNA was omitted from the reaction suggesting that under these in vitro conditions RNA plays a critical role in the Pat1-promoted enhancement of Dhh1 oligomerization and higher-order phase separation. Consistent with this, the Pat1 N- terminus alone which cannot bind to RNA also does not enhance the phase separation of Dhh1 even in the presence of RNA and ATP.",0
78,465,PMID: 30648970,RNAPS0000256,https://pubmed.ncbi.nlm.nih.gov/30648970,RNA + proteins,-,-,polyU,-,-,poly RNA,-,"sp|P39517|DHH1_YEAST ATP-dependent RNA helicase DHH1 OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) OX=559292 GN=DHH1 PE=1 SV=1|length=506aa|residues=1-506
MGSINNNFNTNNNSNTDLDRDWKTALNIPKKDTRPQTDDVLNTKGNTFEDFYLKRELLMG
IFEAGFEKPSPIQEEAIPVAITGRDILARAKNGTGKTAAFVIPTLEKVKPKLNKIQALIM
VPTRELALQTSQVVRTLGKHCGISCMVTTGGTNLRDDILRLNETVHILVGTPGRVLDLAS
RKVADLSDCSLFIMDEADKMLSRDFKTIIEQILSFLPPTHQSLLFSATFPLTVKEFMVKH
LHKPYEINLMEELTLKGITQYYAFVEERQKLHCLNTLFSKLQINQAIIFCNSTNRVELLA
KKITDLGYSCYYSHARMKQQERNKVFHEFRQGKVRTLVCSDLLTRGIDIQAVNVVINFDF
PKTAETYLHRIGRSGRFGHLGLAINLINWNDRFNLYKIEQELGTEIAAIPATIDKSLYVA
ENDETVPVPFPIEQQSYHQQAIPQQQLPSQQQFAIPPQQHHPQFMVPPSHQQQQAYPPPQ
MPSQQGYPPQQEHFMAMPPGQSQPQY;
sp|P25644|PAT1_YEAST DNA topoisomerase 2-associated protein PAT1 OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) OX=559292 GN=PAT1 PE=1 SV=4|length=419aa|residues=5-79,456-787|mutation=D39A,E40A,T41A,F42A
GLENSGNARDGPLDFEESYKGYGEHELEENDYLNAAAAGDNVQVGTDFDFGNPHSSGSSG
NAIGGNGVGATARSYGGSGGSGGSGGSSSYAFNNGNGATNLNKSGGKKFILELIETVYEE
ILDLEANLRNGQQTDSTAMWEALHIDDSSYDVNPFISMLSFDKGIKIMPRIFNFLDKQQK
LKILQKIFNELSHLQIIILSSYKTTPKPTLTQLKKVDLFQMIILKIIVSFLSNNSNFIEI
MGLLLQLIRNNNVSFLTTSKIGLNLITILISRAALIKQDSSRSNILSSPEISTWNEIYDK
LFTSLESKIQLIFPPREYNDHIMRLQNDKFMDEAYIWQFLASLALSGKLNHQRIIIDEVR
DEIFATINEAETLQKKEKELSVLPQRSQELDTELKSIIYNKEKLYQDLNLFLNVMGLVY",DHH1;|PAT1,[DHH1]:-;|[PAT1]:NC,"protein_mutation:-,|protein_mutation:D39A,E40A,T41A,F42A","506aa(1-506);|419aa(5-79,456-787)",P39517;P25644,"DrLLPS,LLPSDB,PhaSepDB;DrLLPS,LLPSDB,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Sac-0503,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0168,http://db.phasep.pro/browse/;http://llps.biocuckoo.cn/view.php?id=LLPS-Sac-0330,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0246,http://db.phasep.pro/browse/","-;|[5-16],[63-79],[456-475],[501-510],[660-667],[742-748],[756-771]",-;|-,In vitro,4 µM [DHH1];|2-8 µM [PAT1 NC];|0.2 mg/ml polyU,"150 mM KCl, 2 mM MgCl2",30 mM HEPES-KOH pH 7.4,RT,> 20 min,other_molecular:3.2 mM ATP,Fluorescence microscopy,liquid,"While no LLPS of Pat1 NC alone was detected, addition of increasing concentrations of wild-type Pat1 NC strongly enhanced the LLPS of Dhh1 in the presence of ATP and RNA as judged by an increase in the area * intensity of Dhh1 droplets. Furthermore, Pat1 NC itself enriched in Dhh1 droplets, suggesting that Pat1 and Dhh1 co-oligomerize with RNA to form a composite phase-separated compartment. Dhh1-RNA droplet formation was either not at all or only mildly stimulated upon addition of these Pat1 variants.",0
79,466,PMID: 30648970,RNAPS0000256,https://pubmed.ncbi.nlm.nih.gov/30648970,RNA + proteins,-,-,polyU,-,-,poly RNA,-,"sp|P39517|DHH1_YEAST ATP-dependent RNA helicase DHH1 OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) OX=559292 GN=DHH1 PE=1 SV=1|length=506aa|residues=1-506
MGSINNNFNTNNNSNTDLDRDWKTALNIPKKDTRPQTDDVLNTKGNTFEDFYLKRELLMG
IFEAGFEKPSPIQEEAIPVAITGRDILARAKNGTGKTAAFVIPTLEKVKPKLNKIQALIM
VPTRELALQTSQVVRTLGKHCGISCMVTTGGTNLRDDILRLNETVHILVGTPGRVLDLAS
RKVADLSDCSLFIMDEADKMLSRDFKTIIEQILSFLPPTHQSLLFSATFPLTVKEFMVKH
LHKPYEINLMEELTLKGITQYYAFVEERQKLHCLNTLFSKLQINQAIIFCNSTNRVELLA
KKITDLGYSCYYSHARMKQQERNKVFHEFRQGKVRTLVCSDLLTRGIDIQAVNVVINFDF
PKTAETYLHRIGRSGRFGHLGLAINLINWNDRFNLYKIEQELGTEIAAIPATIDKSLYVA
ENDETVPVPFPIEQQSYHQQAIPQQQLPSQQQFAIPPQQHHPQFMVPPSHQQQQAYPPPQ
MPSQQGYPPQQEHFMAMPPGQSQPQY;
sp|P25644|PAT1_YEAST DNA topoisomerase 2-associated protein PAT1 OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) OX=559292 GN=PAT1 PE=1 SV=4|length=419aa|residues=5-79,456-787|mutation=S456E,S457E
GLENSGNARDGPLDFEESYKGYGEHELEENDYLNDETFGDNVQVGTDFDFGNPHSSGSSG
NAIGGNGVGATARSYGGSGGSGGSGGSAAYAFNNGNGATNLNKSGGKKFILELIETVYEE
ILDLEANLRNGQQTDSTAMWEALHIDDSSYDVNPFISMLSFDKGIKIMPRIFNFLDKQQK
LKILQKIFNELSHLQIIILSSYKTTPKPTLTQLKKVDLFQMIILKIIVSFLSNNSNFIEI
MGLLLQLIRNNNVSFLTTSKIGLNLITILISRAALIKQDSSRSNILSSPEISTWNEIYDK
LFTSLESKIQLIFPPREYNDHIMRLQNDKFMDEAYIWQFLASLALSGKLNHQRIIIDEVR
DEIFATINEAETLQKKEKELSVLPQRSQELDTELKSIIYNKEKLYQDLNLFLNVMGLVY",DHH1;|PAT1,[DHH1]:-;|[PAT1]:NC,"protein_mutation:-;|protein_mutation:S456E,S457E","506aa(1-506);|419aa(5-79,456-787)",P39517;P25644,"DrLLPS,LLPSDB,PhaSepDB;DrLLPS,LLPSDB,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Sac-0503,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0168,http://db.phasep.pro/browse/;http://llps.biocuckoo.cn/view.php?id=LLPS-Sac-0330,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0246,http://db.phasep.pro/browse/","-;|[5-16],[63-79],[456-473],[501-510],[660-667],[742-748],[756-771]",-;|-,In vitro,4 µM [DHH1];|2-8 µM [PAT1 NC];|0.2 mg/ml polyU,"150 mM KCl, 2 mM MgCl2",30 mM HEPES-KOH pH 7.4,RT,> 20 min,other_molecular:3.2 mM ATP,Fluorescence microscopy,liquid,"While no LLPS of Pat1 NC alone was detected, addition of increasing concentrations of wild-type Pat1 NC strongly enhanced the LLPS of Dhh1 in the presence of ATP and RNA as judged by an increase in the area * intensity of Dhh1 droplets. Furthermore, Pat1 NC itself enriched in Dhh1 droplets, suggesting that Pat1 and Dhh1 co-oligomerize with RNA to form a composite phase-separated compartment. Dhh1-RNA droplet formation was either not at all or only mildly stimulated upon addition of these Pat1 variants.",0
80,467,PMID: 30648970,RNAPS0000256,https://pubmed.ncbi.nlm.nih.gov/30648970,RNA + proteins,-,-,polyU,-,-,poly RNA,-,"sp|P39517|DHH1_YEAST ATP-dependent RNA helicase DHH1 OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) OX=559292 GN=DHH1 PE=1 SV=1|length=506aa|residues=1-506
MGSINNNFNTNNNSNTDLDRDWKTALNIPKKDTRPQTDDVLNTKGNTFEDFYLKRELLMG
IFEAGFEKPSPIQEEAIPVAITGRDILARAKNGTGKTAAFVIPTLEKVKPKLNKIQALIM
VPTRELALQTSQVVRTLGKHCGISCMVTTGGTNLRDDILRLNETVHILVGTPGRVLDLAS
RKVADLSDCSLFIMDEADKMLSRDFKTIIEQILSFLPPTHQSLLFSATFPLTVKEFMVKH
LHKPYEINLMEELTLKGITQYYAFVEERQKLHCLNTLFSKLQINQAIIFCNSTNRVELLA
KKITDLGYSCYYSHARMKQQERNKVFHEFRQGKVRTLVCSDLLTRGIDIQAVNVVINFDF
PKTAETYLHRIGRSGRFGHLGLAINLINWNDRFNLYKIEQELGTEIAAIPATIDKSLYVA
ENDETVPVPFPIEQQSYHQQAIPQQQLPSQQQFAIPPQQHHPQFMVPPSHQQQQAYPPPQ
MPSQQGYPPQQEHFMAMPPGQSQPQY;
sp|P25644|PAT1_YEAST DNA topoisomerase 2-associated protein PAT1 OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) OX=559292 GN=PAT1 PE=1 SV=4|length=419aa|residues=5-79,456-787
GLENSGNARDGPLDFEESYKGYGEHELEENDYLNDETFGDNVQVGTDFDFGNPHSSGSSG
NAIGGNGVGATARSYGGSGGSGGSGGSSSYAFNNGNGATNLNKSGGKKFILELIETVYEE
ILDLEANLRNGQQTDSTAMWEALHIDDSSYDVNPFISMLSFDKGIKIMPRIFNFLDKQQK
LKILQKIFNELSHLQIIILSSYKTTPKPTLTQLKKVDLFQMIILKIIVSFLSNNSNFIEI
MGLLLQLIRNNNVSFLTTSKIGLNLITILISRAALIKQDSSRSNILSSPEISTWNEIYDK
LFTSLESKIQLIFPPREYNDHIMRLQNDKFMDEAYIWQFLASLALSGKLNHQRIIIDEVR
DEIFATINEAETLQKKEKELSVLPQRSQELDTELKSIIYNKEKLYQDLNLFLNVMGLVY",DHH1;|PAT1,[DHH1]:-;|[PAT1]:NC,-;|-,"506aa(1-506);|419aa(5-79,456-787)",P39517;P25644,"DrLLPS,LLPSDB,PhaSepDB;DrLLPS,LLPSDB,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Sac-0503,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0168,http://db.phasep.pro/browse/;http://llps.biocuckoo.cn/view.php?id=LLPS-Sac-0330,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0246,http://db.phasep.pro/browse/","-;|[5-24],[55-79],[456-469]","-;|[59-74],[545-555],[571-583]",In vitro,4 µM [DHH1];|2-8 µM [PAT1 NC];|0.2 mg/ml polyU,"150 mM KCl, 2 mM MgCl2",30 mM HEPES-KOH pH 7.4,RT,> 20 min,other_molecular:3.2 mM ATP,Fluorescence microscopy,liquid,"While no LLPS of Pat1 NC alone was detected, addition of increasing concentrations of wild-type Pat1 NC strongly enhanced the LLPS of Dhh1 in the presence of ATP and RNA as judged by an increase in the area * intensity of Dhh1 droplets. Furthermore, Pat1 NC itself enriched in Dhh1 droplets, suggesting that Pat1 and Dhh1 co-oligomerize with RNA to form a composite phase-separated compartment. Dhh1-RNA droplet formation was either not at all or only mildly stimulated upon addition of these Pat1 variants.",0
81,468,PMID: 30648970,RNAPS0000257,https://pubmed.ncbi.nlm.nih.gov/30648970,RNA + protein,-,-,polyU,-,-,poly RNA,-,"sp|P25644|PAT1_YEAST DNA topoisomerase 2-associated protein PAT1 OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) OX=559292 GN=PAT1 PE=1 SV=4|length=419aa|residues=5-79,456-787|mutation=D39A,E40A,T41A,F42A
GLENSGNARDGPLDFEESYKGYGEHELEENDYLNAAAAGDNVQVGTDFDFGNPHSSGSSG
NAIGGNGVGATARSYGGSGGSGGSGGSSSYAFNNGNGATNLNKSGGKKFILELIETVYEE
ILDLEANLRNGQQTDSTAMWEALHIDDSSYDVNPFISMLSFDKGIKIMPRIFNFLDKQQK
LKILQKIFNELSHLQIIILSSYKTTPKPTLTQLKKVDLFQMIILKIIVSFLSNNSNFIEI
MGLLLQLIRNNNVSFLTTSKIGLNLITILISRAALIKQDSSRSNILSSPEISTWNEIYDK
LFTSLESKIQLIFPPREYNDHIMRLQNDKFMDEAYIWQFLASLALSGKLNHQRIIIDEVR
DEIFATINEAETLQKKEKELSVLPQRSQELDTELKSIIYNKEKLYQDLNLFLNVMGLVY",PAT1,NC,"protein_mutation:D39A,E40A,T41A,F42A","419aa(5-79,456-787)",P25644,"DrLLPS,LLPSDB,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Sac-0330,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0246,http://db.phasep.pro/browse/","[5-16],[63-79],[456-475],[501-510],[660-667],[742-748],[756-771]",-,In vitro,2-8 µM [PAT1 NC];|0.2 mg/ml polyU,"150 mM KCl, 2 mM MgCl2",30 mM HEPES-KOH pH 7.4,RT,> 20 min,other_molecular:3.2 mM ATP,Fluorescence microscopy,solute,"While no LLPS of Pat1 NC alone was detected, addition of increasing concentrations of wild-type Pat1 NC strongly enhanced the LLPS of Dhh1 in the presence of ATP and RNA as judged by an increase in the area * intensity of Dhh1 droplets. Furthermore, Pat1 NC itself enriched in Dhh1 droplets, suggesting that Pat1 and Dhh1 co-oligomerize with RNA to form a composite phase-separated compartment. Dhh1-RNA droplet formation was either not at all or only mildly stimulated upon addition of these Pat1 variants.",0
82,469,PMID: 30648970,RNAPS0000257,https://pubmed.ncbi.nlm.nih.gov/30648970,RNA + protein,-,-,polyU,-,-,poly RNA,-,"sp|P25644|PAT1_YEAST DNA topoisomerase 2-associated protein PAT1 OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) OX=559292 GN=PAT1 PE=1 SV=4|length=419aa|residues=5-79,456-787|mutation=S456E,S457E
GLENSGNARDGPLDFEESYKGYGEHELEENDYLNDETFGDNVQVGTDFDFGNPHSSGSSG
NAIGGNGVGATARSYGGSGGSGGSGGSAAYAFNNGNGATNLNKSGGKKFILELIETVYEE
ILDLEANLRNGQQTDSTAMWEALHIDDSSYDVNPFISMLSFDKGIKIMPRIFNFLDKQQK
LKILQKIFNELSHLQIIILSSYKTTPKPTLTQLKKVDLFQMIILKIIVSFLSNNSNFIEI
MGLLLQLIRNNNVSFLTTSKIGLNLITILISRAALIKQDSSRSNILSSPEISTWNEIYDK
LFTSLESKIQLIFPPREYNDHIMRLQNDKFMDEAYIWQFLASLALSGKLNHQRIIIDEVR
DEIFATINEAETLQKKEKELSVLPQRSQELDTELKSIIYNKEKLYQDLNLFLNVMGLVY",PAT1,NC,"protein_mutation:S456E,S457E","419aa(5-79,456-787)",P25644,"DrLLPS,LLPSDB,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Sac-0330,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0246,http://db.phasep.pro/browse/","[5-16],[63-79],[456-473],[501-510],[660-667],[742-748],[756-771]",-,In vitro,2-8 µM [PAT1 NC];|0.2 mg/ml polyU,"150 mM KCl, 2 mM MgCl2",30 mM HEPES-KOH pH 7.4,RT,> 20 min,other_molecular:3.2 mM ATP,Fluorescence microscopy,solute,"While no LLPS of Pat1 NC alone was detected, addition of increasing concentrations of wild-type Pat1 NC strongly enhanced the LLPS of Dhh1 in the presence of ATP and RNA as judged by an increase in the area * intensity of Dhh1 droplets. Furthermore, Pat1 NC itself enriched in Dhh1 droplets, suggesting that Pat1 and Dhh1 co-oligomerize with RNA to form a composite phase-separated compartment. Dhh1-RNA droplet formation was either not at all or only mildly stimulated upon addition of these Pat1 variants.",0
83,470,PMID: 30648970,RNAPS0000257,https://pubmed.ncbi.nlm.nih.gov/30648970,RNA + protein,-,-,polyU,-,-,poly RNA,-,"sp|P25644|PAT1_YEAST DNA topoisomerase 2-associated protein PAT1 OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) OX=559292 GN=PAT1 PE=1 SV=4|length=419aa|residues=5-79,456-787
GLENSGNARDGPLDFEESYKGYGEHELEENDYLNDETFGDNVQVGTDFDFGNPHSSGSSG
NAIGGNGVGATARSYGGSGGSGGSGGSSSYAFNNGNGATNLNKSGGKKFILELIETVYEE
ILDLEANLRNGQQTDSTAMWEALHIDDSSYDVNPFISMLSFDKGIKIMPRIFNFLDKQQK
LKILQKIFNELSHLQIIILSSYKTTPKPTLTQLKKVDLFQMIILKIIVSFLSNNSNFIEI
MGLLLQLIRNNNVSFLTTSKIGLNLITILISRAALIKQDSSRSNILSSPEISTWNEIYDK
LFTSLESKIQLIFPPREYNDHIMRLQNDKFMDEAYIWQFLASLALSGKLNHQRIIIDEVR
DEIFATINEAETLQKKEKELSVLPQRSQELDTELKSIIYNKEKLYQDLNLFLNVMGLVY",PAT1,NC,-,"419aa(5-79,456-787)",P25644,"DrLLPS,LLPSDB,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Sac-0330,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0246,http://db.phasep.pro/browse/","[5-24],[55-79],[456-469]","[59-74],[545-555],[571-583]",In vitro,2-8 µM [PAT1 NC];|0.2 mg/ml polyU,"150 mM KCl, 2 mM MgCl2",30 mM HEPES-KOH pH 7.4,RT,> 20 min,other_molecular:3.2 mM ATP,Fluorescence microscopy,solute,"While no LLPS of Pat1 NC alone was detected, addition of increasing concentrations of wild-type Pat1 NC strongly enhanced the LLPS of Dhh1 in the presence of ATP and RNA as judged by an increase in the area * intensity of Dhh1 droplets. Furthermore, Pat1 NC itself enriched in Dhh1 droplets, suggesting that Pat1 and Dhh1 co-oligomerize with RNA to form a composite phase-separated compartment. Dhh1-RNA droplet formation was either not at all or only mildly stimulated upon addition of these Pat1 variants.",0
84,471,PMID: 30648970,RNAPS0000258,https://pubmed.ncbi.nlm.nih.gov/30648970,RNA + proteins,-,-,polyU,-,-,poly RNA,-,"sp|P39517|DHH1_YEAST ATP-dependent RNA helicase DHH1 OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) OX=559292 GN=DHH1 PE=1 SV=1|length=506aa|residues=1-506
MGSINNNFNTNNNSNTDLDRDWKTALNIPKKDTRPQTDDVLNTKGNTFEDFYLKRELLMG
IFEAGFEKPSPIQEEAIPVAITGRDILARAKNGTGKTAAFVIPTLEKVKPKLNKIQALIM
VPTRELALQTSQVVRTLGKHCGISCMVTTGGTNLRDDILRLNETVHILVGTPGRVLDLAS
RKVADLSDCSLFIMDEADKMLSRDFKTIIEQILSFLPPTHQSLLFSATFPLTVKEFMVKH
LHKPYEINLMEELTLKGITQYYAFVEERQKLHCLNTLFSKLQINQAIIFCNSTNRVELLA
KKITDLGYSCYYSHARMKQQERNKVFHEFRQGKVRTLVCSDLLTRGIDIQAVNVVINFDF
PKTAETYLHRIGRSGRFGHLGLAINLINWNDRFNLYKIEQELGTEIAAIPATIDKSLYVA
ENDETVPVPFPIEQQSYHQQAIPQQQLPSQQQFAIPPQQHHPQFMVPPSHQQQQAYPPPQ
MPSQQGYPPQQEHFMAMPPGQSQPQY;
sp|P25644|PAT1_YEAST DNA topoisomerase 2-associated protein PAT1 OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) OX=559292 GN=PAT1 PE=1 SV=4|length=419aa|residues=5-79,456-787
GLENSGNARDGPLDFEESYKGYGEHELEENDYLNDETFGDNVQVGTDFDFGNPHSSGSSG
NAIGGNGVGATARSYGGSGGSGGSGGSSSYAFNNGNGATNLNKSGGKKFILELIETVYEE
ILDLEANLRNGQQTDSTAMWEALHIDDSSYDVNPFISMLSFDKGIKIMPRIFNFLDKQQK
LKILQKIFNELSHLQIIILSSYKTTPKPTLTQLKKVDLFQMIILKIIVSFLSNNSNFIEI
MGLLLQLIRNNNVSFLTTSKIGLNLITILISRAALIKQDSSRSNILSSPEISTWNEIYDK
LFTSLESKIQLIFPPREYNDHIMRLQNDKFMDEAYIWQFLASLALSGKLNHQRIIIDEVR
DEIFATINEAETLQKKEKELSVLPQRSQELDTELKSIIYNKEKLYQDLNLFLNVMGLVY;
sp|P25655|NOT1_YEAST General negative regulator of transcription subunit 1 OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) OX=559292 GN=CDC39 PE=1 SV=3|length=247aa|residues=754-1000
RSRPVQEMIPLKFFAVDEVSCQINQEGAPKDVVEKVLFVLNNVTLANLNNKVDELKKSLT
PNYFSWFSTYLVTQRAKTEPNYHDLYSKVIVAMGSGLLHQFMVNVTLRQLFVLLSTKDEQ
AIDKKHLKNLASWLGCITLALNKPIKHKNIAFREMLIEAYKENRLEIVVPFVTKILQRAS
ESKIFKPPNPWTVGILKLLIELNEKANWKLSLTFEVEVLLKSFNLTTKSLKPSNFINTPE
VIETLSG",DHH1;|PAT1;|Not1,-;|-;|-,-;|-;|-,"506aa(1-506);|419aa(5-79,456-787);|247aa(754-1000)",P39517;P25644;P25655,"DrLLPS,LLPSDB,PhaSepDB;DrLLPS,LLPSDB,PhaSepDB;DrLLPS,LLPSDB,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Sac-0503,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0168,http://db.phasep.pro/browse/;http://llps.biocuckoo.cn/view.php?id=LLPS-Sac-0330,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0246,http://db.phasep.pro/browse/;http://llps.biocuckoo.cn/view.php?id=LLPS-Sac-0403,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0169,http://db.phasep.pro/browse/",-;|-;|-,-;|-;|-,In vitro,4 µM [DHH1];|4-8 µM [PAT1 NC];|4 µM [Not1 MIF4G];|0.2 mg/ml polyU,"150 mM KCl, 2 mM MgCl2",30 mM HEPES-KOH pH 7.4,RT,> 20 min,other_molecular:3.2 mM ATP,Fluorescence microscopy,liquid,"We therefore next analyzed whether the Pat1-Dhh1 droplets are still responsive to Not1. Similar to what we observed in vivo (Figure 5), Not1MIF4G also diminishes formation Dhh1 droplets in the presence of Pat1 in vitro (Figure 6B)",0
85,499,PMID: 30765518,RNAPS0000264,https://pubmed.ncbi.nlm.nih.gov/30765518,RNA + protein,-,-,polyA,-,-,poly RNA,-,"sp|Q06787|FMR1_HUMAN Synaptic functional regulator FMR1 OS=Homo sapiens OX=9606 GN=FMR1 PE=1 SV=1|length=188aa|residues=445-632
GASSRPPPNRTDKEKSYVTDDGQGMGRGSRPYRNRGHGRRGPGYTSGTNSEASNASETES
DHRDELSDWSLAPTEEERESFLRRGDGRRRGGGGRGQGGRGRGGGFKGNDDHSRTDNRPR
NPREAKGRTTDGSLQIRVDCNNERSVHTKTLQNTSSEGSRLRTGKDRNQKKEKPDSVDGQ
QPLVNGVP",FMR1,LCR,-,188aa(445-632),Q06787,"PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q06787,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-2426,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0024,http://db.phasep.pro/browse/","[445-515],[516-632]","[492-504],[527-549]",In vitro,125 µM [FMR1 LCR];|0.05 mg/mL polyA,30 mM NaCl,"25 mM Na2PO4, pH 7.4, 2 mM DTT",4˚C,> 5 min,-,Microscopy,liquid,"By mixing different RNA sequences with FMRP LCR, we showed that FMRP LCR-RNA phase separation is not sequence-specific and does not require sequences capable of G-quadruplex formation. FMRPLCR:RNA phase separation is not dependent on RNA sequence or structure but is likely driven by protein:RNA electrostatic and pi-pi interactions.",0
86,500,PMID: 30765518,RNAPS0000265,https://pubmed.ncbi.nlm.nih.gov/30765518,RNA + protein,-,-,polyU,-,-,poly RNA,-,"sp|Q06787|FMR1_HUMAN Synaptic functional regulator FMR1 OS=Homo sapiens OX=9606 GN=FMR1 PE=1 SV=1|length=188aa|residues=445-632
GASSRPPPNRTDKEKSYVTDDGQGMGRGSRPYRNRGHGRRGPGYTSGTNSEASNASETES
DHRDELSDWSLAPTEEERESFLRRGDGRRRGGGGRGQGGRGRGGGFKGNDDHSRTDNRPR
NPREAKGRTTDGSLQIRVDCNNERSVHTKTLQNTSSEGSRLRTGKDRNQKKEKPDSVDGQ
QPLVNGVP",FMR1,LCR,-,188aa(445-632),Q06787,"PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q06787,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-2426,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0024,http://db.phasep.pro/browse/","[445-515],[516-632]","[492-504],[527-549]",In vitro,125 µM [FMR1 LCR];|0.05 mg/mL polyU,30 mM NaCl,"25 mM Na2PO4, pH 7.4, 2 mM DTT",4˚C,> 5 min,-,Microscopy,liquid,"By mixing different RNA sequences with FMRP LCR, we showed that FMRP LCR-RNA phase separation is not sequence-specific and does not require sequences capable of G-quadruplex formation. FMRPLCR:RNA phase separation is not dependent on RNA sequence or structure but is likely driven by protein:RNA electrostatic and pi-pi interactions.",0
87,501,PMID: 30765518,RNAPS0000266,https://pubmed.ncbi.nlm.nih.gov/30765518,RNA + protein,-,-,polyC,-,-,poly RNA,-,"sp|Q06787|FMR1_HUMAN Synaptic functional regulator FMR1 OS=Homo sapiens OX=9606 GN=FMR1 PE=1 SV=1|length=188aa|residues=445-632
GASSRPPPNRTDKEKSYVTDDGQGMGRGSRPYRNRGHGRRGPGYTSGTNSEASNASETES
DHRDELSDWSLAPTEEERESFLRRGDGRRRGGGGRGQGGRGRGGGFKGNDDHSRTDNRPR
NPREAKGRTTDGSLQIRVDCNNERSVHTKTLQNTSSEGSRLRTGKDRNQKKEKPDSVDGQ
QPLVNGVP",FMR1,LCR,-,188aa(445-632),Q06787,"PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q06787,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-2426,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0024,http://db.phasep.pro/browse/","[445-515],[516-632]","[492-504],[527-549]",In vitro,125 µM [FMR1 LCR];|0.05 mg/mL polyC,30 mM NaCl,"25 mM Na2PO4, pH 7.4, 2 mM DTT",4˚C,> 5 min,-,Microscopy,liquid,"By mixing different RNA sequences with FMRP LCR, we showed that FMRP LCR-RNA phase separation is not sequence-specific and does not require sequences capable of G-quadruplex formation. FMRPLCR:RNA phase separation is not dependent on RNA sequence or structure but is likely driven by protein:RNA electrostatic and pi-pi interactions.",0
88,502,PMID: 30765518,RNAPS0000267,https://pubmed.ncbi.nlm.nih.gov/30765518,RNA + protein,-,-,polyG,-,-,poly RNA,-,"sp|Q06787|FMR1_HUMAN Synaptic functional regulator FMR1 OS=Homo sapiens OX=9606 GN=FMR1 PE=1 SV=1|length=188aa|residues=445-632
GASSRPPPNRTDKEKSYVTDDGQGMGRGSRPYRNRGHGRRGPGYTSGTNSEASNASETES
DHRDELSDWSLAPTEEERESFLRRGDGRRRGGGGRGQGGRGRGGGFKGNDDHSRTDNRPR
NPREAKGRTTDGSLQIRVDCNNERSVHTKTLQNTSSEGSRLRTGKDRNQKKEKPDSVDGQ
QPLVNGVP",FMR1,LCR,-,188aa(445-632),Q06787,"PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q06787,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-2426,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0024,http://db.phasep.pro/browse/","[445-515],[516-632]","[492-504],[527-549]",In vitro,125 µM [FMR1 LCR];|0.05 mg/mL polyG,30 mM NaCl,"25 mM Na2PO4, pH 7.4, 2 mM DTT",4˚C,> 5 min,-,Microscopy,liquid,"By mixing different RNA sequences with FMRP LCR, we showed that FMRP LCR-RNA phase separation is not sequence-specific and does not require sequences capable of G-quadruplex formation. FMRPLCR:RNA phase separation is not dependent on RNA sequence or structure but is likely driven by protein:RNA electrostatic and pi-pi interactions.",0
89,530,PMID: 30926670,RNAPS0000272,https://pubmed.ncbi.nlm.nih.gov/30926670,RNA + protein,-,-,polyrU,-,-,poly RNA,-,PKPKPKPKPKPKPKPKPKPKPKPKPKPKPKPKPKPKPKPKPKPKPKPKPKPKPKPKPKPK,poly(proline−arginine)30,-,-,60aa,-,-,-,[1-60],-,In vitro,250 µM [PR30];|0-1.5 µg/µL [poly-rU],-,"1 μg/μL in 100 mM K2HPO4/KH2PO4,pH 7",RT,-,"crowding agent:,30%PEG","Microscopy,FRAP",liquid,"Increasing the concentration of poly-rU in PEG-induced PR droplets decreases PR dynamics, even at lower RNA concentrations than used for PR-RNA droplet formation in the absence of PEG.",0
90,531,PMID: 30926670,RNAPS0000272,https://pubmed.ncbi.nlm.nih.gov/30926670,RNA + protein,-,-,polyrU,-,-,poly RNA,-,PRPRPRPRPRPRPRPRPRPRPRPRPRPRPRPRPRPRPRPRPRPRPRPRPRPRPRPRPRPR,poly(proline−arginine)30,-,-,60aa,-,-,-,[1-60],-,In vitro,250 µM [PR30];|0.5-8 µg/µL [poly-rU],-,"1 μg/μL in 100 mM K2HPO4/KH2PO4,pH 7",RT,-,-,"Microscopy,FRAP",liquid,"As can be seen in Fig. 2 A and B (and Movie S1), mixing of PR with homopolymeric RNAs (except poly-rG) results in the formation of liquid-like condensates.",0
91,532,PMID: 30926670,RNAPS0000273,https://pubmed.ncbi.nlm.nih.gov/30926670,RNA + protein,-,-,polyrA,-,-,poly RNA,-,PRPRPRPRPRPRPRPRPRPRPRPRPRPRPRPRPRPRPRPRPRPRPRPRPRPRPRPRPRPR,poly(proline−arginine)30,-,-,60aa,-,-,-,[1-60],-,In vitro,250 µM [PR30];|1 µg/µL [poly-rA],-,"1 μg/μL in 100 mM K2HPO4/KH2PO4,pH 7",RT,-,-,"Microscopy,FRAP",liquid,"As can be seen in Fig. 2 A and B (and Movie S1), mixing of PR with homopolymeric RNAs (except poly-rG) results in the formation of liquid-like condensates.",0
92,533,PMID: 30926670,RNAPS0000274,https://pubmed.ncbi.nlm.nih.gov/30926670,RNA + protein,-,-,polyrC,-,-,poly RNA,-,PRPRPRPRPRPRPRPRPRPRPRPRPRPRPRPRPRPRPRPRPRPRPRPRPRPRPRPRPRPR,poly(proline−arginine)30,-,-,60aa,-,-,-,[1-60],-,In vitro,250 µM [PR30];|1 µg/µL [poly-rC],-,"1 μg/μL in 100 mM K2HPO4/KH2PO4,pH 7",RT,-,-,"Microscopy,FRAP",liquid,"As can be seen in Fig. 2 A and B (and Movie S1), mixing of PR with homopolymeric RNAs (except poly-rG) results in the formation of liquid-like condensates.",0
93,534,PMID: 30926670,RNAPS0000275,https://pubmed.ncbi.nlm.nih.gov/30926670,RNA + protein,-,-,polyrG,-,-,poly RNA,-,PRPRPRPRPRPRPRPRPRPRPRPRPRPRPRPRPRPRPRPRPRPRPRPRPRPRPRPRPRPR,poly(proline−arginine)30,-,-,60aa,-,-,-,[1-60],-,In vitro,250 µM [PR30];|1 µg/µL [poly-rG],-,"1 μg/μL in 100 mM K2HPO4/KH2PO4,pH 7",RT,-,-,"Microscopy,FRAP",-,"In contrast, poly-rG is known to form G quadruplexes, and these structural elements are highly stable. Interestingly, unlike the spherical coacervates formed by complexation of each of poly-rA, poly-rC, and poly-rU with PR, the assemblies formed by poly-rG and PR peptides are characterized by an open, fractal-like network structure that is resistant to thermal denaturation at high salt concentrations.",0
94,535,PMID: 30926670,RNAPS0000276,https://pubmed.ncbi.nlm.nih.gov/30926670,RNA,-,-,polyrA,-,-,poly RNA,-,-,-,-,-,-,-,-,-,-,-,In vitro,2 µg/µL[poly-rA],10 mM MgCl2,"1x PBS,pH 7",RT,-,"crowding agent:,30%PEG","Microscopy,FRAP",liquid,"Under these conditions, poly-rA, poly-rC, and poly-rU form spherical, liquid-like droplets. However, poly-rA droplets fuse more slowly compared with poly-rU and poly-rC RNA droplets, implying a difference in the strengths of intradroplet interactions and the interfacial tension between the droplet and dispersed phases.",0
95,536,PMID: 30926670,RNAPS0000277,https://pubmed.ncbi.nlm.nih.gov/30926670,RNA,-,-,polyrU,-,-,poly RNA,-,-,-,-,-,-,-,-,-,-,-,In vitro,2 µg/µL[poly-rU],10 mM MgCl2,"1x PBS,pH 7",RT,-,"crowding agent:,30%PEG","Microscopy,FRAP",liquid,"Under these conditions, poly-rA, poly-rC, and poly-rU form spherical, liquid-like droplets. However, poly-rA droplets fuse more slowly compared with poly-rU and poly-rC RNA droplets, implying a difference in the strengths of intradroplet interactions and the interfacial tension between the droplet and dispersed phases.",0
96,537,PMID: 30926670,RNAPS0000278,https://pubmed.ncbi.nlm.nih.gov/30926670,RNA,-,-,polyrC,-,-,poly RNA,-,-,-,-,-,-,-,-,-,-,-,In vitro,2 µg/µL[poly-rC],10 mM MgCl2,"1x PBS,pH 7",RT,-,"crowding agent:,30%PEG","Microscopy,FRAP",liquid,"Under these conditions, poly-rA, poly-rC, and poly-rU form spherical, liquid-like droplets. However, poly-rA droplets fuse more slowly compared with poly-rU and poly-rC RNA droplets, implying a difference in the strengths of intradroplet interactions and the interfacial tension between the droplet and dispersed phases.",0
97,538,PMID: 30926670,RNAPS0000279,https://pubmed.ncbi.nlm.nih.gov/30926670,RNA + protein,-,-,polyrA,-,-,poly RNA,-,PKPKPKPKPKPKPKPKPKPKPKPKPKPKPKPKPKPKPKPKPKPKPKPKPKPKPKPKPKPK,poly(proline-lysine)30,-,-,60aa,-,-,-,[1-60],-,In vitro,250 µM [PK30];|1 µg/µL [poly-rA],-,"1 μg/μL in 100 mM K2HPO4/KH2PO4,pH 7",RT,-,-,"Microscopy,FRAP",liquid,PK−polynucleotide droplets are uniformly less viscous than PR−polynucleotide droplets as assayed by spontaneous fusion events,0
98,539,PMID: 30926670,RNAPS0000280,https://pubmed.ncbi.nlm.nih.gov/30926670,RNA + protein,-,-,polyrU,-,-,poly RNA,-,PKPKPKPKPKPKPKPKPKPKPKPKPKPKPKPKPKPKPKPKPKPKPKPKPKPKPKPKPKPK,poly(proline-lysine)30,-,-,60aa,-,-,-,[1-60],-,In vitro,250 µM [PK30];|1 µg/µL [poly-rU],-,"1 μg/μL in 100 mM K2HPO4/KH2PO4,pH 7",RT,-,-,"Microscopy,FRAP",liquid,PK−polynucleotide droplets are uniformly less viscous than PR−polynucleotide droplets as assayed by spontaneous fusion events,0
99,540,PMID: 30926670,RNAPS0000281,https://pubmed.ncbi.nlm.nih.gov/30926670,RNA + protein,-,-,polyrC,-,-,poly RNA,-,PKPKPKPKPKPKPKPKPKPKPKPKPKPKPKPKPKPKPKPKPKPKPKPKPKPKPKPKPKPK,poly(proline-lysine)30,-,-,60aa,-,-,-,[1-60],-,In vitro,250 µM [PK30];|1 µg/µL [poly-rC],-,"1 μg/μL in 100 mM K2HPO4/KH2PO4,pH 7",RT,-,-,"Microscopy,FRAP",liquid,PK−polynucleotide droplets are uniformly less viscous than PR−polynucleotide droplets as assayed by spontaneous fusion events,0
100,548,PMID: 30950394,RNAPS0000118,https://pubmed.ncbi.nlm.nih.gov/30950394,RNA + protein,-,-,polyU,-(800-1000 kDa),-,poly RNA,-,"sp|P10636-8|TAU_HUMAN Isoform Tau-F of Microtubule-associated protein tau OS=Homo sapiens OX=9606 GN=MAPT|length=207aa|residues=255-441|mutation=C291S
MGSSHHHHHHSSGLVPRGSHMVKSKIGSTENLKHQPGGGKVQIINKKLDLSNVQSKSGSK
DNIKHVPGGGSVQIVYKPVDLSKVTSKCGSLGNIHHKPGGGQVEVKSEKLDFKDRVQSKI
GSLDNITHVPGGGNKKIETHKLTFRENAKAKTDHGAEIVYKSPVVSGDTSPRHLSNVSST
GSIDMVDSPQLATLADEVSASLAKQGL",MAPT,C,protein_mutation:C291S,207aa(255-441),P10636,"DrLLPS,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-2853,http://db.phasep.pro/browse/","[255-277],[300-302],[304-306],[311-319],[360-370],[416-456]",-,In vitro,20 µM [Tau C];|60 µg/mL polyU,30 mM NaCl,"20 mM ammonium acetate buffer, pH 7.0",10-17˚C,-,-,Turbidity measurement,solute,"The turbidity-temperature curves show that at high temperature, samples became turbid with Abs500~1.5 and abundance of complex coacervations (CCs), while at low temperature, samples became transparent with Abs500~0 and absence of CCs. This demonstrates tau187-RNA CC formation is favored at higher temperature, following clearly a lower critical solution temperature behavior (LCST). By cycling the temperature, we robustly and reversibly changed the tau187-RNA mixture between a turbid state to a completely transparent state. The transition temperatures at which the turbidity emerged during heating and vanished during cooling stay invariant with repeated heating-cooling cycles. The method of extracting a cloud point for the LCST transition temperature from such data will be described in detail in the next section. Importantly, the history of temperature change does not affect the resulting state. Hence the formation and dissolution of tau187-RNA CCs are reversible and consistent with a path-independent equilibrium process. The Thioflavin T (ThT) fluorescence curves of the same sample system as a function of time confirms the absence of amyloid aggregate formation in tau187-RNA CCs. These results together suggest that tau187-RNA CCs are in an equilibrium state, in which tau retains its solution-like dynamics.",
101,549,PMID: 30950394,RNAPS0000118,https://pubmed.ncbi.nlm.nih.gov/30950394,RNA + protein,-,-,polyU,-(800-1000 kDa),-,poly RNA,-,"sp|P10636-8|TAU_HUMAN Isoform Tau-F of Microtubule-associated protein tau OS=Homo sapiens OX=9606 GN=MAPT|length=207aa|residues=255-441|mutation=C291S
MGSSHHHHHHSSGLVPRGSHMVKSKIGSTENLKHQPGGGKVQIINKKLDLSNVQSKSGSK
DNIKHVPGGGSVQIVYKPVDLSKVTSKCGSLGNIHHKPGGGQVEVKSEKLDFKDRVQSKI
GSLDNITHVPGGGNKKIETHKLTFRENAKAKTDHGAEIVYKSPVVSGDTSPRHLSNVSST
GSIDMVDSPQLATLADEVSASLAKQGL",MAPT,C,protein_mutation:C291S,207aa(255-441),P10636,"DrLLPS,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-2853,http://db.phasep.pro/browse/","[255-277],[300-302],[304-306],[311-319],[360-370],[416-456]",-,In vitro,20 µM [Tau C];|60 µg/mL polyU,30 mM NaCl,"20 mM ammonium acetate buffer, pH 7.0",18-25˚C,-,-,Turbidity measurement,liquid,"The turbidity-temperature curves show that at high temperature, samples became turbid with Abs500~1.5 and abundance of complex coacervations (CCs), while at low temperature, samples became transparent with Abs500~0 and absence of CCs. This demonstrates tau187-RNA CC formation is favored at higher temperature, following clearly a lower critical solution temperature behavior (LCST). By cycling the temperature, we robustly and reversibly changed the tau187-RNA mixture between a turbid state to a completely transparent state. The transition temperatures at which the turbidity emerged during heating and vanished during cooling stay invariant with repeated heating-cooling cycles. The method of extracting a cloud point for the LCST transition temperature from such data will be described in detail in the next section. Importantly, the history of temperature change does not affect the resulting state. Hence the formation and dissolution of tau187-RNA CCs are reversible and consistent with a path-independent equilibrium process. The Thioflavin T (ThT) fluorescence curves of the same sample system as a function of time confirms the absence of amyloid aggregate formation in tau187-RNA CCs. These results together suggest that tau187-RNA CCs are in an equilibrium state, in which tau retains its solution-like dynamics.",
102,550,PMID: 30950394,RNAPS0000118,https://pubmed.ncbi.nlm.nih.gov/30950394,RNA + protein,-,-,polyU,-(800-1000 kDa),-,poly RNA,-,"sp|P10636-8|TAU_HUMAN Isoform Tau-F of Microtubule-associated protein tau OS=Homo sapiens OX=9606 GN=MAPT|length=207aa|residues=255-441|mutation=C291S
MGSSHHHHHHSSGLVPRGSHMVKSKIGSTENLKHQPGGGKVQIINKKLDLSNVQSKSGSK
DNIKHVPGGGSVQIVYKPVDLSKVTSKCGSLGNIHHKPGGGQVEVKSEKLDFKDRVQSKI
GSLDNITHVPGGGNKKIETHKLTFRENAKAKTDHGAEIVYKSPVVSGDTSPRHLSNVSST
GSIDMVDSPQLATLADEVSASLAKQGL",MAPT,C,protein_mutation:C291S,207aa(255-441),P10636,"DrLLPS,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-2853,http://db.phasep.pro/browse/","[255-277],[300-302],[304-306],[311-319],[360-370],[416-456]",-,In vitro,100 µM [Tau C];|300 µg/mL polyU,30 mM NaCl,"20 mM ammonium acetate buffer, pH 7.0",RT,-,-,Microscopy,liquid,"The turbidity-temperature curves show that at high temperature, samples became turbid with Abs500~1.5 and abundance of complex coacervations (CCs), while at low temperature, samples became transparent with Abs500~0 and absence of CCs. This demonstrates tau187-RNA CC formation is favored at higher temperature, following clearly a lower critical solution temperature behavior (LCST). By cycling the temperature, we robustly and reversibly changed the tau187-RNA mixture between a turbid state to a completely transparent state. The transition temperatures at which the turbidity emerged during heating and vanished during cooling stay invariant with repeated heating-cooling cycles. The method of extracting a cloud point for the LCST transition temperature from such data will be described in detail in the next section. Importantly, the history of temperature change does not affect the resulting state. Hence the formation and dissolution of tau187-RNA CCs are reversible and consistent with a path-independent equilibrium process. The Thioflavin T (ThT) fluorescence curves of the same sample system as a function of time confirms the absence of amyloid aggregate formation in tau187-RNA CCs. These results together suggest that tau187-RNA CCs are in an equilibrium state, in which tau retains its solution-like dynamics.",
103,551,PMID: 30950394,RNAPS0000118,https://pubmed.ncbi.nlm.nih.gov/30950394,RNA + protein,-,-,polyU,-(800-1000 kDa),-,poly RNA,-,"sp|P10636-8|TAU_HUMAN Isoform Tau-F of Microtubule-associated protein tau OS=Homo sapiens OX=9606 GN=MAPT|length=207aa|residues=255-441|mutation=C291S
MGSSHHHHHHSSGLVPRGSHMVKSKIGSTENLKHQPGGGKVQIINKKLDLSNVQSKSGSK
DNIKHVPGGGSVQIVYKPVDLSKVTSKCGSLGNIHHKPGGGQVEVKSEKLDFKDRVQSKI
GSLDNITHVPGGGNKKIETHKLTFRENAKAKTDHGAEIVYKSPVVSGDTSPRHLSNVSST
GSIDMVDSPQLATLADEVSASLAKQGL",MAPT,C,protein_mutation:C291S,207aa(255-441),P10636,"DrLLPS,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-2853,http://db.phasep.pro/browse/","[255-277],[300-302],[304-306],[311-319],[360-370],[416-456]",-,In vitro,20 µM [Tau C];|60 µg/mL polyU,0-131 mM NaCl,"20 mM ammonium acetate buffer, pH 7.0",20˚C,-,-,Turbidity measurement,liquid,"Titrating RNA to tau187, the turbidity was found to be peaked when [RNA]:[tau] reached charge matching condition at which the charge ratio between net positive and negative charges was 1:1 (which for tau187 and RNA used in this study corresponded to [tau187]:[RNA]=1 µM: 3 µg/mL), validating once more that LLPS is driven by complex coacervation (CC). Henceforth, all phase diagram data are acquired at a charge matching condition between RNA and tau. Titrating NaCl to tau187-RNA, CC formation showed a steady decrease of turbidity. Combined, these demonstrate that tau187-RNA CC favors the condition of charge balance and low ionic strength, which is consistent with known properties of CC and previous findings. Increasing [tau] lowers Tcp, favoring CC formation, while increasing [NaCl] raises Tcp, disfavoring CC formation. Such trends were observed at two [NaCl] and two [tau] values, respectively. Tau187-RNA complex coacervation (CC) and tau114-RNA CC were prepared with 20 µM tau187 and 28 µM tau114, so that the total concentration of polymer, that is tau and RNA, reaches 0.5 mg/mL. Turbidity was recorded at varying [NaCl]. Similar to the observation with tau187-RNA CC, tau114-RNA CC showed decreasing turbidity at increasing [NaCl]. The [NaCl] values where turbidity reaches 0 were estimated as 131 mM and 150 mM for tau187 and tau114, respectively, implying CC formation is more favorable with tau114 that hence can sustain higher [NaCl]. Based on this, 20 µM of tau187, 131 mM of NaCl and room temperature, 20˚C, were used as the phase separation conditions ([tau], [NaCl] and Tcp) for tau187, and 28 µM, 150 mM and 20˚C for tau114. Comparison of the two constructs shows that tau114-RNA CC has a lower Tcp than tau187-RNA CC, suggesting it is more favorable to phase separation. This qualitatively agrees with experimental observations. Notice that the shorter tau114 has a slightly higher propensity to form CC as compared to the longer tau187 fragment, an observation that is opposite of what one would expect from purely entropic considerations based on the mixing of homopolymers or simple coacervation.",
104,552,PMID: 30950394,RNAPS0000118,https://pubmed.ncbi.nlm.nih.gov/30950394,RNA + protein,-,-,polyU,-(800-1000 kDa),-,poly RNA,-,"sp|P10636-8|TAU_HUMAN Isoform Tau-F of Microtubule-associated protein tau OS=Homo sapiens OX=9606 GN=MAPT|length=207aa|residues=255-441|mutation=C291S
MGSSHHHHHHSSGLVPRGSHMVKSKIGSTENLKHQPGGGKVQIINKKLDLSNVQSKSGSK
DNIKHVPGGGSVQIVYKPVDLSKVTSKCGSLGNIHHKPGGGQVEVKSEKLDFKDRVQSKI
GSLDNITHVPGGGNKKIETHKLTFRENAKAKTDHGAEIVYKSPVVSGDTSPRHLSNVSST
GSIDMVDSPQLATLADEVSASLAKQGL",MAPT,C,protein_mutation:C291S,207aa(255-441),P10636,"DrLLPS,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-2853,http://db.phasep.pro/browse/","[255-277],[300-302],[304-306],[311-319],[360-370],[416-456]",-,In vitro,2-240 µM [Tau C];|6-720 µg/mL polyU,30 mM NaCl,"20 mM ammonium acetate buffer, pH 7.0",RT,-,-,Turbidity measurement,liquid,"Titrating RNA to tau187, the turbidity was found to be peaked when [RNA]:[tau] reached charge matching condition at which the charge ratio between net positive and negative charges was 1:1 (which for tau187 and RNA used in this study corresponded to [tau187]:[RNA]=1 µM: 3 µg/mL), validating once more that LLPS is driven by complex coacervation (CC). Henceforth, all phase diagram data are acquired at a charge matching condition between RNA and tau. Titrating NaCl to tau187-RNA, CC formation showed a steady decrease of turbidity. Combined, these demonstrate that tau187-RNA CC favors the condition of charge balance and low ionic strength, which is consistent with known properties of CC and previous findings. Increasing [tau] lowers Tcp, favoring CC formation, while increasing [NaCl] raises Tcp, disfavoring CC formation. Such trends were observed at two [NaCl] and two [tau] values, respectively. Tau187-RNA complex coacervation (CC) and tau114-RNA CC were prepared with 20 µM tau187 and 28 µM tau114, so that the total concentration of polymer, that is tau and RNA, reaches 0.5 mg/mL. Turbidity was recorded at varying [NaCl]. Similar to the observation with tau187-RNA CC, tau114-RNA CC showed decreasing turbidity at increasing [NaCl]. The [NaCl] values where turbidity reaches 0 were estimated as 131 mM and 150 mM for tau187 and tau114, respectively, implying CC formation is more favorable with tau114 that hence can sustain higher [NaCl]. Based on this, 20 µM of tau187, 131 mM of NaCl and room temperature, 20˚C, were used as the phase separation conditions ([tau], [NaCl] and Tcp) for tau187, and 28 µM, 150 mM and 20˚C for tau114. Comparison of the two constructs shows that tau114-RNA CC has a lower Tcp than tau187-RNA CC, suggesting it is more favorable to phase separation. This qualitatively agrees with experimental observations. Notice that the shorter tau114 has a slightly higher propensity to form CC as compared to the longer tau187 fragment, an observation that is opposite of what one would expect from purely entropic considerations based on the mixing of homopolymers or simple coacervation.",
105,553,PMID: 30950394,RNAPS0000118,https://pubmed.ncbi.nlm.nih.gov/30950394,RNA + protein,-,-,polyU,-(800-1000 kDa),-,poly RNA,-,"sp|P10636-8|TAU_HUMAN Isoform Tau-F of Microtubule-associated protein tau OS=Homo sapiens OX=9606 GN=MAPT|length=207aa|residues=255-441|mutation=C291S
MGSSHHHHHHSSGLVPRGSHMVKSKIGSTENLKHQPGGGKVQIINKKLDLSNVQSKSGSK
DNIKHVPGGGSVQIVYKPVDLSKVTSKCGSLGNIHHKPGGGQVEVKSEKLDFKDRVQSKI
GSLDNITHVPGGGNKKIETHKLTFRENAKAKTDHGAEIVYKSPVVSGDTSPRHLSNVSST
GSIDMVDSPQLATLADEVSASLAKQGL",MAPT,C,protein_mutation:C291S,207aa(255-441),P10636,"DrLLPS,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-2853,http://db.phasep.pro/browse/","[255-277],[300-302],[304-306],[311-319],[360-370],[416-456]",-,In vitro,1-120 µM [Tau C];|3-360 µg/mL polyU,30 mM NaCl,"20 mM ammonium acetate buffer, pH 7.0",RT,-,-,Turbidity measurement,"solute, liquid","Titrating RNA to tau187, the turbidity was found to be peaked when [RNA]:[tau] reached charge matching condition at which the charge ratio between net positive and negative charges was 1:1 (which for tau187 and RNA used in this study corresponded to [tau187]:[RNA]=1 µM: 3 µg/mL), validating once more that LLPS is driven by complex coacervation (CC). Henceforth, all phase diagram data are acquired at a charge matching condition between RNA and tau. Titrating NaCl to tau187-RNA, CC formation showed a steady decrease of turbidity. Combined, these demonstrate that tau187-RNA CC favors the condition of charge balance and low ionic strength, which is consistent with known properties of CC and previous findings. Increasing [tau] lowers Tcp, favoring CC formation, while increasing [NaCl] raises Tcp, disfavoring CC formation. Such trends were observed at two [NaCl] and two [tau] values, respectively. Tau187-RNA complex coacervation (CC) and tau114-RNA CC were prepared with 20 µM tau187 and 28 µM tau114, so that the total concentration of polymer, that is tau and RNA, reaches 0.5 mg/mL. Turbidity was recorded at varying [NaCl]. Similar to the observation with tau187-RNA CC, tau114-RNA CC showed decreasing turbidity at increasing [NaCl]. The [NaCl] values where turbidity reaches 0 were estimated as 131 mM and 150 mM for tau187 and tau114, respectively, implying CC formation is more favorable with tau114 that hence can sustain higher [NaCl]. Based on this, 20 µM of tau187, 131 mM of NaCl and room temperature, 20˚C, were used as the phase separation conditions ([tau], [NaCl] and Tcp) for tau187, and 28 µM, 150 mM and 20˚C for tau114. Comparison of the two constructs shows that tau114-RNA CC has a lower Tcp than tau187-RNA CC, suggesting it is more favorable to phase separation. This qualitatively agrees with experimental observations. Notice that the shorter tau114 has a slightly higher propensity to form CC as compared to the longer tau187 fragment, an observation that is opposite of what one would expect from purely entropic considerations based on the mixing of homopolymers or simple coacervation.",
106,554,PMID: 30950394,RNAPS0000118,https://pubmed.ncbi.nlm.nih.gov/30950394,RNA + protein,-,-,polyU,-(800-1000 kDa),-,poly RNA,-,"sp|P10636-8|TAU_HUMAN Isoform Tau-F of Microtubule-associated protein tau OS=Homo sapiens OX=9606 GN=MAPT|length=207aa|residues=255-441|mutation=C291S
MGSSHHHHHHSSGLVPRGSHMVKSKIGSTENLKHQPGGGKVQIINKKLDLSNVQSKSGSK
DNIKHVPGGGSVQIVYKPVDLSKVTSKCGSLGNIHHKPGGGQVEVKSEKLDFKDRVQSKI
GSLDNITHVPGGGNKKIETHKLTFRENAKAKTDHGAEIVYKSPVVSGDTSPRHLSNVSST
GSIDMVDSPQLATLADEVSASLAKQGL",MAPT,C,protein_mutation:C291S,207aa(255-441),P10636,"DrLLPS,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-2853,http://db.phasep.pro/browse/","[255-277],[300-302],[304-306],[311-319],[360-370],[416-456]",-,In vitro,1-120 µM [Tau C];|3-360 µg/mL polyU,120 mM NaCl,"20 mM ammonium acetate buffer, pH 7.0",RT,-,-,Turbidity measurement,"solute, liquid","Titrating RNA to tau187, the turbidity was found to be peaked when [RNA]:[tau] reached charge matching condition at which the charge ratio between net positive and negative charges was 1:1 (which for tau187 and RNA used in this study corresponded to [tau187]:[RNA]=1 µM: 3 µg/mL), validating once more that LLPS is driven by complex coacervation (CC). Henceforth, all phase diagram data are acquired at a charge matching condition between RNA and tau. Titrating NaCl to tau187-RNA, CC formation showed a steady decrease of turbidity. Combined, these demonstrate that tau187-RNA CC favors the condition of charge balance and low ionic strength, which is consistent with known properties of CC and previous findings. Increasing [tau] lowers Tcp, favoring CC formation, while increasing [NaCl] raises Tcp, disfavoring CC formation. Such trends were observed at two [NaCl] and two [tau] values, respectively. Tau187-RNA complex coacervation (CC) and tau114-RNA CC were prepared with 20 µM tau187 and 28 µM tau114, so that the total concentration of polymer, that is tau and RNA, reaches 0.5 mg/mL. Turbidity was recorded at varying [NaCl]. Similar to the observation with tau187-RNA CC, tau114-RNA CC showed decreasing turbidity at increasing [NaCl]. The [NaCl] values where turbidity reaches 0 were estimated as 131 mM and 150 mM for tau187 and tau114, respectively, implying CC formation is more favorable with tau114 that hence can sustain higher [NaCl]. Based on this, 20 µM of tau187, 131 mM of NaCl and room temperature, 20˚C, were used as the phase separation conditions ([tau], [NaCl] and Tcp) for tau187, and 28 µM, 150 mM and 20˚C for tau114. Comparison of the two constructs shows that tau114-RNA CC has a lower Tcp than tau187-RNA CC, suggesting it is more favorable to phase separation. This qualitatively agrees with experimental observations. Notice that the shorter tau114 has a slightly higher propensity to form CC as compared to the longer tau187 fragment, an observation that is opposite of what one would expect from purely entropic considerations based on the mixing of homopolymers or simple coacervation.",
107,555,PMID: 30950394,RNAPS0000118,https://pubmed.ncbi.nlm.nih.gov/30950394,RNA + protein,-,-,polyU,-(800-1000 kDa),-,poly RNA,-,"sp|P10636-8|TAU_HUMAN Isoform Tau-F of Microtubule-associated protein tau OS=Homo sapiens OX=9606 GN=MAPT|length=207aa|residues=255-441|mutation=C291S
MGSSHHHHHHSSGLVPRGSHMVKSKIGSTENLKHQPGGGKVQIINKKLDLSNVQSKSGSK
DNIKHVPGGGSVQIVYKPVDLSKVTSKCGSLGNIHHKPGGGQVEVKSEKLDFKDRVQSKI
GSLDNITHVPGGGNKKIETHKLTFRENAKAKTDHGAEIVYKSPVVSGDTSPRHLSNVSST
GSIDMVDSPQLATLADEVSASLAKQGL",MAPT,C,protein_mutation:C291S,207aa(255-441),P10636,"DrLLPS,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-2853,http://db.phasep.pro/browse/","[255-277],[300-302],[304-306],[311-319],[360-370],[416-456]",-,In vitro,5 µM [Tau C];|15 µg/mL polyU,10-300 mM NaCl,"20 mM ammonium acetate buffer, pH 7.0",RT,-,-,Turbidity measurement,"solute, liquid","Titrating RNA to tau187, the turbidity was found to be peaked when [RNA]:[tau] reached charge matching condition at which the charge ratio between net positive and negative charges was 1:1 (which for tau187 and RNA used in this study corresponded to [tau187]:[RNA]=1 µM: 3 µg/mL), validating once more that LLPS is driven by complex coacervation (CC). Henceforth, all phase diagram data are acquired at a charge matching condition between RNA and tau. Titrating NaCl to tau187-RNA, CC formation showed a steady decrease of turbidity. Combined, these demonstrate that tau187-RNA CC favors the condition of charge balance and low ionic strength, which is consistent with known properties of CC and previous findings. Increasing [tau] lowers Tcp, favoring CC formation, while increasing [NaCl] raises Tcp, disfavoring CC formation. Such trends were observed at two [NaCl] and two [tau] values, respectively. Tau187-RNA complex coacervation (CC) and tau114-RNA CC were prepared with 20 µM tau187 and 28 µM tau114, so that the total concentration of polymer, that is tau and RNA, reaches 0.5 mg/mL. Turbidity was recorded at varying [NaCl]. Similar to the observation with tau187-RNA CC, tau114-RNA CC showed decreasing turbidity at increasing [NaCl]. The [NaCl] values where turbidity reaches 0 were estimated as 131 mM and 150 mM for tau187 and tau114, respectively, implying CC formation is more favorable with tau114 that hence can sustain higher [NaCl]. Based on this, 20 µM of tau187, 131 mM of NaCl and room temperature, 20˚C, were used as the phase separation conditions ([tau], [NaCl] and Tcp) for tau187, and 28 µM, 150 mM and 20˚C for tau114. Comparison of the two constructs shows that tau114-RNA CC has a lower Tcp than tau187-RNA CC, suggesting it is more favorable to phase separation. This qualitatively agrees with experimental observations. Notice that the shorter tau114 has a slightly higher propensity to form CC as compared to the longer tau187 fragment, an observation that is opposite of what one would expect from purely entropic considerations based on the mixing of homopolymers or simple coacervation.",
108,556,PMID: 30950394,RNAPS0000118,https://pubmed.ncbi.nlm.nih.gov/30950394,RNA + protein,-,-,polyU,-(800-1000 kDa),-,poly RNA,-,"sp|P10636-8|TAU_HUMAN Isoform Tau-F of Microtubule-associated protein tau OS=Homo sapiens OX=9606 GN=MAPT|length=207aa|residues=255-441|mutation=C291S
MGSSHHHHHHSSGLVPRGSHMVKSKIGSTENLKHQPGGGKVQIINKKLDLSNVQSKSGSK
DNIKHVPGGGSVQIVYKPVDLSKVTSKCGSLGNIHHKPGGGQVEVKSEKLDFKDRVQSKI
GSLDNITHVPGGGNKKIETHKLTFRENAKAKTDHGAEIVYKSPVVSGDTSPRHLSNVSST
GSIDMVDSPQLATLADEVSASLAKQGL",MAPT,C,protein_mutation:C291S,207aa(255-441),P10636,"DrLLPS,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-2853,http://db.phasep.pro/browse/","[255-277],[300-302],[304-306],[311-319],[360-370],[416-456]",-,In vitro,20 µM [Tau C];|60 µg/mL polyU,10-300 mM NaCl,"20 mM ammonium acetate buffer, pH 7.0",RT,-,-,Turbidity measurement,"solute, liquid","Titrating RNA to tau187, the turbidity was found to be peaked when [RNA]:[tau] reached charge matching condition at which the charge ratio between net positive and negative charges was 1:1 (which for tau187 and RNA used in this study corresponded to [tau187]:[RNA]=1 µM: 3 µg/mL), validating once more that LLPS is driven by complex coacervation (CC). Henceforth, all phase diagram data are acquired at a charge matching condition between RNA and tau. Titrating NaCl to tau187-RNA, CC formation showed a steady decrease of turbidity. Combined, these demonstrate that tau187-RNA CC favors the condition of charge balance and low ionic strength, which is consistent with known properties of CC and previous findings. Increasing [tau] lowers Tcp, favoring CC formation, while increasing [NaCl] raises Tcp, disfavoring CC formation. Such trends were observed at two [NaCl] and two [tau] values, respectively. Tau187-RNA complex coacervation (CC) and tau114-RNA CC were prepared with 20 µM tau187 and 28 µM tau114, so that the total concentration of polymer, that is tau and RNA, reaches 0.5 mg/mL. Turbidity was recorded at varying [NaCl]. Similar to the observation with tau187-RNA CC, tau114-RNA CC showed decreasing turbidity at increasing [NaCl]. The [NaCl] values where turbidity reaches 0 were estimated as 131 mM and 150 mM for tau187 and tau114, respectively, implying CC formation is more favorable with tau114 that hence can sustain higher [NaCl]. Based on this, 20 µM of tau187, 131 mM of NaCl and room temperature, 20˚C, were used as the phase separation conditions ([tau], [NaCl] and Tcp) for tau187, and 28 µM, 150 mM and 20˚C for tau114. Comparison of the two constructs shows that tau114-RNA CC has a lower Tcp than tau187-RNA CC, suggesting it is more favorable to phase separation. This qualitatively agrees with experimental observations. Notice that the shorter tau114 has a slightly higher propensity to form CC as compared to the longer tau187 fragment, an observation that is opposite of what one would expect from purely entropic considerations based on the mixing of homopolymers or simple coacervation.",
109,557,PMID: 30950394,RNAPS0000118,https://pubmed.ncbi.nlm.nih.gov/30950394,RNA + protein,-,-,polyU,-(800-1000 kDa),-,poly RNA,-,"sp|P10636-8|TAU_HUMAN Isoform Tau-F of Microtubule-associated protein tau OS=Homo sapiens OX=9606 GN=MAPT|length=134aa|residues=255-368|mutation=C291S
MGSSHHHHHHSSGLVPRGSHMVKSKIGSTENLKHQPGGGKVQIINKKLDLSNVQSKSGSK
DNIKHVPGGGSVQIVYKPVDLSKVTSKCGSLGNIHHKPGGGQVEVKSEKLDFKDRVQSKI
GSLDNITHVPGGGN",MAPT,-,-,134aa(255-368),P10636,"DrLLPS,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-2853,http://db.phasep.pro/browse/","[255-277],[300-302],[304-306],[311-319],[360-370],[384-384],[386-388]  254",-,In vitro,28 µM [Tau 255-368];|the total concentration of tau and polyU RNA reaches 0.5 mg/mL,0-150 mM NaCl,"20 mM ammonium acetate buffer, pH 7.0",20˚C,-,-,Turbidity measurement,liquid,"Titrating RNA to tau187, the turbidity was found to be peaked when [RNA]:[tau] reached charge matching condition at which the charge ratio between net positive and negative charges was 1:1 (which for tau187 and RNA used in this study corresponded to [tau187]:[RNA]=1 µM: 3 µg/mL), validating once more that LLPS is driven by complex coacervation (CC). Henceforth, all phase diagram data are acquired at a charge matching condition between RNA and tau. Titrating NaCl to tau187-RNA, CC formation showed a steady decrease of turbidity. Combined, these demonstrate that tau187-RNA CC favors the condition of charge balance and low ionic strength, which is consistent with known properties of CC and previous findings. Increasing [tau] lowers Tcp, favoring CC formation, while increasing [NaCl] raises Tcp, disfavoring CC formation. Such trends were observed at two [NaCl] and two [tau] values, respectively. Tau187-RNA complex coacervation (CC) and tau114-RNA CC were prepared with 20 µM tau187 and 28 µM tau114, so that the total concentration of polymer, that is tau and RNA, reaches 0.5 mg/mL. Turbidity was recorded at varying [NaCl]. Similar to the observation with tau187-RNA CC, tau114-RNA CC showed decreasing turbidity at increasing [NaCl]. The [NaCl] values where turbidity reaches 0 were estimated as 131 mM and 150 mM for tau187 and tau114, respectively, implying CC formation is more favorable with tau114 that hence can sustain higher [NaCl]. Based on this, 20 µM of tau187, 131 mM of NaCl and room temperature, 20˚C, were used as the phase separation conditions ([tau], [NaCl] and Tcp) for tau187, and 28 µM, 150 mM and 20˚C for tau114. Comparison of the two constructs shows that tau114-RNA CC has a lower Tcp than tau187-RNA CC, suggesting it is more favorable to phase separation. This qualitatively agrees with experimental observations. Notice that the shorter tau114 has a slightly higher propensity to form CC as compared to the longer tau187 fragment, an observation that is opposite of what one would expect from purely entropic considerations based on the mixing of homopolymers or simple coacervation.",
110,558,PMID: 30950394,RNAPS0000118,https://pubmed.ncbi.nlm.nih.gov/30950394,RNA + protein,-,-,polyU,-(800-1000 kDa),-,poly RNA,-,"sp|P10636-8|TAU_HUMAN Isoform Tau-F of Microtubule-associated protein tau OS=Homo sapiens OX=9606 GN=MAPT|length=134aa|residues=255-368|mutation=C291S
MGSSHHHHHHSSGLVPRGSHMVKSKIGSTENLKHQPGGGKVQIINKKLDLSNVQSKSGSK
DNIKHVPGGGSVQIVYKPVDLSKVTSKCGSLGNIHHKPGGGQVEVKSEKLDFKDRVQSKI
GSLDNITHVPGGGN",MAPT,-,protein_mutation:C291S,134aa(255-368),P10636,"DrLLPS,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-2853,http://db.phasep.pro/browse/","[255-277],[300-302],[304-306],[311-319],[360-370],[384-384],[386-388]  254",-,In vitro,1-300 µM [Tau 255-368];|the total concentration of tau and polyU RNA reaches 0.5 mg/mL,30 mM NaCl,"20 mM ammonium acetate buffer, pH 7.0",RT,-,-,Turbidity measurement,"solute, liquid","Titrating RNA to tau187, the turbidity was found to be peaked when [RNA]:[tau] reached charge matching condition at which the charge ratio between net positive and negative charges was 1:1 (which for tau187 and RNA used in this study corresponded to [tau187]:[RNA]=1 µM: 3 µg/mL), validating once more that LLPS is driven by complex coacervation (CC). Henceforth, all phase diagram data are acquired at a charge matching condition between RNA and tau. Titrating NaCl to tau187-RNA, CC formation showed a steady decrease of turbidity. Combined, these demonstrate that tau187-RNA CC favors the condition of charge balance and low ionic strength, which is consistent with known properties of CC and previous findings. Increasing [tau] lowers Tcp, favoring CC formation, while increasing [NaCl] raises Tcp, disfavoring CC formation. Such trends were observed at two [NaCl] and two [tau] values, respectively. Tau187-RNA complex coacervation (CC) and tau114-RNA CC were prepared with 20 µM tau187 and 28 µM tau114, so that the total concentration of polymer, that is tau and RNA, reaches 0.5 mg/mL. Turbidity was recorded at varying [NaCl]. Similar to the observation with tau187-RNA CC, tau114-RNA CC showed decreasing turbidity at increasing [NaCl]. The [NaCl] values where turbidity reaches 0 were estimated as 131 mM and 150 mM for tau187 and tau114, respectively, implying CC formation is more favorable with tau114 that hence can sustain higher [NaCl]. Based on this, 20 µM of tau187, 131 mM of NaCl and room temperature, 20˚C, were used as the phase separation conditions ([tau], [NaCl] and Tcp) for tau187, and 28 µM, 150 mM and 20˚C for tau114. Comparison of the two constructs shows that tau114-RNA CC has a lower Tcp than tau187-RNA CC, suggesting it is more favorable to phase separation. This qualitatively agrees with experimental observations. Notice that the shorter tau114 has a slightly higher propensity to form CC as compared to the longer tau187 fragment, an observation that is opposite of what one would expect from purely entropic considerations based on the mixing of homopolymers or simple coacervation.",
111,559,PMID: 30950394,RNAPS0000118,https://pubmed.ncbi.nlm.nih.gov/30950394,RNA + protein,-,-,polyU,-(800-1000 kDa),-,poly RNA,-,"sp|P10636-8|TAU_HUMAN Isoform Tau-F of Microtubule-associated protein tau OS=Homo sapiens OX=9606 GN=MAPT|length=134aa|residues=255-368|mutation=C291S
MGSSHHHHHHSSGLVPRGSHMVKSKIGSTENLKHQPGGGKVQIINKKLDLSNVQSKSGSK
DNIKHVPGGGSVQIVYKPVDLSKVTSKCGSLGNIHHKPGGGQVEVKSEKLDFKDRVQSKI
GSLDNITHVPGGGN",MAPT,-,protein_mutation:C291S,134aa(255-368),P10636,"DrLLPS,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-2853,http://db.phasep.pro/browse/","[255-277],[300-302],[304-306],[311-319],[360-370],[384-384],[386-388]  254",-,In vitro,1-300 µM [Tau 255-368];|the total concentration of tau and polyU RNA reaches 0.5 mg/mL,120 mM NaCl,"20 mM ammonium acetate buffer, pH 7.0",RT,-,-,Turbidity measurement,"solute, liquid","Titrating RNA to tau187, the turbidity was found to be peaked when [RNA]:[tau] reached charge matching condition at which the charge ratio between net positive and negative charges was 1:1 (which for tau187 and RNA used in this study corresponded to [tau187]:[RNA]=1 µM: 3 µg/mL), validating once more that LLPS is driven by complex coacervation (CC). Henceforth, all phase diagram data are acquired at a charge matching condition between RNA and tau. Titrating NaCl to tau187-RNA, CC formation showed a steady decrease of turbidity. Combined, these demonstrate that tau187-RNA CC favors the condition of charge balance and low ionic strength, which is consistent with known properties of CC and previous findings. Increasing [tau] lowers Tcp, favoring CC formation, while increasing [NaCl] raises Tcp, disfavoring CC formation. Such trends were observed at two [NaCl] and two [tau] values, respectively. Tau187-RNA complex coacervation (CC) and tau114-RNA CC were prepared with 20 µM tau187 and 28 µM tau114, so that the total concentration of polymer, that is tau and RNA, reaches 0.5 mg/mL. Turbidity was recorded at varying [NaCl]. Similar to the observation with tau187-RNA CC, tau114-RNA CC showed decreasing turbidity at increasing [NaCl]. The [NaCl] values where turbidity reaches 0 were estimated as 131 mM and 150 mM for tau187 and tau114, respectively, implying CC formation is more favorable with tau114 that hence can sustain higher [NaCl]. Based on this, 20 µM of tau187, 131 mM of NaCl and room temperature, 20˚C, were used as the phase separation conditions ([tau], [NaCl] and Tcp) for tau187, and 28 µM, 150 mM and 20˚C for tau114. Comparison of the two constructs shows that tau114-RNA CC has a lower Tcp than tau187-RNA CC, suggesting it is more favorable to phase separation. This qualitatively agrees with experimental observations. Notice that the shorter tau114 has a slightly higher propensity to form CC as compared to the longer tau187 fragment, an observation that is opposite of what one would expect from purely entropic considerations based on the mixing of homopolymers or simple coacervation.",
112,563,PMID: 33247108,RNAPS0000290,https://pubmed.ncbi.nlm.nih.gov/33247108,RNA + proteins,-,-,polyU,-(800 kDa),-,poly RNA,-,"sp|P0DTC9|NCAP_SARS2 Nucleoprotein OS=Severe acute respiratory syndrome coronavirus 2 OX=2697049 GN=N PE=1 SV=1
MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHG
KEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAG
LPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGS
QASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQ
QQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKH
WPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAY
KTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA",SARS-CoV-2 Nucleoprotein;|RdRp-complex(RNA-dependent RNA polymerase),-,-,419aa(1-419);|42aa,P0DTC9;P0DTC9,-;-,-;-,"[1-40],[44-49],[174-174],[181-212],[233-247],[249-256],[365-391];|-","[175-208],[211-230],[236-249],[361-379];|-",In vitro,1 µM[polyU];|50 µM [N protein],-,"20 mM NaPi, pH 7.5",RT,-,-,"Differential interference contrast microscopy,Fluorescence microscopy",liquid,"Next,nsp12, nsp7, and nsp8 were reconstituted in a 1:1:2 stoichiometry together with a RNA template-product duplex, which carried fluorescein at the 5’ end29. The RdRp/RNA-complex was added to preformed NSARS-CoV-2/polyU droplets into which the RdRp/ RNA-complex was recruited",
113,564,PMID: 32857953,RNAPS0000413,https://pubmed.ncbi.nlm.nih.gov/32857953,Undefined,-,-,ployA,-,-,poly RNA,-,"sp|Q13283|G3BP1_HUMAN Ras GTPase-activating protein-binding protein 1 OS=Homo sapiens OX=9606 GN=G3BP1 PE=1 SV=1
MVMEKPSPLLVGREFVRQYYTLLNQAPDMLHRFYGKNSSYVHGGLDSNGKPADAVYGQKE
IHRKVMSQNFTNCHTKIRHVDAHATLNDGVVVQVMGLLSNNNQALRRFMQTFVLAPEGSV
ANKFYVHNDIFRYQDEVFGGFVTEPQEESEEEVEEPEERQQTPEVVPDDSGTFYDQAVVS
NDMEEHLEEPVAEPEPDPEPEPEQEPVSEIQEEKPEPVLEETAPEDAQKSSSPAPADIAQ
TVQEDLRTFSWASVTSKNLPPSGAVPVTGIPPHVVKVPASQPRPESKPESQIPPQRPQRD
QRVREQRINIPPQRGPRPIREAGEQGDIEPRRMVRHPDSHQLFIGNLPHEVDKSELKDFF
QSYGNVVELRINSGGKLPNFGFVVFDDSEPVQKVLSNRPIMFRGEVRLNVEEKKTRAARE
GDRRDNRLRGPGGPRGGLGGGMRGPPRGGMVQKPGFGVGRGLAPRQ",G3BP1,-,-,466aa(1-466),Q13283,"DrLLPS,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-0862,http://db.phasep.pro/browse/","[144-172],[184-243],[255-329],[413-466]","[142-167],[184-213],[291-307],[421-450]",In vivo,-,-,-,-,-,other molecular:sodium arsenite for 60 min;cell:U2OS cells,"FISH,Immunofluorescence",-,"At this later time point, however, G3BP and polyA RNA showed significant focus formation ( 100–200 foci per cell,200–300 nm in diameter; Figures 1A and S1A), in line with pre vious observations (Bounedjah et al., 2012), with  13% of cellular G3BP partitioning into foci.",0
114,586,PMID: 31266957,RNAPS0000301,https://pubmed.ncbi.nlm.nih.gov/31266957,RNA + protein,-,-,polyU,2000–3300nt,-,poly RNA,-,KKASLKKASLKKASL,K3,-,-,15aa,-,-,-,-,-,In vitro,0.5 mg/ml [polyU RNA];|1 mM.[K3],-,"25 mM HEPES,pH 7.4",RT,-,-,Differential interference contrast microscopy,liquid,DIC image of a pair of K3/RNA liquid droplets undergoing fusion. The concentration of polyU RNA was 0.5 mg ml−1 and K3 was 1 mM.,3300
115,587,PMID: 31266957,RNAPS0000301,https://pubmed.ncbi.nlm.nih.gov/31266957,RNA + protein,-,-,polyU,2000–3300nt,-,poly RNA,-,KKASLKKASLKKASL,K3,-,-,15aa,-,-,-,-,-,In vitro,1 mg/ml[polyU RNA];|1 mM[K3],-,"25 mM HEPES,PH 5.4 or 7.4 or 9.4",RT,5 min-20 min,-,Fluorescence microscopy,"solute, liquid",Distribution of droplet diameters after 5 and 20 min with the corresponding fluorescence images.The K3 droplets grew in time at the expense of smaller droplets,3300
116,588,PMID: 31266957,RNAPS0000301,https://pubmed.ncbi.nlm.nih.gov/31266957,RNA + protein,-,-,polyU,2000–3300nt,-,poly RNA,-,KKASLKKASLKKASL,K3,-,-,15aa,-,-,-,-,-,In vitro,0.5 mg/ml[polyU RNA];|1 mM[K3],-,"25 mM HEPES,pH 7.4",RT,≤ 90 min,other_molecular:CREB/p300,Turbidity measurement,liquid,"The specificity of acetylation-dependent complex coacervation was further supported by KAT reactions with lysine- and arginine-rich peptide/RNA-coacervates (Fig. 6e), demonstrating that R3/RNA-coacervates are not dissolved in the presence of CREB or p300.",3300
117,589,PMID: 31266957,RNAPS0000301,https://pubmed.ncbi.nlm.nih.gov/31266957,RNA + protein,-,-,polyU,2000–3300nt,-,poly RNA,-,KKASLKKASLKKASL,K3,-,-,15aa,-,-,-,-,-,In vitro,0.5 mg/ml[polyU RNA];|1 mM[K3],-,"25 mM HEPES,pH 7.4",RT,≤ 90 min,other_molecular:AcCoA,Turbidity measurement,liquid,"The specificity of acetylation-dependent complex coacervation was further supported by KAT reactions with lysine- and arginine-rich peptide/RNA-coacervates (Fig. 6e), demonstrating that R3/RNA-coacervates are not dissolved in the presence of CREB or p300.",3300
118,590,PMID: 31266957,RNAPS0000301,https://pubmed.ncbi.nlm.nih.gov/31266957,RNA + protein,-,-,polyU,2000–3300nt,-,poly RNA,-,KKASLKKASLKKASL,K3,-,-,15aa,-,-,-,-,-,In vitro,0.5 mg/ml[polyU RNA];|1 mM[K3],-,"25 mM HEPES,pH 7.4",RT,≤ 90 min,other_molecular:both the enzyme and AcCoA.,Turbidity measurement,liquid,"The specificity of acetylation-dependent complex coacervation was further supported by KAT reactions with lysine- and arginine-rich peptide/RNA-coacervates (Fig. 6e), demonstrating that R3/RNA-coacervates are not dissolved in the presence of CREB or p300.",3300
119,591,PMID: 31266957,RNAPS0000302,https://pubmed.ncbi.nlm.nih.gov/31266957,RNA + protein,-,-,polyU,2000–3300nt,-,poly RNA,-,KKASLKKASLRRASL,K2R1,-,-,15aa,-,-,-,-,-,In vitro,1 mg/ml[polyU RNA ];|1 mM[K2R1R3],-,"25 mM HEPES,pH 7.4",RT,≤ 25 min,-,"FRAP,Differential interference contrast microscopy,Fluorescence microscopy",-,"The concentration of K3, K2R1, R3, and polyU RNA in DIC, fluorescence imaging, and FRAP were identical and equal to 1 mM K3/K2R1/ R3 and 1 mg ml−1 polyU RNA, in 50 mM HEPES, pH 7.4.",3300
120,592,PMID: 31266957,RNAPS0000303,https://pubmed.ncbi.nlm.nih.gov/31266957,RNA + protein,-,-,polyU,2000–3300nt,-,poly RNA,-,KKKKKKKKKKKKKKKKKKKKR,K18,-,-,21aa,-,-,-,-,-,In vitro,50 µM[K18];|125 µg/ml[polyU RNA],-,-,RT,≤ 20 min,-,"Differential interference contrast microscopy,Fluorescence microscopy",liquid,"DIC and fluorescence micrographs of hTau40, K25, and K18 solutions in the presence of different co-factors/buffer conditions. The concentration of the proteins was 50 μM.",3300
121,593,PMID: 31266957,RNAPS0000303,https://pubmed.ncbi.nlm.nih.gov/31266957,RNA + protein,-,-,polyU,2000–3300nt,-,poly RNA,-,KKKKKKKKKKKKKKKKKKKKR,K18,-,-,21aa,-,-,-,-,-,In vitro,50 µM[K18];|125 µg/ml[polyU RNA],-,"25 mM HEPES,pH 7.4",RT,≤ 20 min,-,"Differential interference contrast microscopy,Fluorescence microscopy",solute,"DIC and fluorescence micrographs of hTau40, K25, and K18 solutions in the presence of different co-factors/buffer conditions. The concentration of the proteins was 50 μM.",3300
122,594,PMID: 31266957,RNAPS0000303,https://pubmed.ncbi.nlm.nih.gov/31266957,RNA + protein,-,-,polyU,2000–3300nt,-,poly RNA,-,KKKKKKKKKKKKKKKKKKKKR,K18,-,-,21aa,-,-,-,-,-,In vitro,50 µM[K18];|125 µg/ml[polyU RNA],-,-,RT,≤ 20 min,crowding agent:10% dextran,"Differential interference contrast microscopy,Fluorescence microscopy",solute,"DIC and fluorescence micrographs of hTau40, K25, and K18 solutions in the presence of different co-factors/buffer conditions. The concentration of the proteins was 50 μM.",3300
123,595,PMID: 31266957,RNAPS0000303,https://pubmed.ncbi.nlm.nih.gov/31266957,RNA + protein,-,-,polyU,2000–3300nt,-,poly RNA,-,KKKKKKKKKKKKKKKKKKKKR,K18,-,-,21aa,-,-,-,-,-,In vitro,125 µg/ml[RNA];|50 µM[K18],-,"25 mM HEPES,pH 7.4",RT,≤ 1 h,other_molecular:CREB/p300,Turbidity measurement,liquid,"The specificity of acetylation-dependent complex coacervation was further supported by KAT reactions with lysine- and arginine-rich peptide/RNA-coacervates (Fig. 6e), demonstrating that R3/RNA-coacervates are not dissolved in the presence of CREB or p300.",3300
124,596,PMID: 31266957,RNAPS0000303,https://pubmed.ncbi.nlm.nih.gov/31266957,RNA + protein,-,-,polyU,2000–3300nt,-,poly RNA,-,KKKKKKKKKKKKKKKKKKKKR,K18,-,-,21aa,-,-,-,-,-,In vitro,125 µg/ml[RNA];|50 µM[K18],-,"25 mM HEPES,pH 7.4",RT,≤ 1 h,other_molecular:AcCoA,Turbidity measurement,liquid,"The specificity of acetylation-dependent complex coacervation was further supported by KAT reactions with lysine- and arginine-rich peptide/RNA-coacervates (Fig. 6e), demonstrating that R3/RNA-coacervates are not dissolved in the presence of CREB or p300.",3300
125,597,PMID: 31266957,RNAPS0000303,https://pubmed.ncbi.nlm.nih.gov/31266957,RNA + protein,-,-,polyU,2000–3300nt,-,poly RNA,-,KKKKKKKKKKKKKKKKKKKKR,K18,-,-,21aa,-,-,-,-,-,In vitro,125 µg/ml[RNA];|50 µM[K18],-,"25 mM HEPES,pH 7.4",RT,≤ 1 h,other_molecular:both the enzyme and AcCoA.,Turbidity measurement,liquid,"The specificity of acetylation-dependent complex coacervation was further supported by KAT reactions with lysine- and arginine-rich peptide/RNA-coacervates (Fig. 6e), demonstrating that R3/RNA-coacervates are not dissolved in the presence of CREB or p300.",3300
126,598,PMID: 31266957,RNAPS0000304,https://pubmed.ncbi.nlm.nih.gov/31266957,RNA + protein,-,-,polyU,2000–3300nt,-,poly RNA,-,"SKIGSTENLKHQPGGGKVQIINKKLDLSNVQSKSGSKDNIKHVPGGGSVQIVYKPVD
LSKVTSKCGSLGNIHHKPGGGQVEVKSEKLDFKDRVQSKIGSLDNITHVPGGGNKKIETH
KLTFRENAKAKTDHGAEIVYKSPVVSGDTSPRHLSNVSSTGSIDMVDSPQLATLADEVSA
SLAKQGL",K25,-,-,184aa,-,-,-,"[1-10],[23-25],[27-29],[34-42],[83-93],[139-179]",-,In vitro,50 µM[K25];|100 µg/ml[polyU RNA],-,-,RT,≤ 20 min,-,"Differential interference contrast microscopy,Fluorescence microscopy",liquid,"DIC and fluorescence micrographs of hTau40, K25, and K18 solutions in the presence of different co-factors/buffer conditions. The concentration of the proteins was 50μM.",3300
127,599,PMID: 31266957,RNAPS0000304,https://pubmed.ncbi.nlm.nih.gov/31266957,RNA + protein,-,-,polyU,2000–3300nt,-,poly RNA,-,"SKIGSTENLKHQPGGGKVQIINKKLDLSNVQSKSGSKDNIKHVPGGGSVQIVYKPVD
LSKVTSKCGSLGNIHHKPGGGQVEVKSEKLDFKDRVQSKIGSLDNITHVPGGGNKKIETH
KLTFRENAKAKTDHGAEIVYKSPVVSGDTSPRHLSNVSSTGSIDMVDSPQLATLADEVSA
SLAKQGL",K25,-,-,184aa,-,-,-,"[1-10],[23-25],[27-29],[34-42],[83-93],[139-179]",-,In vitro,50 µM[K25];|100 µg/ml[polyU RNA],-,"25 mM HEPES,pH 7.4",RT,≤ 20 min,-,"Differential interference contrast microscopy,Fluorescence microscopy",solute,"DIC and fluorescence micrographs of hTau40, K25, and K18 solutions in the presence of different co-factors/buffer conditions. The concentration of the proteins was 50μM.",3300
128,600,PMID: 31266957,RNAPS0000304,https://pubmed.ncbi.nlm.nih.gov/31266957,RNA + protein,-,-,polyU,2000–3300nt,-,poly RNA,-,"SKIGSTENLKHQPGGGKVQIINKKLDLSNVQSKSGSKDNIKHVPGGGSVQIVYKPVD
LSKVTSKCGSLGNIHHKPGGGQVEVKSEKLDFKDRVQSKIGSLDNITHVPGGGNKKIETH
KLTFRENAKAKTDHGAEIVYKSPVVSGDTSPRHLSNVSSTGSIDMVDSPQLATLADEVSA
SLAKQGL",K25,-,-,184aa,-,-,-,"[1-10],[23-25],[27-29],[34-42],[83-93],[139-179]",-,In vitro,50 µM[K25];|100 µg/ml[polyU RNA],-,-,RT,≤ 20 min,crowding agent:10% dextran,"Differential interference contrast microscopy,Fluorescence microscopy",solute,"DIC and fluorescence micrographs of hTau40, K25, and K18 solutions in the presence of different co-factors/buffer conditions. The concentration of the proteins was 50μM.",3300
129,601,PMID: 31266957,RNAPS0000305,https://pubmed.ncbi.nlm.nih.gov/31266957,RNA + protein,-,-,polyU,2000–3300nt,-,poly RNA,-,"sp|P10636-8|TAU_HUMAN Isoform Tau-F of Microtubule-associated protein tau OS=Homo sapiens OX=9606 GN=MAPT
MAEPRQEFEVMEDHAGTYGLGDRKDQGGYTMHQDQEGDTDAGLKESPLQTPTEDGSEEPG
SETSDAKSTPTAEDVTAPLVDEGAPGKQAAAQPHTEIPEGTTAEEAGIGDTPSLEDEAAG
HVTQARMVSKSKDGTGSDDKKAKGADGKTKIATPRGAAPPGQKGQANATRIPAKTPPAPK
TPPSSGEPPKSGDRSGYSSPGSPGTPGSRSRTPSLPTPPTREPKKVAVVRTPPKSPSSAK
SRLQTAPVPMPDLKNVKSKIGSTENLKHQPGGGKVQIINKKLDLSNVQSKCGSKDNIKHV
PGGGSVQIVYKPVDLSKVTSKCGSLGNIHHKPGGGQVEVKSEKLDFKDRVQSKIGSLDNI
THVPGGGNKKIETHKLTFRENAKAKTDHGAEIVYKSPVVSGDTSPRHLSNVSSTGSIDMV
DSPQLATLADEVSASLAKQGL",MAPT,-,-,441aa(1-441),P10636,"DrLLPS,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-2853,http://db.phasep.pro/browse/","[125-375],[395-441]","[216-226],[323-340],[380-403]",In vitro,50 µM[hTau40];|40 µg/ml[polyU RNA],-,-,RT,≤ 20 min,-,"Differential interference contrast microscopy,Fluorescence microscopy",liquid,"DIC and fluorescence micrographs of hTau40, K25, and K18 solutions in the presence of different co-factors/buffer conditions. The concentration of the proteins was 52 μM.",3300
130,602,PMID: 31266957,RNAPS0000305,https://pubmed.ncbi.nlm.nih.gov/31266957,RNA + protein,-,-,polyU,2000–3300nt,-,poly RNA,-,"sp|P10636-8|TAU_HUMAN Isoform Tau-F of Microtubule-associated protein tau OS=Homo sapiens OX=9606 GN=MAPT
MAEPRQEFEVMEDHAGTYGLGDRKDQGGYTMHQDQEGDTDAGLKESPLQTPTEDGSEEPG
SETSDAKSTPTAEDVTAPLVDEGAPGKQAAAQPHTEIPEGTTAEEAGIGDTPSLEDEAAG
HVTQARMVSKSKDGTGSDDKKAKGADGKTKIATPRGAAPPGQKGQANATRIPAKTPPAPK
TPPSSGEPPKSGDRSGYSSPGSPGTPGSRSRTPSLPTPPTREPKKVAVVRTPPKSPSSAK
SRLQTAPVPMPDLKNVKSKIGSTENLKHQPGGGKVQIINKKLDLSNVQSKCGSKDNIKHV
PGGGSVQIVYKPVDLSKVTSKCGSLGNIHHKPGGGQVEVKSEKLDFKDRVQSKIGSLDNI
THVPGGGNKKIETHKLTFRENAKAKTDHGAEIVYKSPVVSGDTSPRHLSNVSSTGSIDMV
DSPQLATLADEVSASLAKQGL",MAPT,-,-,441aa(1-441),P10636,"DrLLPS,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-2853,http://db.phasep.pro/browse/","[125-375],[395-441]","[216-226],[323-340],[380-403]",In vitro,50 µM[hTau40];|40 µg/ml[polyU RNA],-,"25 mM HEPES,pH 7.4",RT,≤ 20 min,-,"Differential interference contrast microscopy,Fluorescence microscopy",liquid,"DIC and fluorescence micrographs of hTau40, K25, and K18 solutions in the presence of different co-factors/buffer conditions. The concentration of the proteins was 52 μM.",3300
131,603,PMID: 31266957,RNAPS0000305,https://pubmed.ncbi.nlm.nih.gov/31266957,RNA + protein,-,-,polyU,2000–3300nt,-,poly RNA,-,"sp|P10636-8|TAU_HUMAN Isoform Tau-F of Microtubule-associated protein tau OS=Homo sapiens OX=9606 GN=MAPT
MAEPRQEFEVMEDHAGTYGLGDRKDQGGYTMHQDQEGDTDAGLKESPLQTPTEDGSEEPG
SETSDAKSTPTAEDVTAPLVDEGAPGKQAAAQPHTEIPEGTTAEEAGIGDTPSLEDEAAG
HVTQARMVSKSKDGTGSDDKKAKGADGKTKIATPRGAAPPGQKGQANATRIPAKTPPAPK
TPPSSGEPPKSGDRSGYSSPGSPGTPGSRSRTPSLPTPPTREPKKVAVVRTPPKSPSSAK
SRLQTAPVPMPDLKNVKSKIGSTENLKHQPGGGKVQIINKKLDLSNVQSKCGSKDNIKHV
PGGGSVQIVYKPVDLSKVTSKCGSLGNIHHKPGGGQVEVKSEKLDFKDRVQSKIGSLDNI
THVPGGGNKKIETHKLTFRENAKAKTDHGAEIVYKSPVVSGDTSPRHLSNVSSTGSIDMV
DSPQLATLADEVSASLAKQGL",MAPT,-,-,441aa(1-441),P10636,"DrLLPS,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-2853,http://db.phasep.pro/browse/","[125-375],[395-441]","[216-226],[323-340],[380-403]",In vitro,50 µM[hTau40];|40 µg/ml[polyU RNA],-,-,RT,≤ 20 min,crowding agent:10% dextran,"Differential interference contrast microscopy,Fluorescence microscopy",liquid,"DIC and fluorescence micrographs of hTau40, K25, and K18 solutions in the presence of different co-factors/buffer conditions. The concentration of the proteins was 52 μM.",3300
132,604,PMID: 31266957,RNAPS0000306,https://pubmed.ncbi.nlm.nih.gov/31266957,RNA + protein,-,-,polyU,2000–3300nt,-,poly RNA,-,RRASLRRASLRRASL,R3,-,-,15aa,-,-,-,-,-,In vitro,0.5 mg/ml[polyU RNA];|1 mM[R3],-,"25 mM HEPES,pH 7.4",RT,≤ 90 min,other_molecular:CREB/p300,Turbidity measurement,liquid,"The specificity of acetylation-dependent complex coacervation was further supported by KAT reactions with lysine- and arginine-rich peptide/RNA-coacervates (Fig. 6e), demonstrating that R3/RNA-coacervates are not dissolved in the presence of CREB or p300.",3300
133,605,PMID: 31266957,RNAPS0000306,https://pubmed.ncbi.nlm.nih.gov/31266957,RNA + protein,-,-,polyU,2000–3300nt,-,poly RNA,-,RRASLRRASLRRASL,R3,-,-,15aa,-,-,-,-,-,In vitro,0.5 mg/ml[polyU RNA];|1 mM[R3],-,"25 mM HEPES,pH 7.4",RT,≤ 90 min,other_molecular:AcCoA,Turbidity measurement,liquid,"The specificity of acetylation-dependent complex coacervation was further supported by KAT reactions with lysine- and arginine-rich peptide/RNA-coacervates (Fig. 6e), demonstrating that R3/RNA-coacervates are not dissolved in the presence of CREB or p300.",3300
134,606,PMID: 31266957,RNAPS0000306,https://pubmed.ncbi.nlm.nih.gov/31266957,RNA + protein,-,-,polyU,2000–3300nt,-,poly RNA,-,RRASLRRASLRRASL,R3,-,-,15aa,-,-,-,-,-,In vitro,0.5 mg/ml[polyU RNA];|1 mM[R3],-,"25 mM HEPES,pH 7.4",RT,≤ 90 min,other_molecular:both the enzyme and AcCoA.,Turbidity measurement,liquid,"The specificity of acetylation-dependent complex coacervation was further supported by KAT reactions with lysine- and arginine-rich peptide/RNA-coacervates (Fig. 6e), demonstrating that R3/RNA-coacervates are not dissolved in the presence of CREB or p300.",3300
135,619,PMID: 31334587,RNAPS0000087,https://pubmed.ncbi.nlm.nih.gov/31334587,RNA + protein,-,-,polyU,-,-,poly RNA,-,"sp|P39517|DHH1_YEAST ATP-dependent RNA helicase DHH1 OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) OX=559292 GN=DHH1 PE=1 SV=1|length=506aa|residues=1-506
MGSINNNFNTNNNSNTDLDRDWKTALNIPKKDTRPQTDDVLNTKGNTFEDFYLKRELLMG
IFEAGFEKPSPIQEEAIPVAITGRDILARAKNGTGKTAAFVIPTLEKVKPKLNKIQALIM
VPTRELALQTSQVVRTLGKHCGISCMVTTGGTNLRDDILRLNETVHILVGTPGRVLDLAS
RKVADLSDCSLFIMDEADKMLSRDFKTIIEQILSFLPPTHQSLLFSATFPLTVKEFMVKH
LHKPYEINLMEELTLKGITQYYAFVEERQKLHCLNTLFSKLQINQAIIFCNSTNRVELLA
KKITDLGYSCYYSHARMKQQERNKVFHEFRQGKVRTLVCSDLLTRGIDIQAVNVVINFDF
PKTAETYLHRIGRSGRFGHLGLAINLINWNDRFNLYKIEQELGTEIAAIPATIDKSLYVA
ENDETVPVPFPIEQQSYHQQAIPQQQLPSQQQFAIPPQQHHPQFMVPPSHQQQQAYPPPQ
MPSQQGYPPQQEHFMAMPPGQSQPQY",DHH1,-,-,506aa(1-506),P39517,"DrLLPS,LLPSDB,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Sac-0503,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0168,http://db.phasep.pro/browse/",-,-,In vitro,0.2 mg/ml[polyU];|5µM[DHH1],2 mM MgCl2,30 mM HEPES-KOH pH 7.4,RT,60-200 s,other_molecular:50 mM ATP,Turbidity measurement,"solute, liquid","In the first junction, liquid-liquid phase separation (LLPS) is triggered by mixing a one-phase protein solution of Dhh1 with ATP and polyU.",0
136,630,PMID: 31435012,RNAPS0000087,https://pubmed.ncbi.nlm.nih.gov/31435012,RNA + protein,-,-,polyU,-,-,poly RNA,-,"sp|P39517|DHH1_YEAST ATP-dependent RNA helicase DHH1 OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) OX=559292 GN=DHH1 PE=1 SV=1
MGSINNNFNTNNNSNTDLDRDWKTALNIPKKDTRPQTDDVLNTKGNTFEDFYLKRELLMG
IFEAGFEKPSPIQEEAIPVAITGRDILARAKNGTGKTAAFVIPTLEKVKPKLNKIQALIM
VPTRELALQTSQVVRTLGKHCGISCMVTTGGTNLRDDILRLNETVHILVGTPGRVLDLAS
RKVADLSDCSLFIMDEADKMLSRDFKTIIEQILSFLPPTHQSLLFSATFPLTVKEFMVKH
LHKPYEINLMEELTLKGITQYYAFVEERQKLHCLNTLFSKLQINQAIIFCNSTNRVELLA
KKITDLGYSCYYSHARMKQQERNKVFHEFRQGKVRTLVCSDLLTRGIDIQAVNVVINFDF
PKTAETYLHRIGRSGRFGHLGLAINLINWNDRFNLYKIEQELGTEIAAIPATIDKSLYVA
ENDETVPVPFPIEQQSYHQQAIPQQQLPSQQQFAIPPQQHHPQFMVPPSHQQQQAYPPPQ
MPSQQGYPPQQEHFMAMPPGQSQPQY",DHH1,-,-,506aa(1-506),P39517,"DrLLPS,LLPSDB,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Sac-0503,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0168,http://db.phasep.pro/browse/",-,-,In vitro,1.25 µl 1mg/ml[polyU](final concentration 0.05 mg/ml);|3 µl[DHH1],-,"13.4 µl LSB-100(100 mM KCl, 30 mM HEPES-KOH pH 7.4, 2 mM MgCl2),2.1 µl 0.5M KCl (final KCl concentration 100mM) ,1 µl CKM（40 mM ATP, 40 mM MgCl2, 200 mM creatine phosphate, 70 U ml−1 creatine kinase）mix ,1.25 µl 100mM ATP/MgCl2 (final concentration 5mM) ,1 µl 10 mg/ml BSA, 2 µl 1M Hepes of the respective pH ,3 µl mix of MH200G and Dhh1 stock to the final concentration as indicated,pH=6.2-7.2",RT,-,-,"Wide-field microscopy,FISH,Immunofluorescence microscopy",-,Phase separation behaviour of full-length and tail-less (core) Dhh1 in different pH conditions.,0
137,631,PMID: 31435012,RNAPS0000087,https://pubmed.ncbi.nlm.nih.gov/31435012,RNA + protein,-,-,polyU,-,-,poly RNA,-,"sp|P39517|DHH1_YEAST ATP-dependent RNA helicase DHH1 OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) OX=559292 GN=DHH1 PE=1 SV=1
MGSINNNFNTNNNSNTDLDRDWKTALNIPKKDTRPQTDDVLNTKGNTFEDFYLKRELLMG
IFEAGFEKPSPIQEEAIPVAITGRDILARAKNGTGKTAAFVIPTLEKVKPKLNKIQALIM
VPTRELALQTSQVVRTLGKHCGISCMVTTGGTNLRDDILRLNETVHILVGTPGRVLDLAS
RKVADLSDCSLFIMDEADKMLSRDFKTIIEQILSFLPPTHQSLLFSATFPLTVKEFMVKH
LHKPYEINLMEELTLKGITQYYAFVEERQKLHCLNTLFSKLQINQAIIFCNSTNRVELLA
KKITDLGYSCYYSHARMKQQERNKVFHEFRQGKVRTLVCSDLLTRGIDIQAVNVVINFDF
PKTAETYLHRIGRSGRFGHLGLAINLINWNDRFNLYKIEQELGTEIAAIPATIDKSLYVA
ENDETVPVPFPIEQQSYHQQAIPQQQLPSQQQFAIPPQQHHPQFMVPPSHQQQQAYPPPQ
MPSQQGYPPQQEHFMAMPPGQSQPQY",DHH1,-,-,506aa(1-506),P39517,"DrLLPS,LLPSDB,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Sac-0503,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0168,http://db.phasep.pro/browse/",-,-,In vitro,1.25 µl 1mg/ml[polyU];|3 µl[DHH1],-,"12.5 µl LSB-100(100 mM KCl, 30 mM HEPES-KOH pH 7.4, 2 mM MgCl2),3 µl mix of 0.5M KCl / water to the final KCl concentration as indicated ,1 µl CKM（40 mM ATP, 40 mM MgCl2, 200 mM creatine phosphate, 70 U ml−1 creatine kinase）mix ,1.25 µl 100mM ATP/MgCl2 (final concentration 5 mM) ,1 µl 10 mg/ml BSA, 2 µl 1M Hepes of the respective pH ,3 µl mix of MH200G and Dhh1 stock to the final concentration as indicated,0-15mM ATP",RT,-,-,"Wide-field microscopy,FISH,Immunofluorescence microscopy",-,Phase separation behaviour of full-length and tail-less (core) Dhh1 in different ATP concentrations.,0
138,632,PMID: 31435012,RNAPS0000087,https://pubmed.ncbi.nlm.nih.gov/31435012,RNA + protein,-,-,polyU,-,-,poly RNA,-,"sp|P39517|DHH1_YEAST ATP-dependent RNA helicase DHH1 OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) OX=559292 GN=DHH1 PE=1 SV=1
MGSINNNFNTNNNSNTDLDRDWKTALNIPKKDTRPQTDDVLNTKGNTFEDFYLKRELLMG
IFEAGFEKPSPIQEEAIPVAITGRDILARAKNGTGKTAAFVIPTLEKVKPKLNKIQALIM
VPTRELALQTSQVVRTLGKHCGISCMVTTGGTNLRDDILRLNETVHILVGTPGRVLDLAS
RKVADLSDCSLFIMDEADKMLSRDFKTIIEQILSFLPPTHQSLLFSATFPLTVKEFMVKH
LHKPYEINLMEELTLKGITQYYAFVEERQKLHCLNTLFSKLQINQAIIFCNSTNRVELLA
KKITDLGYSCYYSHARMKQQERNKVFHEFRQGKVRTLVCSDLLTRGIDIQAVNVVINFDF
PKTAETYLHRIGRSGRFGHLGLAINLINWNDRFNLYKIEQELGTEIAAIPATIDKSLYVA
ENDETVPVPFPIEQQSYHQQAIPQQQLPSQQQFAIPPQQHHPQFMVPPSHQQQQAYPPPQ
MPSQQGYPPQQEHFMAMPPGQSQPQY",DHH1,-,-,506aa(1-506),P39517,"DrLLPS,LLPSDB,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Sac-0503,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0168,http://db.phasep.pro/browse/",-,-,In vitro,0.05-0.5mg/ml[polyU](final concentration 0.05 mg/ml);|3 µl[DHH1],-,"13.4 µl LSB-100(100 mM KCl, 30 mM HEPES-KOH pH 7.4, 2 mM MgCl2),2.1 µl 0.5M KCl (final KCl concentration 100 mM) ,1 µl CKM（40 mM ATP, 40 mM MgCl2, 200 mM creatine phosphate, 70 U ml−1 creatine kinase）mix .1.25 µl 100mM ATP/MgCl2 (final concentration 5 mM) ,1 µl 10 mg/ml BSA, 2 µl 1M Hepes ofthe respective pH .1.25 µl mix of water / 10mg/ml polyU to the final concentration as indicated ,3 µl mix of MH200G and Dhh1 stock to the final concentration as indicate",RT,-,-,"Wide-field microscopy,FISH,Immunofluorescence microscopy",-,Phase separation behaviour of full-length and tail-less (core) Dhh1 in different polyU concentrations,0
139,633,PMID: 31435012,RNAPS0000087,https://pubmed.ncbi.nlm.nih.gov/31435012,RNA + protein,-,-,polyU,-,-,poly RNA,-,"sp|P39517|DHH1_YEAST ATP-dependent RNA helicase DHH1 OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) OX=559292 GN=DHH1 PE=1 SV=1
MGSINNNFNTNNNSNTDLDRDWKTALNIPKKDTRPQTDDVLNTKGNTFEDFYLKRELLMG
IFEAGFEKPSPIQEEAIPVAITGRDILARAKNGTGKTAAFVIPTLEKVKPKLNKIQALIM
VPTRELALQTSQVVRTLGKHCGISCMVTTGGTNLRDDILRLNETVHILVGTPGRVLDLAS
RKVADLSDCSLFIMDEADKMLSRDFKTIIEQILSFLPPTHQSLLFSATFPLTVKEFMVKH
LHKPYEINLMEELTLKGITQYYAFVEERQKLHCLNTLFSKLQINQAIIFCNSTNRVELLA
KKITDLGYSCYYSHARMKQQERNKVFHEFRQGKVRTLVCSDLLTRGIDIQAVNVVINFDF
PKTAETYLHRIGRSGRFGHLGLAINLINWNDRFNLYKIEQELGTEIAAIPATIDKSLYVA
ENDETVPVPFPIEQQSYHQQAIPQQQLPSQQQFAIPPQQHHPQFMVPPSHQQQQAYPPPQ
MPSQQGYPPQQEHFMAMPPGQSQPQY",DHH1,-,-,506aa(1-506),P39517,"DrLLPS,LLPSDB,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Sac-0503,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0168,http://db.phasep.pro/browse/",-,-,In vitro,1.25 µl 1mg/ml[polyU](final concentration 0.05 mg/ml);|3 µl[DHH1],-,"13.4 µl LSB-100(100 mM KCl, 30 mM HEPES-KOH pH 7.4, 2 mM MgCl2),2.1 µl 0.5M KCl (final KCl concentration 100mM) ,1 µl CKM（40 mM ATP, 40 mM MgCl2, 200 mM creatine phosphate, 70 U ml−1 creatine kinase）mix ,1.5 µl mix of ATP/MgCl2 (250mM stock) and H2O to the final concentration as indicated ,1 µl 10 mg/ml BSA ,2 µl 1M Hepes of the respective pH ,3 µl mix of MH200G and Dhh1 stock to the final concentration as indicated",RT,-,-,"Wide-field microscopy,FISH,Immunofluorescence microscopy",-,Phase separation behaviour of full-length and tail-less (core) Dhh1 in different salt concentrations.,0
140,634,PMID: 31435012,RNAPS0000087,https://pubmed.ncbi.nlm.nih.gov/31435012,RNA + protein,-,-,polyU,-,-,poly RNA,-,"sp|P39517|DHH1_YEAST ATP-dependent RNA helicase DHH1 OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) OX=559292 GN=DHH1 PE=1 SV=1
MGSINNNFNTNNNSNTDLDRDWKTALNIPKKDTRPQTDDVLNTKGNTFEDFYLKRELLMG
IFEAGFEKPSPIQEEAIPVAITGRDILARAKNGTGKTAAFVIPTLEKVKPKLNKIQALIM
VPTRELALQTSQVVRTLGKHCGISCMVTTGGTNLRDDILRLNETVHILVGTPGRVLDLAS
RKVADLSDCSLFIMDEADKMLSRDFKTIIEQILSFLPPTHQSLLFSATFPLTVKEFMVKH
LHKPYEINLMEELTLKGITQYYAFVEERQKLHCLNTLFSKLQINQAIIFCNSTNRVELLA
KKITDLGYSCYYSHARMKQQERNKVFHEFRQGKVRTLVCSDLLTRGIDIQAVNVVINFDF
PKTAETYLHRIGRSGRFGHLGLAINLINWNDRFNLYKIEQELGTEIAAIPATIDKSLYVA
ENDETVPVPFPIEQQSYHQQAIPQQQLPSQQQFAIPPQQHHPQFMVPPSHQQQQAYPPPQ
MPSQQGYPPQQEHFMAMPPGQSQPQY",DHH1,-,-,506aa(1-506),P39517,"DrLLPS,LLPSDB,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Sac-0503,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0168,http://db.phasep.pro/browse/",-,-,In vitro,0.25µl 10mg/ml[polyU];|5.25µl 50µM[DHH1],-,"15.75 µl LSB-150 (150 mM KCl, 30 mM HEPES-KOH pH 7.4, 2 mM MgCl2),1 µl CKM（40 mM ATP, 40 mM MgCl2, 200 mM creatine phosphate, 70 U ml−1 creatine kinase）,1 µl 10 mg/ml BSA,1 µl Hepes,pH 6.4 ",RT,-,-,"Wide-field microscopy,FISH,Immunofluorescence microscopy",liquid,"Recombinant Ded1, Dbp1 and Dbp2 all readily undergo LLPS and form droplets in the presence of ATP and RNA. To examine whether DDX-mediated phase separation is conserved, we next analysed DDX6 and DDX3X, the human orthologues of Dhh1 and Ded1. Although the sequences of the unstructured tails have diverged considerably between yeast and human, both recombinant DDX6 and DDX3X still form phase separated droplets in vitro.",0
141,635,PMID: 31435012,RNAPS0000087,https://pubmed.ncbi.nlm.nih.gov/31435012,RNA + protein,-,-,polyU,-,-,poly RNA,-,"sp|P39517|DHH1_YEAST ATP-dependent RNA helicase DHH1 OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) OX=559292 GN=DHH1 PE=1 SV=1|residue=48-425
FEDFYLKRELLMGIFEAGFEKPSPIQEEAIPVAITGRDILARAKNGTGKTAAFVIPTLEKVKPKLNKIQALIM
VPTRELALQTSQVVRTLGKHCGISCMVTTGGTNLRDDILRLNETVHILVGTPGRVLDLAS
RKVADLSDCSLFIMDEADKMLSRDFKTIIEQILSFLPPTHQSLLFSATFPLTVKEFMVKH
LHKPYEINLMEELTLKGITQYYAFVEERQKLHCLNTLFSKLQINQAIIFCNSTNRVELLA
KKITDLGYSCYYSHARMKQQERNKVFHEFRQGKVRTLVCSDLLTRGIDIQAVNVVINFDF
PKTAETYLHRIGRSGRFGHLGLAINLINWNDRFNLYKIEQELGTEIAAIPATI
",DHH1,-,-,378aa(48-425),P39517,"DrLLPS,LLPSDB,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Sac-0503,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0168,http://db.phasep.pro/browse/",-,-,In vitro,0.25µl 10mg/ml[polyU];|5.25µl 50µM[DHH1-core],-,"15.75 µl LSB-150 (150 mM KCl, 30 mM HEPES-KOH pH 7.4, 2 mM MgCl2),1 µl CKM（40 mM ATP, 40 mM MgCl2, 200 mM creatine phosphate, 70 U ml−1 creatine kinase）,1 µl 10 mg/ml BSA,1 µl Hepes,pH 6.4 ",RT,-,-,"Wide-field microscopy,FISH,Immunofluorescence microscopy",liquid,"Recombinant Ded1, Dbp1 and Dbp2 all readily undergo LLPS and form droplets in the presence of ATP and RNA. To examine whether DDX-mediated phase separation is conserved, we next analysed DDX6 and DDX3X, the human orthologues of Dhh1 and Ded1. Although the sequences of the unstructured tails have diverged considerably between yeast and human, both recombinant DDX6 and DDX3X still form phase separated droplets in vitro.",0
142,636,PMID: 31435012,RNAPS0000326,https://pubmed.ncbi.nlm.nih.gov/31435012,RNA + protein,-,-,polyU,-,-,poly RNA,-,"sp|P06634|DED1_YEAST ATP-dependent RNA helicase DED1 OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) OX=559292 GN=DED1 PE=1 SV=2
MAELSEQVQNLSINDNNENGYVPPHLRGKPRSARNNSSNYNNNNGGYNGGRGGGSFFSNN
RRGGYGNGGFFGGNNGGSRSNGRSGGRWIDGKHVPAPRNEKAEIAIFGVPEDPNFQSSGI
NFDNYDDIPVDASGKDVPEPITEFTSPPLDGLLLENIKLARFTKPTPVQKYSVPIVANGR
DLMACAQTGSGKTGGFLFPVLSESFKTGPSPQPESQGSFYQRKAYPTAVIMAPTRELATQ
IFDEAKKFTYRSWVKACVVYGGSPIGNQLREIERGCDLLVATPGRLNDLLERGKISLANV
KYLVLDEADRMLDMGFEPQIRHIVEDCDMTPVGERQTLMFSATFPADIQHLARDFLSDYI
FLSVGRVGSTSENITQKVLYVENQDKKSALLDLLSASTDGLTLIFVETKRMADQLTDFLI
MQNFRATAIHGDRTQSERERALAAFRSGAATLLVATAVAARGLDIPNVTHVINYDLPSDV
DDYVHRIGRTGRAGNTGLATAFFNSENSNIVKGLHEILTEANQEVPSFLKDAMMSAPGSR
SNSRRGGFGRNNNRDYRKAGGASAGGWGSSRSRDNSFRGGSGWGSDSKSSGWGNSGGSNN
SSWW",DED1,-,-,604aa(1-604),P06634,"DrLLPS,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Sac-0016,http://db.phasep.pro/browse/",-,"[34-87],[385-403],[449-460],[538-554],[559-570],[579-604]",In vitro,1.5µl 1mg/ml[polyU];|2.5µl 50µM[DED1],-,"13ul LSB-50(50 mM KCl, 30 mM HEPES-KOH pH 7.4, 2 mM MgCl2),1ul CK mix,2ul Hepes pH 6.8,1ul 10mg/ml BSA",RT,-,-,"Wide-field microscopy,FISH,Immunofluorescence microscopy",liquid,"Recombinant Ded1, Dbp1 and Dbp2 all readily undergo LLPS and form droplets in the presence of ATP and RNA.To examine whether DDX-mediated phase separation is conserved, we next analysed DDX6 and DDX3X, the human orthologues of Dhh1 and Ded1. Although the sequences of the unstructured tails have diverged considerably between yeast and human , both recombinant DDX6 and DDX3X still form phase?separated droplets in vitro.",0
143,637,PMID: 31435012,RNAPS0000327,https://pubmed.ncbi.nlm.nih.gov/31435012,RNA + protein,-,-,polyU,-,-,poly RNA,-,"sp|P24784|DBP1_YEAST ATP-dependent RNA helicase DBP1 OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) OX=559292 GN=DBP1 PE=1 SV=2
MADLPQKVSNLSINNKENGGGGGKSSYVPPHLRSRGKPSFERSTPKQEDKVTGGDFFRRA
GRQTGNNGGFFGFSKERNGGTSANYNRGGSSNYKSSGNRWVNGKHIPGPKNAKLEAELFG
VHDDPDYHSSGIKFDNYDNIPVDASGKDVPEPILDFSSPPLDELLMENIKLASFTKPTPV
QKYSIPIVTKGRDLMACAQTGSGKTGGFLFPLFTELFRSGPSPVPEKAQSFYSRKGYPSA
LVLAPTRELATQIFEEARKFTYRSWVRPCVVYGGAPIGNQMREVDRGCDLLVATPGRLND
LLERGKVSLANIKYLVLDEADRMLDMGFEPQIRHIVEECDMPSVENRQTLMFSATFPVDI
QHLARDFLDNYIFLSVGRVGSTSENITQRILYVDDMDKKSALLDLLSAEHKGLTLIFVET
KRMADQLTDFLIMQNFKATAIHGDRTQAERERALSAFKANVADILVATAVAARGLDIPNV
THVINYDLPSDIDDYVHRIGRTGRAGNTGVATSFFNSNNQNIVKGLMEILNEANQEVPTF
LSDLSRQNSRGGRTRGGGGFFNSRNNGSRDYRKHGGNGSFGSTRPRNTGTSNWGSIGGGF
RNDNEKNGYGNSNASWW",DBP1,-,-,617aa(1-617),P24784,"LLPSDB,PhaSepDB","http://bio-comp.org.cn/llpsdb/protein.php?protein=p0221,http://db.phasep.pro/browse/",-,"[19-23],[545-569]",In vitro,1µl 1mg/ml[polyU];|3µl 50µM[DBP1],-,"14 µl LSB-50(50 mM KCl, 30 mM HEPES-KOH pH 7.4, 2 mM MgCl2),1 µl CKM（40 mM ATP, 40 mM MgCl2, 200 mM creatine phosphate, 70 U ml−1 creatine kinase）,2 µl Hepes pH 6.4,1 µl 10mg/ml BSA",RT,-,-,"Wide-field microscopy,FISH,Immunofluorescence microscopy",liquid,"Recombinant Ded1, Dbp1 and Dbp2 all readily undergo LLPS and form droplets in the presence of ATP and RNA.To examine whether DDX-mediated phase separation is conserved, we next analysed DDX6 and DDX3X, the human orthologues of Dhh1 and Ded1. Although the sequences of the unstructured tails have diverged considerably between yeast and human , both recombinant DDX6 and DDX3X still form phase?separated droplets in vitro.",0
144,638,PMID: 31435012,RNAPS0000328,https://pubmed.ncbi.nlm.nih.gov/31435012,RNA + protein,-,-,polyU,-,-,poly RNA,-,"sp|P24783|DBP2_YEAST ATP-dependent RNA helicase DBP2 OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) OX=559292 GN=DBP2 PE=1 SV=1
MTYGGRDQQYNKTNYKSRGGDFRGGRNSDRNSYNDRPQGGNYRGGFGGRSNYNQPQELIK
PNWDEELPKLPTFEKNFYVEHESVRDRSDSEIAQFRKENEMTISGHDIPKPITTFDEAGF
PDYVLNEVKAEGFDKPTGIQCQGWPMALSGRDMVGIAATGSGKTLSYCLPGIVHINAQPL
LAPGDGPIVLVLAPTRELAVQIQTECSKFGHSSRIRNTCVYGGVPKSQQIRDLSRGSEIV
IATPGRLIDMLEIGKTNLKRVTYLVLDEADRMLDMGFEPQIRKIVDQIRPDRQTLMWSAT
WPKEVKQLAADYLNDPIQVQVGSLELSASHNITQIVEVVSDFEKRDRLNKYLETASQDNE
YKTLIFASTKRMCDDITKYLREDGWPALAIHGDKDQRERDWVLQEFRNGRSPIMVATDVA
ARGIDVKGINYVINYDMPGNIEDYVHRIGRTGRAGATGTAISFFTEQNKGLGAKLISIMR
EANQNIPPELLKYDRRSYGGGHPRYGGGRGGRGGYGRRGGYGGGRGGYGGNRQRDGGWGN
RGRSNY",DBP2,-,-,546aa(1-546),P24783,DrLLPS,http://llps.biocuckoo.cn/view.php?id=LLPS-Sac-0566,-,"[39-53],[447-461],[495-543]",In vitro,1µl 1mg/ml[polyU];|2.5µl 50µM[DBP2],-,"11.5 µl MH200G,1 µl 1M phosphate pH 6.0,1 µl CKM（40 mM ATP, 40 mM MgCl2, 200 mM creatine phosphate, 70 U ml−1 creatine kinase）,2 µl Hepes pH 6.0,1 µl 10mg/ml BSA",RT,-,-,"Wide-field microscopy,FISH,Immunofluorescence microscopy",liquid,"Recombinant Ded1, Dbp1 and Dbp2 all readily undergo LLPS and form droplets in the presence of ATP and RNA.To examine whether DDX-mediated phase separation is conserved, we next analysed DDX6 and DDX3X, the human orthologues of Dhh1 and Ded1. Although the sequences of the unstructured tails have diverged considerably between yeast and human , both recombinant DDX6 and DDX3X still form phase?separated droplets in vitro.",0
145,639,PMID: 31435012,RNAPS0000329,https://pubmed.ncbi.nlm.nih.gov/31435012,RNA + protein,-,-,polyU,-,-,poly RNA,-,"sp|P60842|IF4A1_HUMAN Eukaryotic initiation factor 4A-I OS=Homo sapiens OX=9606 GN=EIF4A1 PE=1 SV=1
MSASQDSRSRDNGPDGMEPEGVIESNWNEIVDSFDDMNLSESLLRGIYAYGFEKPSAIQQ
RAILPCIKGYDVIAQAQSGTGKTATFAISILQQIELDLKATQALVLAPTRELAQQIQKVV
MALGDYMGASCHACIGGTNVRAEVQKLQMEAPHIIVGTPGRVFDMLNRRYLSPKYIKMFV
LDEADEMLSRGFKDQIYDIFQKLNSNTQVVLLSATMPSDVLEVTKKFMRDPIRILVKKEE
LTLEGIRQFYINVEREEWKLDTLCDLYETLTITQAVIFINTRRKVDWLTEKMHARDFTVS
AMHGDMDQKERDVIMREFRSGSSRVLITTDLLARGIDVQQVSLVINYDLPTNRENYIHRI
GRGGRFGRKGVAINMVTEEDKRTLRDIETFYNTSIEEMPLNVADLI",EIF4A1,-,-,406aa(1-406),P60842,DrLLPS,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-2247,[20-21],[359-370],In vitro,2µl 1mg/ml[polyU];|2µl 500µM[EIF4A1],100 mM NaCl,"9µl LSB-150(150 mM KCl, 30 mM HEPES-KOH pH 7.4, 2 mM MgCl2),2µl CKM（40 mM ATP, 40 mM MgCl2, 200 mM creatine phosphate, 70 U ml−1 creatine kinase）,1µl BSA 10mg/ml,1µl Hepes pH 6.6,3µl 1x ATPase buffer(30 mM HEPES-KOH pH 7.5, 100 mM NaCl, 2 mM MgCl2)",RT,-,-,"Wide-field microscopy,FISH,Immunofluorescence microscopy",solute,"Recombinant Ded1, Dbp1 and Dbp2 all readily undergo LLPS and form droplets in the presence of ATP and RNA.To examine whether DDX-mediated phase separation is conserved, we next analysed DDX6 and DDX3X, the human orthologues of Dhh1 and Ded1. Although the sequences of the unstructured tails have diverged considerably between yeast and human , both recombinant DDX6 and DDX3X still form phase?separated droplets in vitro.",0
146,640,PMID: 31435012,RNAPS0000330,https://pubmed.ncbi.nlm.nih.gov/31435012,RNA + protein,-,-,polyU,-,-,poly RNA,-,"sp|Q07478|SUB2_YEAST ATP-dependent RNA helicase SUB2 OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) OX=559292 GN=SUB2 PE=1 SV=1
MSHEGEEDLLEYSDNEQEIQIDASKAAEAGETGAATSATEGDNNNNTAAGDKKGSYVGIH
STGFKDFLLKPELSRAIIDCGFEHPSEVQQHTIPQSIHGTDVLCQAKSGLGKTAVFVLST
LQQLDPVPGEVAVVVICNARELAYQIRNEYLRFSKYMPDVKTAVFYGGTPISKDAELLKN
KDTAPHIVVATPGRLKALVREKYIDLSHVKNFVIDECDKVLEELDMRRDVQEIFRATPRD
KQVMMFSATLSQEIRPICRRFLQNPLEIFVDDEAKLTLHGLQQYYIKLEEREKNRKLAQL
LDDLEFNQVIIFVKSTTRANELTKLLNASNFPAITVHGHMKQEERIARYKAFKDFEKRIC
VSTDVFGRGIDIERINLAINYDLTNEADQYLHRVGRAGRFGTKGLAISFVSSKEDEEVLA
KIQERFDVKIAEFPEEGIDPSTYLNN",SUB2,-,-,446aa(1-446),Q07478,PhaSepDB,http://db.phasep.pro/browse/,-,[23-41],In vitro,2µl 1mg/ml[polyU];|2µl 500µM[SUB2],100 mM NaCl,"9µl LSB-150(150 mM KCl, 30 mM HEPES-KOH pH 7.4, 2 mM MgCl2),2µl CKM（40 mM ATP, 40 mM MgCl2, 200 mM creatine phosphate, 70 U ml−1 creatine kinase）,1µl BSA 10mg/ml,1µl Hepes pH 6.6,3µl 1x ATPase buffer(30 mM HEPES-KOH pH 7.5, 100 mM NaCl, 2 mM MgCl2)",RT,-,-,"Wide-field microscopy,FISH,Immunofluorescence microscopy",solute,"Recombinant Ded1, Dbp1 and Dbp2 all readily undergo LLPS and form droplets in the presence of ATP and RNA.To examine whether DDX-mediated phase separation is conserved, we next analysed DDX6 and DDX3X, the human orthologues of Dhh1 and Ded1. Although the sequences of the unstructured tails have diverged considerably between yeast and human , both recombinant DDX6 and DDX3X still form phase?separated droplets in vitro.",0
147,641,PMID: 31435012,RNAPS0000331,https://pubmed.ncbi.nlm.nih.gov/31435012,RNA + protein,-,-,polyU,-,-,poly RNA,-,"sp|P20449|DBP5_YEAST ATP-dependent RNA helicase DBP5 OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) OX=559292 GN=DBP5 PE=1 SV=2
MSDTKRDPADLLASLKIDNEKEDTSEVSTKETVKSQPEKTADSIKPAEKLVPKVEEKKTK
QEDSNLISSEYEVKVKLADIQADPNSPLYSAKSFDELGLAPELLKGIYAMKFQKPSKIQE
RALPLLLHNPPRNMIAQSQSGTGKTAAFSLTMLTRVNPEDASPQAICLAPSRELARQTLE
VVQEMGKFTKITSQLIVPDSFEKNKQINAQVIVGTPGTVLDLMRRKLMQLQKIKIFVLDE
ADNMLDQQGLGDQCIRVKRFLPKDTQLVLFSATFADAVRQYAKKIVPNANTLELQTNEVN
VDAIKQLYMDCKNEADKFDVLTELYGLMTIGSSIIFVATKKTANVLYGKLKSEGHEVSIL
HGDLQTQERDRLIDDFREGRSKVLITTNVLARGIDIPTVSMVVNYDLPTLANGQADPATY
IHRIGRTGRFGRKGVAISFVHDKNSFNILSAIQKYFGDIEMTRVPTDDWDEVEKIVKKVL
KD",DBP5,-,-,482aa(1-482),P20449,-,-,-,-,In vitro,2µl 1mg/ml[polyU];|2µl 500µM[DBP5],100 mM NaCl,"9µl LSB-150(150 mM KCl, 30 mM HEPES-KOH pH 7.4, 2 mM MgCl2),2µl CKM（40 mM ATP, 40 mM MgCl2, 200 mM creatine phosphate, 70 U ml−1 creatine kinase）,1µl BSA 10mg/ml,1µl Hepes pH 6.6,3µl 1x ATPase buffer(30 mM HEPES-KOH pH 7.5, 100 mM NaCl, 2 mM MgCl2)",RT,-,-,"Wide-field microscopy,FISH,Immunofluorescence microscopy",solute,"Recombinant Ded1, Dbp1 and Dbp2 all readily undergo LLPS and form droplets in the presence of ATP and RNA.To examine whether DDX-mediated phase separation is conserved, we next analysed DDX6 and DDX3X, the human orthologues of Dhh1 and Ded1. Although the sequences of the unstructured tails have diverged considerably between yeast and human , both recombinant DDX6 and DDX3X still form phase?separated droplets in vitro.",0
148,642,PMID: 31435012,RNAPS0000332,https://pubmed.ncbi.nlm.nih.gov/31435012,RNA + protein,-,-,polyU,-,-,poly RNA,-,"sp|P26196|DDX6_HUMAN Probable ATP-dependent RNA helicase DDX6 OS=Homo sapiens OX=9606 GN=DDX6 PE=1 SV=2
MSTARTENPVIMGLSSQNGQLRGPVKPTGGPGGGGTQTQQQMNQLKNTNTINNGTQQQAQ
SMTTTIKPGDDWKKTLKLPPKDLRIKTSDVTSTKGNEFEDYCLKRELLMGIFEMGWEKPS
PIQEESIPIALSGRDILARAKNGTGKSGAYLIPLLERLDLKKDNIQAMVIVPTRELALQV
SQICIQVSKHMGGAKVMATTGGTNLRDDIMRLDDTVHVVIATPGRILDLIKKGVAKVDHV
QMIVLDEADKLLSQDFVQIMEDIILTLPKNRQILLYSATFPLSVQKFMNSHLQKPYEINL
MEELTLKGVTQYYAYVTERQKVHCLNTLFSRLQINQSIIFCNSSQRVELLAKKISQLGYS
CFYIHAKMRQEHRNRVFHDFRNGLCRNLVCTDLFTRGIDIQAVNVVINFDFPKLAETYLH
RIGRSGRFGHLGLAINLITYDDRFNLKSIEEQLGTEIKPIPSNIDKSLYVAEYHSEPVED
EKP",DDX6,-,-,483aa(1-483),P26196,"DrLLPS,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-0982,http://db.phasep.pro/browse/",-,-,In vitro,3µl 2mg/ml[polyU];|2.5µl 50µM[DDX6],-,"14.5 µl LSB-50(50 mM KCl, 30 mM HEPES-KOH pH 7.4, 2 mM MgCl2),2 µl CKM（40 mM ATP, 40 mM MgCl2, 200 mM creatine phosphate, 70 U ml−1 creatine kinase）,1 µl BSA 10mg/ml,1 µl Hepes pH 6.4",RT,-,-,"Wide-field microscopy,FISH,Immunofluorescence microscopy",liquid,"Recombinant Ded1, Dbp1 and Dbp2 all readily undergo LLPS and form droplets in the presence of ATP and RNA.To examine whether DDX-mediated phase separation is conserved, we next analysed DDX6 and DDX3X, the human orthologues of Dhh1 and Ded1. Although the sequences of the unstructured tails have diverged considerably between yeast and human , both recombinant DDX6 and DDX3X still form phase?separated droplets in vitro.",0
149,643,PMID: 31435012,RNAPS0000333,https://pubmed.ncbi.nlm.nih.gov/31435012,RNA + protein,-,-,polyU,-,-,poly RNA,-,"sp|O00571|DDX3X_HUMAN ATP-dependent RNA helicase DDX3X OS=Homo sapiens OX=9606 GN=DDX3X PE=1 SV=3
MSHVAVENALGLDQQFAGLDLNSSDNQSGGSTASKGRYIPPHLRNREATKGFYDKDSSGW
SSSKDKDAYSSFGSRSDSRGKSSFFSDRGSGSRGRFDDRGRSDYDGIGSRGDRSGFGKFE
RGGNSRWCDKSDEDDWSKPLPPSERLEQELFSGGNTGINFEKYDDIPVEATGNNCPPHIE
SFSDVEMGEIIMGNIELTRYTRPTPVQKHAIPIIKEKRDLMACAQTGSGKTAAFLLPILS
QIYSDGPGEALRAMKENGRYGRRKQYPISLVLAPTRELAVQIYEEARKFSYRSRVRPCVV
YGGADIGQQIRDLERGCHLLVATPGRLVDMMERGKIGLDFCKYLVLDEADRMLDMGFEPQ
IRRIVEQDTMPPKGVRHTMMFSATFPKEIQMLARDFLDEYIFLAVGRVGSTSENITQKVV
WVEESDKRSFLLDLLNATGKDSLTLVFVETKKGADSLEDFLYHEGYACTSIHGDRSQRDR
EEALHQFRSGKSPILVATAVAARGLDISNVKHVINFDLPSDIEEYVHRIGRTGRVGNLGL
ATSFFNERNINITKDLLDLLVEAKQEVPSWLENMAYEHHYKGSSRGRSKSSRFSGGFGAR
DYRQSSGASSSSFSSSRASSSRSGGGGHGSSRGFGGGGYGGFYNSDGYGGNYNSQGVDWW
GN",DDX3X,-,-,662aa(1-662),O00571,"PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/O00571,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-1500,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0261,http://db.phasep.pro/browse/","[1-167],[256-263],[407-411],[437-437],[439-441],[473-480],[500-506],[535-536],[576-584]",-,In vitro,2µl 2mg/ml[polyU];|3µl 50µM[DDX3X],-,"14 µl LSB-50(50 mM KCl, 30 mM HEPES-KOH pH 7.4, 2 mM MgCl2),2 µl CKM（40 mM ATP, 40 mM MgCl2, 200 mM creatine phosphate, 70 U ml−1 creatine kinase）,1 µl BSA 10mg/ml,1 µl Hepes pH 6.8",RT,-,-,"Wide-field microscopy,FISH,Immunofluorescence microscopy",liquid,"Recombinant Ded1, Dbp1 and Dbp2 all readily undergo LLPS and form droplets in the presence of ATP and RNA.To examine whether DDX-mediated phase separation is conserved, we next analysed DDX6 and DDX3X, the human orthologues of Dhh1 and Ded1. Although the sequences of the unstructured tails have diverged considerably between yeast and human , both recombinant DDX6 and DDX3X still form phase?separated droplets in vitro.",0
150,644,PMID: 31435012,RNAPS0000334,https://pubmed.ncbi.nlm.nih.gov/31435012,RNA + protein,-,-,polyU,-,-,poly RNA,-,"sp|P21693|DBPA_ECOLI ATP-dependent RNA helicase DbpA OS=Escherichia coli (strain K12) OX=83333 GN=dbpA PE=1 SV=2
MTAFSTLNVLPPAQLTNLNELGYLTMTPVQAAALPAILAGKDVRVQAKTGSGKTAAFGLG
LLQQIDASLFQTQALVLCPTRELADQVAGELRRLARFLPNTKILTLCGGQPFGMQRDSLQ
HAPHIIVATPGRLLDHLQKGTVSLDALNTLVMDEADRMLDMGFSDAIDDVIRFAPASRQT
LLFSATWPEAIAAISGRVQRDPLAIEIDSTDALPPIEQQFYETSSKGKIPLLQRLLSLHQ
PSSCVVFCNTKKDCQAVCDALNEVGQSALSLHGDLEQRDRDQTLVRFANGSARVLVATDV
AARGLDIKSLELVVNFELAWDPEVHVHRIGRTARAGNSGLAISFCAPEEAQRANIISDML
QIKLNWQTPPANSSIATLEAEMATLCIDGGKKAKMRPGDVLGALTGDIGLDGADIGKIAV
HPAHVYVAVRQAVAHKAWKQLQGGKIKGKTCRVRLLK",dbpA,-,-,457aa(1-457),P21693,-,-,-,-,In vitro,2µl 2mg/ml[polyU];|3µl 50µM[dbpA],-,"16 µl LSB-100(100 mM KCl, 30 mM HEPES-KOH pH 7.4, 2 mM MgCl2),2 µl CKM（40 mM ATP, 40 mM MgCl2, 200 mM creatine phosphate, 70 U ml−1 creatine kinase）,1 µl BSA 10 mg/ml,1 µl 1M Hepes pH 6.4",RT,-,-,"Wide-field microscopy,FISH,Immunofluorescence microscopy",solute,"Recombinant Ded1, Dbp1 and Dbp2 all readily undergo LLPS and form droplets in the presence of ATP and RNA.To examine whether DDX-mediated phase separation is conserved, we next analysed DDX6 and DDX3X, the human orthologues of Dhh1 and Ded1. Although the sequences of the unstructured tails have diverged considerably between yeast and human , both recombinant DDX6 and DDX3X still form phase?separated droplets in vitro.",0
151,645,PMID: 31435012,RNAPS0000335,https://pubmed.ncbi.nlm.nih.gov/31435012,RNA + protein,-,-,polyU,-,-,poly RNA,-,"sp|P0A8J8|RHLB_ECOLI ATP-dependent RNA helicase RhlB OS=Escherichia coli (strain K12) OX=83333 GN=rhlB PE=1 SV=2
MSKTHLTEQKFSDFALHPKVVEALEKKGFHNCTPIQALALPLTLAGRDVAGQAQTGTGKT
MAFLTSTFHYLLSHPAIADRKVNQPRALIMAPTRELAVQIHADAEPLAEATGLKLGLAYG
GDGYDKQLKVLESGVDILIGTTGRLIDYAKQNHINLGAIQVVVLDEADRMYDLGFIKDIR
WLFRRMPPANQRLNMLFSATLSYRVRELAFEQMNNAEYIEVEPEQKTGHRIKEELFYPSN
EEKMRLLQTLIEEEWPDRAIIFANTKHRCEEIWGHLAADGHRVGLLTGDVAQKKRLRILD
EFTRGDLDILVATDVAARGLHIPAVTHVFNYDLPDDCEDYVHRIGRTGRAGASGHSISLA
CEEYALNLPAIETYIGHSIPVSKYNPDALMTDLPKPLRLTRPRTGNGPRRTGAPRNRRRS
G",RhlB,-,-,421aa(1-421),P0A8J8,PhaSepDB,http://db.phasep.pro/browse/,-,[398-419],In vitro,2µl 2mg/ml[polyU];|3µl 50µM[RhlB],-,"16 µl LSB-100(100 mM KCl, 30 mM HEPES-KOH pH 7.4, 2 mM MgCl2),2 µl CKM（40 mM ATP, 40 mM MgCl2, 200 mM creatine phosphate, 70 U ml−1 creatine kinase）,1 µl BSA 10 mg/ml,1 µl 1M Hepes pH 6.4",RT,-,-,"Wide-field microscopy,FISH,Immunofluorescence microscopy",solute,"Recombinant Ded1, Dbp1 and Dbp2 all readily undergo LLPS and form droplets in the presence of ATP and RNA.To examine whether DDX-mediated phase separation is conserved, we next analysed DDX6 and DDX3X, the human orthologues of Dhh1 and Ded1. Although the sequences of the unstructured tails have diverged considerably between yeast and human , both recombinant DDX6 and DDX3X still form phase?separated droplets in vitro.",0
152,646,PMID: 31435012,RNAPS0000336,https://pubmed.ncbi.nlm.nih.gov/31435012,RNA + protein,-,-,polyU,-,-,poly RNA,-,"sp|P0A9P6|DEAD_ECOLI ATP-dependent RNA helicase DeaD OS=Escherichia coli (strain K12) OX=83333 GN=deaD PE=1 SV=2
MAEFETTFADLGLKAPILEALNDLGYEKPSPIQAECIPHLLNGRDVLGMAQTGSGKTAAF
SLPLLQNLDPELKAPQILVLAPTRELAVQVAEAMTDFSKHMRGVNVVALYGGQRYDVQLR
ALRQGPQIVVGTPGRLLDHLKRGTLDLSKLSGLVLDEADEMLRMGFIEDVETIMAQIPEG
HQTALFSATMPEAIRRITRRFMKEPQEVRIQSSVTTRPDISQSYWTVWGMRKNEALVRFL
EAEDFDAAIIFVRTKNATLEVAEALERNGYNSAALNGDMNQALREQTLERLKDGRLDILI
ATDVAARGLDVERISLVVNYDIPMDSESYVHRIGRTGRAGRAGRALLFVENRERRLLRNI
ERTMKLTIPEVELPNAELLGKRRLEKFAAKVQQQLESSDLDQYRALLSKIQPTAEGEELD
LETLAAALLKMAQGERTLIVPPDAPMRPKREFRDRDDRGPRDRNDRGPRGDREDRPRRER
RDVGDMQLYRIEVGRDDGVEVRHIVGAIANEGDISSRYIGNIKLFASHSTIELPKGMPGE
VLQHFTRTRILNKPMNMQLLGDAQPHTGGERRGGGRGFGGERREGGRNFSGERREGGRGD
GRRFSGERREGRAPRRDDSTGRRRFGGDA",DeaD,-,-,629aa(1-629),P0A9P6,-,-,-,-,In vitro,1.5µl 2mg/ml[polyU];|3µl 50µM[DeaD],-,"17.5 µl LSB-100(100 mM KCl, 30 mM HEPES-KOH pH 7.4, 2 mM MgCl2),1 µl CKM（40 mM ATP, 40 mM MgCl2, 200 mM creatine phosphate, 70 U ml−1 creatine kinase）,1 µl BSA 10mg/ml,1 µl Hepes pH 6.4",RT,-,-,"Wide-field microscopy,FISH,Immunofluorescence microscopy",liquid,"Recombinant Ded1, Dbp1 and Dbp2 all readily undergo LLPS and form droplets in the presence of ATP and RNA.To examine whether DDX-mediated phase separation is conserved, we next analysed DDX6 and DDX3X, the human orthologues of Dhh1 and Ded1. Although the sequences of the unstructured tails have diverged considerably between yeast and human , both recombinant DDX6 and DDX3X still form phase?separated droplets in vitro.",0
153,647,PMID: 31435012,RNAPS0000337,https://pubmed.ncbi.nlm.nih.gov/31435012,RNA + protein,-,-,polyU,-,-,poly RNA,-,"sp|P21507|SRMB_ECOLI ATP-dependent RNA helicase SrmB OS=Escherichia coli (strain K12) OX=83333 GN=srmB PE=1 SV=1
MTVTTFSELELDESLLEALQDKGFTRPTAIQAAAIPPALDGRDVLGSAPTGTGKTAAYLL
PALQHLLDFPRKKSGPPRILILTPTRELAMQVSDHARELAKHTHLDIATITGGVAYMNHA
EVFSENQDIVVATTGRLLQYIKEENFDCRAVETLILDEADRMLDMGFAQDIEHIAGETRW
RKQTLLFSATLEGDAIQDFAERLLEDPVEVSANPSTRERKKIHQWYYRADDLEHKTALLV
HLLKQPEATRSIVFVRKRERVHELANWLREAGINNCYLEGEMVQGKRNEAIKRLTEGRVN
VLVATDVAARGIDIPDVSHVFNFDMPRSGDTYLHRIGRTARAGRKGTAISLVEAHDHLLL
GKVGRYIEEPIKARVIDELRPKTRAPSEKQTGKPSKKVLAKRAEKKKAKEKEKPRVKKRH
RDTKNIGKRRKPSGTGVPPQTTEE",SrmB,-,-,444aa(1-444),P21507,PhaSepDB,http://db.phasep.pro/browse/,[389-444],"[7-17],[29-38],[396-419]",In vitro,1.5µl 2mg/ml[polyU];|3µl 50µM[SrmB],-,"18.5 µl LSB-50(50 mM KCl, 30 mM HEPES-KOH pH 7.4, 2 mM MgCl2),1 µl CKM（40 mM ATP, 40 mM MgCl2, 200 mM creatine phosphate, 70 U ml−1 creatine kinase）,1 µl BSA 10mg/ml",RT,-,-,"Wide-field microscopy,FISH,Immunofluorescence microscopy",liquid,"Recombinant Ded1, Dbp1 and Dbp2 all readily undergo LLPS and form droplets in the presence of ATP and RNA.To examine whether DDX-mediated phase separation is conserved, we next analysed DDX6 and DDX3X, the human orthologues of Dhh1 and Ded1. Although the sequences of the unstructured tails have diverged considerably between yeast and human , both recombinant DDX6 and DDX3X still form phase?separated droplets in vitro.",0
154,648,PMID: 31435012,RNAPS0000338,https://pubmed.ncbi.nlm.nih.gov/31435012,RNA + protein,-,-,polyU,-,-,poly RNA,-,"sp|P25888|RHLE_ECOLI ATP-dependent RNA helicase RhlE OS=Escherichia coli (strain K12) OX=83333 GN=rhlE PE=1 SV=3
MSFDSLGLSPDILRAVAEQGYREPTPIQQQAIPAVLEGRDLMASAQTGTGKTAGFTLPLL
QHLITRQPHAKGRRPVRALILTPTRELAAQIGENVRDYSKYLNIRSLVVFGGVSINPQMM
KLRGGVDVLVATPGRLLDLEHQNAVKLDQVEILVLDEADRMLDMGFIHDIRRVLTKLPAK
RQNLLFSATFSDDIKALAEKLLHNPLEIEVARRNTASDQVTQHVHFVDKKRKRELLSHMI
GKGNWQQVLVFTRTKHGANHLAEQLNKDGIRSAAIHGNKSQGARTRALADFKSGDIRVLV
ATDIAARGLDIEELPHVVNYELPNVPEDYVHRIGRTGRAAATGEALSLVCVDEHKLLRDI
EKLLKKEIPRIAIPGYEPDPSIKAEPIQNGRQQRGGGGRGQGGGRGQQQPRRGEGGAKSA
SAKPAEKPSRRLGDAKPAGEQQRRRRPRKPAAA",RhlE,-,-,453aa(1-453),P25888,-,-,-,"[334-343],[390-430],[441-453]",In vitro,1.5µl 2mg/ml[polyU];|2µl 50µM[RhlE],-,"18.5 µl LSB-100(100 mM KCl, 30 mM HEPES-KOH pH 7.4, 2 mM MgCl2),1 µl CKM（40 mM ATP, 40 mM MgCl2, 200 mM creatine phosphate, 70 U ml−1 creatine kinase）,1 µl BSA 10mg/ml,1 µl Hepes 1M pH 6.8",RT,-,-,"Wide-field microscopy,FISH,Immunofluorescence microscopy",liquid,"Recombinant Ded1, Dbp1 and Dbp2 all readily undergo LLPS and form droplets in the presence of ATP and RNA.To examine whether DDX-mediated phase separation is conserved, we next analysed DDX6 and DDX3X, the human orthologues of Dhh1 and Ded1. Although the sequences of the unstructured tails have diverged considerably between yeast and human , both recombinant DDX6 and DDX3X still form phase-separated droplets in vitro.",0
155,650,PMID: 31630970,RNAPS0000340,https://pubmed.ncbi.nlm.nih.gov/31630970,RNA + protein,-,-,polyrU(40),40nt,UUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUU,poly RNA,-,"sp|P35637|FUS_HUMAN RNA-binding protein FUS OS=Homo sapiens OX=9606 GN=FUS PE=1 SV=1
MASNDYTQQATQSYGAYPTQPGQGYSQQSSQPYGQQSYSGYSQSTDTSGYGQSSYSSYGQ
SQNTGYGTQSTPQGYGSTGGYGSSQSSQSSYGQQSSYPGYGQQPAPSSTSGSYGSSSQSS
SYGQPQSGSYSQQPSYGGQQQSYGQQQSYNPPQGYGQQNQYNSSSGGGGGGGGGGNYGQD
QSSMSSGGGSGGGYGNQDQSGGGGSGGYGQQDRGGRGRGGSGGGGGGGGGGYNRSSGGYE
PRGRGGGRGGRGGMGGSDRGGFNKFGGPRDQGSRHDSEQDNSDNNTIFVQGLGENVTIES
VADYFKQIGIIKTNKKTGQPMINLYTDRETGKLKGEATVSFDDPPSAKAAIDWFDGKEFS
GNPIKVSFATRRADFNRGGGNGRGGRGRGGPMGRGGYGGGGSGGGGRGGFPSGGGGGGGQ
QRAGDWKCPNPTCENMNFSWRNECNQCKAPKPDGPGGGPGGSHMGGNYGDDRRGGRGGYD
RGGYRGRGGDRGGFRGGRGGGDRGGFGPGKMDSRGEHRQDRRERPY",FUS,-,-,526aa(1-526),P35637,"PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/P35637,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-1390,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0002,http://db.phasep.pro/browse/","[1-507],[508-512]","[17-104],[106-261],[371-425],[450-507]",In vitro,1µM poly(rU)40;|1µM FUS,100mM NaCl,"100mM Tris-HCl,pH 7.5,1mM EDTA,1mM DTT",RT,≤ 6 h,-,FRAP,"solute, liquid","The size of condensates was determined over the course of six hours; whereas WT-FUS, NLS, and G mutant FUS form small droplets (area of ~1.5μm2, R) R mutants grow much larger (area ~ 3-6 μm2) (Fig. 6B). Even after three hours, a stark difference in droplet size is observed (Fig 6C).",40
156,684,PMID: 31975687,RNAPS0000039,https://pubmed.ncbi.nlm.nih.gov/31975687,RNA + protein,NCBI ID:174158,https://www.ncbi.nlm.nih.gov/gene/174158,polyU(30),30nt,UUUUUUUUUUUUUUUUUUUUUUUUUUUUUU,poly RNA,Caenorhabditis elegans,"tr|Q9TXM1|Q9TXM1_CAEEL Uncharacterized protein OS=Caenorhabditis elegans OX=6239 GN=meg-3 PE=4 SV=1
MSSSKPYPSGLPNSRRKRGGRRSSSRSNQESASNNMEHQITLDELFNPIAKQDSAQSTSR
EYGAKSGISHHGSVSFNGNTFMNGQQLNHSMTRHGRVFNQSMHAAQGNGSNAFNSIPPTA
PVFSADFRRNLQTRNSSSWYERRFPVSTDQDDVQQSNTRRSRSRQNGQHGLSFSDGSNNY
GHAGNKSFSVSSVPVGFQKQENNSKKLRQTNVHQQCLGNKSFNAQAGVHGHAFKKGHKDN
KNASGKEVINSSLVQKHDAIKSRNLNQSFSGFPTHETSSMKNQQQKSRNDRKKSRGSSNF
QDRTYFNTNDDELTDDVFIDDSMDAARGRRSRSVTKKLQQSTYSKQNAGSKQLTEKCKSS
EEAAKRNLVSNVFSKDGTELSIEQLLEIVSMKIGQQIHLPSSSHGECSNLNRTLPASDLN
CSIGEDFDSSFVDANNQTLPVSLPKKTSLSIKRRGSSRSASRLASLDVTLETVEEDEEPT
PSPQPSSPPKISRRKWTGTFDANVEEMRRLLHGDPEMPKSANRASSSKDQINRNNVDVKR
TPSSSIIPTPKALIGERCLTSSSKSSKLNKSLGVVDSKATKSPMYSVTVSGKETASGKRI
AQKLTPKVVALESSYITGIPVSTDCNGCPTPKRSGINCEIRAAEVYNQAGKWPFEITSDP
APLPCESADRIEYPSQDCTQDPASTSPPPRISESLTAFLEAQQDFNDYIDTNYKEKTQLL
KVNLNIHGMSPERWLYLNYFCTETIPRLDGPYADDPRVPPVRNMFRKWFLRFAEACLGNP
HQLAVMQEIAATFVQARLDDTSSSTDSTNMLYMLWKECIGQKNIIAIADACLLAHLRKSD
PIKYLNVKRDWLESIFDPPRDQ",meg-3,-,-,862aa(1-862),Q9TXM1,"PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q9TXM1,http://llps.biocuckoo.cn/view.php?id=LLPS-Cae-2080,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0145,http://db.phasep.pro/browse/","[1-37],[52-71],[141-187],[259-307],[326-352],[446-495],[510-534]","[14-27],[154-168],[456-492],[559-572],[799-808]",In vitro,20 ng/µL [nos-2];|500 nM [meg-3],"150 mM (37.5 mM
KCl, 112.5 mM NaCl)",25 mM HEPES (pH 7.4),RT,30 min,-,"FISH,FRAP",liquid,"To determine whether RNA length affects MEG-3 condensation behavior, we tested RNAs of varying sizes in the condensation assay. We found that short RNAs (30 and 100 nt) were not as efficient as longer RNAs at stimulating MEG-3 condensation.",30
157,696,PMID: 31975687,RNAPS0000091,https://pubmed.ncbi.nlm.nih.gov/31975687,RNA + protein,-,-,polyU(30),30nt,UUUUUUUUUUUUUUUUUUUUUUUUUUUUUU,poly RNA,-,"tr|Q9TXM1|Q9TXM1_CAEEL Uncharacterized protein OS=Caenorhabditis elegans OX=6239 GN=meg-3 PE=4 SV=1
MSSSKPYPSGLPNSRRKRGGRRSSSRSNQESASNNMEHQITLDELFNPIAKQDSAQSTSR
EYGAKSGISHHGSVSFNGNTFMNGQQLNHSMTRHGRVFNQSMHAAQGNGSNAFNSIPPTA
PVFSADFRRNLQTRNSSSWYERRFPVSTDQDDVQQSNTRRSRSRQNGQHGLSFSDGSNNY
GHAGNKSFSVSSVPVGFQKQENNSKKLRQTNVHQQCLGNKSFNAQAGVHGHAFKKGHKDN
KNASGKEVINSSLVQKHDAIKSRNLNQSFSGFPTHETSSMKNQQQKSRNDRKKSRGSSNF
QDRTYFNTNDDELTDDVFIDDSMDAARGRRSRSVTKKLQQSTYSKQNAGSKQLTEKCKSS
EEAAKRNLVSNVFSKDGTELSIEQLLEIVSMKIGQQIHLPSSSHGECSNLNRTLPASDLN
CSIGEDFDSSFVDANNQTLPVSLPKKTSLSIKRRGSSRSASRLASLDVTLETVEEDEEPT
PSPQPSSPPKISRRKWTGTFDANVEEMRRLLHGDPEMPKSANRASSSKDQINRNNVDVKR
TPSSSIIPTPKALIGERCLTSSSKSSKLNKSLGVVDSKATKSPMYSVTVSGKETASGKRI
AQKLTPKVVALESSYITGIPVSTDCNGCPTPKRSGINCEIRAAEVYNQAGKWPFEITSDP
APLPCESADRIEYPSQDCTQDPASTSPPPRISESLTAFLEAQQDFNDYIDTNYKEKTQLL
KVNLNIHGMSPERWLYLNYFCTETIPRLDGPYADDPRVPPVRNMFRKWFLRFAEACLGNP
HQLAVMQEIAATFVQARLDDTSSSTDSTNMLYMLWKECIGQKNIIAIADACLLAHLRKSD
PIKYLNVKRDWLESIFDPPRDQ",meg-3,-,-,862aa(1-862),Q9TXM1,"PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q9TXM1,http://llps.biocuckoo.cn/view.php?id=LLPS-Cae-2080,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0145,http://db.phasep.pro/browse/","[1-37],[52-71],[141-187],[259-307],[326-352],[446-495],[510-534]","[14-27],[154-168],[456-492],[559-572],[799-808]",In vitro,20 ng/µL [U30];|500 nM [meg-3],"150 mM (37.5 mM
KCl, 112.5 mM NaCl)",25 mM HEPES (pH 7.4),RT,30 min,-,"FISH,FRAP",liquid,"To determine whether RNA length affects MEG-3 condensation behavior, we tested RNAs of varying sizes in the condensation assay. We found that short RNAs (30 and 100 nt) were not as efficient as longer RNAs at stimulating MEG-3 condensation.",30
158,697,PMID: 31975687,RNAPS0000377,https://pubmed.ncbi.nlm.nih.gov/31975687,RNA + protein,-,-,polyU(100),100nt,UUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUU,poly RNA,-,"tr|Q9TXM1|Q9TXM1_CAEEL Uncharacterized protein OS=Caenorhabditis elegans OX=6239 GN=meg-3 PE=4 SV=1
MSSSKPYPSGLPNSRRKRGGRRSSSRSNQESASNNMEHQITLDELFNPIAKQDSAQSTSR
EYGAKSGISHHGSVSFNGNTFMNGQQLNHSMTRHGRVFNQSMHAAQGNGSNAFNSIPPTA
PVFSADFRRNLQTRNSSSWYERRFPVSTDQDDVQQSNTRRSRSRQNGQHGLSFSDGSNNY
GHAGNKSFSVSSVPVGFQKQENNSKKLRQTNVHQQCLGNKSFNAQAGVHGHAFKKGHKDN
KNASGKEVINSSLVQKHDAIKSRNLNQSFSGFPTHETSSMKNQQQKSRNDRKKSRGSSNF
QDRTYFNTNDDELTDDVFIDDSMDAARGRRSRSVTKKLQQSTYSKQNAGSKQLTEKCKSS
EEAAKRNLVSNVFSKDGTELSIEQLLEIVSMKIGQQIHLPSSSHGECSNLNRTLPASDLN
CSIGEDFDSSFVDANNQTLPVSLPKKTSLSIKRRGSSRSASRLASLDVTLETVEEDEEPT
PSPQPSSPPKISRRKWTGTFDANVEEMRRLLHGDPEMPKSANRASSSKDQINRNNVDVKR
TPSSSIIPTPKALIGERCLTSSSKSSKLNKSLGVVDSKATKSPMYSVTVSGKETASGKRI
AQKLTPKVVALESSYITGIPVSTDCNGCPTPKRSGINCEIRAAEVYNQAGKWPFEITSDP
APLPCESADRIEYPSQDCTQDPASTSPPPRISESLTAFLEAQQDFNDYIDTNYKEKTQLL
KVNLNIHGMSPERWLYLNYFCTETIPRLDGPYADDPRVPPVRNMFRKWFLRFAEACLGNP
HQLAVMQEIAATFVQARLDDTSSSTDSTNMLYMLWKECIGQKNIIAIADACLLAHLRKSD
PIKYLNVKRDWLESIFDPPRDQ",meg-3,-,-,862aa(1-862),Q9TXM1,"PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q9TXM1,http://llps.biocuckoo.cn/view.php?id=LLPS-Cae-2080,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0145,http://db.phasep.pro/browse/","[1-37],[52-71],[141-187],[259-307],[326-352],[446-495],[510-534]","[14-27],[154-168],[456-492],[559-572],[799-808]",In vitro,20 ng/µL [U100];|500 nM [meg-3],"150 mM (37.5 mM
KCl, 112.5 mM NaCl)",25 mM HEPES (pH 7.4),RT,30 min,-,"FISH,FRAP",liquid,"To determine whether RNA length affects MEG-3 condensation behavior, we tested RNAs of varying sizes in the condensation assay. We found that short RNAs (30 and 100 nt) were not as effi cient as longer RNAs at stimulating MEG-3 condensation",100
159,698,PMID: 31975687,RNAPS0000378,https://pubmed.ncbi.nlm.nih.gov/31975687,RNA + protein,-,-,polyU(200),200nt,UUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUU,poly RNA,-,"tr|Q9TXM1|Q9TXM1_CAEEL Uncharacterized protein OS=Caenorhabditis elegans OX=6239 GN=meg-3 PE=4 SV=1
MSSSKPYPSGLPNSRRKRGGRRSSSRSNQESASNNMEHQITLDELFNPIAKQDSAQSTSR
EYGAKSGISHHGSVSFNGNTFMNGQQLNHSMTRHGRVFNQSMHAAQGNGSNAFNSIPPTA
PVFSADFRRNLQTRNSSSWYERRFPVSTDQDDVQQSNTRRSRSRQNGQHGLSFSDGSNNY
GHAGNKSFSVSSVPVGFQKQENNSKKLRQTNVHQQCLGNKSFNAQAGVHGHAFKKGHKDN
KNASGKEVINSSLVQKHDAIKSRNLNQSFSGFPTHETSSMKNQQQKSRNDRKKSRGSSNF
QDRTYFNTNDDELTDDVFIDDSMDAARGRRSRSVTKKLQQSTYSKQNAGSKQLTEKCKSS
EEAAKRNLVSNVFSKDGTELSIEQLLEIVSMKIGQQIHLPSSSHGECSNLNRTLPASDLN
CSIGEDFDSSFVDANNQTLPVSLPKKTSLSIKRRGSSRSASRLASLDVTLETVEEDEEPT
PSPQPSSPPKISRRKWTGTFDANVEEMRRLLHGDPEMPKSANRASSSKDQINRNNVDVKR
TPSSSIIPTPKALIGERCLTSSSKSSKLNKSLGVVDSKATKSPMYSVTVSGKETASGKRI
AQKLTPKVVALESSYITGIPVSTDCNGCPTPKRSGINCEIRAAEVYNQAGKWPFEITSDP
APLPCESADRIEYPSQDCTQDPASTSPPPRISESLTAFLEAQQDFNDYIDTNYKEKTQLL
KVNLNIHGMSPERWLYLNYFCTETIPRLDGPYADDPRVPPVRNMFRKWFLRFAEACLGNP
HQLAVMQEIAATFVQARLDDTSSSTDSTNMLYMLWKECIGQKNIIAIADACLLAHLRKSD
PIKYLNVKRDWLESIFDPPRDQ",meg-3,-,-,862aa(1-862),Q9TXM1,"PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q9TXM1,http://llps.biocuckoo.cn/view.php?id=LLPS-Cae-2080,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0145,http://db.phasep.pro/browse/","[1-37],[52-71],[141-187],[259-307],[326-352],[446-495],[510-534]","[14-27],[154-168],[456-492],[559-572],[799-808]",In vitro,20 ng/µL [U200];|500 nM [meg-3],"150 mM (37.5 mM
KCl, 112.5 mM NaCl)",25 mM HEPES (pH 7.4),RT,30 min,-,"FISH,FRAP",liquid,"To determine whether RNA length affects MEG-3 condensation behavior, we tested RNAs of varying sizes in the condensation assay. We found that short RNAs (30 and 100 nt) were not as effi cient as longer RNAs at stimulating MEG-3 condensation",200
160,699,PMID: 31975687,RNAPS0000379,https://pubmed.ncbi.nlm.nih.gov/31975687,RNA + protein,-,-,polyU(300),300nt,UUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUU,poly RNA,-,"tr|Q9TXM1|Q9TXM1_CAEEL Uncharacterized protein OS=Caenorhabditis elegans OX=6239 GN=meg-3 PE=4 SV=1
MSSSKPYPSGLPNSRRKRGGRRSSSRSNQESASNNMEHQITLDELFNPIAKQDSAQSTSR
EYGAKSGISHHGSVSFNGNTFMNGQQLNHSMTRHGRVFNQSMHAAQGNGSNAFNSIPPTA
PVFSADFRRNLQTRNSSSWYERRFPVSTDQDDVQQSNTRRSRSRQNGQHGLSFSDGSNNY
GHAGNKSFSVSSVPVGFQKQENNSKKLRQTNVHQQCLGNKSFNAQAGVHGHAFKKGHKDN
KNASGKEVINSSLVQKHDAIKSRNLNQSFSGFPTHETSSMKNQQQKSRNDRKKSRGSSNF
QDRTYFNTNDDELTDDVFIDDSMDAARGRRSRSVTKKLQQSTYSKQNAGSKQLTEKCKSS
EEAAKRNLVSNVFSKDGTELSIEQLLEIVSMKIGQQIHLPSSSHGECSNLNRTLPASDLN
CSIGEDFDSSFVDANNQTLPVSLPKKTSLSIKRRGSSRSASRLASLDVTLETVEEDEEPT
PSPQPSSPPKISRRKWTGTFDANVEEMRRLLHGDPEMPKSANRASSSKDQINRNNVDVKR
TPSSSIIPTPKALIGERCLTSSSKSSKLNKSLGVVDSKATKSPMYSVTVSGKETASGKRI
AQKLTPKVVALESSYITGIPVSTDCNGCPTPKRSGINCEIRAAEVYNQAGKWPFEITSDP
APLPCESADRIEYPSQDCTQDPASTSPPPRISESLTAFLEAQQDFNDYIDTNYKEKTQLL
KVNLNIHGMSPERWLYLNYFCTETIPRLDGPYADDPRVPPVRNMFRKWFLRFAEACLGNP
HQLAVMQEIAATFVQARLDDTSSSTDSTNMLYMLWKECIGQKNIIAIADACLLAHLRKSD
PIKYLNVKRDWLESIFDPPRDQ",meg-3,-,-,862aa(1-862),Q9TXM1,"PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q9TXM1,http://llps.biocuckoo.cn/view.php?id=LLPS-Cae-2080,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0145,http://db.phasep.pro/browse/","[1-37],[52-71],[141-187],[259-307],[326-352],[446-495],[510-534]","[14-27],[154-168],[456-492],[559-572],[799-808]",In vitro,20 ng/µL [U300];|500 nM [meg-3],"150 mM (37.5 mM
KCl, 112.5 mM NaCl)",25 mM HEPES (pH 7.4),RT,30 min,-,"FISH,FRAP",liquid,"To determine whether RNA length affects MEG-3 condensation behavior, we tested RNAs of varying sizes in the condensation assay. We found that short RNAs (30 and 100 nt) were not as effi cient as longer RNAs at stimulating MEG-3 condensation",300
161,700,PMID: 31975687,RNAPS0000380,https://pubmed.ncbi.nlm.nih.gov/31975687,RNA + protein,-,-,polyU(600),600nt,UUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUU,poly RNA,-,"tr|Q9TXM1|Q9TXM1_CAEEL Uncharacterized protein OS=Caenorhabditis elegans OX=6239 GN=meg-3 PE=4 SV=1
MSSSKPYPSGLPNSRRKRGGRRSSSRSNQESASNNMEHQITLDELFNPIAKQDSAQSTSR
EYGAKSGISHHGSVSFNGNTFMNGQQLNHSMTRHGRVFNQSMHAAQGNGSNAFNSIPPTA
PVFSADFRRNLQTRNSSSWYERRFPVSTDQDDVQQSNTRRSRSRQNGQHGLSFSDGSNNY
GHAGNKSFSVSSVPVGFQKQENNSKKLRQTNVHQQCLGNKSFNAQAGVHGHAFKKGHKDN
KNASGKEVINSSLVQKHDAIKSRNLNQSFSGFPTHETSSMKNQQQKSRNDRKKSRGSSNF
QDRTYFNTNDDELTDDVFIDDSMDAARGRRSRSVTKKLQQSTYSKQNAGSKQLTEKCKSS
EEAAKRNLVSNVFSKDGTELSIEQLLEIVSMKIGQQIHLPSSSHGECSNLNRTLPASDLN
CSIGEDFDSSFVDANNQTLPVSLPKKTSLSIKRRGSSRSASRLASLDVTLETVEEDEEPT
PSPQPSSPPKISRRKWTGTFDANVEEMRRLLHGDPEMPKSANRASSSKDQINRNNVDVKR
TPSSSIIPTPKALIGERCLTSSSKSSKLNKSLGVVDSKATKSPMYSVTVSGKETASGKRI
AQKLTPKVVALESSYITGIPVSTDCNGCPTPKRSGINCEIRAAEVYNQAGKWPFEITSDP
APLPCESADRIEYPSQDCTQDPASTSPPPRISESLTAFLEAQQDFNDYIDTNYKEKTQLL
KVNLNIHGMSPERWLYLNYFCTETIPRLDGPYADDPRVPPVRNMFRKWFLRFAEACLGNP
HQLAVMQEIAATFVQARLDDTSSSTDSTNMLYMLWKECIGQKNIIAIADACLLAHLRKSD
PIKYLNVKRDWLESIFDPPRDQ",meg-3,-,-,862aa(1-862),Q9TXM1,"PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/Q9TXM1,http://llps.biocuckoo.cn/view.php?id=LLPS-Cae-2080,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0145,http://db.phasep.pro/browse/","[1-37],[52-71],[141-187],[259-307],[326-352],[446-495],[510-534]","[14-27],[154-168],[456-492],[559-572],[799-808]",In vitro,20 ng/µL [U600];|500 nM [meg-3],"150 mM (37.5 mM
KCl, 112.5 mM NaCl)",25 mM HEPES (pH 7.4),RT,30 min,-,"FISH,FRAP",liquid,"To determine whether RNA length affects MEG-3 condensation behavior, we tested RNAs of varying sizes in the condensation assay. We found that short RNAs (30 and 100 nt) were not as effi cient as longer RNAs at stimulating MEG-3 condensation",600
162,713,PMID: 32513655,RNAPS0000391,https://pubmed.ncbi.nlm.nih.gov/32513655,RNA + protein,-,-,polyA(15),15nt,AAAAAAAAAAAAAAA,poly RNA,-,"sp|P25644|PAT1_YEAST DNA topoisomerase 2-associated protein PAT1 OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) OX=559292 GN=PAT1 PE=1 SV=4|residues=296-754
TEDPYNEDFYFQVYKIIQRGGITSESNKGLIARAYLEHSGHRLGGRYKRTDIALQRMQSQVEKA
VTVAKERPSKLKDQQAAAGNSSQDNKQANTVLGKISSTLNSKNPRRQLQIPRQQPSDPDA
LKDVTDSLTNVDLASSGSSSTGSSAAAVASKQRRRSSYAFNNGNGATNLNKSGGKKFILE
LIETVYEEILDLEANLRNGQQTDSTAMWEALHIDDSSYDVNPFISMLSFDKGIKIMPRIF
NFLDKQQKLKILQKIFNELSHLQIIILSSYKTTPKPTLTQLKKVDLFQMIILKIIVSFLS
NNSNFIEIMGLLLQLIRNNNVSFLTTSKIGLNLITILISRAALIKQDSSRSNILSSPEIS
TWNEIYDKLFTSLESKIQLIFPPREYNDHIMRLQNDKFMDEAYIWQFLASLALSGKLNHQ
RIIIDEVRDEIFATINEAETLQKKEKELSVLPQR;|-",PAT1;|Dcp1-Dcp2,M+C-term,-;|-,458aa(296-754),"P25644;Q12517,P53550 ","DrLLPS,LLPSDB,PhaSepDB;Dcp-1:DrLLPS,PhaSepDB,
Dcp-2:PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Sac-0330,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0246,http://db.phasep.pro/browse/;http://llps.biocuckoo.cn/view.php?id=LLPS-Sac-0754,http://db.phasep.pro/browse/;http://db.phasep.pro/browse/","[1-4],[5-24],[55-79],[164-200],[365-421],[422-469];|-","[59-74],[111-137],[149-157],[165-183],[187-224],[404-415],[434-450],[545-555],[571-583];|-",In vitro,13.4 ng/µl [polyA];|2.5µM [Pat1];|2.5µM Dcp1/Dcp2Ext,60 mM NaCl,"20 mM HEPES pH 7.0, 1 mM DTT",RT,20 min,-,"Bright-field microscopy,Fluorescence microscopy",liquid,"PatMC and Dcp2 both weakly interact with RNA, which can trigger or potentiate liquid-liquid phase separation with oligomeric RNA binding proteins (RBPs)The PatMC/Dcp1/Dcp2Ext droplets were able to incorporate A15 RNA,though A15 RNA did not change the critical concentration required for phase separation However, neither short A15 RNAs nor polyA RNA promoted droplet formation with either PatMC",15
163,714,PMID: 32513655,RNAPS0000391,https://pubmed.ncbi.nlm.nih.gov/32513655,RNA + protein,-,-,polyA(15),15nt,AAAAAAAAAAAAAAA,poly RNA,-,"sp|P25644|PAT1_YEAST DNA topoisomerase 2-associated protein PAT1 OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) OX=559292 GN=PAT1 PE=1 SV=4|residues=296-754
TEDPYNEDFYFQVYKIIQRGGITSESNKGLIARAYLEHSGHRLGGRYKRTDIALQRMQSQVEKA
VTVAKERPSKLKDQQAAAGNSSQDNKQANTVLGKISSTLNSKNPRRQLQIPRQQPSDPDA
LKDVTDSLTNVDLASSGSSSTGSSAAAVASKQRRRSSYAFNNGNGATNLNKSGGKKFILE
LIETVYEEILDLEANLRNGQQTDSTAMWEALHIDDSSYDVNPFISMLSFDKGIKIMPRIF
NFLDKQQKLKILQKIFNELSHLQIIILSSYKTTPKPTLTQLKKVDLFQMIILKIIVSFLS
NNSNFIEIMGLLLQLIRNNNVSFLTTSKIGLNLITILISRAALIKQDSSRSNILSSPEIS
TWNEIYDKLFTSLESKIQLIFPPREYNDHIMRLQNDKFMDEAYIWQFLASLALSGKLNHQ
RIIIDEVRDEIFATINEAETLQKKEKELSVLPQR",PAT1,M+C-term,-,458aa(296-754),P25644,"DrLLPS,LLPSDB,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Sac-0330,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0246,http://db.phasep.pro/browse/","[1-4],[5-24],[55-79],[164-200],[365-421],[422-469]","[59-74],[111-137],[149-157],[165-183],[187-224],[404-415],[434-450],[545-555],[571-583]",In vitro,13.4 ng/µl [polyA];|2.5µM [Pat1],60 mM NaCl,"20 mM HEPES pH 7.0, 1 mM DTT",RT,20 min,-,"Bright-field microscopy,Fluorescence microscopy",solute,"PatMC and Dcp2 both weakly interact with RNA, which can trigger or potentiate liquid-liquid phase separation with oligomeric RNA binding proteins (RBPs)The PatMC/Dcp1/Dcp2Ext droplets were able to incorporate A15 RNA,though A15 RNA did not change the critical concentration required for phase separation However, neither short A15 RNAs nor polyA RNA promoted droplet formation with either PatMC",15
164,715,PMID: 32561643,RNAPS0000392,https://pubmed.ncbi.nlm.nih.gov/32561643,RNA + protein,-,-,polyU,-,-,poly RNA,-,OIOOASVEELTEVPGIGPOLAOOILEOLA,Precursor-Orn,-,-,29aa,-,-,-,-,-,In vitro,1.2 mg/mL [polyU];|240 µM [Precursor-Orn];|1.2 µM [fluorescein-labeled Precursor-Orn],-,50 mM MES pH 5.6,RT,-,-,Fluorescence microscopy,liquid,"On mixing with polyU, both Precursor-Orn and -Arg formed coacervates  as did Ancestor- (HhH)2 (SI Appendix, Fig. S10). Neither polypeptide formed droplets in the absence of polyU. Further, precursor-Arg consistently made larger droplets than Precursor-Orn, and at lower concen trations. Thus, by increasing the coacervate forming potential, statistical modification of ornithine to arginine could also provide an advantage at this early stage",0
165,716,PMID: 32561643,RNAPS0000393,https://pubmed.ncbi.nlm.nih.gov/32561643,RNA + protein,-,-,polyU,-,-,poly RNA,-,RIRRASVEELTEVPGIGPRLARRILERLA,Precursor-Arg,-,-,29aa,-,-,-,-,-,In vitro,1.4 mg/mL [polyU];|190 µM [Precursor-Arg];|20 µM [fluorescein-labeled Precursor-Arg],-,50 mM MES pH 5.6,RT,-,-,Fluorescence microscopy,liquid,"On mixing with polyU, both Precursor-Orn and -Arg formed coacervates  as did Ancestor- (HhH)2 (SI Appendix, Fig. S10). Neither polypeptide formed droplets in the absence of polyU. Further, precursor-Arg consistently made larger droplets than Precursor-Orn, and at lower concen trations. Thus, by increasing the coacervate forming potential, statistical modification of ornithine to arginine could also provide an advantage at this early stage",0
166,717,PMID: 32561643,RNAPS0000394,https://pubmed.ncbi.nlm.nih.gov/32561643,RNA + protein,-,-,polyU,-,-,poly RNA,-,GRVRRSEIPLGIELEAGTLRLARRPEIRVA,all residues except arginine(Scrambled),-,-,30aa,-,-,-,"[1-2],[4-6],[8-8],[12-30]",-,In vitro,1 mg/mL [polyU];|200 µM [Scrambled];|8 µM [fluorescein-labeled Scrambled],-,50 mM MES pH 5.6,RT,-,-,Fluorescence microscopy,solid,"Phase separation of these polypeptides is perhaps un surprising, given that arginine-rich peptides have been shown to phase-separate on the addition of RNA or crowding agents . However, scrambling the sequence of the Precursor-Arg—either completely or while preserving only the positions of the arginine residues (scrambled 1 and 2, respectively)—resulted in amor phous aggregate on polyU addition (Fig. 4B). Thus, basic amino acids are likely necessary but not sufficient to encode phase separation.",0
167,718,PMID: 32561643,RNAPS0000395,https://pubmed.ncbi.nlm.nih.gov/32561643,RNA + protein,-,-,polyU,-,-,poly RNA,-,GEPAIRSEPIRLRLEGVRALRTEVGLRIRA,Precursor-Arg(Scrambled),-,-,30aa,-,-,-,"[1-10],[16-26],[28-30]",-,In vitro,1 mg/mL [polyU];|200 µM [Scrambled];|8 µM [fluorescein-labeled Scrambled],-,50 mM MES pH 5.6,RT,-,-,Fluorescence microscopy,solid,"Phase separation of these polypeptides is perhaps un surprising, given that arginine-rich peptides have been shown to phase-separate on the addition of RNA or crowding agents . However, scrambling the sequence of the Precursor-Arg—either completely or while preserving only the positions of the arginine residues (scrambled 1 and 2, respectively)—resulted in amor phous aggregate on polyU addition (Fig. 4B). Thus, basic amino acids are likely necessary but not sufficient to encode phase separation.",0
168,719,PMID: 32571937,RNAPS0000396,https://pubmed.ncbi.nlm.nih.gov/32571937,RNA + protein,-,-,polyU,-(600-1000 kDa),-,poly RNA,-,"sp|P04554|PRM2_HUMAN Protamine-2 OS=Homo sapiens OX=9606 GN=PRM2 PE=1 SV=3
MVRYRVRSLSERSHEVYRQQLHGQEQGHHGQEEQGLSPEHVEVYERTHGQSHYRRRHCSR
RRLHRIHRRQHRSCRRRKRRSCRHRRRHRRGCRTRKRTCRRH",PRM2,-,-,102aa(1-102),P04554,PhaSepDB,http://db.phasep.pro/browse/,-,"[19-36],[52-101]",In vitro,1.1-22 mg/mL [polyU];|4.4 mg/mL [PRM2];|,-,"25 mM Tris-HCl, pH 7.5",RT,-,-,Fluorescence microscopy,liquid,"Remarkably, we observed that micrometer-sized hollow condensates are readily formed by mixing 4.4 mg/mL PRM with 22 mg/mL RNA. These hollow condensates closely resemble lipid vesicles in their appearance. Furthermore, we observed that these hollow condensates are relatively stable across a wide range of temperature and salt concentrations.",
169,720,PMID: 32571937,RNAPS0000396,https://pubmed.ncbi.nlm.nih.gov/32571937,RNA + protein,-,-,polyU,-(600-1000 kDa),-,poly RNA,-,"sp|P04554|PRM2_HUMAN Protamine-2 OS=Homo sapiens OX=9606 GN=PRM2 PE=1 SV=3
MVRYRVRSLSERSHEVYRQQLHGQEQGHHGQEEQGLSPEHVEVYERTHGQSHYRRRHCSR
RRLHRIHRRQHRSCRRRKRRSCRHRRRHRRGCRTRKRTCRRH",PRM2,-,-,102aa(1-102),P04554,PhaSepDB,http://db.phasep.pro/browse/,-,"[19-36],[52-101]",In vitro,2.2 mg/mL [polyU];|4.4 mg/mL [PRM2];|,-,"25 mM Tris-HCl, pH 7.5",RT,-,-,"Fluorescence microscopy,Differential interference contrast microscopy",liquid,"Remarkably, we observed that micrometer-sized hollow condensates are readily formed by mixing 4.4 mg/mL PRM with 22 mg/mL RNA. These hollow condensates closely resemble lipid vesicles in their appearance. Furthermore, we observed that these hollow condensates are relatively stable across a wide range of temperature and salt concentrations.",
170,721,PMID: 32571937,RNAPS0000397,https://pubmed.ncbi.nlm.nih.gov/32571937,RNA + protein,-,-,polyU,-(600-1000 kDa),-,poly RNA,-,"sp|P04554|PRM2_HUMAN Protamine-2 OS=Homo sapiens OX=9606 GN=PRM2 PE=1 SV=3
MVRYRVRSLSERSHEVYRQQLHGQEQGHHGQEEQGLSPEHVEVYERTHGQSHYRRRHCSR
RRLHRIHRRQHRSCRRRKRRSCRHRRRHRRGCRTRKRTCRRH",PRM2,-,-,102aa(1-102),P04554,PhaSepDB,http://db.phasep.pro/browse/,-,"[19-36],[52-101]",In vitro,22 mg/mL [polyU];|4.4 mg/mL [PRM2];|,-,"25 mM Tris-HCl, pH 7.5",RT,-,-,"Fluorescence microscopy,Differential interference contrast microscopy",liquid,"Remarkably, we observed that micrometer-sized hollow condensates are readily formed by mixing 4.4 mg/mL PRM with 22 mg/mL RNA. These hollow condensates closely resemble lipid vesicles in their appearance. Furthermore, we observed that these hollow condensates are relatively stable across a wide range of temperature and salt concentrations.",
171,722,PMID: 32571937,RNAPS0000398,https://pubmed.ncbi.nlm.nih.gov/32571937,RNA + protein,-,-,polyU,-(600-1000 kDa),-,poly RNA,-,-,poly(acrylic acid),-,-,-,-,-,-,-,-,In vitro,4 mg/mL [polyU];|40 mg/mL [poly(acrylic acid)],-,"25 mM Tris-HCl, pH 7.5",RT,-,-,"Fluorescence microscopy,Differential interference contrast microscopy",liquid,"Second, we changed the polycation, keeping the polyanionic RNA unchanged. Similar to the PRM−poly(U) system, we observed that RNA can also form hollow condensates upon interaction with a synthetic cationic poly electrolyte, poly(Allylamine) (PAH) under similar conditions",
172,786,PMID: 32857953,RNAPS0000413,https://pubmed.ncbi.nlm.nih.gov/32857953,Undefined,-,-,ployA,-,-,poly RNA,-,"sp|Q13283|G3BP1_HUMAN Ras GTPase-activating protein-binding protein 1 OS=Homo sapiens OX=9606 GN=G3BP1 PE=1 SV=1
MVMEKPSPLLVGREFVRQYYTLLNQAPDMLHRFYGKNSSYVHGGLDSNGKPADAVYGQKE
IHRKVMSQNFTNCHTKIRHVDAHATLNDGVVVQVMGLLSNNNQALRRFMQTFVLAPEGSV
ANKFYVHNDIFRYQDEVFGGFVTEPQEESEEEVEEPEERQQTPEVVPDDSGTFYDQAVVS
NDMEEHLEEPVAEPEPDPEPEPEQEPVSEIQEEKPEPVLEETAPEDAQKSSSPAPADIAQ
TVQEDLRTFSWASVTSKNLPPSGAVPVTGIPPHVVKVPASQPRPESKPESQIPPQRPQRD
QRVREQRINIPPQRGPRPIREAGEQGDIEPRRMVRHPDSHQLFIGNLPHEVDKSELKDFF
QSYGNVVELRINSGGKLPNFGFVVFDDSEPVQKVLSNRPIMFRGEVRLNVEEKKTRAARE
GDRRDNRLRGPGGPRGGLGGGMRGPPRGGMVQKPGFGVGRGLAPRQ",G3BP1,-,-,466aa(1-466),Q13283,"DrLLPS,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-0862,http://db.phasep.pro/browse/","[144-172],[184-243],[255-329],[413-466]","[142-167],[184-213],[291-307],[421-450]",In vivo,-,-,-,-,-,other molecular:300 mM Na+ for 60 min;cell:U2OS cells,"FISH,Immunofluorescence",-,"At this later time point, however, G3BP and polyA RNA showed significant focus formation ( 100–200 foci per cell,200–300 nm in diameter; Figures 1A and S1A), in line with pre vious observations (Bounedjah et al., 2012), with  13% of cellular G3BP partitioning into foci.",0
173,800,PMID: 32901111,RNAPS0000423,https://pubmed.ncbi.nlm.nih.gov/32901111,RNA + protein,-,-,polyU(10),10nt,UUUUUUUUUU,poly RNA,-,"sp|P0DTC9|NCAP_SARS2 Nucleoprotein OS=Severe acute respiratory syndrome coronavirus 2 OX=2697049 GN=N PE=1 SV=1
MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHG
KEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAG
LPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGS
QASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQ
QQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKH
WPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAY
KTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA",SARS-CoV-2 Nucleoprotein,-,-,419aa(1-419),P0DTC9,-,-,"[1-40],[44-49],[174-174],[181-212],[233-247],[249-256],[365-391]","[175-208],[211-230],[236-249],[361-379]",In vitro,10µM[U10];|20µM [N protein],-,"1× PBS, pH 7.4",RT,> 1 h,crowding agent:2.5% PEG8000,"Differential interference contrast microscopy,Fluorescence microscopy",liquid,"Representative fluorescence images of LLPS formed by RNA (orange) of different lengths mixed  with N protein (red). In the experiments, the RNA oligoes of the same mass were used, and the  corresponding molar concentrations are also indicated",10
174,801,PMID: 32901111,RNAPS0000424,https://pubmed.ncbi.nlm.nih.gov/32901111,RNA + protein,-,-,polyU(20),20nt,UUUUUUUUUUUUUUUUUUUU,poly RNA,-,"sp|P0DTC9|NCAP_SARS2 Nucleoprotein OS=Severe acute respiratory syndrome coronavirus 2 OX=2697049 GN=N PE=1 SV=1
MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHG
KEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAG
LPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGS
QASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQ
QQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKH
WPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAY
KTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA",SARS-CoV-2 Nucleoprotein,-,-,419aa(1-419),P0DTC9,-,-,"[1-40],[44-49],[174-174],[181-212],[233-247],[249-256],[365-391]","[175-208],[211-230],[236-249],[361-379]",In vitro,5µM[U20];|20µM [N protein],-,"1× PBS, pH 7.4",RT,> 1 h,crowding agent:2.5% PEG8000,"Differential interference contrast microscopy,Fluorescence microscopy",liquid,"When inducing N protein/RNA LLPS by using these poly-U oligos with the same mass and the same concentrations of N protein, we found that the longest ssRNA, U60, could phase separate with N protein to form much larger droplets compared with other shorter oligoes (Supplementary information, Fig. S5a), confirming that the LLPS is indeed dependent on ssRNA length.Representative fluorescence images of LLPS formed by RNA (orange) of different lengths mixed  with N protein (red). In the experiments, the RNA oligoes of the same mass were used, and the  corresponding molar concentrations are also indicated.",20
175,802,PMID: 32901111,RNAPS0000425,https://pubmed.ncbi.nlm.nih.gov/32901111,RNA + protein,-,-,polyU(40),40nt,UUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUU,poly RNA,-,"sp|P0DTC9|NCAP_SARS2 Nucleoprotein OS=Severe acute respiratory syndrome coronavirus 2 OX=2697049 GN=N PE=1 SV=1
MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHG
KEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAG
LPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGS
QASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQ
QQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKH
WPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAY
KTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA",SARS-CoV-2 Nucleoprotein,-,-,419aa(1-419),P0DTC9,-,-,"[1-40],[44-49],[174-174],[181-212],[233-247],[249-256],[365-391]","[175-208],[211-230],[236-249],[361-379]",In vitro,2.5µM[U40];|20µM [N protein],-,"1× PBS, pH 7.4",RT,> 1 h,crowding agent:2.5% PEG8000,"Differential interference contrast microscopy,Fluorescence microscopy",liquid,"When inducing N protein/RNA LLPS by using these poly-U oligos with the same mass and the same concentrations of N protein, we found that the longest ssRNA, U60, could phase separate with N protein to form much larger droplets compared with other shorter oligoes (Supplementary information, Fig. S5a), confirming that the LLPS is indeed dependent on ssRNA length.Representative fluorescence images of LLPS formed by RNA (orange) of different lengths mixed  with N protein (red). In the experiments, the RNA oligoes of the same mass were used, and the  corresponding molar concentrations are also indicated.",40
176,803,PMID: 32901111,RNAPS0000426,https://pubmed.ncbi.nlm.nih.gov/32901111,RNA + protein,-,-,polyU(60),60nt,UUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUU,poly RNA,-,"sp|P0DTC9|NCAP_SARS2 Nucleoprotein OS=Severe acute respiratory syndrome coronavirus 2 OX=2697049 GN=N PE=1 SV=1
MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHG
KEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAG
LPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGS
QASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQ
QQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKH
WPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAY
KTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA",SARS-CoV-2 Nucleoprotein,-,-,419aa(1-419),P0DTC9,-,-,"[1-40],[44-49],[174-174],[181-212],[233-247],[249-256],[365-391]","[175-208],[211-230],[236-249],[361-379]",In vitro,1.67µM[U60];|20µM [N protein],-,"1× PBS, pH 7.4",RT,> 1 h,crowding agent:2.5% PEG8000,"Differential interference contrast microscopy,Fluorescence microscopy",liquid,"When inducing N protein/RNA LLPS by using these poly-U oligos with the same mass and the same concentrations of N protein, we found that the longest ssRNA, U60, could phase separate with N protein to form much larger droplets compared with other shorter oligoes (Supplementary information, Fig. S5a), confirming that the LLPS is indeed dependent on ssRNA length.Representative fluorescence images of LLPS formed by RNA (orange) of different lengths mixed  with N protein (red). In the experiments, the RNA oligoes of the same mass were used, and the  corresponding molar concentrations are also indicated.",60
177,804,PMID: 32909564,RNAPS0000427,https://pubmed.ncbi.nlm.nih.gov/32909564,RNA + protein,-,-,polyU(20),20nt,UUUUUUUUUUUUUUUUUUUU,poly RNA,-,"sp|D0PV95|DDX3_CAEEL ATP-dependent RNA helicase laf-1 OS=Caenorhabditis elegans OX=6239 GN=laf-1 PE=1 SV=1
MESNQSNNGGSGNAALNRGGRYVPPHLRGGDGGAAAAASAGGDDRRGGAGGGGYRRGGGN
SGGGGGGGYDRGYNDNRDDRDNRGGSGGYGRDRNYEDRGYNGGGGGGGNRGYNNNRGGGG
GGYNRQDRGDGGSSNFSRGGYNNRDEGSDNRGSGRSYNNDRRDNGGDGQNTRWNNLDAPP
SRGTSKWENRGARDERIEQELFSGQLSGINFDKYEEIPVEATGDDVPQPISLFSDLSLHE
WIEENIKTAGYDRPTPVQKYSIPALQGGRDLMSCAQTGSGKTAAFLVPLVNAILQDGPDA
VHRSVTSSGGRKKQYPSALVLSPTRELSLQIFNESRKFAYRTPITSALLYGGRENYKDQI
HKLRLGCHILIATPGRLIDVMDQGLIGMEGCRYLVLDEADRMLDMGFEPQIRQIVECNRM
PSKEERITAMFSATFPKEIQLLAQDFLKENYVFLAVGRVGSTSENIMQKIVWVEEDEKRS
YLMDLLDATGDSSLTLVFVETKRGASDLAYYLNRQNYEVVTIHGDLKQFEREKHLDLFRT
GTAPILVATAVAARGLDIPNVKHVINYDLPSDVDEYVHRIGRTGRVGNVGLATSFFNDKN
RNIARELMDLIVEANQELPDWLEGMSGDMRSGGGYRGRGGRGNGQRFGGRDHRYQGGSGN
GGGGNGGGGGFGGGGQRSGGGGGFQSGGGGGRQQQQQQRAQPQQDWWS",laf-1,-,-,708aa(1-708),D0PV95,"PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/D0PV95,http://llps.biocuckoo.cn/view.php?id=LLPS-Cae-0337,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0001,http://db.phasep.pro/browse/",-,-,In vitro,5 or 10 µM[polyU];|5 µM[laf-1],-,"20 mM Tris–HCl, 5 mM TCEP, pH 7.4",25˚C,-,-,Microscopy,liquid,"Light microscopy snapshots of (A) LAF-1 (5 μM) + polyU20 RNA (5 μM), (B) LAF-1 (5 μM) + polyU20 RNA (10 μM), (C) LAF-1 (5 μM) + polyU20 RNA (5 μM) + LL-III (50 μM), (D) LAF-1 (5 μM) + polyU20 RNA (5 μM) + LL-III (500 μM), at 25˚C in buffer (20 mM Tris–HCl, 5 mM TCEP, pH 7.4). (Scale bar, 30 µm).",20
178,805,PMID: 32909564,RNAPS0000427,https://pubmed.ncbi.nlm.nih.gov/32909564,RNA + protein,-,-,polyU(20),20nt,UUUUUUUUUUUUUUUUUUUU,poly RNA,-,"sp|D0PV95|DDX3_CAEEL ATP-dependent RNA helicase laf-1 OS=Caenorhabditis elegans OX=6239 GN=laf-1 PE=1 SV=1
MESNQSNNGGSGNAALNRGGRYVPPHLRGGDGGAAAAASAGGDDRRGGAGGGGYRRGGGN
SGGGGGGGYDRGYNDNRDDRDNRGGSGGYGRDRNYEDRGYNGGGGGGGNRGYNNNRGGGG
GGYNRQDRGDGGSSNFSRGGYNNRDEGSDNRGSGRSYNNDRRDNGGDGQNTRWNNLDAPP
SRGTSKWENRGARDERIEQELFSGQLSGINFDKYEEIPVEATGDDVPQPISLFSDLSLHE
WIEENIKTAGYDRPTPVQKYSIPALQGGRDLMSCAQTGSGKTAAFLVPLVNAILQDGPDA
VHRSVTSSGGRKKQYPSALVLSPTRELSLQIFNESRKFAYRTPITSALLYGGRENYKDQI
HKLRLGCHILIATPGRLIDVMDQGLIGMEGCRYLVLDEADRMLDMGFEPQIRQIVECNRM
PSKEERITAMFSATFPKEIQLLAQDFLKENYVFLAVGRVGSTSENIMQKIVWVEEDEKRS
YLMDLLDATGDSSLTLVFVETKRGASDLAYYLNRQNYEVVTIHGDLKQFEREKHLDLFRT
GTAPILVATAVAARGLDIPNVKHVINYDLPSDVDEYVHRIGRTGRVGNVGLATSFFNDKN
RNIARELMDLIVEANQELPDWLEGMSGDMRSGGGYRGRGGRGNGQRFGGRDHRYQGGSGN
GGGGNGGGGGFGGGGQRSGGGGGFQSGGGGGRQQQQQQRAQPQQDWWS",laf-1,-,-,708aa(1-708),D0PV95,"PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/D0PV95,http://llps.biocuckoo.cn/view.php?id=LLPS-Cae-0337,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0001,http://db.phasep.pro/browse/",-,-,In vitro,5 or 10 µM[polyU];|5 µM[laf-1],-,"20 mM Tris–HCl, 5 mM TCEP, pH 7.4",25˚C,-,other_molecular:50 μM LL-III200 μM LL-III500 μM LL-III,Microscopy,liquid,"Light microscopy snapshots of (A) LAF-1 (5 μM) + polyU20 RNA (5 μM), (B) LAF-1 (5 μM) + polyU20 RNA (10 μM), (C) LAF-1 (5 μM) + polyU20 RNA (5 μM) + LL-III (50 μM), (D) LAF-1 (5 μM) + polyU20 RNA (5 μM) + LL-III (500 μM), at 25˚C in buffer (20 mM Tris–HCl, 5 mM TCEP, pH 7.4). (Scale bar, 30 µm).",20
179,814,PMID: 32995779,RNAPS0000434,https://pubmed.ncbi.nlm.nih.gov/32995779,RNA + protein,-,-,polyC(2000),2000nt,CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC,poly RNA,-,"sp|P0DTC9|NCAP_SARS2 Nucleoprotein OS=Severe acute respiratory syndrome coronavirus 2 OX=2697049 GN=N PE=1 SV=1
MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHG
KEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAG
LPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGS
QASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQ
QQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKH
WPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAY
KTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA",SARS-CoV-2 Nucleoprotein,-,-,419aa(1-419),P0DTC9,-,-,"[1-40],[44-49],[174-174],[181-212],[233-247],[249-256],[365-391]","[175-208],[211-230],[236-249],[361-379]",In vitro,50 ng/µL [polyC];|2.3-18 µM [N protein],"150 mM NaCl, 5 mM MgCl2","50 mM HEPES pH 7.4, 1 mM EGTA, 1 mM DTT, 1% pluronic",RT,≤ 25 min,-,Electron microscopy,"liquid, solute","Mixing of 50 ng/µL polyC RNA and the N protein resulted in the formation of condensates in 150 mM NaCl. The analysis of the condensates settled on the coverslip revealed a saturation concentration (csat) of 3.3 ± 1.3 µM for N protein in the presence of 50 ng/µL polyC RNA (± s.e.), consistent with the abundance of N protein in infected cells (43). The partition coefficient of N protein into condensates was 13 ± 2 (±s.d.).",2000
180,815,PMID: 32995779,RNAPS0000434,https://pubmed.ncbi.nlm.nih.gov/32995779,RNA + protein,-,-,polyC(2000),2000nt,CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC,poly RNA,-,"sp|P0DTC9|NCAP_SARS2 Nucleoprotein OS=Severe acute respiratory syndrome coronavirus 2 OX=2697049 GN=N PE=1 SV=1|residues=1,31-419
MERSGARSKQRRPQGLPNNTASWFTALTQHG
KEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAG
LPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGS
QASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQ
QQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKH
WPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAY
KTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA",SARS-CoV-2 Nucleoprotein,△PLD,-,"390aa(1,31-419)",P0DTC9,-,-,"[1-1],[31-40],[44-49],[174-174],[181-212],[233-247],[249-256],[365-391]","[175-208],[211-230],[236-249],[361-379]",In vitro,0.5-5000 ng/µL[polyC];|18 µM [N protein],"150 mM NaCl, 5 mM MgCl2","50 mM HEPES pH 7.4, 1 mM EGTA, 1 mM DTT, 1% pluronic",RT,> 25 min,-,Electron microscopy,"liquid, solute","Phase separation was only moderately reduced in the ΔSR, ΔPLD, and ΔR1 mutants, suggesting that these regions are not essential for phase separation. In comparison, deletion of the R2 sequence fully abolished the formation of condensates with polyC RNA.",2000
181,816,PMID: 32995779,RNAPS0000434,https://pubmed.ncbi.nlm.nih.gov/32995779,RNA + protein,-,-,polyC(2000),2000nt,CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC,poly RNA,-,"sp|P0DTC9|NCAP_SARS2 Nucleoprotein OS=Severe acute respiratory syndrome coronavirus 2 OX=2697049 GN=N PE=1 SV=1
MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHG
KEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAG
LPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGS
QASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKH
WPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAY
KTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA",SARS-CoV-2 Nucleoprotein,△R1,-,"397aa(1-234,257-419)",P0DTC9,-,-,"[1-40],[44-49],[174-174],[181-212],[233-234],[365-391]","[175-208],[211-230],[361-379]",In vitro,0.5-5000 ng/µL[polyC];|18 µM [N protein],"150 mM NaCl, 5 mM MgCl2","50 mM HEPES pH 7.4, 1 mM EGTA, 1 mM DTT, 1% pluronic",RT,> 25 min,-,Electron microscopy,"liquid, solute","Phase separation was only moderately reduced in the ΔSR, ΔPLD, and ΔR1 mutants, suggesting that these regions are not essential for phase separation. In comparison, deletion of the R2 sequence fully abolished the formation of condensates with polyC RNA.",2000
182,817,PMID: 32995779,RNAPS0000434,https://pubmed.ncbi.nlm.nih.gov/32995779,RNA + protein,-,-,polyC(2000),2000nt,CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC,poly RNA,-,"sp|P0DTC9|NCAP_SARS2 Nucleoprotein OS=Severe acute respiratory syndrome coronavirus 2 OX=2697049 GN=N PE=1 SV=1|residues=1-368,391-419
MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHG
KEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAG
LPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGS
QASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQ
QQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKH
WPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAY
KTFPPTEPTVTLLPAADLDDFSKQLQQSMSSADSTQA",SARS-CoV-2 Nucleoprotein,△R2,-,"397aa(1-368,391-419)",P0DTC9,-,-,"[1-40],[44-49],[174-174],[181-212],[233-247],[249-256],[365-368],[391-391]","[175-208],[211-230],[236-249],[361-368]",In vitro,0.5-5000 ng/µL[polyC];|18 µM [N protein],"150 mM NaCl, 5 mM MgCl2","50 mM HEPES pH 7.4, 1 mM EGTA, 1 mM DTT, 1% pluronic",RT,> 25 min,-,Electron microscopy,"solute, liquid","Phase separation was only moderately reduced in the ΔSR, ΔPLD, and ΔR1 mutants, suggesting that these regions are not essential for phase separation. In comparison, deletion of the R2 sequence fully abolished the formation of condensates with polyC RNA.",2000
183,818,PMID: 32995779,RNAPS0000434,https://pubmed.ncbi.nlm.nih.gov/32995779,RNA + protein,-,-,polyC(2000),2000nt,CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC,poly RNA,-,"sp|P0DTC9|NCAP_SARS2 Nucleoprotein OS=Severe acute respiratory syndrome coronavirus 2 OX=2697049 GN=N PE=1 SV=1
MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHG
KEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAG
LPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGS
QASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQ
QQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKH
WPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAY
KTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA",SARS-CoV-2 Nucleoprotein,-,protein_ptm:phosphorylated or dePhosphorylated,419aa(1-419),P0DTC9,-,-,"[1-40],[44-49],[174-174],[181-212],[233-247],[249-256],[365-391]","[175-208],[211-230],[236-249],[361-379]",In vitro,50 ng/µL[polyC];|1.9-60 µM [N protein],"150 mM NaCl, 5 mM MgCl2","50 mM HEPES pH 7.4, 1 mM EGTA, 1 mM DTT, 1% pluronic",RT,> 25 min,-,Electron microscopy,"liquid, solute","Phase separation was only moderately reduced in the ΔSR, ΔPLD, and ΔR1 mutants, suggesting that these regions are not essential for phase separation. In comparison, deletion of the R2 sequence fully abolished the formation of condensates with polyC RNA.",2000
184,819,PMID: 32995779,RNAPS0000434,https://pubmed.ncbi.nlm.nih.gov/32995779,RNA + protein,-,-,polyC(2000),2000nt,CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC,poly RNA,-,"sp|P0DTC9|NCAP_SARS2 Nucleoprotein OS=Severe acute respiratory syndrome coronavirus 2 OX=2697049 GN=N PE=1 SV=1|residues=1-182,196-419
MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHG
KEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAG
LPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGS
QASSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQ
QQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKH
WPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAY
KTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA",SARS-CoV-2 Nucleoprotein,△SR,-,"406aa(1-182,196-419)",P0DTC9,-,-,"[1-40],[44-49],[174-174],[181-182],[196-212],[233-247],[249-256],[365-391]","[175-182],[196-208],[211-230],[236-249],[361-379]",In vitro,0.5-5000 ng/µL[polyC];|18 µM [N protein],"150 mM NaCl, 5 mM MgCl2","50 mM HEPES pH 7.4, 1 mM EGTA, 1 mM DTT, 1% pluronic",RT,> 25 min,-,Electron microscopy,"liquid, solute","Phase separation was only moderately reduced in the ΔSR, ΔPLD, and ΔR1 mutants, suggesting that these regions are not essential for phase separation. In comparison, deletion of the R2 sequence fully abolished the formation of condensates with polyC RNA.",2000
185,820,PMID: 32995779,RNAPS0000434,https://pubmed.ncbi.nlm.nih.gov/32995779,RNA + protein,-,-,polyC(2000),2000nt,CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC,poly RNA,-,"sp|P0DTC9|NCAP_SARS2 Nucleoprotein OS=Severe acute respiratory syndrome coronavirus 2 OX=2697049 GN=N PE=1 SV=1|residues=1-368,391-419
MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHG
KEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAG
LPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGS
QASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQ
QQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKH
WPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAY
KTFPPTEPTVTLLPAADLDDFSKQLQQSMSSADSTQA",SARS-CoV-2 Nucleoprotein,△R2,protein_ptm:dePhosphorylated,"397aa(1-368,391-419)",P0DTC9,-,-,"[1-40],[44-49],[174-174],[181-212],[233-247],[249-256],[365-368],[391-391]","[175-208],[211-230],[236-249],[361-368]",In vitro,50 ng/µL[polyC];|1.9-60 µM [N protein],"150 mM NaCl, 5 mM MgCl2","50 mM HEPES pH 7.4, 1 mM EGTA, 1 mM DTT, 1% pluronic",RT,> 25 min,-,Electron microscopy,"liquid, solute","Phase separation was only moderately reduced in the ΔSR, ΔPLD, and ΔR1 mutants, suggesting that these regions are not essential for phase separation. In comparison, deletion of the R2 sequence fully abolished the formation of condensates with polyC RNA.",2000
186,821,PMID: 32995779,RNAPS0000434,https://pubmed.ncbi.nlm.nih.gov/32995779,RNA + protein,-,-,polyC(2000),2000nt,CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC,poly RNA,-,"sp|P0DTC9|NCAP_SARS2 Nucleoprotein OS=Severe acute respiratory syndrome coronavirus 2 OX=2697049 GN=N PE=1 SV=1
MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHG
KEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAG
LPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGS
QASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQ
QQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKH
WPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAY
KTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA",SARS-CoV-2 Nucleoprotein,-,-,419aa(1-419),P0DTC9,-,-,"[1-40],[44-49],[174-174],[181-212],[233-247],[249-256],[365-391]","[175-208],[211-230],[236-249],[361-379]",In vitro,50 ng/µL [polyC];|24 µM [N protein],"50-200 mM NaCl, 5 mM MgCl2","50 mM HEPES pH 7.4, 1 mM EGTA, 1 mM DTT, 1% pluronic",RT,> 25 min,-,Electron microscopy,"solute, liquid","Although N protein is unable to phase separate without RNA in 150 mM salt, 24 µM N protein efficiently formed condensates at lower salt with a half-maximal inhibition constant (IC50) of 90 ± 1 µM NaCl (±s.e.). The addition of 50 ng/µL polyC RNA increased IC50 to 152 ± 6 mM NaCl.",2000
187,822,PMID: 32995779,RNAPS0000434,https://pubmed.ncbi.nlm.nih.gov/32995779,RNA + protein,-,-,polyC(2000),2000nt,CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC,poly RNA,-,"sp|P0DTC9|NCAP_SARS2 Nucleoprotein OS=Severe acute respiratory syndrome coronavirus 2 OX=2697049 GN=N PE=1 SV=1
MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHG
KEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAG
LPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGS
QASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQ
QQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKH
WPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAY
KTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA",SARS-CoV-2 Nucleoprotein,-,-,419aa(1-419),P0DTC9,-,-,"[1-40],[44-49],[174-174],[181-212],[233-247],[249-256],[365-391]","[175-208],[211-230],[236-249],[361-379]",In vitro,50 ng/µL [polyC];|7.8 µM [N protein],"150 mM NaCl, 5 mM MgCl2","50 mM HEPES pH 7.4, 1 mM EGTA, 1 mM DTT, 1% pluronic",RT,> 25 min,"other_molecular:0,10 mM lipoic acid",Electron microscopy,liquid,"The condensates formed by the N protein in the absence or presence of polyC or viral RNA dissolve with the  addition of 10% 1,6 hexanediol, indicating that phase separation is driven, at least partially, by hydrophobic  interactions (Figure 5A). In comparison, lipoic acid that increases the liquidity of stress granules  did  not affect phase separation",2000
188,823,PMID: 32995779,RNAPS0000434,https://pubmed.ncbi.nlm.nih.gov/32995779,RNA + protein,-,-,polyC(2000),2000nt,CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC,poly RNA,-,"sp|P0DTC9|NCAP_SARS2 Nucleoprotein OS=Severe acute respiratory syndrome coronavirus 2 OX=2697049 GN=N PE=1 SV=1
MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHG
KEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAG
LPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGS
QASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQ
QQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKH
WPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAY
KTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA",SARS-CoV-2 Nucleoprotein,-,-,419aa(1-419),P0DTC9,-,-,"[1-40],[44-49],[174-174],[181-212],[233-247],[249-256],[365-391]","[175-208],[211-230],[236-249],[361-379]",In vitro,50 ng/µL [polyC];|7.8 µM [N protein],"150 mM NaCl, 5 mM MgCl2","50 mM HEPES pH 7.4, 1 mM EGTA, 1 mM DTT, 1% pluronic",RT,> 25 min,"other_molecular:10% 1,6-hexanediol",Electron microscopy,"solute, liquid","The condensates formed by the N protein in the absence or presence of polyC or viral RNA dissolve with the  addition of 10% 1,6 hexanediol, indicating that phase separation is driven, at least partially, by hydrophobic  interactions (Figure 5A). In comparison, lipoic acid that increases the liquidity of stress granules  did  not affect phase separation",2000
189,824,PMID: 32995779,RNAPS0000434,https://pubmed.ncbi.nlm.nih.gov/32995779,RNA + protein,-,-,polyC(2000),2000nt,CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC,poly RNA,-,"sp|P0DTC9|NCAP_SARS2 Nucleoprotein OS=Severe acute respiratory syndrome coronavirus 2 OX=2697049 GN=N PE=1 SV=1
MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHG
KEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAG
LPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGS
QASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQ
QQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKH
WPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAY
KTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA",SARS-CoV-2 Nucleoprotein,-,-,419aa(1-419),P0DTC9,-,-,"[1-40],[44-49],[174-174],[181-212],[233-247],[249-256],[365-391]","[175-208],[211-230],[236-249],[361-379]",In vitro,0.5-5000 ng/µL [polyC];|18.5 µM [N protein],"150 mM NaCl, 5 mM MgCl2","50 mM HEPES pH 7.4, 1 mM EGTA, 1 mM DTT, 1% pluronic",RT,> 25 min,-,Electron microscopy,"liquid, solute","Condensate formation of N protein and RNA was dependent on protein-RNA stoichiometry. At 18 µM N  protein, condensate formation was not observed in the presence of 0-5 ng/µL polyC RNA. Increasing the RNA  concentration promoted phase separation with an optimal RNA concentration of 100-500 ng/µL, in which  charge neutralization occurs with the positively-charged N protein",2000
190,825,PMID: 32995779,RNAPS0000434,https://pubmed.ncbi.nlm.nih.gov/32995779,RNA + protein,-,-,polyC(2000),2000nt,CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC,poly RNA,-,"sp|P0DTC9|NCAP_SARS2 Nucleoprotein OS=Severe acute respiratory syndrome coronavirus 2 OX=2697049 GN=N PE=1 SV=1
MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHG
KEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAG
LPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGS
QASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQ
QQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKH
WPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAY
KTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA",SARS-CoV-2 Nucleoprotein,-,-,419aa(1-419),P0DTC9,-,-,"[1-40],[44-49],[174-174],[181-212],[233-247],[249-256],[365-391]","[175-208],[211-230],[236-249],[361-379]",In vitro,50 µg/µL[polyC];|7.8 µM [N protein],"150 mM NaCl, 5 mM MgCl2","50 mM HEPES pH 7.4, 1 mM EGTA, 1 mM DTT, 1% pluronic",RT,> 25 min,"drug:2.5,40 µM Nelfinavir Mesylate",Electron microscopy,liquid,"Nelfinavir mesylate and LDK378 produced larger but  fewer condensates, whereas crystal violet, tolcapone, and chlorhexidine enhanced phase separation by  increasing the number and size of the condensates (Figure 5B, Figure 5_figure supplement 1A-B). Nilotinib  resulted in a 50% increase in condensate volume and altered the shape of the condensates (Figure 5B), which  may be due to changes in condensate fusion or maturation",2000
191,826,PMID: 32995779,RNAPS0000434,https://pubmed.ncbi.nlm.nih.gov/32995779,RNA + protein,-,-,polyC(2000),2000nt,CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC,poly RNA,-,"sp|P0DTC9|NCAP_SARS2 Nucleoprotein OS=Severe acute respiratory syndrome coronavirus 2 OX=2697049 GN=N PE=1 SV=1
MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHG
KEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAG
LPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGS
QASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQ
QQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKH
WPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAY
KTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA",SARS-CoV-2 Nucleoprotein,-,-,419aa(1-419),P0DTC9,-,-,"[1-40],[44-49],[174-174],[181-212],[233-247],[249-256],[365-391]","[175-208],[211-230],[236-249],[361-379]",In vitro,50 µg/µL[polyC];|7.8 µM [N protein],"150 mM NaCl, 5 mM MgCl2","50 mM HEPES pH 7.4, 1 mM EGTA, 1 mM DTT, 1% pluronic",RT,> 25 min,"drug:2.5,40 µM Tolcapone",Electron microscopy,liquid,"Nelfinavir mesylate and LDK378 produced larger but  fewer condensates, whereas crystal violet, tolcapone, and chlorhexidine enhanced phase separation by  increasing the number and size of the condensates (Figure 5B, Figure 5_figure supplement 1A-B). Nilotinib  resulted in a 50% increase in condensate volume and altered the shape of the condensates (Figure 5B), which  may be due to changes in condensate fusion or maturation",2000
192,827,PMID: 32995779,RNAPS0000434,https://pubmed.ncbi.nlm.nih.gov/32995779,RNA + protein,-,-,polyC(2000),2000nt,CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC,poly RNA,-,"sp|P0DTC9|NCAP_SARS2 Nucleoprotein OS=Severe acute respiratory syndrome coronavirus 2 OX=2697049 GN=N PE=1 SV=1
MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHG
KEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAG
LPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGS
QASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQ
QQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKH
WPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAY
KTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA",SARS-CoV-2 Nucleoprotein,-,-,419aa(1-419),P0DTC9,-,-,"[1-40],[44-49],[174-174],[181-212],[233-247],[249-256],[365-391]","[175-208],[211-230],[236-249],[361-379]",In vitro,50 µg/µL[polyC];|7.8 µM [N protein],"150 mM NaCl, 5 mM MgCl2","50 mM HEPES pH 7.4, 1 mM EGTA, 1 mM DTT, 1% pluronic",RT,> 25 min,"drug:2.5,40 µM Nilotinib",Electron microscopy,liquid,"Nelfinavir mesylate and LDK378 produced larger but  fewer condensates, whereas crystal violet, tolcapone, and chlorhexidine enhanced phase separation by  increasing the number and size of the condensates (Figure 5B, Figure 5_figure supplement 1A-B). Nilotinib  resulted in a 50% increase in condensate volume and altered the shape of the condensates (Figure 5B), which  may be due to changes in condensate fusion or maturation",2000
193,828,PMID: 32995779,RNAPS0000435,https://pubmed.ncbi.nlm.nih.gov/32995779,RNA + protein,-,-,polyU,-,-,poly RNA,-,"sp|P0DTC9|NCAP_SARS2 Nucleoprotein OS=Severe acute respiratory syndrome coronavirus 2 OX=2697049 GN=N PE=1 SV=1
MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHG
KEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAG
LPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGS
QASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQ
QQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKH
WPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAY
KTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA",SARS-CoV-2 Nucleoprotein,-,-,419aa(1-419),P0DTC9,-,-,"[1-40],[44-49],[174-174],[181-212],[233-247],[249-256],[365-391]","[175-208],[211-230],[236-249],[361-379]",In vitro,5-5000 ng/µL [polyU];|18.5 µM [N protein],"150 mM NaCl, 5 mM MgCl2","50 mM HEPES pH 7.4, 1 mM EGTA, 1 mM DTT, 1% pluronic",RT,> 25 min,-,Microscopy,"liquid, solute","Similar to polyC RNA, polyA and polyU RNA substrates produced spherical condensates at micromolar  concentrations of the N protein (Figure 2A). However, combining N protein with polyG that forms G quadruplexes or polyAU that forms base-pair interactions led to the formation of non-spherical condensates",0
194,829,PMID: 32995779,RNAPS0000436,https://pubmed.ncbi.nlm.nih.gov/32995779,RNA + protein,-,-,polyG,-,-,poly RNA,-,"sp|P0DTC9|NCAP_SARS2 Nucleoprotein OS=Severe acute respiratory syndrome coronavirus 2 OX=2697049 GN=N PE=1 SV=1
MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHG
KEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAG
LPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGS
QASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQ
QQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKH
WPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAY
KTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA",SARS-CoV-2 Nucleoprotein,-,-,419aa(1-419),P0DTC9,-,-,"[1-40],[44-49],[174-174],[181-212],[233-247],[249-256],[365-391]","[175-208],[211-230],[236-249],[361-379]",In vitro,5-5000 ng/µL [polyG];|18.5 µM [N protein],"150 mM NaCl, 5 mM MgCl2","50 mM HEPES pH 7.4, 1 mM EGTA, 1 mM DTT, 1% pluronic",RT,> 25 min,-,Microscopy,solid,"Similar to polyC RNA, polyA and polyU RNA substrates produced spherical condensates at micromolar  concentrations of the N protein (Figure 2A). However, combining N protein with polyG that forms G quadruplexes or polyAU that forms base-pair interactions led to the formation of non-spherical condensates",0
195,830,PMID: 32995779,RNAPS0000437,https://pubmed.ncbi.nlm.nih.gov/32995779,RNA + protein,-,-,polyA,-,-,poly RNA,-,"sp|P0DTC9|NCAP_SARS2 Nucleoprotein OS=Severe acute respiratory syndrome coronavirus 2 OX=2697049 GN=N PE=1 SV=1
MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHG
KEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAG
LPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGS
QASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQ
QQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKH
WPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAY
KTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA",SARS-CoV-2 Nucleoprotein,-,-,419aa(1-419),P0DTC9,-,-,"[1-40],[44-49],[174-174],[181-212],[233-247],[249-256],[365-391]","[175-208],[211-230],[236-249],[361-379]",In vitro,5-5000 ng/µL [polyA];|18.5 µM [N protein],"150 mM NaCl, 5 mM MgCl2","50 mM HEPES pH 7.4, 1 mM EGTA, 1 mM DTT, 1% pluronic",RT,> 25 min,-,Microscopy,"liquid, solute","Similar to polyC RNA, polyA and polyU RNA substrates produced spherical condensates at micromolar  concentrations of the N protein (Figure 2A). However, combining N protein with polyG that forms G quadruplexes or polyAU that forms base-pair interactions led to the formation of non-spherical condensates",0
196,832,PMID: 33056997,RNAPS0000439,https://pubmed.ncbi.nlm.nih.gov/33056997,RNA + protein,-,-,polyU(2200),2200nt,UUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUU,poly RNA,-,FRGRGRGD,Ac-FRGRGRGD-OH (precursor),-,-,8aa,-,-,-,-,-,In vitro,4.1 mM [polyU];|23 mM[Ac-FRGRGRGD-OH],-,MES buffer (500-1000 mM),25˚C,≤ 40 min,other_molecular:0-100 mM EDC,Turbidity measurement,"liquid, solute",We dissolved 23 mM of the peptide precursor in an aqueous 200 mM MES buffer solution at pH 5.3 with 4.1 mM RNA (expressed in [Uracil nucleotides]).We performed the same experiments with various fuel concentrations to make a phase diagram,2200
197,833,PMID: 33056997,RNAPS0000439,https://pubmed.ncbi.nlm.nih.gov/33056997,RNA + protein,-,-,polyU(2200),2200nt,UUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUU,poly RNA,-,FRGRGRGD,Ac-FRGRGRGD-OH (precursor),-,-,8aa,-,-,-,-,-,In vitro,0-5 mM [polyU];|23 mM[Ac-FRGRGRGD-OH],-,MES buffer (500-1000 mM),25˚C,≤ 40 min,other_molecular:0-60 mM EDC,Turbidity measurement,"liquid, solute","We found that more than 7.5 mM fuel was required to induce an increase in turbidity, which corresponds to 0.9 mM product. This result suggests a critical coacervation concentration of 0.9 mM anhydride product. Between 7.5 mM and 40 mM fuel, we found dynamic droplets. Above 40 mM of fuel, the droplets were metastable. We tested the effect of the RNA concentration on the droplet’s behavior",2200
198,834,PMID: 33200826,RNAPS0000435,https://pubmed.ncbi.nlm.nih.gov/33200826,RNA + protein,-,-,polyU,-,-,poly RNA,-,"sp|P0DTC9|NCAP_SARS2 Nucleoprotein OS=Severe acute respiratory syndrome coronavirus 2 OX=2697049 GN=N PE=1 SV=1
MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHG
KEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAG
LPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGS
QASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQ
QQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKH
WPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAY
KTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA",SARS-CoV-2 Nucleoprotein,-,-,419aa(1-419),P0DTC9,-,-,"[1-40],[44-49],[174-174],[181-212],[233-247],[249-256],[365-391]","[175-208],[211-230],[236-249],[361-379]",In vitro,0.5 mg/ml[ploy-U];|50 µM [N protein],70 mM NaCl,50 mM Tris pH 7.4,25˚C,≤ 2 h,-,"Turbidity measurement,Differential interference contrast microscopy",liquid,"To compare the effect of homopolymeric RNAs on nucleocapsid phase separation, we first performed turbidity measurements at condi tions where N phase separates alone. Importantly, the homopoly meric RNA stock solutions are all buffer exchanged via a spin desalting column and therefore are soluble in these conditions alone. Like torula yeast RNA, all homopolymeric RNAs enhanced the turbidity of solutions of N (Fig 6A), suggesting that particular sequences or RNA structures are not essential for interaction with N.",0
199,835,PMID: 33200826,RNAPS0000436,https://pubmed.ncbi.nlm.nih.gov/33200826,RNA + protein,-,-,polyG,-,-,poly RNA,-,"sp|P0DTC9|NCAP_SARS2 Nucleoprotein OS=Severe acute respiratory syndrome coronavirus 2 OX=2697049 GN=N PE=1 SV=1
MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHG
KEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAG
LPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGS
QASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQ
QQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKH
WPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAY
KTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA",SARS-CoV-2 Nucleoprotein,-,-,419aa(1-419),P0DTC9,-,-,"[1-40],[44-49],[174-174],[181-212],[233-247],[249-256],[365-391]","[175-208],[211-230],[236-249],[361-379]",In vitro,0.5 mg/ml[ploy-G];|50 µM [N protein],70 mM NaCl,50 mM Tris pH 7.4,25˚C,≤ 2 h,-,"Turbidity measurement,Differential interference contrast microscopy",solid,"To compare the effect of homopolymeric RNAs on nucleocapsid phase separation, we first performed turbidity measurements at condi tions where N phase separates alone. Importantly, the homopoly meric RNA stock solutions are all buffer exchanged via a spin desalting column and therefore are soluble in these conditions alone. Like torula yeast RNA, all homopolymeric RNAs enhanced the turbidity of solutions of N (Fig 6A), suggesting that particular sequences or RNA structures are not essential for interaction with N.",0
200,836,PMID: 33200826,RNAPS0000437,https://pubmed.ncbi.nlm.nih.gov/33200826,RNA + protein,-,-,polyA,-,-,poly RNA,-,"sp|P0DTC9|NCAP_SARS2 Nucleoprotein OS=Severe acute respiratory syndrome coronavirus 2 OX=2697049 GN=N PE=1 SV=1
MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHG
KEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAG
LPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGS
QASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQ
QQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKH
WPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAY
KTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA",SARS-CoV-2 Nucleoprotein,-,-,419aa(1-419),P0DTC9,-,-,"[1-40],[44-49],[174-174],[181-212],[233-247],[249-256],[365-391]","[175-208],[211-230],[236-249],[361-379]",In vitro,0.5 mg/ml[ploy-A];|50 µM [N protein],70 mM NaCl,50 mM Tris pH 7.4,25˚C,≤ 2 h,-,"Turbidity measurement,Differential interference contrast microscopy",liquid,"To compare the effect of homopolymeric RNAs on nucleocapsid phase separation, we first performed turbidity measurements at condi tions where N phase separates alone. Importantly, the homopoly meric RNA stock solutions are all buffer exchanged via a spin desalting column and therefore are soluble in these conditions alone. Like torula yeast RNA, all homopolymeric RNAs enhanced the turbidity of solutions of N (Fig 6A), suggesting that particular sequences or RNA structures are not essential for interaction with N.",0
201,837,PMID: 33200826,RNAPS0000440,https://pubmed.ncbi.nlm.nih.gov/33200826,RNA + protein,-,-,polyC,-,-,poly RNA,-,"sp|P0DTC9|NCAP_SARS2 Nucleoprotein OS=Severe acute respiratory syndrome coronavirus 2 OX=2697049 GN=N PE=1 SV=1
MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHG
KEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAG
LPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGS
QASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQ
QQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKH
WPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAY
KTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA",SARS-CoV-2 Nucleoprotein,-,-,419aa(1-419),P0DTC9,-,-,"[1-40],[44-49],[174-174],[181-212],[233-247],[249-256],[365-391]","[175-208],[211-230],[236-249],[361-379]",In vitro,0.5 mg/ml[ploy-C;|50 µM [N protein],70 mM NaCl,50 mM Tris pH 7.4,25˚C,≤ 2 h,-,"Turbidity measurement,Differential interference contrast microscopy",liquid,"To compare the effect of homopolymeric RNAs on nucleocapsid phase separation, we first performed turbidity measurements at condi tions where N phase separates alone. Importantly, the homopoly meric RNA stock solutions are all buffer exchanged via a spin desalting column and therefore are soluble in these conditions alone. Like torula yeast RNA, all homopolymeric RNAs enhanced the turbidity of solutions of N (Fig 6A), suggesting that particular sequences or RNA structures are not essential for interaction with N.",0
202,847,PMID: 33247108,RNAPS0000441,https://pubmed.ncbi.nlm.nih.gov/33247108,RNA + protein,-,-,polyU,-(800 kDa),-,poly RNA,-,"sp|P0DTC9|NCAP_SARS2 Nucleoprotein OS=Severe acute respiratory syndrome coronavirus 2 OX=2697049 GN=N PE=1 SV=1
MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHG
KEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAG
LPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGS
QASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQ
QQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKH
WPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAY
KTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA",SARS-CoV-2 Nucleoprotein;|non-structural protein (nsp) 12 of SARS-CoV-2,-,-,419aa(1-419);|42aa,P0DTC9;P0DTC9,-;-,-;-,"[1-40],[44-49],[174-174],[181-212],[233-247],[249-256],[365-391];|-","[175-208],[211-230],[236-249],[361-379];|-",In vitro,1 µM[polyU];|50 µM [N protein],-,"20 mM NaPi, pH 7.5",RT,-,-,"Differential interference contrast microscopy,Fluorescence microscopy",liquid,"Next,nsp12, nsp7, and nsp8 were reconstituted in a 1:1:2 stoichiometry together with a RNA template-product duplex, which carried fluorescein at the 5’ end29. The RdRp/RNA-complex was added to preformed NSARS-CoV-2/polyU droplets into which the RdRp/ RNA-complex was recruited",
203,848,PMID: 33247108,RNAPS0000442,https://pubmed.ncbi.nlm.nih.gov/33247108,RNA + protein,-,-,polyU,-(800 kDa),-,poly RNA,-,"sp|P0DTC9|NCAP_SARS2 Nucleoprotein OS=Severe acute respiratory syndrome coronavirus 2 OX=2697049 GN=N PE=1 SV=1
MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHG
KEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAG
LPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGS
QASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQ
QQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKH
WPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAY
KTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA",SARS-CoV-2 Nucleoprotein,-,-,419aa(1-419),P0DTC9,-,-,"[1-40],[44-49],[174-174],[181-212],[233-247],[249-256],[365-391]","[175-208],[211-230],[236-249],[361-379]",In vitro,1 µM[polyU];|50 µM [N protein],50-200 mM NaCl,"20 mM NaPi, pH 7.5",RT,-,"other_molecular:5-20% 1,6-hexanediol",Fluorescence microscopy,"liquid, solute","NSARS-CoV-2/polyU droplets were robust against the presence of the aliphatic alcohol 1,6-hexanediol. In contrast, the addition of increasing amounts of NaCl dissolved the droplets, indicating an important role of electrostatic interactions for RNA induced LLPS of NSARS-CoV-2. Fluorescence microscopy of droplets formed by 50 µM NSARS-CoV-2 and 1 µM polyU in 20 mM NaPi, pH 7.5, at increasing concentrations of 1,6-hexanediol (a) or NaCl (b).",
204,849,PMID: 33279579,RNAPS0000443,https://pubmed.ncbi.nlm.nih.gov/33279579,RNA + protein,-,-,polyU,-,-,poly RNA,-,"sp|P10636-8|TAU_HUMAN Isoform Tau-F of Microtubule-associated protein tau OS=Homo sapiens OX=9606 GN=MAPT|residues=255-441
NVKSKIGSTENLKHQPGGGKVQIINKKLDLSNVQSKCGSKDNIKHV
PGGGSVQIVYKPVDLSKVTSKCGSLGNIHHKPGGGQVEVKSEKLDFKDRVQSKIGSLDNI
THVPGGGNKKIETHKLTFRENAKAKTDHGAEIVYKSPVVSGDTSPRHLSNVSSTGSIDMV
DSPQLATLADEVSASLAKQGL",MAPT,-,-,187aa(255-441),P10636,"DrLLPS,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-2853,http://db.phasep.pro/browse/","[257-264],[280-282],[284-286],[291-299],[340-350],[396-436]",-,In vitro,20 µM[2N4R];|40 µg/mL[polyU],5 mM NaCl,-,RT,10 min,"other_molecular:0 or 4 wt% 1,6-hexanediol",Transmission electron microscopy,liquid,"We prepared tau LLPS-ED in two ways: by mixing tau187 with  RNA by the complex coacervation mechanism, or by lowering the ionic strength of the solution  containing 2N4R (< 10 mM, referred to as low-salt droplets) that induces simple coacervation  (Figure 1D). When adding 4% 1,6-HD, neither form of tau LLPS-ED, tau-RNA droplets formed  by complex coacervation or tau low-salt droplets formed by simple coacervation, dissolved  (Figure 1D).",0
205,850,PMID: 33279579,RNAPS0000443,https://pubmed.ncbi.nlm.nih.gov/33279579,RNA + protein,-,-,polyU,-,-,poly RNA,-,"sp|P10636-8|TAU_HUMAN Isoform Tau-F of Microtubule-associated protein tau OS=Homo sapiens OX=9606 GN=MAPT|residues=255-441
NVKSKIGSTENLKHQPGGGKVQIINKKLDLSNVQSKCGSKDNIKHV
PGGGSVQIVYKPVDLSKVTSKCGSLGNIHHKPGGGQVEVKSEKLDFKDRVQSKIGSLDNI
THVPGGGNKKIETHKLTFRENAKAKTDHGAEIVYKSPVVSGDTSPRHLSNVSSTGSIDMV
DSPQLATLADEVSASLAKQGL",MAPT,-,-,187aa(255-441),P10636,"DrLLPS,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-2853,http://db.phasep.pro/browse/","[257-264],[280-282],[284-286],[291-299],[340-350],[396-436]",-,In vitro,100 µM[tau];|40 µg/mL[polyU],4.75M NaCl,-,RT,10 min,-,Transmission electron microscopy,liquid,"We prepared tau LLPS-ED in two ways: by mixing tau187 with  RNA by the complex coacervation mechanism, or by lowering the ionic strength of the solution  containing 2N4R (< 10 mM, referred to as low-salt droplets) that induces simple coacervation  (Figure 1D). When adding 4% 1,6-HD, neither form of tau LLPS-ED, tau-RNA droplets formed  by complex coacervation or tau low-salt droplets formed by simple coacervation, dissolved  (Figure 1D).",0
206,875,PMID: 33452693,RNAPS0000443,https://pubmed.ncbi.nlm.nih.gov/33452693,RNA + protein,-,-,polyU,-,-,poly RNA,-,"sp|P10636-8|TAU_HUMAN Isoform Tau-F of Microtubule-associated protein tau OS=Homo sapiens OX=9606 GN=MAPT|
MAEPRQEFEVMEDHAGTYGLGDRKDQGGYTMHQDQEGDTDAGLKESPLQTPTEDGSEEPG
SETSDAKSTPTAEDVTAPLVDEGAPGKQAAAQPHTEIPEGTTAEEAGIGDTPSLEDEAAG
HVTQARMVSKSKDGTGSDDKKAKGADGKTKIATPRGAAPPGQKGQANATRIPAKTPPAPK
TPPSSGEPPKSGDRSGYSSPGSPGTPGSRSRTPSLPTPPTREPKKVAVVRTPPKSPSSAK
SRLQTAPVPMPDLKNVKSKIGSTENLKHQPGGGKVQIINKKLDLSNVQSKCGSKDNIKHV
PGGGSVQIVYKPVDLSKVTSKCGSLGNIHHKPGGGQVEVKSEKLDFKDRVQSKIGSLDNI
THVPGGGNKKIETHKLTFRENAKAKTDHGAEIVYKSPVVSGDTSPRHLSNVSSTGSIDMV
DSPQLATLADEVSASLAKQGL",MAPT,-,-,441aa(1-441),P10636,"DrLLPS,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-2853,http://db.phasep.pro/browse/","[125-375],[395-441]","[216-226],[323-340],[380-403]",In vitro,60nM[polyU];|60µM[tau],50 mM KCl ,"50 mM HEPES pH 7.4, 1 mM DTT",RT,immediately or 20 - 30 min,other_molecular:2.5% dextran,"Differential interference contrast microscopy,FRAP",liquid,"We therefore formed droplets by mixing tau (50 μM) with polyU RNA (60 nM). To increase the stabil ity of the droplets, we additionally added 2.5% dextranWe then added 10 μM of aSyn to the preformed tau droplets such that the tau concentration was fivefold higher when compared to aSyn. aSyn alone did not form droplets (Figure S1). Fluorescence microscopy showed that aSyn concentrates inside the tau droplets independent of the presence of RNA",0
207,876,PMID: 33452693,RNAPS0000455,https://pubmed.ncbi.nlm.nih.gov/33452693,RNA + proteins,-,-,polyU,-,-,poly RNA,-,"sp|P10636|TAU_HUMAN Microtubule-associated protein tau OS=Homo sapiens OX=9606 GN=MAPT PE=1 SV=5
MAEPRQEFEVMEDHAGTYGLGDRKDQGGYTMHQDQEGDTDAGLKESPLQTPTEDGSEEPG
SETSDAKSTPTAEDVTAPLVDEGAPGKQAAAQPHTEIPEGTTAEEAGIGDTPSLEDEAAG
HVTQEPESGKVVQEGFLREPGPPGLSHQLMSGMPGAPLLPEGPREATRQPSGTGPEDTEG
GRHAPELLKHQLLGDLHQEGPPLKGAGGKERPGSKEEVDEDRDVDESSPQDSPPSKASPA
QDGRPPQTAAREATSIPGFPAEGAIPLPVDFLSKVSTEIPASEPDGPSVGRAKGQDAPLE
FTFHVEITPNVQKEQAHSEEHLGRAAFPGAPGEGPEARGPSLGEDTKEADLPEPSEKQPA
AAPRGKPVSRVPQLKARMVSKSKDGTGSDDKKAKTSTRSSAKTLKNRPCLSPKHPTPGSS
DPLIQPSSPAVCPEPPSSPKYVSSVTSRTGSSGAKEMKLKGADGKTKIATPRGAAPPGQK
GQANATRIPAKTPPAPKTPPSSGEPPKSGDRSGYSSPGSPGTPGSRSRTPSLPTPPTREP
KKVAVVRTPPKSPSSAKSRLQTAPVPMPDLKNVKSKIGSTENLKHQPGGGKVQIINKKLD
LSNVQSKCGSKDNIKHVPGGGSVQIVYKPVDLSKVTSKCGSLGNIHHKPGGGQVEVKSEK
LDFKDRVQSKIGSLDNITHVPGGGNKKIETHKLTFRENAKAKTDHGAEIVYKSPVVSGDT
SPRHLSNVSSTGSIDMVDSPQLATLADEVSASLAKQGL;
sp|P37840|SYUA_HUMAN Alpha-synuclein OS=Homo sapiens OX=9606 GN=SNCA PE=1 SV=1|residues=1-107
MDVFMKGLSKAKEGVVAAAEKTKQGVAEAAGKTKEGVLYVGSKTKEGVVHGVATVAEKTK
EQVTNVGGAVVTGVTAVAQKTVEGAGSIAAATGFVKKDQLGKNEEGA",MAPT;|SNCA,-;|△C,-;|-,758aa(1-758);|107aa(1-107),P10636;P37840,"DrLLPS,PhaSepDB;PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-2853,http://db.phasep.pro/browse/;http://db.phasep.pro/browse/","MAPT:[125-375],[395-460],[528-534],[542-547],[552-560],[720-725];|SNCA:[1-140]","[216-226],[323-340],[380-403],[442-453],[489-540];|[10-23],[63-78]",In vitro,60nM[polyU];|50µM[MAPT];|10 µM[SNCA ΔC],50 mM KCl ,"50 mM HEPES pH 7.4, 1 mM DTT",RT,immediately or 20 - 30 min,other_molecular:2.5% dextran,"Differential interference contrast microscopy,FRAP",liquid,"We therefore formed droplets by mixing tau (50 μM) with polyU RNA (60 nM). To increase the stabil ity of the droplets, we additionally added 2.5% dextranWe then added 10 μM of aSyn to the preformed tau droplets such that the tau concentration was fivefold higher when compared to aSyn. aSyn alone did not form droplets (Figure S1). Fluorescence microscopy showed that aSyn concentrates inside the tau droplets independent of the presence of RNA",0
208,877,PMID: 33452693,RNAPS0000455,https://pubmed.ncbi.nlm.nih.gov/33452693,RNA + proteins,-,-,polyU,-,-,poly RNA,-,"sp|P10636|TAU_HUMAN Microtubule-associated protein tau OS=Homo sapiens OX=9606 GN=MAPT PE=1 SV=5
MAEPRQEFEVMEDHAGTYGLGDRKDQGGYTMHQDQEGDTDAGLKESPLQTPTEDGSEEPG
SETSDAKSTPTAEDVTAPLVDEGAPGKQAAAQPHTEIPEGTTAEEAGIGDTPSLEDEAAG
HVTQEPESGKVVQEGFLREPGPPGLSHQLMSGMPGAPLLPEGPREATRQPSGTGPEDTEG
GRHAPELLKHQLLGDLHQEGPPLKGAGGKERPGSKEEVDEDRDVDESSPQDSPPSKASPA
QDGRPPQTAAREATSIPGFPAEGAIPLPVDFLSKVSTEIPASEPDGPSVGRAKGQDAPLE
FTFHVEITPNVQKEQAHSEEHLGRAAFPGAPGEGPEARGPSLGEDTKEADLPEPSEKQPA
AAPRGKPVSRVPQLKARMVSKSKDGTGSDDKKAKTSTRSSAKTLKNRPCLSPKHPTPGSS
DPLIQPSSPAVCPEPPSSPKYVSSVTSRTGSSGAKEMKLKGADGKTKIATPRGAAPPGQK
GQANATRIPAKTPPAPKTPPSSGEPPKSGDRSGYSSPGSPGTPGSRSRTPSLPTPPTREP
KKVAVVRTPPKSPSSAKSRLQTAPVPMPDLKNVKSKIGSTENLKHQPGGGKVQIINKKLD
LSNVQSKCGSKDNIKHVPGGGSVQIVYKPVDLSKVTSKCGSLGNIHHKPGGGQVEVKSEK
LDFKDRVQSKIGSLDNITHVPGGGNKKIETHKLTFRENAKAKTDHGAEIVYKSPVVSGDT
SPRHLSNVSSTGSIDMVDSPQLATLADEVSASLAKQGL;
sp|P37840|SYUA_HUMAN Alpha-synuclein OS=Homo sapiens OX=9606 GN=SNCA PE=1 SV=1
MDVFMKGLSKAKEGVVAAAEKTKQGVAEAAGKTKEGVLYVGSKTKEGVVHGVATVAEKTK
EQVTNVGGAVVTGVTAVAQKTVEGAGSIAAATGFVKKDQLGKNEEGAPQEGILEDMPVDP
DNEAYEMPSEEGYQDYEPEA",MAPT;|SNCA,-;|-,-;|-,758aa(1-758);|140aa,P10636;P37840,"DrLLPS,PhaSepDB;PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-2853,http://db.phasep.pro/browse/;http://db.phasep.pro/browse/","MAPT:[125-375],[395-460],[528-534],[542-547],[552-560],[720-725];|SNCA:[1-140]","[216-226],[323-340],[380-403],[442-453],[489-540];|[10-23],[63-78]",In vitro,60nM[polyU];|50µM[MAPT];|10 µM[SNCA ],50 mM KCl ,"50 mM HEPES pH 7.4, 1 mM DTT",RT,immediately or 20 - 30 min,other_molecular:2.5% dextran,"Differential interference contrast microscopy,FRAP",liquid,"We therefore formed droplets by mixing tau (50 μM) with polyU RNA (60 nM). To increase the stabil ity of the droplets, we additionally added 2.5% dextranWe then added 10 μM of aSyn to the preformed tau droplets such that the tau concentration was fivefold higher when compared to aSyn. aSyn alone did not form droplets (Figure S1). Fluorescence microscopy showed that aSyn concentrates inside the tau droplets independent of the presence of RNA",0
209,878,PMID: 33477032,RNAPS0000456,https://pubmed.ncbi.nlm.nih.gov/33477032,RNA + protein,-,-,polyA(24),24nt,AAAAAAAAAAAAAAAAAAAAAAAA,poly RNA,-,"sp|P0DTC9|NCAP_SARS2 Nucleoprotein OS=Severe acute respiratory syndrome coronavirus 2 OX=2697049 GN=N PE=1 SV=1
MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHG
KEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAG
LPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGS
QASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQ
QQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKH
WPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAY
KTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA",SARS-CoV-2 Nucleoprotein,-,-,419aa(1-419),P0DTC9,-,-,"[1-40],[44-49],[174-174],[181-212],[233-247],[249-256],[365-391]","[175-208],[211-230],[236-249],[361-379]",In vitro,Molar Ratio of N protein and A24 from 1:0.5 to 1:1000,70 mM KCl,25 mM HEPES pH 7.5,RT,-,-,Turbidity measurement,liquid,"Indeed, here we found that A24 also biphasically modulated LLPS of the N protein as ATP but the ratios required to induce and dissolve droplets were much lower than those of ATP. Addition of A24 even at 1:0.5 resulted a turbidity value of 0.97 (Fig. 1C)",24
210,879,PMID: 33477032,RNAPS0000456,https://pubmed.ncbi.nlm.nih.gov/33477032,RNA + protein,-,-,polyA(24),24nt,AAAAAAAAAAAAAAAAAAAAAAAA,poly RNA,-,"sp|P0DTC9|NCAP_SARS2 Nucleoprotein OS=Severe acute respiratory syndrome coronavirus 2 OX=2697049 GN=N PE=1 SV=1
MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHG
KEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAG
LPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGS
QASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQ
QQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKH
WPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAY
KTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA",SARS-CoV-2 Nucleoprotein,-,-,419aa(1-419),P0DTC9,-,-,"[1-40],[44-49],[174-174],[181-212],[233-247],[249-256],[365-391]","[175-208],[211-230],[236-249],[361-379]",In vitro,10 µM[polyA];|20 µM[SARS-CoV-2 Nucleoprotein],70 mM KCl,25 mM HEPES pH 7.5,RT,-,other_molecular:0-8000 µM ATP,Differential interference contrast microscopy,-,"Indeed, here we found that A24 also biphasically  modulated LLPS of the N protein as ATP but the ratios required to  induce and dissolve droplets were much lower than those of ATP.  Addition of A24 even at 1:0.5 resulted a turbidity value of 0.97 as well as the formation of a large number of dynamic  droplets with the diameter of some even close to ~2 mm",24
211,896,PMID: 33558506,RNAPS0000465,https://pubmed.ncbi.nlm.nih.gov/33558506,RNA + protein,-,-,polyrU(40),40nt,UUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUU,poly RNA,-,"sp|P35637|FUS_HUMAN RNA-binding protein FUS OS=Homo sapiens OX=9606 GN=FUS PE=1 SV=1|residues=471-510
DRRGGRGGYDRGGYRGRGGDRGGFRGGRGGGDRGGFGPGK",FUS,RGG3,-,40aa(471-510),P35637,"PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/P35637,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-1390,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0002,http://db.phasep.pro/browse/","[1-507],[508-512]","[17-104],[106-261],[371-425],[450-507]",In vitro,0.2 mg/ml µM[GLS1];|0.2 µM [GIRGL];|1 mg/ml µM [FUS],150 mM NaCl,"25 mM Tris-HCl (pH = 7.5), 20 mM DTT",RT,-,-,Confocal fluorescence microscopy,liquid,"MD simulations similar to those in Fig. 1d but now including π-rich FUSPLP as a client (Table S2) revealed enhanced surface recruitment of PLP chains into RRP-RNA droplets only at low-RNA conditions(Fig. 1f, Fig. S9), thereby lending support to this idea. To test this experimentally, we utilized PLPs from two different RNPs, EWS and FUS, and quantified their partitioning in FUSRGG3-poly(rU) condensates.",40
212,897,PMID: 33558506,RNAPS0000465,https://pubmed.ncbi.nlm.nih.gov/33558506,RNA + protein,-,-,polyrU(40),40nt,UUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUU,poly RNA,-,"sp|P35637|FUS_HUMAN RNA-binding protein FUS OS=Homo sapiens OX=9606 GN=FUS PE=1 SV=1
MASNDYTQQATQSYGAYPTQPGQGYSQQSSQPYGQQSYSGYSQSTDTSGYGQSSYSSYGQ
SQNTGYGTQSTPQGYGSTGGYGSSQSSQSSYGQQSSYPGYGQQPAPSSTSGSYGSSSQSS
SYGQPQSGSYSQQPSYGGQQQSYGQQQSYNPPQGYGQQNQYNSSSGGGGGGGGGGNYGQD
QSSMSSGGGSGGGYGNQDQSGGGGSGGYGQQDRGGRGRGGSGGGGGGGGGGYNRSSGGYE
PRGRGGGRGGRGGMGGSDRGGFNKFGGPRDQGSRHDSEQDNSDNNTIFVQGLGENVTIES
VADYFKQIGIIKTNKKTGQPMINLYTDRETGKLKGEATVSFDDPPSAKAAIDWFDGKEFS
GNPIKVSFATRRADFNRGGGNGRGGRGRGGPMGRGGYGGGGSGGGGRGGFPSGGGGGGGQ
QRAGDWKCPNPTCENMNFSWRNECNQCKAPKPDGPGGGPGGSHMGGNYGDDRRGGRGGYD
RGGYRGRGGDRGGFRGGRGGGDRGGFGPGKMDSRGEHRQDRRERPY",FUS,-,-,526aa(1-526),P35637,"PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/P35637,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-1390,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0002,http://db.phasep.pro/browse/","[1-507],[508-512]","[17-104],[106-261],[371-425],[450-507]",In vitro,2.5 mg/ml µM[GLS1];|0.2 µM [GIRGL];|1 mg/ml µM [FUS],150 mM NaCl,"25 mM Tris-HCl (pH = 7.5), 20 mM DTT",RT,-,-,Confocal fluorescence microscopy,liquid,"MD simulations similar to those in Fig. 1d but now including π-rich FUSPLP as a client (Table S2) revealed enhanced surface recruitment of PLP chains into RRP-RNA droplets only at low-RNA conditions(Fig. 1f, Fig. S9), thereby lending support to this idea. To test this experimentally, we utilized PLPs from two different RNPs, EWS and FUS, and quantified their partitioning in FUSRGG3-poly(rU) condensates.",40
213,898,PMID: 33597515,RNAPS0000466,https://pubmed.ncbi.nlm.nih.gov/33597515,RNA + protein,-,-,polyU,-,-,poly RNA,-,"sp|P35637|FUS_HUMAN RNA-binding protein FUS OS=Homo sapiens OX=9606 GN=FUS PE=1 SV=1
MASNDYTQQATQSYGAYPTQPGQGYSQQSSQPYGQQSYSGYSQSTDTSGYGQSSYSSYGQ
SQNTGYGTQSTPQGYGSTGGYGSSQSSQSSYGQQSSYPGYGQQPAPSSTSGSYGSSSQSS
SYGQPQSGSYSQQPSYGGQQQSYGQQQSYNPPQGYGQQNQYNSSSGGGGGGGGGGNYGQD
QSSMSSGGGSGGGYGNQDQSGGGGSGGYGQQDRGGRGRGGSGGGGGGGGGGYNRSSGGYE
PRGRGGGRGGRGGMGGSDRGGFNKFGGPRDQGSRHDSEQDNSDNNTIFVQGLGENVTIES
VADYFKQIGIIKTNKKTGQPMINLYTDRETGKLKGEATVSFDDPPSAKAAIDWFDGKEFS
GNPIKVSFATRRADFNRGGGNGRGGRGRGGPMGRGGYGGGGSGGGGRGGFPSGGGGGGGQ
QRAGDWKCPNPTCENMNFSWRNECNQCKAPKPDGPGGGPGGSHMGGNYGDDRRGGRGGYD
RGGYRGRGGDRGGFRGGRGGGDRGGFGPGKMDSRGEHRQDRRERPY",FUS,-,-,526aa(1-526),P35637,"PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/P35637,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-1390,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0002,http://db.phasep.pro/browse/","[1-507],[508-512]","[17-104],[106-261],[371-425],[450-507]",In vitro,1.25 mg/mL [PolyU];|4.5 µM [FUS],2.7 M KCl,50 mM Tris-HCl (pH 7.2) ,RT,-,"other_molecular:10% 1,6-hexanediol,12.5 mM ATP",Fluorescence microscopy,"liquid, solute","To test this hypothesis, we probed the ability of pre-formed FUS condensates to dissociate when exposed to a range of additional components acting as phase separation disruptors, as shown in Fig. 3a. We selected a representative set of compounds with the ability to modulate both electrostatic interactions, such as poly-uridine (PolyU) RNA and ATP, both highly negatively charged molecules previously described to disrupt phase separation20,64,65, as well as 1,6-hexanediol, an aliphatic alcohol known to disrupt weak protein–protein hydrophobic interactions and selectively dissolve liquid condensates but not solid ones70. At low-salt concentrations, PolyU RNA, ATP, and 1,6-hexanediol were all able to dissolve FUS condensates, confirming that both hydrophobic and electrostatic interactions contribute to the stability of FUS condensates in the low-salt regime. At high-salt conditions, 1,6-hexanediol was the only disruptor that could dissolve FUS condensates, while the addition of PolyU RNA and ATP did not show any effects. These observations, summarized in Fig. 3b, suggest that reentrant high-salt phase separation of proteins is indeed primarily a hydrophobically driven process where electrostatics are screened out.",0
214,899,PMID: 33597515,RNAPS0000466,https://pubmed.ncbi.nlm.nih.gov/33597515,RNA + protein,-,-,polyU,-,-,poly RNA,-,"sp|P35637|FUS_HUMAN RNA-binding protein FUS OS=Homo sapiens OX=9606 GN=FUS PE=1 SV=1
MASNDYTQQATQSYGAYPTQPGQGYSQQSSQPYGQQSYSGYSQSTDTSGYGQSSYSSYGQ
SQNTGYGTQSTPQGYGSTGGYGSSQSSQSSYGQQSSYPGYGQQPAPSSTSGSYGSSSQSS
SYGQPQSGSYSQQPSYGGQQQSYGQQQSYNPPQGYGQQNQYNSSSGGGGGGGGGGNYGQD
QSSMSSGGGSGGGYGNQDQSGGGGSGGYGQQDRGGRGRGGSGGGGGGGGGGYNRSSGGYE
PRGRGGGRGGRGGMGGSDRGGFNKFGGPRDQGSRHDSEQDNSDNNTIFVQGLGENVTIES
VADYFKQIGIIKTNKKTGQPMINLYTDRETGKLKGEATVSFDDPPSAKAAIDWFDGKEFS
GNPIKVSFATRRADFNRGGGNGRGGRGRGGPMGRGGYGGGGSGGGGRGGFPSGGGGGGGQ
QRAGDWKCPNPTCENMNFSWRNECNQCKAPKPDGPGGGPGGSHMGGNYGDDRRGGRGGYD
RGGYRGRGGDRGGFRGGRGGGDRGGFGPGKMDSRGEHRQDRRERPY",FUS,-,-,526aa(1-526),P35637,"PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/P35637,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-1390,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0002,http://db.phasep.pro/browse/","[1-507],[508-512]","[17-104],[106-261],[371-425],[450-507]",In vitro,1.25 mg/mL [PolyU];|4.5 µM [FUS],50 mM KCl,50 mM Tris-HCl (pH 7.2) ,RT,-,"other_molecular:10% 1,6-hexanediol,12.5 mM ATP",Fluorescence microscopy,solute,"To test this hypothesis, we probed the ability of pre-formed FUS condensates to dissociate when exposed to a range of additional components acting as phase separation disruptors, as shown in Fig. 3a. We selected a representative set of compounds with the ability to modulate both electrostatic interactions, such as poly-uridine (PolyU) RNA and ATP, both highly negatively charged molecules previously described to disrupt phase separation20,64,65, as well as 1,6-hexanediol, an aliphatic alcohol known to disrupt weak protein–protein hydrophobic interactions and selectively dissolve liquid condensates but not solid ones70. At low-salt concentrations, PolyU RNA, ATP, and 1,6-hexanediol were all able to dissolve FUS condensates, confirming that both hydrophobic and electrostatic interactions contribute to the stability of FUS condensates in the low-salt regime. At high-salt conditions, 1,6-hexanediol was the only disruptor that could dissolve FUS condensates, while the addition of PolyU RNA and ATP did not show any effects. These observations, summarized in Fig. 3b, suggest that reentrant high-salt phase separation of proteins is indeed primarily a hydrophobically driven process where electrostatics are screened out.",0
215,906,PMID: 33649309,RNAPS0000473,https://pubmed.ncbi.nlm.nih.gov/33649309,RNA + protein,-,-,polyA,2100–10000nt,-,poly RNA,-,"sp|Q6ZN16|M3K15_HUMAN Mitogen-activated protein kinase kinase kinase 15 OS=Homo sapiens OX=9606 GN=MAP3K15 PE=1 SV=2
MESGGGNAPAGALGAASESPQCPPPPGVEGAAGPAEPDGAAEGAAGGSGEGESGGGPRRA
LRAVYVRSESSQGGAAGGPEAGARQCLLRACEAEGAHLTSVPFGELDFGETAVLDAFYDA
DVAVVDMSDVSRQPSLFYHLGVRESFDMANNVILYHDTDADTALSLKDMVTQKNTASSGN
YYFIPYIVTPCADYFCCESDAQRRASEYMQPNWDNILGPLCMPLVDRFISLLKDIHVTSC
VYYKETLLNDIRKAREKYQGEELAKELARIKLRMDNTEVLTSDIIINLLLSYRDIQDYDA
MVKLVETLEMLPTCDLADQHNIKFHYAFALNRRNSTGDREKALQIMLQVLQSCDHPGPDM
FCLCGRIYKDIFLDSDCKDDTSRDSAIEWYRKGFELQSSLYSGINLAVLLIVAGQQFETS
LELRKIGVRLNSLLGRKGSLEKMNNYWDVGQFFSVSMLAHDVGKAVQAAERLFKLKPPVW
YLRSLVQNLLLIRRFKKTIIEHSPRQERLNFWLDIIFEATNEVTNGLRFPVLVIEPTKVY
QPSYVSINNEAEERTVSLWHVSPTEMKQMHEWNFTASSIKGISLSKFDERCCFLYVHDNS
DDFQIYFSTEEQCSRFFSLVKEMITNTAGSTVELEGETDGDTLEYEYDHDANGERVVLGK
GTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKYLKHRNIVQYLGSVSENG
YIKIFMEQVPGGSLSALLRSKWGPMKEPTIKFYTKQILEGLKYLHENQIVHRDIKGDNVL
VNTYSGVVKISDFGTSKRLAGVNPCTETFTGTLQYMAPEIIDQGPRGYGAPADIWSLGCT
IIEMATSKPPFHELGEPQAAMFKVGMFKIHPEIPEALSAEARAFILSCFEPDPHKRATTA
ELLREGFLRQVNKGKKNRIAFKPSEGPRGVVLALPTQGEPMATSSSEHGSVSPDSDAQPD
ALFERTRAPRHHLGHLLSVPDESSALEDRGLASSPEDRDQGLFLLRKDSERRAILYKILW
EEQNQVASNLQECVAQSSEELHLSVGHIKQIIGILRDFIRSPEHRVMATTISKLKVDLDF
DSSSISQIHLVLFGFQDAVNKILRNHLIRPHWMFAMDNIIRRAVQAAVTILIPELRAHFE
PTCETEGVDKDMDEAEEGYPPATGPGQEAQPHQQHLSLQLGELRQETNRLLEHLVEKERE
YQNLLRQTLEQKTQELYHLQLKLKSNCITENPAGPYGQRTDKELIDWLRLQGADAKTIEK
IVEEGYTLSDILNEITKEDLRYLRLRGGLLCRLWSAVSQYRRAQEASETKDKA",ASK3,-,-,1313aa(1-1313),Q6ZN16,-,-,"[1-58],[939-958]","[4-16],[23-57],[73-83],[112-131],[1280-1293]",In vitro,2.5 µM[polyA],150 mM NaCl,"20 mM Tris (pH 7.5), 1 mM DTT",0˚C,15 min,crowding agent:20% PEG,Electron microscopy,solute,"Of note, we found that poly(A) RNA also inhibits the formation of solid-like ASK3 condensates in vitro, suggesting that the common physicochemical property between PAR and RNA is important for the liquidity maintenance of ASK3 condensates.",10000
216,914,PMID: 33782395,RNAPS0000479,https://pubmed.ncbi.nlm.nih.gov/33782395,RNA + protein,-,-,polyrU,200–250nt,-,poly RNA,-,"sp|P0DTC9|NCAP_SARS2 Nucleoprotein OS=Severe acute respiratory syndrome coronavirus 2 OX=2697049 GN=N PE=1 SV=1
MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHG
KEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAG
LPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGS
QASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQ
QQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKH
WPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAY
KTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA",SARS-CoV-2 Nucleoprotein,-,-,419aa(1-419),P0DTC9,-,-,"[1-40],[44-49],[174-174],[181-212],[233-247],[249-256],[365-391]","[175-208],[211-230],[236-249],[361-379]",In vitro,10-1000 µM [poly(rU)];|0.5-20 µM [N protein],0 mM NaCl,"50 mM Tris, pH 7.5",RT,-,-,Turbidity measurement,"solute, liquid","In line with this expectation, we observed robust droplet formation with homopolymeric RNA (Fig. 5A, B) under aqueous buffer conditions, both at 50 mM Tris and at a higher salt concentration of 50 mM NaCl. Turbidity assays at different concentrations of protein and poly(rU) (200–250 nucleotides) demonstrate the classical re-entrant phase behavior expected for a system undergoing heterotypic interaction",250
217,915,PMID: 33782395,RNAPS0000479,https://pubmed.ncbi.nlm.nih.gov/33782395,RNA + protein,-,-,polyrU,200–250nt,-,poly RNA,-,"sp|P0DTC9|NCAP_SARS2 Nucleoprotein OS=Severe acute respiratory syndrome coronavirus 2 OX=2697049 GN=N PE=1 SV=1
MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHG
KEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAG
LPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGS
QASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQ
QQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKH
WPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAY
KTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA",SARS-CoV-2 Nucleoprotein,-,-,419aa(1-419),P0DTC9,-,-,"[1-40],[44-49],[174-174],[181-212],[233-247],[249-256],[365-391]","[175-208],[211-230],[236-249],[361-379]",In vitro,10-1000 µM [poly(rU)];|0.5-20 µM [N protein],50 mM NaCl,"50 mM Tris, pH 7.5",RT,-,-,Turbidity measurement,"solute, liquid","In line with this expectation, we observed robust droplet formation with homopolymeric RNA (Fig. 5A, B) under aqueous buffer conditions, both at 50 mM Tris and at a higher salt concentration of 50 mM NaCl. Turbidity assays at different concentrations of protein and poly(rU) (200–250 nucleotides) demonstrate the classical re-entrant phase behavior expected for a system undergoing heterotypic interaction",250
218,959,PMID: 31437398,RNAPS0000523,https://pubmed.ncbi.nlm.nih.gov/31437398,RNA + protein,-,-,polyA,-(100-500 kDa),-,poly RNA,Homo sapiens,"sp|P35637|FUS_HUMAN RNA-binding protein FUS OS=Homo sapiens OX=9606 GN=FUS PE=1 SV=1|residue=211-421,454-526
DRGGRGRGGSGGGGGGGGGGYNRSSGGYEPRGRGGGRGGRGGMGGSDRGGFNKFGGPRDQGSRHDSEQDNSDNNTIFVQGLGENVTIESVADYFKQIGIIKTNKKTGQPMINLYT
DRETGKLKGEATVSFDDPPSAKAAIDWFDGKEFSGNPIKVSFATRRADFNRGGGNGRGGRGRGGPMGRGGYGGGGSGGGGRGGFPSGGGGGGGQQ
GPGGGPGGSHMGGNYGDDRRGGRGGYDRGGYRGRGGDRGGFRGGRGGGDRGGFGPGKMDSRGEHRQDRRERPY",FUS,-, ,"284aa(211-421,454-526)",P35637,"PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/P35637,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-1390,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0002,http://db.phasep.pro/browse/","[211-421],[454-507],[508-512]","[211-261],[371-421],[454-507]",In vitro,-,-,"25 mM Tris-HCl pH 7.5,20 mM DTT",RT,≤ 2.4 s,-,"FRAP,Trap-induced fusion",liquid,"In presence of poly(A) RNA, FUSR/G-rich LCD condensates showed almost an order of magnitude slower fusion kinetics than condensates formed by poly(U) RNA. Simultaneously, FRAP measurements revealed ~ 2-fold decrease in protein diffusion rate within poly(A)-FUSR/G-rich LCD condensates as compared to the poly(U)-FUSR/G-rich LCD droplets.",
219,960,PMID: 31437398,RNAPS0000524,https://pubmed.ncbi.nlm.nih.gov/31437398,RNA + protein,-,-,polyU,-(600-1000 kDa),-,poly RNA,Homo sapiens,"sp|P35637|FUS_HUMAN RNA-binding protein FUS OS=Homo sapiens OX=9606 GN=FUS PE=1 SV=1|residue=472-505
RRGGRGGYD RGGYRGRGGD RGGFRGGRGGGDRGG",FUS,-, ,34aa(472-505),P35637,"PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/P35637,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-1390,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0002,http://db.phasep.pro/browse/",[472-505],[472-505],In vitro,-,-,"25 mM Tris-HCl pH 7.5,20 mM DTT",RT,≤ 1.2 s,-,"FRAP,Trap-induced fusion",liquid,"In presence of poly(A) RNA, FUSR/G-rich LCD condensates showed almost an order of magnitude slower fusion kinetics than condensates formed by poly(U) RNA. Simultaneously, FRAP measurements revealed ~ 2-fold decrease in protein diffusion rate within poly(A)-FUSR/G-rich LCD condensates as compared to the poly(U)-FUSR/G-rich LCD droplets.",
220,961,PMID: 31437398,RNAPS0000523,https://pubmed.ncbi.nlm.nih.gov/31437398,RNA + protein,-,-,polyA,-(100-500 kDa),-,poly RNA,Homo sapiens,"sp|P35637|FUS_HUMAN RNA-binding protein FUS OS=Homo sapiens OX=9606 GN=FUS PE=1 SV=1|residue=211-421,454-526
DRGGRGRGGSGGGGGGGGGGYNRSSGGYEPRGRGGGRGGRGGMGGSDRGGFNKFGGPRDQGSRHDSEQDNSDNNTIFVQGLGENVTIESVADYFKQIGIIKTNKKTGQPMINLYT
DRETGKLKGEATVSFDDPPSAKAAIDWFDGKEFSGNPIKVSFATRRADFNRGGGNGRGGRGRGGPMGRGGYGGGGSGGGGRGGFPSGGGGGGGQQ
GPGGGPGGSHMGGNYGDDRRGGRGGYDRGGYRGRGGDRGGFRGGRGGGDRGGFGPGKMDSRGEHRQDRRERPY",FUS,-, ,"284aa(211-421,454-526)",P35637,"PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/P35637,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-1390,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0002,http://db.phasep.pro/browse/","[211-421],[454-507],[508-512]","[211-261],[371-421],[454-507]",In vitro,-,-,"25 mM Tris-HCl pH 7.5,20 mM DTT",RT,≤ 11.4 s,-,"FRAP,Trap-induced fusion",liquid,"In presence of poly(A) RNA, FUSR/G-rich LCD condensates showed almost an order of magnitude slower fusion kinetics than condensates formed by poly(U) RNA. Simultaneously, FRAP measurements revealed ~ 2-fold decrease in protein diffusion rate within poly(A)-FUSR/G-rich LCD condensates as compared to the poly(U)-FUSR/G-rich LCD droplets.",
221,962,PMID: 31437398,RNAPS0000524,https://pubmed.ncbi.nlm.nih.gov/31437398,RNA + protein,-,-,polyU,-(600-1000 kDa),-,poly RNA,Homo sapiens,"sp|P35637|FUS_HUMAN RNA-binding protein FUS OS=Homo sapiens OX=9606 GN=FUS PE=1 SV=1|residue=472-505
RRGGRGGYD RGGYRGRGGD RGGFRGGRGGGDRGG",FUS,-, ,34aa(472-505),P35637,"PhaSePro,DrLLPS,LLPSDB,PhaSepDB","https://phasepro.elte.hu/entry/P35637,http://llps.biocuckoo.cn/view.php?id=LLPS-Hos-1390,http://bio-comp.org.cn/llpsdb/protein.php?protein=p0002,http://db.phasep.pro/browse/",[472-505],[472-505],In vitro,-,-,"25 mM Tris-HCl pH 7.5,20 mM DTT",RT,≤ 1.8 s,-,"FRAP,Trap-induced fusion",liquid,"In presence of poly(A) RNA, FUSR/G-rich LCD condensates showed almost an order of magnitude slower fusion kinetics than condensates formed by poly(U) RNA. Simultaneously, FRAP measurements revealed ~ 2-fold decrease in protein diffusion rate within poly(A)-FUSR/G-rich LCD condensates as compared to the poly(U)-FUSR/G-rich LCD droplets.",
222,1060,PMID: 33895773,RNAPS0000606,https://pubmed.ncbi.nlm.nih.gov/33895773,Undefined,-,-,polyU,-,-,poly RNA,-,"sp|P0DTC9|NCAP_SARS2 Nucleoprotein OS=Severe acute respiratory syndrome coronavirus 2 OX=2697049 GN=N PE=1 SV=1
MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHG
KEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAG
LPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGS
QASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQ
QQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKH
WPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAY
KTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA",SARS-CoV-2 Nucleoprotein,-,-,419aa(1-419),P0DTC9,-,-,"[1-40],[44-49],[174-174],[181-212],[233-247],[249-256],[365-391]","[175-208],[211-230],[236-249],[361-379]",In vivo,;|1µg/mL[polyU],-,-,37˚C,-,cell:HeLa cells,FRAP,liquid,"To investigate whether SARS-CoV-2 N protein forms liquid-like droplets in cells, we constructed HeLa and Huh7 cells stably expressing EGFP-labeled N protein, and found that N protein formed foci after poly(I:C) or polyU treatment through live-cell image (Fig. 3c)",0
223,1061,PMID: 33895773,RNAPS0000607,https://pubmed.ncbi.nlm.nih.gov/33895773,RNA + protein,-,-,polyU,-,-,poly RNA,-,"sp|P0DTC9|NCAP_SARS2 Nucleoprotein OS=Severe acute respiratory syndrome coronavirus 2 OX=2697049 GN=N PE=1 SV=1
MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHG
KEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAG
LPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGS
QASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQ
QQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKH
WPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAY
KTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA",SARS-CoV-2 Nucleoprotein,-,-,419aa(1-419),P0DTC9,-,-,"[1-40],[44-49],[174-174],[181-212],[233-247],[249-256],[365-391]","[175-208],[211-230],[236-249],[361-379]",In vitro,10µM[mCherry-N protein];|10 ng/mL[polyU],-,-,37˚C,20 min,-,FRAP,liquid,We further found that recombinant mCherry-fusion SARS-CoV-2 N protein formed micrometer-sized liquid droplets within 1 min when blended with poly(I:C) or polyU in vitro,0
224,1062,PMID: 33895773,RNAPS0000607,https://pubmed.ncbi.nlm.nih.gov/33895773,RNA + protein,-,-,polyU,-,-,poly RNA,-,"sp|P0DTC9|NCAP_SARS2 Nucleoprotein OS=Severe acute respiratory syndrome coronavirus 2 OX=2697049 GN=N PE=1 SV=1
MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHG
KEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAG
LPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGS
QASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQ
QQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKH
WPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAY
KTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA",SARS-CoV-2 Nucleoprotein,-,-,419aa(1-419),P0DTC9,-,-,"[1-40],[44-49],[174-174],[181-212],[233-247],[249-256],[365-391]","[175-208],[211-230],[236-249],[361-379]",In vitro,0.25-5µM[mCherry-N protein];|0-50 ng/mL[polyU],-,-,37˚C,-,-,FRAP,"solute, liquid","N protein was able to form liquid-like droplets at the concentration of 1μM with the presence of poly(I: C) or polyU over 5 ng/mL (Fig. 3f, g). Small liquid droplets tended to coalesce and formed larger droplets over time, together with larger equivalent diameter in vitro (Fig. 3h). ",0
225,1063,PMID: 33895773,RNAPS0000608,https://pubmed.ncbi.nlm.nih.gov/33895773,RNA + proteins,-,-,polyU,-,-,poly RNA,-,"sp|P0DTC9|NCAP_SARS2 Nucleoprotein OS=Severe acute respiratory syndrome coronavirus 2 OX=2697049 GN=N PE=1 SV=1
MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHG
KEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAG
LPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGS
QASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQ
QQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKH
WPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAY
KTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA;

sp|Q9VEZ5|IKKB_DROME Inhibitor of nuclear factor kappa-B kinase subunit beta OS=Drosophila melanogaster OX=7227 GN=IKKbeta PE=1 SV=2
MITVVFCFSDCHGGIQILGRMSSVNKIKLNENNKMHSFGNWERCRNLGEGGFGLVIHWRN
RTTGREIATKHIKEMGALSADQQVKLSERWNKELNWSRQFKNFPHIVAGVDIEDPDFLEY
LNGMFSAKLPVIVLEYCNGGDVRKRLQSPENANGLTEFEVRQILGALRKALHFLHSQCGI
CHRDLKPDNIVIQRGVDGKKIYKLTDFGLARGTPDQTMVQSVVGTRHYYAPEVVENGFYN
STVDLWSFGVIAYELVTGELPFIPHQTLKNIILNLIKKPAKCIAITEDPEDNTRFVNQFE
LPQTHHLSRPWAAQFTKWLASPLNSNYKERGQLAANNVPVVFADLDKILNMNVLTIFAVN
NCERLEYAVSAEMTMKDLIALIVLDTGMDEKELYFVLPTSHPHKTITPKSTPLQLYVEEW
SDTSKDSRKWTKRSNPPVMLYIFQVKKECDYKIPEPILSILSRKFIANKFKTKERWLQKR
VVLDMLYVLTKEQARYEMLVSGINERALSLEDEMMENSFIDSIDKQRIIISFAYDQLTSL
LKEAQAKIPSRQLISSAQWEKLNRNYNFIIQSAKSIRSFLEACLREAKDMVKTTNQLRKE
VCEKDLFDCARFYKKYLCNGAIISPSELNNDAEEFAKSRFKLYNEGEARHLPKSIDHMHY
LYFKTKESIPVLLQQFCDIKKEIFQINLQMLMSASSTPPPKLELSAAMDRLAISSGSPSS
DPFDSLRTINAIEEAERINNILVNEMKIDHY",SARS-CoV-2 Nucleoprotein;|IKKbeta,-;|-,-;|-,419aa(1-419);|751aa(1-751),P0DTC9;Q9VEZ5,-;-,-;-,"SARS-CoV-2 Nucleoprotein:[1-40],[44-49],[174-174],[181-212],[233-247],[249-256],[365-391];|-","[175-208],[211-230],[236-249],[361-379];|[714-725]",In vitro,10 µM[mCherry-N protein];|5µM[EGFP-TAK1];|10 ng/mL[polyU],-,-,37˚C,10 min,-,FRAP,liquid,"To find out whether LLPS of N protein recruits TAK1 and IKK complex to promote NF-κB cascade, we prepared recombinant EGFP-TAK1 and EGFP-IKKβ, and found that both TAK1 and IKKβ failed to form puncta with poly(I:C) or polyU alone, but they were shown to be recruited to the condensates of N protein in the presence of RNA in vitro ",0
226,1064,PMID: 33895773,RNAPS0000609,https://pubmed.ncbi.nlm.nih.gov/33895773,RNA + proteins,-,-,polyU,-,-,poly RNA,-,"sp|P0DTC9|NCAP_SARS2 Nucleoprotein OS=Severe acute respiratory syndrome coronavirus 2 OX=2697049 GN=N PE=1 SV=1
MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHG
KEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAG
LPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGS
QASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQ
QQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKH
WPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAY
KTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA;

sp|P49116|NR2C2_HUMAN Nuclear receptor subfamily 2 group C member 2 OS=Homo sapiens OX=9606 GN=NR2C2 PE=1 SV=1
MTSPSPRIQIISTDSAVASPQRIQIVTDQQTGQKIQIVTAVDASGSPKQQFILTSPDGAG
TGKVILASPETSSAKQLIFTTSDNLVPGRIQIVTDSASVERLLGKTDVQRPQVVEYCVVC
GDKASGRHYGAVSCEGCKGFFKRSVRKNLTYSCRSNQDCIINKHHRNRCQFCRLKKCLEM
GMKMESVQSERKPFDVQREKPSNCAASTEKIYIRKDLRSPLIATPTFVADKDGARQTGLL
DPGMLVNIQQPLIREDGTVLLATDSKAETSQGALGTLANVVTSLANLSESLNNGDTSEIQ
PEDQSASEITRAFDTLAKALNTTDSSSSPSLADGIDTSGGGSIHVISRDQSTPIIEVEGP
LLSDTHVTFKLTMPSPMPEYLNVHYICESASRLLFLSMHWARSIPAFQALGQDCNTSLVR
ACWNELFTLGLAQCAQVMSLSTILAAIVNHLQNSIQEDKLSGDRIKQVMEHIWKLQEFCN
SMAKLDIDGYEYAYLKAIVLFSPDHPGLTSTSQIEKFQEKAQMELQDYVQKTYSEDTYRL
ARILVRLPALRLMSSNITEELFFTGLIGNVSIDSIIPYILKMETAEYNGQITGASL",SARS-CoV-2 Nucleoprotein;|NR2C2,-;|-,-;|-,419aa(1-419);|596aa(1-596),P0DTC9;P49116,-;-,-;-,"SARS-CoV-2 Nucleoprotein:[1-40],[44-49],[174-174],[181-212],[233-247],[249-256],[365-391];|-","[175-208],[211-230],[236-249],[361-379];|-",In vitro,10 µM[mCherry-N protein];|5µM[EGFP-IKKβ];|10 ng/mL[polyU],-,-,37˚C,10 min,-,FRAP,liquid,"To find out whether LLPS of N protein recruits TAK1 and IKK complex to promote NF-κB cascade, we prepared recombinant EGFP-TAK1 and EGFP-IKKβ, and found that both TAK1 and IKKβ failed to form puncta with poly(I:C) or polyU alone, but they were shown to be recruited to the condensates of N protein in the presence of RNA in vitro ",0
227,1065,PMID: 33910901,RNAPS0000610,https://pubmed.ncbi.nlm.nih.gov/33910901,RNA + protein,-,-,polyU,-,-,poly RNA,-,"sp|Q94BV4|RH6_ARATH DEAD-box ATP-dependent RNA helicase 6 OS=Arabidopsis thaliana OX=3702 GN=RH6 PE=2 SV=2
MNNNNNNRGRFPPGIGAAGPGPDPNFQSRNPNPPQPQQYLQSRTPFPQQPQPQPPQYLQS
QSDAQQYVQRGYPQQIQQQQQLQQQQQQQQQQQEQQWSRRAQLPGDPSYIDEVEKTVQSE
AISDSNNEDWKATLKLPPRDNRYQTEDVTATKGNEFEDYFLKRDLLRGIYEKGFEKPSPI
QEESIPIALTGSDILARAKNGTGKTGAFCIPTLEKIDPENNVIQAVILVPTRELALQTSQ
VCKELSKYLKIEVMVTTGGTSLRDDIMRLYQPVHLLVGTPGRILDLAKKGVCVLKDCAML
VMDEADKLLSVEFQPSIEELIQFLPESRQILMFSATFPVTVKSFKDRYLKKPYIINLMDQ
LTLMGVTQYYAFVEERQKVHCLNTLFSKLQINQSIIFCNSVNRVELLAKKITELGYSCFY
IHAKMVQDHRNRVFHDFRNGACRNLVCTDLFTRGIDIQAVNVVINFDFPRTSESYLHRVG
RSGRFGHLGLAVNLVTYEDRFKMYQTEQELGTEIKPIPSLIDKAIYCQ",RH6,-,-,528aa(1-528),Q94BV4,DrLLPS,http://llps.biocuckoo.cn/view.php?id=LLPS-Art-0517,-,"[2-41],[45-56],[65-97]",In vitro,300ng/µL[polyU];|8µM[RH6],200 mM MgCl2,1 μl of Hepes-KOH (pH 6.6),-,-,other_moleculer:5mM[ATP];crowding agent:2 μl of 50% PEG8000,"Fluorescence 
microscopy ",liquid,"In contrast, RH12, RH6, and RH8 remained dispersed in the absence of RNA or ATP, indicating that these helicases at high concentrations can undergo phase separation in an RNA- and ATP-dependent manner in vitro.",0
228,1066,PMID: 33910901,RNAPS0000611,https://pubmed.ncbi.nlm.nih.gov/33910901,RNA + protein,-,-,polyU,-,-,poly RNA,-,"sp|Q8RXK6|RH8_ARATH DEAD-box ATP-dependent RNA helicase 8 OS=Arabidopsis thaliana OX=3702 GN=RH8 PE=2 SV=1
MNNRGRYPPGIGAGRGAFNPNPNYQSRSGYQQHPPPQYVQRGNYAQNHQQQFQQAPSQPH
QYQQQQQQQQQWLRRGQIPGGNSNGDAVVEVEKTVQSEVIDPNSEDWKARLKLPAPDTRY
RTEDVTATKGNEFEDYFLKRELLMGIYEKGFERPSPIQEESIPIALTGRDILARAKNGTG
KTAAFCIPVLEKIDQDNNVIQAVIIVPTRELALQTSQVCKELGKHLKIQVMVTTGGTSLK
DDIMRLYQPVHLLVGTPGRILDLTKKGVCVLKDCSVLVMDEADKLLSQEFQPSVEHLISF
LPESRQILMFSATFPVTVKDFKDRFLTNPYVINLMDELTLKGITQFYAFVEERQKIHCLN
TLFSKLQINQSIIFCNSVNRVELLAKKITELGYSCFYIHAKMLQDHRNRVFHDFRNGACR
NLVCTDLFTRGIDIQAVNVVINFDFPKNAETYLHRVGRSGRFGHLGLAVNLITYEDRFNL
YRIEQELGTEIKQIPPHIDQAIYCQ",RH8,-,-,505aa(1-505),Q8RXK6,"DrLLPS,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Art-1431,http://db.phasep.pro/browse/",-,[43-72],In vitro,300ng/µL[polyU];|8µM[RH8],200 mM MgCl2,1 μl of Hepes-KOH (pH 6.6),-,-,other_moleculer:5mM[ATP];crowding agent:2 μl of 50% PEG8000,"Fluorescence 
microscopy ",liquid,"In contrast, RH12, RH6, and RH8 remained dispersed in the absence of RNA or ATP, indicating that these helicases at high concentrations can undergo phase separation in an RNA- and ATP-dependent manner in vitro.",0
229,1067,PMID: 33910901,RNAPS0000612,https://pubmed.ncbi.nlm.nih.gov/33910901,RNA + protein,-,-,polyU,-,-,poly RNA,-,"sp|Q9M2E0|RH12_ARATH DEAD-box ATP-dependent RNA helicase 12 OS=Arabidopsis thaliana OX=3702 GN=RH12 PE=2 SV=1
MNTNRGRYPPGVGTGRGAPPNPDYHQSYRQQQPPQDQQYVQRGYSQNPQQMQLQQQHQQQ
QQQQQWSRRPQLPGNASNANEVVQQTTQPEASSDANGQDWKATLRLPPPDTRYQTADVTA
TKGNEFEDYFLKRDLLKGIYEKGFEKPSPIQEESIPIALTGSDILARAKNGTGKTGAFCI
PVLEKIDPNNNVIQAMILVPTRELALQTSQVCKELSKYLNIQVMVTTGGTSLRDDIMRLH
QPVHLLVGTPGRILDLTKKGVCVLKDCAMLVMDEADKLLSAEFQPSLEELIQFLPQNRQF
LMFSATFPVTVKAFKDRHLRKPYVINLMDQLTLMGVTQYYAFVEERQKVHCLNTLFSKLQ
INQSIIFCNSVNRVELLAKKITELGYSCFYIHAKMVQDHRNRVFHEFRNGACRNLVCTDL
FTRGIDIQAVNVVINFDFPRTSESYLHRVGRSGRFGHLGLAVNLVTYEDRFKMYQTEQEL
GTEIKPIPSNIDQAIYCQ",RH12,-,-,498aa(1-498),Q9M2E0,"DrLLPS,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Art-1808,http://db.phasep.pro/browse/",-,"[26-42],[46-66]",In vitro,300ng/µL[polyU];|8µM[RH12],200 mM MgCl2,1 μl of Hepes-KOH (pH 6.6),-,-,other_moleculer:5mM[ATP];crowding agent:2 μl of 50% PEG8000,"Fluorescence 
microscopy ",liquid,"In contrast, RH12, RH6, and RH8 remained dispersed in the absence of RNA or ATP, indicating that these helicases at high concentrations can undergo phase separation in an RNA- and ATP-dependent manner in vitro.",0
230,1068,PMID: 33910901,RNAPS0000610,https://pubmed.ncbi.nlm.nih.gov/33910901,RNA + protein,-,-,polyU,-,-,poly RNA,-,"sp|Q94BV4|RH6_ARATH DEAD-box ATP-dependent RNA helicase 6 OS=Arabidopsis thaliana OX=3702 GN=RH6 PE=2 SV=2
MNNNNNNRGRFPPGIGAAGPGPDPNFQSRNPNPPQPQQYLQSRTPFPQQPQPQPPQYLQS
QSDAQQYVQRGYPQQIQQQQQLQQQQQQQQQQQEQQWSRRAQLPGDPSYIDEVEKTVQSE
AISDSNNEDWKATLKLPPRDNRYQTEDVTATKGNEFEDYFLKRDLLRGIYEKGFEKPSPI
QEESIPIALTGSDILARAKNGTGKTGAFCIPTLEKIDPENNVIQAVILVPTRELALQTSQ
VCKELSKYLKIEVMVTTGGTSLRDDIMRLYQPVHLLVGTPGRILDLAKKGVCVLKDCAML
VMDEADKLLSVEFQPSIEELIQFLPESRQILMFSATFPVTVKSFKDRYLKKPYIINLMDQ
LTLMGVTQYYAFVEERQKVHCLNTLFSKLQINQSIIFCNSVNRVELLAKKITELGYSCFY
IHAKMVQDHRNRVFHDFRNGACRNLVCTDLFTRGIDIQAVNVVINFDFPRTSESYLHRVG
RSGRFGHLGLAVNLVTYEDRFKMYQTEQELGTEIKPIPSLIDKAIYCQ",RH6,-,-,528aa(1-528),Q94BV4,DrLLPS,http://llps.biocuckoo.cn/view.php?id=LLPS-Art-0517,-,"[2-41],[45-56],[65-97]",In vitro,300ng/µL[polyU];|8µM[RH6],200 mM MgCl2,1 μl of Hepes-KOH (pH 6.6),-,-,crowding agent:2 μl of 50% PEG8000,"Fluorescence 
microscopy ",solute,"In contrast, RH12, RH6, and RH8 remained dispersed in the absence of RNA or ATP, indicating that these helicases at high concentrations can undergo phase separation in an RNA- and ATP-dependent manner in vitro.",0
231,1069,PMID: 33910901,RNAPS0000611,https://pubmed.ncbi.nlm.nih.gov/33910901,RNA + protein,-,-,polyU,-,-,poly RNA,-,"sp|Q8RXK6|RH8_ARATH DEAD-box ATP-dependent RNA helicase 8 OS=Arabidopsis thaliana OX=3702 GN=RH8 PE=2 SV=1
MNNRGRYPPGIGAGRGAFNPNPNYQSRSGYQQHPPPQYVQRGNYAQNHQQQFQQAPSQPH
QYQQQQQQQQQWLRRGQIPGGNSNGDAVVEVEKTVQSEVIDPNSEDWKARLKLPAPDTRY
RTEDVTATKGNEFEDYFLKRELLMGIYEKGFERPSPIQEESIPIALTGRDILARAKNGTG
KTAAFCIPVLEKIDQDNNVIQAVIIVPTRELALQTSQVCKELGKHLKIQVMVTTGGTSLK
DDIMRLYQPVHLLVGTPGRILDLTKKGVCVLKDCSVLVMDEADKLLSQEFQPSVEHLISF
LPESRQILMFSATFPVTVKDFKDRFLTNPYVINLMDELTLKGITQFYAFVEERQKIHCLN
TLFSKLQINQSIIFCNSVNRVELLAKKITELGYSCFYIHAKMLQDHRNRVFHDFRNGACR
NLVCTDLFTRGIDIQAVNVVINFDFPKNAETYLHRVGRSGRFGHLGLAVNLITYEDRFNL
YRIEQELGTEIKQIPPHIDQAIYCQ",RH8,-,-,505aa(1-505),Q8RXK6,"DrLLPS,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Art-1431,http://db.phasep.pro/browse/",-,[43-72],In vitro,300ng/µL[polyU];|8µM[RH8],200 mM MgCl2,1 μl of Hepes-KOH (pH 6.6),-,-,crowding agent:2 μl of 50% PEG8000,"Fluorescence 
microscopy ",solute,"In contrast, RH12, RH6, and RH8 remained dispersed in the absence of RNA or ATP, indicating that these helicases at high concentrations can undergo phase separation in an RNA- and ATP-dependent manner in vitro.",0
232,1070,PMID: 33910901,RNAPS0000612,https://pubmed.ncbi.nlm.nih.gov/33910901,RNA + protein,-,-,polyU,-,-,poly RNA,-,"sp|Q9M2E0|RH12_ARATH DEAD-box ATP-dependent RNA helicase 12 OS=Arabidopsis thaliana OX=3702 GN=RH12 PE=2 SV=1
MNTNRGRYPPGVGTGRGAPPNPDYHQSYRQQQPPQDQQYVQRGYSQNPQQMQLQQQHQQQ
QQQQQWSRRPQLPGNASNANEVVQQTTQPEASSDANGQDWKATLRLPPPDTRYQTADVTA
TKGNEFEDYFLKRDLLKGIYEKGFEKPSPIQEESIPIALTGSDILARAKNGTGKTGAFCI
PVLEKIDPNNNVIQAMILVPTRELALQTSQVCKELSKYLNIQVMVTTGGTSLRDDIMRLH
QPVHLLVGTPGRILDLTKKGVCVLKDCAMLVMDEADKLLSAEFQPSLEELIQFLPQNRQF
LMFSATFPVTVKAFKDRHLRKPYVINLMDQLTLMGVTQYYAFVEERQKVHCLNTLFSKLQ
INQSIIFCNSVNRVELLAKKITELGYSCFYIHAKMVQDHRNRVFHEFRNGACRNLVCTDL
FTRGIDIQAVNVVINFDFPRTSESYLHRVGRSGRFGHLGLAVNLVTYEDRFKMYQTEQEL
GTEIKPIPSNIDQAIYCQ",RH12,-,-,498aa(1-498),Q9M2E0,"DrLLPS,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Art-1808,http://db.phasep.pro/browse/",-,"[26-42],[46-66]",In vitro,300ng/µL[polyU];|8µM[RH12],200 mM MgCl2,1 μl of Hepes-KOH (pH 6.6),-,-,crowding agent:2 μl of 50% PEG8000,"Fluorescence 
microscopy ",solute,"In contrast, RH12, RH6, and RH8 remained dispersed in the absence of RNA or ATP, indicating that these helicases at high concentrations can undergo phase separation in an RNA- and ATP-dependent manner in vitro.",0
233,1071,PMID: 33910901,RNAPS0000613,https://pubmed.ncbi.nlm.nih.gov/33910901,RNA + protein,-,-,polyU,-,-,poly RNA,-,-,Turnip mosaic virus Vpg,-,-,-,-,-,-,-,-,In vitro,0-150ng/µL[polyU];|15µM[VPg],1 μl of 200 mM MgCl2,1 μl of Hepes-KOH (pH 6.6),-,-,-,"Fluorescence 
microscopy ",liquid,"we found that VPg protein undergoes LLPS in the absence of RNA, and ssRNA (polyU) decreases its phase separation (fig. S12, C to E). VPg directly interacts with RH12 in vitro (Fig. 5D). Although high concentration of RNA inhibits the phase separation of VPg, phase separation of RH12 is dependent on RNA ",0
234,1072,PMID: 33910901,RNAPS0000613,https://pubmed.ncbi.nlm.nih.gov/33910901,RNA + protein,-,-,polyU,-,-,poly RNA,-,-,Turnip mosaic virus Vpg,-,-,-,-,-,-,-,-,In vitro,8µM[VPg];|50ng/µL[polyU],1 μl of 200 mM MgCl2,1 μl of Hepes-KOH (pH 6.6),-,-,-,"Fluorescence 
microscopy ",liquid,"As expected, the droplet number and size of VPg proteins increased with the addition of RH8 or RH12 proteins under high concentration of RNAs",0
235,1073,PMID: 33910901,RNAPS0000611,https://pubmed.ncbi.nlm.nih.gov/33910901,RNA + protein,-,-,polyU,-,-,poly RNA,-,"sp|Q8RXK6|RH8_ARATH DEAD-box ATP-dependent RNA helicase 8 OS=Arabidopsis thaliana OX=3702 GN=RH8 PE=2 SV=1
MNNRGRYPPGIGAGRGAFNPNPNYQSRSGYQQHPPPQYVQRGNYAQNHQQQFQQAPSQPH
QYQQQQQQQQQWLRRGQIPGGNSNGDAVVEVEKTVQSEVIDPNSEDWKARLKLPAPDTRY
RTEDVTATKGNEFEDYFLKRELLMGIYEKGFERPSPIQEESIPIALTGRDILARAKNGTG
KTAAFCIPVLEKIDQDNNVIQAVIIVPTRELALQTSQVCKELGKHLKIQVMVTTGGTSLK
DDIMRLYQPVHLLVGTPGRILDLTKKGVCVLKDCSVLVMDEADKLLSQEFQPSVEHLISF
LPESRQILMFSATFPVTVKDFKDRFLTNPYVINLMDELTLKGITQFYAFVEERQKIHCLN
TLFSKLQINQSIIFCNSVNRVELLAKKITELGYSCFYIHAKMLQDHRNRVFHDFRNGACR
NLVCTDLFTRGIDIQAVNVVINFDFPKNAETYLHRVGRSGRFGHLGLAVNLITYEDRFNL
YRIEQELGTEIKQIPPHIDQAIYCQ",RH8,-,-,505aa(1-505),Q8RXK6,"DrLLPS,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Art-1431,http://db.phasep.pro/browse/",-,[43-72],In vitro,8µM[RH8];|50ng/µL[polyU],1 μl of 200 mM MgCl2,1 μl of Hepes-KOH (pH 6.6),-,-,-,"Fluorescence 
microscopy ",liquid,"As expected, the droplet number and size of VPg proteins increased with the addition of RH8 or RH12 proteins under high concentration of RNAs",0
236,1074,PMID: 33910901,RNAPS0000614,https://pubmed.ncbi.nlm.nih.gov/33910901,RNA + proteins,-,-,polyU,-,-,poly RNA,-,"sp|Q8RXK6|RH8_ARATH DEAD-box ATP-dependent RNA helicase 8 OS=Arabidopsis thaliana OX=3702 GN=RH8 PE=2 SV=1
MNNRGRYPPGIGAGRGAFNPNPNYQSRSGYQQHPPPQYVQRGNYAQNHQQQFQQAPSQPH
QYQQQQQQQQQWLRRGQIPGGNSNGDAVVEVEKTVQSEVIDPNSEDWKARLKLPAPDTRY
RTEDVTATKGNEFEDYFLKRELLMGIYEKGFERPSPIQEESIPIALTGRDILARAKNGTG
KTAAFCIPVLEKIDQDNNVIQAVIIVPTRELALQTSQVCKELGKHLKIQVMVTTGGTSLK
DDIMRLYQPVHLLVGTPGRILDLTKKGVCVLKDCSVLVMDEADKLLSQEFQPSVEHLISF
LPESRQILMFSATFPVTVKDFKDRFLTNPYVINLMDELTLKGITQFYAFVEERQKIHCLN
TLFSKLQINQSIIFCNSVNRVELLAKKITELGYSCFYIHAKMLQDHRNRVFHDFRNGACR
NLVCTDLFTRGIDIQAVNVVINFDFPKNAETYLHRVGRSGRFGHLGLAVNLITYEDRFNL
YRIEQELGTEIKQIPPHIDQAIYCQ;-
",RH8;|Turnip mosaic virus Vpg,-;|-,-;|-,505aa(1-505);|-,Q8RXK6;-,"DrLLPS,PhaSepDB;-","http://llps.biocuckoo.cn/view.php?id=LLPS-Art-1431,http://db.phasep.pro/browse/;-",-;|-,"[26-42],[46-66];|-",In vitro,8µM[VPg];|8µM[RH8];|50ng/µL[polyU],1 μl of 200 mM MgCl2,1 μl of Hepes-KOH (pH 6.6),-,-,-,"Fluorescence 
microscopy ",liquid,"As expected, the droplet number and size of VPg proteins increased with the addition of RH8 or RH12 proteins under high concentration of RNAs",0
237,1075,PMID: 33910901,RNAPS0000612,https://pubmed.ncbi.nlm.nih.gov/33910901,RNA + protein,-,-,polyU,-,-,poly RNA,-,"sp|Q9M2E0|RH12_ARATH DEAD-box ATP-dependent RNA helicase 12 OS=Arabidopsis thaliana OX=3702 GN=RH12 PE=2 SV=1
MNTNRGRYPPGVGTGRGAPPNPDYHQSYRQQQPPQDQQYVQRGYSQNPQQMQLQQQHQQQ
QQQQQWSRRPQLPGNASNANEVVQQTTQPEASSDANGQDWKATLRLPPPDTRYQTADVTA
TKGNEFEDYFLKRDLLKGIYEKGFEKPSPIQEESIPIALTGSDILARAKNGTGKTGAFCI
PVLEKIDPNNNVIQAMILVPTRELALQTSQVCKELSKYLNIQVMVTTGGTSLRDDIMRLH
QPVHLLVGTPGRILDLTKKGVCVLKDCAMLVMDEADKLLSAEFQPSLEELIQFLPQNRQF
LMFSATFPVTVKAFKDRHLRKPYVINLMDQLTLMGVTQYYAFVEERQKVHCLNTLFSKLQ
INQSIIFCNSVNRVELLAKKITELGYSCFYIHAKMVQDHRNRVFHEFRNGACRNLVCTDL
FTRGIDIQAVNVVINFDFPRTSESYLHRVGRSGRFGHLGLAVNLVTYEDRFKMYQTEQEL
GTEIKPIPSNIDQAIYCQ",RH12,-,-,498aa(1-498),Q9M2E0,"DrLLPS,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Art-1808,http://db.phasep.pro/browse/",-,"[26-42],[46-66]",In vitro,8µM[RH12];|50ng/µL[polyU],1 μl of 200 mM MgCl2,1 μl of Hepes-KOH (pH 6.6),-,-,-,"Fluorescence 
microscopy ",liquid,"As expected, the droplet number and size of VPg proteins increased with the addition of RH8 or RH12 proteins under high concentration of RNAs",0
238,1076,PMID: 33910901,RNAPS0000615,https://pubmed.ncbi.nlm.nih.gov/33910901,RNA + proteins,-,-,polyU,-,-,poly RNA,-,"sp|Q9M2E0|RH12_ARATH DEAD-box ATP-dependent RNA helicase 12 OS=Arabidopsis thaliana OX=3702 GN=RH12 PE=2 SV=1
MNTNRGRYPPGVGTGRGAPPNPDYHQSYRQQQPPQDQQYVQRGYSQNPQQMQLQQQHQQQ
QQQQQWSRRPQLPGNASNANEVVQQTTQPEASSDANGQDWKATLRLPPPDTRYQTADVTA
TKGNEFEDYFLKRDLLKGIYEKGFEKPSPIQEESIPIALTGSDILARAKNGTGKTGAFCI
PVLEKIDPNNNVIQAMILVPTRELALQTSQVCKELSKYLNIQVMVTTGGTSLRDDIMRLH
QPVHLLVGTPGRILDLTKKGVCVLKDCAMLVMDEADKLLSAEFQPSLEELIQFLPQNRQF
LMFSATFPVTVKAFKDRHLRKPYVINLMDQLTLMGVTQYYAFVEERQKVHCLNTLFSKLQ
INQSIIFCNSVNRVELLAKKITELGYSCFYIHAKMVQDHRNRVFHEFRNGACRNLVCTDL
FTRGIDIQAVNVVINFDFPRTSESYLHRVGRSGRFGHLGLAVNLVTYEDRFKMYQTEQEL
GTEIKPIPSNIDQAIYCQ;-",RH12;|Turnip mosaic virus Vpg,-;|-,-;|-,498aa(1-498);|-,Q9M2E0;-,"DrLLPS,PhaSepDB;-","http://llps.biocuckoo.cn/view.php?id=LLPS-Art-1808,http://db.phasep.pro/browse/;-",-;|-,"[26-42],[46-66];|-",In vitro,8µM[VPg];|8µM[RH12];|50ng/µL[polyU],1 μl of 200 mM MgCl2,1 μl of Hepes-KOH (pH 6.6),-,-,-,"Fluorescence 
microscopy ",liquid,"As expected, the droplet number and size of VPg proteins increased with the addition of RH8 or RH12 proteins under high concentration of RNAs",0
239,1077,PMID: 33910901,RNAPS0000615,https://pubmed.ncbi.nlm.nih.gov/33910901,RNA + proteins,-,-,polyU,-,-,poly RNA,-,"sp|Q9M2E0|RH12_ARATH DEAD-box ATP-dependent RNA helicase 12 OS=Arabidopsis thaliana OX=3702 GN=RH12 PE=2 SV=1
MNTNRGRYPPGVGTGRGAPPNPDYHQSYRQQQPPQDQQYVQRGYSQNPQQMQLQQQHQQQ
QQQQQWSRRPQLPGNASNANEVVQQTTQPEASSDANGQDWKATLRLPPPDTRYQTADVTA
TKGNEFEDYFLKRDLLKGIYEKGFEKPSPIQEESIPIALTGSDILARAKNGTGKTGAFCI
PVLEKIDPNNNVIQAMILVPTRELALQTSQVCKELSKYLNIQVMVTTGGTSLRDDIMRLH
QPVHLLVGTPGRILDLTKKGVCVLKDCAMLVMDEADKLLSAEFQPSLEELIQFLPQNRQF
LMFSATFPVTVKAFKDRHLRKPYVINLMDQLTLMGVTQYYAFVEERQKVHCLNTLFSKLQ
INQSIIFCNSVNRVELLAKKITELGYSCFYIHAKMVQDHRNRVFHEFRNGACRNLVCTDL
FTRGIDIQAVNVVINFDFPRTSESYLHRVGRSGRFGHLGLAVNLVTYEDRFKMYQTEQEL
GTEIKPIPSNIDQAIYCQ;-",RH12;|Turnip mosaic virus Vpg,-;|-,-;|-,498aa(1-498);|-,Q9M2E0;-,"DrLLPS,PhaSepDB;-","http://llps.biocuckoo.cn/view.php?id=LLPS-Art-1808,http://db.phasep.pro/browse/;-",-;|-,"[26-42],[46-66];|-",In vitro,8µM[VPg];|0-8µM[RH12];|50ng/µL[polyU],2 μl of 1 M KCl,1 μl of Hepes-KOH (pH 6.6),-,-,-,"Fluorescence 
microscopy ",liquid,"Therefore, VPg may recruit RH12 to facilitate its phase separation. We tested whether these helicases promote VPg phase separation under high concentration of RNA. As phase separations of these helicases are ATP dependent ",0
240,1078,PMID: 33910901,RNAPS0000612,https://pubmed.ncbi.nlm.nih.gov/33910901,RNA + protein,-,-,polyU,-,-,poly RNA,-,"sp|Q9M2E0|RH12_ARATH DEAD-box ATP-dependent RNA helicase 12 OS=Arabidopsis thaliana OX=3702 GN=RH12 PE=2 SV=1
MNTNRGRYPPGVGTGRGAPPNPDYHQSYRQQQPPQDQQYVQRGYSQNPQQMQLQQQHQQQ
QQQQQWSRRPQLPGNASNANEVVQQTTQPEASSDANGQDWKATLRLPPPDTRYQTADVTA
TKGNEFEDYFLKRDLLKGIYEKGFEKPSPIQEESIPIALTGSDILARAKNGTGKTGAFCI
PVLEKIDPNNNVIQAMILVPTRELALQTSQVCKELSKYLNIQVMVTTGGTSLRDDIMRLH
QPVHLLVGTPGRILDLTKKGVCVLKDCAMLVMDEADKLLSAEFQPSLEELIQFLPQNRQF
LMFSATFPVTVKAFKDRHLRKPYVINLMDQLTLMGVTQYYAFVEERQKVHCLNTLFSKLQ
INQSIIFCNSVNRVELLAKKITELGYSCFYIHAKMVQDHRNRVFHEFRNGACRNLVCTDL
FTRGIDIQAVNVVINFDFPRTSESYLHRVGRSGRFGHLGLAVNLVTYEDRFKMYQTEQEL
GTEIKPIPSNIDQAIYCQ",RH12,-,-,498aa(1-498),Q9M2E0,"DrLLPS,PhaSepDB","http://llps.biocuckoo.cn/view.php?id=LLPS-Art-1808,http://db.phasep.pro/browse/",-,"[26-42],[46-66]",In vitro,8µM[RH12];|300ng/µL[polyU],200 mM MgCl2,1 μl of Hepes-KOH (pH 6.6),-,-,crowding agent:2μl of 50% PEG8000;other_moleculer:5mM[ATP],"Fluorescence 
microscopy ",liquid,"To evaluate whether VPg directly inhibits RH12 phase separation, we mixed VPg and RH12 under high concentration of RNA. VPg proteins remain dispersed at polyU",0
241,1079,PMID: 33910901,RNAPS0000613,https://pubmed.ncbi.nlm.nih.gov/33910901,RNA + protein,-,-,polyU,-,-,poly RNA,-,-,Turnip mosaic virus Vpg,-,-,-,-,-,-,-,-,In vitro,10µM[VPg];|300ng/µL[polyU],200 mM MgCl2,1 μl of Hepes-KOH (pH 6.6),-,-,crowding agent:2μl of 50% PEG8000;other_moleculer:5mM[ATP],"Fluorescence 
microscopy ",solute,"To evaluate whether VPg directly inhibits RH12 phase separation, we mixed VPg and RH12 under high concentration of RNA. VPg proteins remain dispersed at polyU",0
242,1080,PMID: 33910901,RNAPS0000419,https://pubmed.ncbi.nlm.nih.gov/33910901,RNA + proteins,-,-,polyU,-,-,poly RNA,-,"sp|Q9M2E0|RH12_ARATH DEAD-box ATP-dependent RNA helicase 12 OS=Arabidopsis thaliana OX=3702 GN=RH12 PE=2 SV=1
MNTNRGRYPPGVGTGRGAPPNPDYHQSYRQQQPPQDQQYVQRGYSQNPQQMQLQQQHQQQ
QQQQQWSRRPQLPGNASNANEVVQQTTQPEASSDANGQDWKATLRLPPPDTRYQTADVTA
TKGNEFEDYFLKRDLLKGIYEKGFEKPSPIQEESIPIALTGSDILARAKNGTGKTGAFCI
PVLEKIDPNNNVIQAMILVPTRELALQTSQVCKELSKYLNIQVMVTTGGTSLRDDIMRLH
QPVHLLVGTPGRILDLTKKGVCVLKDCAMLVMDEADKLLSAEFQPSLEELIQFLPQNRQF
LMFSATFPVTVKAFKDRHLRKPYVINLMDQLTLMGVTQYYAFVEERQKVHCLNTLFSKLQ
INQSIIFCNSVNRVELLAKKITELGYSCFYIHAKMVQDHRNRVFHEFRNGACRNLVCTDL
FTRGIDIQAVNVVINFDFPRTSESYLHRVGRSGRFGHLGLAVNLVTYEDRFKMYQTEQEL
GTEIKPIPSNIDQAIYCQ;-",RH12;|Turnip mosaic virus Vpg,-;|-,-;|-,498aa(1-498);|-,Q9M2E0;-,"DrLLPS,PhaSepDB;-","http://llps.biocuckoo.cn/view.php?id=LLPS-Art-1808,http://db.phasep.pro/browse/;-",-;|-,"[26-42],[46-66];|-",In vitro,8µM[RH12];|10µM[VPg];|300ng/µL[polyU];|,200 mM MgCl2,1 μl of Hepes-KOH (pH 6.6),-,-,crowding agent:2μl of 50% PEG8000;other_moleculer:5mM[ATP],"Fluorescence 
microscopy ",liquid,"To evaluate whether VPg directly inhibits RH12 phase separation, we mixed VPg and RH12 under high concentration of RNA. VPg proteins remain dispersed at polyU",0
